<SEC-DOCUMENT>0001638833-24-000106.txt : 20240425
<SEC-HEADER>0001638833-24-000106.hdr.sgml : 20240425
<ACCEPTANCE-DATETIME>20240425170117
ACCESSION NUMBER:		0001638833-24-000106
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240606
FILED AS OF DATE:		20240425
DATE AS OF CHANGE:		20240425

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surgery Partners, Inc.
		CENTRAL INDEX KEY:			0001638833
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				473620923
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37576
		FILM NUMBER:		24877303

	BUSINESS ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		615-234-5900

	MAIL ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>sgry-20240425.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:070e72ad-b5ec-4d42-99f8-3fee09a3b359,g:667ac803-2758-4174-bee1-6fa36ced4494,d:227833c13def44249bd1572bf17f4242-->
<html xmlns:sgry="http://www.surgerypartners.com/20240425" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgry-20240425</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-2">0001638833</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-3">DEF 14A</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-4">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sgry-20240425.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i227833c13def44249bd1572bf17f4242_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE 14A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section 14(a) of the </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">________________________________________________________________</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed by a party other than the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.086%"><tr><td style="width:1.0%"/><td style="width:1.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.073%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Check the appropriate box: </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Proxy Statement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Material Pursuant to &#167;240.14a-12</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">Surgery Partners, Inc.</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Registrant as Specified In Its Charter) </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of Filing Fee (Check the appropriate box): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%">x</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="sgry-20240425_g1.jpg" alt="logostockholderltra01.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:413px"/></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">April 25, 2024</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TO OUR STOCKHOLDERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">:</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">You are cordially invited to attend the 2024 annual meeting of stockholders of Surgery Partners, Inc., to be held on June 6, 2024, at 2:00 p.m. (Central Daylight Time). The annual meeting will be held solely by remote communication in a virtual meeting format. If you attend the annual meeting virtually by following the instructions set forth in the proxy materials, you will be considered present at the meeting.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In accordance with rules adopted by the Securities and Exchange Commission, we are mailing to many of our stockholders a Notice of Internet Availability of Proxy Materials instead of a paper copy of the Proxy Statement, the proxy card and our Annual Report to Stockholders. The Notice of Internet Availability of Proxy Materials contains instructions on how stockholders can access the proxy materials over the internet as well as request a paper or email copy if desired.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is important that your shares be represented at the annual meeting. Whether or not you plan to attend the annual meeting, we would greatly appreciate your efforts to vote your shares as soon as possible by following the instructions located in the Notice of Internet Availability of Proxy Materials or in our proxy statement. If you attend the annual meeting and wish to vote at that time, you may withdraw your proxy and vote your shares personally.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sincerely,</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">/s/ Wayne S. DeVeydt</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Wayne S. DeVeydt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Executive Chairman of the Board of Directors</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><img src="sgry-20240425_g1.jpg" alt="logostockholderltra04.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:413px"/></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">APRIL 25, 2024</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DATE: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;June 6, 2024</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TIME: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2:00 p.m. CDT</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PLACE: &#160;&#160;&#160;&#160;The annual meeting will be held solely by remote communication in a virtual meeting format. You will be able to </span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">attend the annual meeting by visiting www.meetnow.global/MFATQXS and entering th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">e 15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">-digit control number found on the proxy card or voting instruction form. If you attend the annual meeting virtually, you will be considered present at the meeting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">ITEMS&#160;OF&#160;BUSINESS:</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:126pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect the four Class III director nominees named in this Proxy Statement to the Board of Directors of Surgery Partners, Inc. (the "Company") for a term of three years;</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:126pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve, on an advisory basis, the compensation paid by the Company to its named executive officers;</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:126pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve the Surgery Partners, Inc. Employee Stock Purchase Plan (the "ESPP");</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:126pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the appointment of Deloitte &amp; Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; and</span></div><div style="margin-top:9pt;padding-left:126pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To consider and act upon any other business that may properly come before the 2024 annual meeting of stockholders and at any adjournment or postponement thereof.</span></div><div style="padding-left:108pt"><span><br/></span></div><div style="padding-left:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Information relating to the matters to be considered and voted on at the annual meeting is set forth in the enclosed proxy materials.</span></div><div style="padding-left:108pt"><span><br/></span></div><div style="padding-left:108pt;text-indent:-108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">RECORD DATE: &#160;&#160;&#160;&#160;Holders of shares of our common stock of record at the close of business on April 8, 2024 are entitled to receive notice of and vote at the annual meeting and at any adjournment or postponement thereof.</span></div><div style="padding-left:108pt;text-indent:-108pt"><span><br/></span></div><div style="padding-left:108pt;text-indent:-108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ANNUAL REPORT: &#160;&#160;&#160;&#160;The Company's Annual Report to Stockholders for the fiscal year ended December 31, 2023 is available to you on the internet or, upon request, will be delivered to you by mail or email.</span></div><div style="padding-left:108pt;text-indent:-108pt"><span><br/></span></div><div style="padding-left:108pt;text-indent:-108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PROXY VOTING:&#160;&#160;&#160;&#160;Your vote is important. Whether or not you plan to attend the annual meeting, after reviewing the proxy materials, please vote by phone or online following the instructions set forth in the following proxy materials, or if you requested a printed copy, please complete, date, sign and return the proxy card in the enclosed stamped envelope. You can revoke a proxy at any time prior to its exercise at the annual meeting by following the instructions in the attached Proxy Statement. If you decide to attend the annual meeting and wish to change your proxy, you may do so by voting during the meeting.</span></div><div style="padding-left:108pt;text-indent:-108pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Board of Directors unanimously recommends that you vote: (i) "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">" the election of the four Class III director nominees named in the Proxy Statement, (ii) "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">" the approval, on an advisory basis, of the compensation paid by the Company to its named executive officers, (iii) "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">" the approval of the ESPP, and (iv) "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">" ratification of the Audit Committee&#8217;s appointment of Deloitte &amp; Touche LLP as the Company's independent registered public accounting firm.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">You are welcome to attend the annual meeting by visiting www.meetnow.global/MFATQXS and entering the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15-digit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> control number found on the proxy card or voting instruction form. Once admitted, you may submit questions, vote or view our list of stockholders during the annual meeting by following the instructions that will be available on the meeting website.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">If you hold your shares through an intermediary, such as a bank or broker, you must register in advance to attend the annual meeting virtually on the internet. To register to attend the annual meeting online by webcast you must submit proof of your proxy power (legal proxy) reflecting your Company holdings along with your name and email address to Computershare, Inc. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(a subsidiary of Computershare Trust Company, N.A.), the Company&#8217;s transfer agent. Requests for registration must be labeled as &#8220;Legal Proxy&#8221; and be received no later than 4:00 p.m., Central Daylight Time, on June 3, 2024. You will receive a confirmation of your registration by email after we receive your registration materials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even if you plan to attend, please vote your shares promptly to ensure they are represented at the annual meeting. If you decide to attend the annual meeting and wish to change your proxy, you may do so by voting virtually at the meeting. If you have questions about how to attend the annual meeting, please contact Investor Relations at 340 Seven Springs Way, Suite 600, Brentwood, Tennessee 37027, (615) 234-5900 or email ir@surgerypartners.com.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Thank you for your ongoing support of and interest in Surgery Partners, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By Order of the Board of Directors,</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">/s/ Wayne S. DeVeydt</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Wayne S. DeVeydt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Executive Chairman of the Board of Directors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Brentwood, Tennessee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">April 25, 2024</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 6, 2024:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE PROXY STATEMENT, THE PROXY CARD AND OUR ANNUAL REPORT TO STOCKHOLDERS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 ARE AVAILABLE TO YOU ON THE INTERNET AT WWW.INVESTORVOTE.COM/SGRY AND ON THE "INVESTORS" PAGE OF OUR WEBSITE AT WWW.SURGERYPARTNERS.COM OR, UPON YOUR REQUEST WILL BE DELIVERED TO YOU BY MAIL OR EMAIL, IN CONNECTION WITH THE SOLICITATION OF PROXIES BY THE BOARD OF DIRECTORS OF THE COMPANY TO BE VOTED ON AT THE ANNUAL MEETING. THE NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS IS SCHEDULED TO BE DISTRIBUTED ON OR ABOUT APRIL 25, 2024 TO STOCKHOLDERS OF RECORD AS OF THE CLOSE OF BUSINESS ON APRIL 8, 2024.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.500%"><tr><td style="width:1.0%"/><td style="width:91.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_19">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPOSAL NO. 1: ELECTION OF DIRECTORS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_25">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CORPORATE GOVERNANCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_28">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPOSAL NO. 2: ADVISORY VOTE ON EXECUTIVE COMPENSATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_61">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXECUTIVE OFFICERS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_64">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPENSATION DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_67">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REPORT OF THE COMPENSATION COMMITTEE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_70">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXECUTIVE COMPENSATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_73">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DIRECTOR COMPENSATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_100">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPOSAL NO. 3: APPROVAL OF EMPLOYEE STOCK PURCHASE PLAN</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_103">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPOSAL NO. 4: RATIFICATION OF THE AUDIT COMMITTEE'S APPOINTMENT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_106">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FEES PAID TO INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_109">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REPORT OF THE AUDIT COMMITTEE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_112">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RELATED PERSON TRANSACTIONS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_118">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GENERAL MATTERS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_121">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">APPENDIX A - EMPLOYEE STOCK PURCHASE PLAN</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_1169">A-1</a></span></div></td></tr></table></div><div style="margin-bottom:5pt"><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_16"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;text-align:center"><img src="sgry-20240425_g1.jpg" alt="logostockholderltra05.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:413px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">340 Seven Springs Way, Suite 600</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Brentwood, Tennessee 37027</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">PROXY STATEMENT</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Why is the Company soliciting my proxy?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Board of Directors (the "Board") of Surgery Partners, Inc. ("Surgery Partners," the "Company," "we," "us" or "our") is soliciting your proxy to vote at the 2024 annual meeting of stockholders (the "Annual Meeting") to be held solely by remote communication in a virtual meeting format on Thursday, June 6, 2024, at 2:00 p.m. Central Daylight Time (CDT) and any adjournments of the Annual Meeting.  </span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">How can I attend the Annual Meeting?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Annual Meeting will be conducted exclusively by webcast. You are entitled to participate in the Annual Meeting only if you were a stockholder of the Company as of the close of business on April 8, 2024 (the "Record Date"), or if you hold a valid proxy for the Annual Meeting. No physical meeting will be held.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">You will be able to attend the Annual Meeting online and submit your questions during the meeting by visiting www.meetnow.global/MFATQXS and entering the 15-digit control number found on the proxy card or voting instruction form. You also will be able to vote your shares online by attending the Annual Meeting by webcast.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To participate in the Annual Meeting, you will need to review the information included on your Notice, on your proxy card or on the instructions that accompanied your proxy materials.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If you hold your shares through an intermediary, such as a bank or broker, you must register in advance using the instructions below.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The virtual meeting will begin promptly at 2:00 p.m. Central Daylight Time (CDT). We encourage you to access the meeting prior to the start time leaving ample time for the check in. Please follow the registration instructions as outlined in this proxy statement.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Do I need to register to attend the Annual Meeting virtually on the Internet?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If you are a registered stockholder (i.e., you hold your shares through our transfer agent, Computershare), you do not need to register to attend the Annual Meeting virtually on the Internet. Please follow the instructions on the notice or proxy card that you received.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">If you hold your shares through an intermediary, such as a bank or broker, you must register in advance to attend the Annual Meeting virtually on the internet. To register to attend the Annual Meeting online by webcast you must submit proof of your proxy power (legal proxy) reflecting your Company holdings along with your name and email address to Computershare, Inc. (a subsidiary of Computershare Trust Company, N.A.), the Company&#8217;s transfer agent. Requests for registration must be labeled as &#8220;Legal Proxy&#8221; and be received no later than 4:00 p.m., Central Daylight Time, on June 3, 2024. You will receive a confirmation of your registration by email after we receive your registration materials.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Requests for registration should be directed to us at the following:</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">By email</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forward the email from your broker, or attach an image of your legal proxy, to legalproxy@computershare.com</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">By mail</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Computershare</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Surgery Partners, Inc. Legal Proxy</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">P.O. Box 43001</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Providence, RI 02940-3001</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If you attend the Annual Meeting virtually, you will be considered present at the meeting.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">What if I have trouble accessing the Annual Meeting virtually?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The virtual meeting platform is fully supported across browsers (MS Edge, Firefox, Chrome and Safari) and devices (desktops, laptops, tablets and cell phones) running the most up-to-date version of applicable software and plugins. Please note that Internet Explorer is not a supported browser. Participants should ensure that they have a strong WiFi connection wherever they intend to participate in the meeting. We encourage you to access the meeting prior to the start time. For further assistance should you need it you may call Local 1-888-724-2416 or International +1 781-575-2748.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">What proxy materials are available and how do I receive them?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Proxy Statement, the proxy card and our Annual Report to Stockholders for the year ended December 31, 2023 (the "Annual Report to Stockholders") are being made available to you on the internet instead of mailing a printed copy of these materials to each stockholder. The Notice of Internet Availability of Proxy Materials (the "Notice of Internet Availability") is scheduled to be distributed on or about April 25, 2024. The Notice of Internet Availability contains instructions as to how stockholders may access and review the proxy materials on the internet, including information about how stockholders may vote by telephone or over the internet. You will not receive a printed or email copy of these materials unless you make such a request by following the instructions on the Notice of Internet Availability.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">What proposals will be voted on at the Annual Meeting?</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There are four proposals scheduled to be voted on at the Annual Meeting:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the election of the four Class III director nominees named in this Proxy Statement for a three-year term (Proposal 1);</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the approval, on an advisory basis, of the compensation paid by the Company to its named executive officers (Proposal 2);</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the approval of the Surgery Partners, Inc. Employee Stock Purchase Plan (the "ESPP") (Proposal 3); and</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the ratification of the Audit Committee's appointment of Deloitte &amp; Touche LLP ("Deloitte") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 (Proposal 4).</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">What is the Board's voting recommendation?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Board recommends that you vote your shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> "FOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the election of the four Class III director nominees named in this Proxy Statement,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> "FOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the approval, on an advisory basis, of the compensation paid by the Company to its named executive officers,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> "FOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the approval of the ESPP, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">"FOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the ratification of the Audit Committee's appointment of Deloitte as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If you submit a proxy but do not indicate any voting instructions, your shares will be voted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> "FOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the election of the four Class III director nominees named in this Proxy Statement,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> "FOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the approval, on an advisory basis, of the compensation paid by the Company to its named executive officers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">"FOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the approval of the ESPP, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> "FOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the ratification of the Audit Committee's appointment of Deloitte as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">What is the quorum requirement for the Annual Meeting?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The quorum requirement for holding the Annual Meeting and transacting business is a majority of the voting power of the outstanding shares entitled to be voted and present at the meeting. The shares may be present or represented by proxy at the Annual Meeting. Both abstentions and broker non-votes will be counted as present for the purpose of determining the presence of a quorum.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">What shares owned by me can be voted at the Annual Meeting?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All shares owned by you as of the close of business on April 8, 2024 (the "Record Date") may be voted. You may cast one vote per share of common stock that you held on the Record Date. These include shares that are: (1) held directly in your name as the stockholder of record, and (2) held for you as the beneficial owner through a stockbroker, bank or other nominee. On the Record Date, the Company had 127,101,670 shares of common stock issued and outstanding. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">What is the difference between holding shares as a stockholder of record and as a beneficial owner?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Most stockholders of the Company hold their shares through a broker, bank or other nominee rather than directly in their own name. As summarized below, there are some differences between shares held of record and those owned beneficially.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Stockholder of Record</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If your shares are registered directly in your name with the Company's transfer agent, Computershare, Inc. (a subsidiary of Computershare Trust Company, N.A.), you are the stockholder of record with respect to those shares, and the proxy materials are being sent directly to you. As the stockholder of record, you have the right to direct your vote by proxy or to vote in person at the Annual Meeting.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Beneficial Owner</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the beneficial owner and these proxy materials are being forwarded to you by your broker, bank or nominee who is the stockholder of record with respect to such shares. As the beneficial owner, you are invited to attend the Annual Meeting. You also have the right to direct your broker on how to vote these shares. Your broker or nominee should have enclosed a voting instruction card for you to direct your broker or nominee how to vote your shares. However, shares held in "street name" may be voted in person by you only if you obtain a signed proxy from the record holder (stock brokerage, bank or other nominee) giving you the right to vote the shares.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">How can I vote my shares at the Annual Meeting?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If you choose to vote your shares at the Annual Meeting, you may do so by visiting www.meetnow.global/MFATQXS and entering the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-digit control number found on the proxy card or voting instruction form and following the instructions on the website for voting your shares at the meeting. Even if you plan to attend the Annual Meeting, the Company recommends that you vote your shares in advance as described below so that your vote will be counted if you later decide not to attend the Annual Meeting.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">How can I vote my shares without attending the Annual Meeting?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Whether you hold your shares directly as the stockholder of record or beneficially in "street name," you may direct your vote without attending the Annual Meeting by proxy. You can vote by following the instructions on the Notice of Internet Availability which includes information about how stockholders may submit proxies by telephone or over the internet. Alternatively, upon request, you can vote by proxy by mail via a proxy card by marking your selections on the proxy card, dating and signing your name exactly as it appears on the proxy card and mailing the proxy card in the pre-paid envelope that will be provided to you. Mailed proxy cards must be received no later than June 5, 2024 in order to be counted for the Annual Meeting.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If you are a beneficial owner, follow the instructions on the voting instruction card provided by your broker, bank or other intermediary. We urge you to review the proxy materials carefully before you vote.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Can I revoke my proxy or change my vote?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">You may revoke your proxy or change your voting instructions prior to the vote at the Annual Meeting. You may enter a new vote by mailing a new proxy card or new voting instruction card bearing a later date (which will automatically revoke your earlier voting instructions). Your new vote must be received by 11:59 p.m. CDT on June 5, 2024. You may also enter a new vote by attending the Annual Meeting and voting during the meeting. Your attendance at the Annual Meeting will not cause your previously granted proxy to be revoked unless you specifically so request.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">How are votes counted?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For Proposal 1, your vote may be cast "FOR" each Class III director nominee, or you may "WITHHOLD" from voting. Shares voting "WITHHOLD" have no effect on the election of directors.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For Proposals 2, 3 and 4, your vote may be cast "FOR" or "AGAINST" or you may "ABSTAIN." If you "ABSTAIN" on one of these proposals, it has no effect on the outcome.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">How are abstentions and broker non-votes treated for determining a quorum and counting votes?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any shares represented by proxies that are marked to "ABSTAIN" from voting on a proposal will be counted as present in determining whether we have a quorum. They will also be counted in determining the total number of shares entitled to vote on a proposal. Abstentions will not be counted as votes "FOR" or "AGAINST" any proposal, and accordingly are not counted for purposes of determining the number of votes cast on any proposal.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If your shares are held in "street name" and you do not instruct your broker on how to vote your shares, your broker, in its discretion, may either leave your shares unvoted or, on routine matters, may use its discretionary authority to vote your shares. If your broker returns a proxy card but does not vote your shares, this results in a "broker non-vote." Generally, broker non-votes occur when </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">shares held by a broker for a beneficial owner are not voted with respect to a particular proposal because (i) the broker has not received voting instructions from the beneficial owner and (ii) the broker lacks discretionary voting power to vote such shares. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Proposal 1 (election of the four Class III director nominees), Proposal 2 (approval, on an advisory basis, of the compensation paid by the Company to its named executive officers) and Proposal 3 (approval of the ESPP) are considered non-routine matters, and without your instruction, your broker cannot vote your shares on those proposals. Proposal 4 (ratifying the appointment of our independent registered public accounting firm) is considered a routine matter for which your broker has discretionary authority to vote your shares. As a result, broker non-votes with respect to any proposal will be treated as shares present for purposes of determining a quorum at the Annual Meeting. Broker non-votes will not be counted as votes "FOR" or "AGAINST" any proposal, and accordingly are not counted for purposes of determining the number of votes cast on any proposal. Therefore, broker non-votes will have no effect on the outcome of any proposal.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">What is the voting requirement to approve each of the proposals?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Proposal 1, Election of Director Nominees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">: Under our plurality voting standard, the four nominees for director who receive the most votes will be elected. Therefore, if you do not vote for a nominee, or you "WITHHOLD" your vote for a nominee, your vote will not count either "FOR" or "AGAINST" the nominee. Abstentions and broker non-votes will have no effect on the outcome of voting for directors.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Proposal 2, Advisory Vote on Executive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">: Under our majority voting standard, the approval, on an advisory basis, of the compensation paid by the Company to its named executive officers requires that the number of votes properly cast "FOR" the proposal (and present, in person or by proxy, at the Annual Meeting) exceed the number of votes cast "AGAINST" the proposal. Abstentions and broker non-votes will have no effect on the outcome of this proposal.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Proposal 3, Approval of Employee Stock Purchase Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">: Under our majority voting standard, the approval of the ESPP requires that the number of votes properly cast "FOR" the proposal (and present, in person or by proxy, at the Annual Meeting) exceed the number of votes cast "AGAINST" the proposal. Abstentions and broker non-votes will have no effect on the outcome of this proposal.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Proposal 4, Ratification of the Audit Committee&#8217;s Appointment of Independent Registered Public Accounting Firm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">: Under our majority voting standard, the ratification of the Audit Committee&#8217;s appointment of Deloitte as our independent registered public accounting firm for fiscal year 2024 requires that the number of votes properly cast "FOR" the proposal (and present, in person or by proxy, at the Annual Meeting) exceed the number of votes cast "AGAINST" the proposal. Abstentions will have no effect on the outcome of this Proposal 4. Brokers, banks and other nominees have discretionary voting power with respect to this proposal, and therefore we do not expect broker non-votes with respect to this proposal.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Where can I find the voting results of the Annual Meeting?</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We will announce preliminary voting results at the Annual Meeting and publish preliminary, or final results if available, in a Current Report on Form 8-K within four business days of the Annual Meeting. If final results are unavailable at the time we file the Form 8-K, then we will file an amended report on Form 8-K to disclose the final voting results within four business days after the final voting results are known.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">What happens if additional proposals are presented at the Annual Meeting?</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other than the four proposals described in this Proxy Statement, we do not expect any matters to be presented for a vote at the Annual Meeting. If other matters are properly presented to the stockholders for action at the Annual Meeting or any adjournments or postponements thereof, it is the intention of the persons named as proxy holders in the proxy card (J. Eric Evans, our Chief Executive Officer, and Jennifer B. Baldock, our Executive Vice President and Chief Administrative and Development Officer) to vote in their discretion on all matters on which the shares represented by such proxy are entitled to vote. If for any unforeseen reason, any of the Company's nominees is not available as a candidate for director, the persons named as proxy holders will vote your proxy for such other candidate(s) as may be nominated by the Board.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Who will count the vote?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">An inspector of election will be appointed to, among other things, tabulate all votes and certify the results.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Is my vote confidential?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Proxy instructions, ballots and voting tabulations that identify individual stockholders are handled in a manner that protects your voting privacy. Your vote will not be disclosed either within Surgery Partners or to third parties except (i) as necessary to meet applicable legal requirements, (ii) to allow for the tabulation of votes and certification of the vote and (iii) to facilitate a successful proxy solicitation by the Board. Additionally, we will forward to management any written comments you provide on a proxy card or through other means.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Who will bear the cost of soliciting proxies for the Annual Meeting?</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company will pay the entire cost of soliciting proxies for the Annual Meeting, including costs for mailing the Notice of Internet Availability, mailing printed proxy materials upon request, and the solicitation of proxies. We have retained Computershare, Inc. to assist us with the distribution of the proxies and will pay their expenses. We will also reimburse brokers or nominees for the expenses that they incur for forwarding the proxies.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">5</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_19"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table sets forth information relating to the beneficial ownership of our common stock as of March 30, 2024 (except as otherwise indicated below), by:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our outstanding shares of common stock&#894;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">each of our named executive officers&#894;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">each of our directors and nominees&#894; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">all of our executive officers and directors as a group.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Information with respect to beneficial ownership in the following table is based on the Company's review of information furnished by or on behalf of each director, officer, or beneficial owner of more than 5% of our common stock and filed with the Securities and Exchange Commission (&#8220;SEC&#8221;). Beneficial ownership is determined in accordance with SEC rules. The information in the following table does not necessarily indicate beneficial ownership for any other purpose. In general, under SEC rules, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise has or shares voting power or investment power with respect to such security. A person is also deemed to be a beneficial owner of a security if that person has the right to acquire beneficial ownership of such security within 60 days.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The percentage of shares of common stock beneficially owned is computed on the basis of 127,101,670 shares of common stock outstanding as of March 30, 2024. Shares of common stock that a person has the right to acquire within 60 days of March 30, 2024 are deemed outstanding for purposes of computing the percentage ownership of such person's holdings, but are not deemed outstanding for purposes of computing the percentage ownership of any other person, except with respect to the percentage ownership of all directors and executive officers as a group. Except as otherwise indicated below, and subject to applicable community property laws, we believe, based on information furnished by such persons, the persons named in the table have sole voting and investment power with respect to all shares of common stock held by that person.</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Beneficial Owner</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares of Common Stock Beneficially Owned</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Common Stock Beneficially Owned</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beneficial owners of 5% or more of our common stock:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bain Capital Investors, LLC </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,946,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FMR LLC </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,331,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellington Group </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,318,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Vanguard Group </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,417,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors and Named Executive Officers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayne S. DeVeydt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brent Turner </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teresa DeLuca, M.D.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clifford G. Adlerz</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John A. Deane</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patricia A. Maryland, Dr.PH</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew T. Kaplan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">T. Devin O'Reilly </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blair E. Hendrix </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All executive officers and directors as a group (18 persons) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,032,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*     Less than one percent.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Bain Capital Investors, LLC ("BCI") is the sole member of (i) BCPE Seminole GP LLC, a Delaware limited liability company ("BCPE GP"), which is the general partner of each of BCPE Seminole Holdings LP, a Delaware limited partnership (&#8220;BCPE Seminole&#8221;), and BCPE Seminole Holdings IV, L.P., a Cayman Islands exempted limited partnership (&#8220;BCPE Seminole IV&#8221;), (ii) BCPE Seminole GP II LLC, a Delaware limited liability company (&#8220;BCPE Seminole GP II&#8221;), which is the general partner of BCPE Seminole Holdings II Intermediate LP, a Delaware limited partnership (&#8220;BCPE Seminole II&#8221;), and (iii) BCPE Seminole GP III LLC, a Delaware limited liability company (&#8220;BCPE Seminole GP III&#8221;), which is the general partner of BCPE Seminole Holdings III, L.P., a Cayman Island exempted limited partnership (&#8220;BCPE Seminole III&#8221;).  Each of BCPE Seminole, BCPE Seminole II, BCPE Seminole III and BCPE Seminole IV has shared voting and dispositive power over 10,708,102 shares of common stock, 30,055,197 shares of common stock, 4,232,353 shares of common stock and 4,951,320 shares of common stock, respectively. By virtue of the relationships described in this footnote, BCI may be deemed to share voting and dispositive power with respect to the securities held by BCPE Seminole, BCPE Seminole II, BCPE Seminole III and BCPE Seminole IV. Information reported in this table and the notes hereto in respect of BCI is based solely on Amendment No. 7 to Schedule 13D filed with the SEC on December 21, 2023 by BCI. The principal business address of each of BCI, BCPE Seminole, BCPE Seminole II, BCPE Seminole III and BCPE Seminole IV is 200 Clarendon Street, Boston, MA 02116.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">FMR LLC ("FMR") has sole voting power over 18,220,445 shares of common stock and sole dispositive power over 18,331,455 shares of common stock. Information reported in this table and the notes hereto in respect of FMR is based solely on the Schedule 13G/A filed with the SEC on February 9, 2024 by FMR. The principal business address of FMR is 245 Summer Street, Boston, MA 02210.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP (the "Wellington Group") has shared voting power over 7,477,563 shares of common stock and shared dispositive power over 8,318,176. Wellington Management Company LLP ("Wellington Management Company" together with the Wellington Group, "Wellington") has shared voting power over 7,453,887 shares of common stock and shared dispositive power over 8,012,137 shares of common stock. Information reported in this table and the notes hereto in respect of Wellington is based solely on the Schedule 13G/A filed with the SEC on February 2, 2024 by Wellington. The principal business address of Wellington is c/o Wellington Management Company LLP, 280 Congress Street, Boston MA 02210.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">The Vanguard Group - 23-1945930 ("Vanguard") has sole voting power over 129,823 shares of common stock, shared dispositive power over 206,275 shares of common stock and sole dispositive power over 7,211,334 shares of common stock. Information reported in this table and the notes hereto in respect of Vanguard is based solely on the Schedule 13G/A filed with the SEC on February 13, 2024 by Vanguard. The principal business address of Vanguard is 100 Vanguard Blvd., Malvern, PA 19355.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Mr. DeVeydt's beneficially owned shares include 890,000 shares of common stock underlying stock options and 200,000 shares of common stock underlying stock-settled stock appreciation right ("SSAR") awards, each of which is exercisable within 60 days of March 30, 2024.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Mr. Evans' beneficially owned shares include 500,000 shares of common stock underlying stock options exercisable within 60 days March 30, 2024.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Ms. Baldock's beneficially owned shares include 199,500 shares of common stock underlying stock options exercisable within 60 days of March 30, 2024.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Mr. Turner's beneficially owned shares include 4,015 shares of common stock underlying stock options exercisable within 60 days of March 30, 2024.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">The shares beneficially owned by each of Messrs. O'Reilly, Kaplan and Hendrix do not include shares held by BCI. Mr. O'Reilly, Mr. Kaplan and Mr. Hendrix are each a Partner of BCI and as a result, by virtue of the relationships described in footnote (1) above, may each be deemed to share beneficial ownership of the shares of common stock held by BCI.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:1.34pt">Includes 1,942,015 shares of common stock underlying stock options and SSAR awards exercisable within 60 days of March 30, 2024.</span></div><div id="i227833c13def44249bd1572bf17f4242_22"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delinquent Section 16(a) Reports</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), requires our executive officers and directors and persons who own more than 10% of a registered class of our equity securities to file initial reports of ownership and reports of changes in ownership with the SEC. Such persons are required by regulation of the SEC to furnish us with copies of all Section 16(a) forms they file. Based solely on our review of the copies of such forms or written representations from certain reporting persons received by us with respect to fiscal year 2023, we believe that our executive officers and directors and persons who own more than 10% of a registered class of our equity securities have complied with all applicable filing requirements with respect to fiscal year 2023, except for (i) filing of a Form 3 upon the appointment of Ms. Burkhalter to Chief Human Resources Officer on January 29, 2023 that was inadvertently filed late on March 6, 2023, (ii) the sale of shares on August 29, 2023 to satisfy the tax withholding obligations in connection with a vesting event on August 28, 2023 for Mr. Doherty that was inadvertently reported late on a Form 4 </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">report filed on September 1, 2023, and (iii) restricted stock awards granted to Drs. DeLuca and Maryland and Messrs. Turner, Deane and Adlerz on June 1, 2023 that were inadvertently reported late on Form 4 reports filed on April 5, 2024.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">8</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 1: ELECTION OF DIRECTORS</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In accordance with the Company's Amended and Restated Certificate of Incorporation (the "charter") and Amended and Restated Bylaws (the "bylaws"), the Board is divided into three classes of approximately equal size. The members of each class are elected to serve a three-year term with the term of office of each class ending in successive years. Clifford G. Adlerz, J. Eric Evans, Blair E. Hendrix and Andrew T. Kaplan are Class III directors whose terms expire at the Annual Meeting.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Messrs. Adlerz, Evans, Hendrix and Kaplan have been nominated for and have agreed to stand for re-election as Class III directors. The Class III directors will serve a term of three years and until his successor is duly elected and qualified or until his death, resignation or removal, whichever is earliest to occur. The four nominees for director with the highest number of affirmative votes will be elected as Class III directors. Except with respect to broker non-votes, unless you otherwise instruct, proxies will be voted for election of the nominees listed above as director nominees. The Company has no reason to believe that any nominee will be unable to serve, but in the event that a nominee is unwilling or unable to serve as a director and the Board does not, in that event, choose to reduce the size of the Board, the persons voting the proxy may vote for the election of another person in accordance with their judgment.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE "FOR" EACH OF THE ABOVE-NAMED NOMINEES FOR CLASS III DIRECTORS.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table sets forth the name, age (as of March 30, 2024) and position of individuals who currently serve as a director of the Company.</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John A. Deane</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class I Director</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teresa DeLuca, M.D.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class I Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayne S. DeVeydt</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class I Director, Chairman</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patricia A. Maryland, Dr.PH</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class II Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">T. Devin O'Reilly</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class II Director</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brent Turner</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class II Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clifford G. Adlerz</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class III Director</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class III Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blair E. Hendrix</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class III Director</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew T. Kaplan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class III Director</span></div></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Information concerning our nominees and directors is set forth below. The biographical description of each director includes the specific experience, qualifications, attributes and skills that the Board would expect to consider if it were making a conclusion currently as to whether such person should serve as a director.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Class III Director Nominees for Election</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Clifford G. Adlerz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as a director of Surgery Partners since October 2017. Mr. Adlerz previously served as a Consultant to Surgery Partners from February 2018 until May 2019 and Interim Chief Executive Officer of Surgery Partners from September 2017 until January 2018. Before his time at Surgery Partners, Mr. Adlerz held several management roles at Symbion, Inc., a large multi-specialty provider of ambulatory surgery centers and hospitals, including as President from May 2002 until Symbion was acquired by Surgery Partners in November 2014. Prior to joining Symbion, Mr. Adlerz served as Division Vice President of HCA, a healthcare facilities operator, as well as Regional Vice President of Midsouth HealthTrust. Mr. Adlerz currently serves on the Board of Directors of Ovation Fertility. Mr. Adlerz previously served as a director for the National Ambulatory Surgery Center Association and was part of the leadership group for ASC Quality Collaboration. Mr. Adlerz holds a B.A. in Business and an M.B.A. from the University of Florida. Our Board believes that Mr. Adlerz is qualified to serve as a director based on, among other things, his experience with the Company and its predecessor as well as in the healthcare industry generally and his general business and financial acumen.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">J. Eric Evans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as a director of Surgery Partners since January 2020. Mr. Evans is currently Chief Executive Officer of Surgery Partners, a role he has held since January 2020, and previously served as Executive Vice President and Chief Operating Officer of Surgery Partners from April 2019 until January 2020. Prior to joining Surgery Partners, Mr. Evans served as President of Hospital Operations of Tenet Healthcare Corporation from March of 2016 through 2018 as Chief Executive Officer of Tenet Healthcare Corporation&#8217;s former Texas region from April 2015 to March 2016, and as Market Chief Executive Officer of The Hospitals of Providence in El Paso from September 2012 to April 2015. Mr. Evans has served as a director of QuVa Pharma since March 2022 and of Teledoc Health since September 2023. Mr. Evans holds a bachelor&#8217;s degree in industrial management from Purdue </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">University and an M.B.A. from Harvard Business School. Our Board believes that Mr. Evans is qualified to serve as a director based on his service as our Chief Executive Officer and his prior experience serving as an executive in the healthcare industry.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Blair E. Hendrix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as a director of Surgery Partners since May 2021. Mr. Hendrix joined Bain Capital Private Equity in 2000 and currently serves as a Partner. Prior to joining Bain Capital, Mr. Hendrix was Executive Vice President and Chief Operating Officer of DigiTrace Care Services, Inc. (now SleepMed), a national healthcare services company he co-founded. Earlier in his career, Mr. Hendrix was employed by Corporate Decisions, Inc. (now Oliver Wyman Consulting), a management consulting firm with a focus in healthcare. He has served on numerous corporate boards within Bain Capital and currently is a member of the firm&#8217;s Investment Committee for the Healthcare Vertical. Additionally, Mr. Hendrix has served as a director of US Renal Care since 2019. He previously served as a director of BMC Software, iHeart Media, Clear Channel Outdoor and The Weather Company. Mr. Hendrix received an A.B. from Brown University. Our Board believes that Mr. Hendrix is qualified to serve as a director based on, among other things, his business and finance experience within the healthcare industry.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Andrew T. Kaplan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as a director of Surgery Partners since August 2018. Mr. Kaplan joined Bain Capital Private Equity in 2009 and is a Partner. Prior to joining Bain Capital Private Equity, Mr. Kaplan was an investment banker with Goldman Sachs. He also co-founded EngagedHealth, LLC, a post-hospitalization service for chronically ill, low income patients aiming to improve outcomes, reduce readmissions, and save costs. Mr. Kaplan has served on the Board of Directors for QuVa Pharma since 2015, US Renal Care since 2019 and InnovaCare Health since 2021. He previously served as a director of Beacon Health Options from 2018 to 2020. Mr. Kaplan holds a B.S. in Economics from The Wharton School at the University of Pennsylvania and an M.B.A from Harvard Business School. Our Board believes that Mr. Kaplan is qualified to serve as a director based on, among other things, his experience in co-founding a healthcare company and his general financial experience.</span></div><div><span><br/></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Directors Continuing in Office</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Class I Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The following directors have terms ending in 2025:</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">John A. Deane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as a director of Surgery Partners since May 2019. Mr. Deane served as the Chairman of the Advisory Board Company from December 2009 until April 2018. Prior to joining the Advisory Board Company, he was the Founder and Chief Executive Officer of Southwind Health Partners, LLC, a start-up health care business focused on providing management services for hospital and health system sponsored medical groups, from October 1998 until December 2009. Following his health care career, Mr. Deane has served on several not-for-profit boards and as the owner/operator of a boutique resort and marina outside of Nashville, Tennessee. Mr. Deane holds a B.A. in Political Science and a M.P.A from American University. Our Board believes that Mr. Deane is qualified to serve as a director based on, among other things, his extensive experience working with physicians in the healthcare industry.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Teresa DeLuca, M.D., MBA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as a director of Surgery Partners since September 2016. Dr. DeLuca served as a Managing Director at Columbia University's NY Life Science Venture Fund from January 2018 until January 2020 and continues to serve as a Faculty Advisor at the University&#8217;s School of Entrepreneurship and Faculty Member of Columbia University School of Professional Studies. She previously served as Assistant Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai in New York City from 2014 to 2017 and as the Chief Medical Officer of Magellan Pharmacy Solutions at Magellan Health from 2012 to 2014. Prior to that, she served as SVP of Pharmacy Health Solutions at Humana, National Medical Director &amp; VP of Clinical Sales Solutions at Walgreen Co., VP of Personalized Medicine, and VP of Medical Policy &amp; Clinical Quality and CMO UHG at Medco. Prior to taking on these executive leadership roles, Dr. DeLuca was a Senior Director of Global Product Development Services at PRA International and a Senior Medical Scientist at GlaxoSmithKline. Dr. DeLuca serves as a director of Life Stance, a behavioral healthcare company, since 2024. She also serves as a director of Rejuveron, a private Swiss drug discovery company since March 2022. Previously, she served as a director of 180 Life Science, a biotechnology company, from May 2021 to December 2023. She also served as a director of North Bud Farms, Inc., a pharmaceutical commercialization company, from May 2018 to February 2020. Dr. DeLuca completed her residency (M.D.) at Jefferson Medical College of Thomas Jefferson University and earned her M.B.A. from Drexel University. Our Board believes that Dr. DeLuca is qualified to serve as a director based on- among other things- her healthcare knowledge, experience and skills gained from being physician with an active medical license, as well as previously serving as a Fortune 50 Chief Medical Officer and P&amp;L business line owner. As a strong advocate for good board governance, Dr. DeLuca earned the Carnegie Mellon Cybersecurity Certificate in 2016 and passed the Digital Directors Network Cyber Risk Masterclass examination for Public Companies in 2022. Dr. DeLuca has continued to maintain good standing with the National Association of Corporate Directors (NACD) as a Board Leadership Fellow (Master Level) since 2016. Dr. DeLuca has also passed the NACD&#8217;s &#8220;Directorship Certified&#8221; examination (NACD.DC) in 2020. In 2023, she became a NACD &#8220;Subject Matter Expert&#8221; in examination development and a Board Advisory Faculty Member, and in 2024 began serving as a NACD Certification Commissioner. She has also earned the American College of Corporate Directors (ACCD) ) &#8220;Master Professional Director &#8211; Public Company&#8221; credential in 2021. Dr. DeLuca was named a &#8220;Director to Watch&#8221; in the 2020 Directors &amp; Board Annual Report and a &#8220;Featured Director of the Month&#8221; in 2022 by the Chief Executive Group. In 2022, Dr. DeLuca became Co-Chair and Leadership Council Member for the international organization, Women Corporate Directors (WCD) and was named in 2024 to &#8220;Who&#8217;s Who in America&#8221;.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Wayne S. DeVeydt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> is a Managing Director with Bain Capital and has served as a director of Surgery Partners since January 2018. Mr. DeVeydt currently is Executive Chairman of Surgery Partners, a role he has held since January 2020 and previously served as Chief Executive Officer of Surgery Partners from January 2018 until January 2020. From January 2017 until January 2018, Mr. DeVeydt served as a Senior Advisor to the Global Healthcare division of Bain Capital Private Equity, the investment advisor of BCPE Seminole Holdings LP, the Company's former controlling stockholder. From May 2007 to May 2016, Mr. DeVeydt served as Executive Vice President and Chief Financial Officer of Anthem, Inc., a health insurance company. From March 2005 to May 2007, he served as Anthem's Senior Vice President and Chief Accounting Officer and for a portion of that time, he also served as Chief of Staff to the Chairman. Prior to joining Anthem, Mr. DeVeydt served as a partner at PricewaterhouseCoopers LLP, focused on companies in the national managed care and insurance industries. Mr. DeVeydt has served as a director of Centene Corporation, the largest Medicaid managed care organization in the United States, since January 2022. He has also served as a director of Zelis since August 2022. Mr. DeVeydt previously served as a director of Grupo Notre Dame Intermedica, Myovant Sciences Ltd, a biopharmaceutical company, and NiSource Inc., a utilities company. Mr. DeVeydt received his B.S. in Business Administration from the University of Missouri in St. Louis. Our Board believes that Mr. DeVeydt is qualified to serve as a director based on his service as our Chief Executive Officer and his prior experience serving as an executive in the healthcare industry.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Class II Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The following directors have terms ending in 2026:</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Patricia A. Maryland, Dr.PH.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as a director of Surgery Partners since February 2021. Dr. Maryland served as the Executive Vice President of Ascension and President and Chief Executive Officer of Ascension Healthcare from July 2017 to July 2019. Prior to those roles, Dr. Maryland served with Ascension Healthcare as President, Healthcare Operations and Chief Executive Officer from July 2013 to July 2017 and Ministry Market Leader, Michigan from September 2007 to June 2013. Dr. Maryland has been a member of over 25 boards in the nonprofit, private, joint venture, and public sectors and has been the recipient of multiple awards, including being named one of the Top 25 COOs in Healthcare in 2017, one of the Top 25 Women in Healthcare in 2019, 2018, 2017, 2016 and 2015 by Modern Healthcare, Woman of the Year in 2014 by the Healthcare Businesswomen&#8217;s Association, and one of Modern Healthcare&#8217;s Top 25 Minority Executives in Healthcare also in 2014. Dr. Maryland received a bachelor&#8217;s degree in applied mathematics from Alabama State University, Montgomery, and a master&#8217;s degree in biostatistics from the University of California, Berkeley. She holds a Doctorate of Public Health from the University of Pittsburgh, concentrating in health services administration and planning. Our Board believes that Dr. Maryland is qualified to serve as a director based on, among other things, her experience in healthcare administration particularly with respect to her past leadership experiences.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">T. Devin O'Reilly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as a director of Surgery Partners since August 2017, including as Chairman from August 2017 to January 2020. Mr. O'Reilly joined Bain Capital Private Equity, LP ("Bain Capital Private Equity") in 2005 and and currently serves as a Partner. Prior to joining Bain Capital Private Equity, Mr. O'Reilly was a consultant at Bain &amp; Company where he consulted for private equity and healthcare industries. Mr. O'Reilly has served as a director of Aveanna Healthcare since 2017, Zelis since 2019, PartsSource since 2021, and athenahealth and LeanTaaS since 2022. He previously served as a director of several Bain Capital portfolio companies including Bio Products Laboratory, Grupo Notre Dame Intermedica, and US Renal Care among others.  Mr. O'Reilly holds a B.A. from Princeton University and an M.B.A. from The Wharton School at the University of Pennsylvania. Our Board believes that Mr. O&#8217;Reilly is qualified to serve as a director based on, among other things, his experience as an investor in other healthcare companies.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Brent Turner</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as a director of Surgery Partners since December 2015. Mr. Turner is the Chief Executive Officer and a member of the Board of Directors of Summit BHC, a leading inpatient behavioral healthcare company. Mr. Turner previously served as the President of Acadia Healthcare Company Inc. from April 2012 until March 2019. Mr. Turner joined Acadia in February 2011 as a Co-President. Prior to joining Acadia, Mr. Turner served as the Executive Vice President, Finance and Administration of Psychiatric Solutions, Inc. from August 2005 to November 2010 and prior to that, as the Vice President, Treasurer and Investor Relations and as a Division President. Mr. Turner currently serves on the Board of Trustees of the National Association of Behavioral Healthcare (NABH), and served as Chairman in 2018 and 2009. Mr. Turner previously served on the Board of Directors of LHC Group, Inc. from 2014 until February 2023 when the company was acquired by UnitedHealth Group.  Mr. Turner holds a B.A. in Economics from Vanderbilt University and an M.B.A. from the Vanderbilt Owen Graduate School of Management. Our Board believes that Mr. Turner is qualified to serve as a director based on, among other things, his experience as an executive in the healthcare industry, his service as a board member of other publicly traded companies and his financial knowledge.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Board Diversity</span></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Based upon voluntary self-identification by each member of our Board, the table below sets forth the diversity composition of our Board. Each of the categories listed in the table below has the meaning set forth in Nasdaq Rule 5605(f).</span></div><div style="text-indent:18pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.819%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board Diversity Matrix </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of April 25, 2024</span></td><td colspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of April 20, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Directors</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I: Gender Identity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Female</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Male</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Female</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Male</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II: Demographic Background</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">African American or Black</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">White</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">Inapplicable categories omitted.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">12</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CORPORATE GOVERNANCE</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Board currently consists of ten directors. At each annual meeting of stockholders, a class of directors will be elected for a three-year term to succeed the directors of the same class whose terms are then expiring. The division of the three classes and their respective election dates are as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the Class I directors' term will expire at the annual meeting of stockholders to be held in 2025;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the Class II directors' term will expire at the annual meeting of stockholders to be held in 2026; and</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the Class III directors' term will expire at the annual meeting of stockholders to be held in 2027; </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. The division of our Board into three classes with staggered three-year terms may delay or prevent a change of our management or a change in control.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our charter provides that directors will be elected at the annual meeting of the stockholders and each director elected will hold office until his or her successor is elected and qualified. The size of the Board is determined exclusively by a majority of the directors then in office and vacancies and newly created directorships on the Board are filled exclusively by a majority of the directors then in office, even if less than a quorum, or by a sole remaining director, except in each case, that any vacancy created by the removal of a director by the stockholders for cause shall only be filled, in addition to any other vote otherwise required by law, by vote of a majority of the then outstanding capital stock entitled to vote generally on the election of directors.</span></div><div id="i227833c13def44249bd1572bf17f4242_31"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Director Independence</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Board has reviewed the independence of our directors based on the corporate governance standards of Nasdaq. Based on this review, the Board determined that each of Drs. DeLuca and Maryland and Messrs. Deane, O'Reilly, Turner, Adlerz, Hendrix and Kaplan is independent within the meaning of the corporate governance standards of Nasdaq. In making this determination, our Board considered the relationships that each of these non-employee directors has with the Company and all other facts and circumstances our Board deemed relevant in determining their independence, including the beneficial ownership of our capital stock held by each non-employee director. As a result, we currently comply with the Nasdaq corporate governance requirements. As required under applicable Nasdaq rules, our independent directors meet in regularly scheduled executive sessions at which only independent directors are present.</span></div><div id="i227833c13def44249bd1572bf17f4242_34"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Board Leadership Structure</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our bylaws provide maximum flexibility to the Board in choosing a Chairman of the Board and a Chief Executive Officer. The bylaws provide that such offices may be held by different people or the same person, as determined by the Board. This flexibility allows the Board to determine whether it is in the best interest of the Company and our stockholders to combine the roles of Chief Executive Officer and Chairman of the Board in the same person. The roles of Chief Executive Officer and Chairman of the Board are currently separate. Mr. DeVeydt, our former Chief Executive Officer, was appointed by the Board to serve as Executive Chairman of the Board in January 2020. The Board determined that Mr. DeVeydt&#8217;s experience as our former Chief Executive Officer gives him a unique and relevant perspective to serve as our Executive Chairman.</span></div><div id="i227833c13def44249bd1572bf17f4242_37"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Selection of New Directors</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Board is responsible for nominating members for election by the stockholders with direct input from the Chief Executive Officer. It is the opinion of the Board that directors should possess the highest personal and professional ethics, integrity and values, and be committed to representing the long-term interests of the Company's stakeholders. The Board believes that each director should possess a combination of skills, professional experience and diversity of viewpoints necessary to oversee the Company's business. In addition, it believes that there are certain attributes that every director should possess, as reflected in its membership criteria. Accordingly, the Board considers the qualifications of directors and director candidates individually and in the broader context of its overall composition and the Company's current and future needs. Among other things, the Board has determined that it is important to have directors with the following skills and experiences: leadership experience, as directors with experience in significant leadership positions possess strong abilities to motivate and manage others and to identify and develop leadership qualities in others; knowledge of the Company's industry, particularly physician and patient relations, which is relevant to understanding the Company's business and strategy; operations experience, as it gives directors a practical understanding of developing, implementing and assessing the Company's business strategy and operating plan; risk management experience, which is relevant to oversight of the risks facing the Company's business; financial/accounting experience, particularly knowledge of finance and financial reporting processes, which is relevant to understanding and evaluating the Company's capital structure, financial statements and reporting requirements; and strategic planning experience, which is relevant to the Board's review of the Company's strategies and monitoring their implementation and results.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Board also requires that each director be able to dedicate sufficient time to ensure the diligent performance of his or her duties on the Company's behalf, including attending all Board and applicable committee meetings. In general, the Board does not have a policy limiting the number of other public company boards of directors upon which a director may sit. However, the Board will consider the number of other boards of directors (or comparable governing bodies), particularly with respect to public companies, on which a prospective nominee is a member. Although the Board does not impose a limit on outside directorships, it does recognize the substantial time commitments attendant to membership on the Board and expects that directors devote all such time as is necessary to fulfill their accompanying responsibilities, both in terms of preparation for, and attendance and participation at, meetings.</span></div><div id="i227833c13def44249bd1572bf17f4242_40"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Board Meeting Attendance</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under our Corporate Governance Guidelines, directors are expected to attend all Board meetings and meetings of the committees of the Board on which they serve, as well as annual meetings of stockholders. During 2023, there were six meetings of our Board. No current director attended fewer than 75% of the aggregate of (i) the total number of meetings of the Board and (ii) the total number of meetings of committees of the Board for the period during which the director served on the Board or such committee in 2023. All directors who served on the Board at the time of the 2023 annual meeting of stockholders attended the meeting.</span></div><div id="i227833c13def44249bd1572bf17f4242_43"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board&#8217;s Role in Risk Oversight</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Board, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, our Board has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning as designed. Our Board, primarily through its Audit Committee, oversees an enterprise-wide approach to risk management, designed to support the achievement of organizational objectives, including strategic objectives, to improve long-term organizational performance and enhance stockholder value.</span></div><div id="i227833c13def44249bd1572bf17f4242_46"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committees of the Board</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have an Audit Committee, a Compensation, Culture and People Committee (&#8220;Compensation Committee&#8221;), a Nominating and Corporate Governance Committee (&#8220;Governance Committee&#8221;) and a Compliance and Ethics Committee with the composition and responsibilities described below. Each committee operates under a charter that is approved by our Board. The members of each committee are appointed by the Board and serve until their successor is elected and qualified, unless they are earlier removed or resign. In addition, from time to time, special committees may be established under the direction of the Board when necessary to address specific issues.</span></div><div id="i227833c13def44249bd1572bf17f4242_49"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have a separately standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Exchange Act. The purpose of the Audit Committee is set forth in the Audit Committee charter. The Audit Committee's primary duties and responsibilities are to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Appoint or replace, compensate and oversee the Company's independent auditor;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Assist the Board with its oversight of the integrity of the Company's financial statements, the Company's compliance with legal and regulatory requirements, the independent auditor's qualifications, independence and audits, and the performance of the Company's internal audit function and the independent auditor; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Prepare the report for inclusion in the Company's annual Proxy Statement as required by the rules of the SEC.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Audit Committee is responsible for the appointment, compensation, retention, oversight and replacement, if necessary, of the Company's independent auditor. The Audit Committee pre-approves all auditing services and permitted non-audit services (including the fees and terms thereof) to be performed by the independent auditor. The Audit Committee reviews and discusses with management and the independent auditor the Company's annual audited and quarterly unaudited financial statements and the disclosures under the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's annual and quarterly reports filed with the SEC, including disclosures of critical accounting policies therein. The Audit Committee also reviews and approves all related party transactions in accordance with Company policy and reviews matters related to the Company's related party transaction policy and the Company's system of internal control, its financial and critical accounting practices, and policies relating to risk assessment and management, including cybersecurity risks.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Audit Committee currently consists of Brent Turner (chair), Teresa DeLuca, M.D. and John A. Deane. Mr. Turner is both an independent director and an "audit committee financial expert" within the meaning of Item 407 of Regulation S-K, and serves as chair of the Audit Committee. In addition, Dr. DeLuca and Mr. Deane are also independent directors within the meaning of Item 407 of Regulation S-K. The Audit Committee met four times in 2023. A copy of the Audit Committee charter, which satisfies the applicable standards of the SEC and Nasdaq, is available on the "Investors - Governance" page of our website at www.surgerypartners.com.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">14</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_52"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation, Culture and People Committee</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purpose of the Compensation Committee is to assist the Board in fulfilling its responsibilities relating to oversight of the compensation of our directors, executive officers and other employees and the administration of our benefits and equity-based compensation programs. Our Board has adopted a written charter under which the Compensation Committee operates, which satisfies the applicable standards of the SEC and Nasdaq. A copy of the Compensation Committee charter is available on the "Investors - Governance" page of our website at www.surgerypartners.com. The Compensation Committee annually reviews and assesses the adequacy of its charter.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compensation Committee's primary duties and responsibilities are to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Review and approve corporate goals and objectives relevant to the compensation of the Company's Chief Executive Officer (the "CEO") and the officers of the Company who report directly to the CEO and all &#8220;officers&#8221; as defined in Section 16 of the Exchange Act (collectively, the "Senior Officers"), evaluate the performance of the CEO and other Senior Officers in light of those goals and objectives and, either as a committee or together with the other independent directors (as directed by the Board), determine and approve, or recommend to the Board for approval, the compensation levels for the CEO and other Senior Officers based on this evaluation, with the deliberations and voting on the CEO's compensation to be conducted without the CEO present;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Make recommendations to the Board about the compensation of non-employee directors;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Review and administer the Company's equity-based compensation plans, management incentive compensation plans and deferred compensation plans for the Senior Officers and make recommendations to the Board about amendments to such plans and the adoption of any new compensation plans for the Senior Officers;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Recommend to the Board any ownership guidelines for the Senior Officers, other executives and non-employee directors, and periodically assess these guidelines and recommend revisions as appropriate;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Review and establish the Company's overall management compensation and benefits philosophy and policies;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Review and discuss the &#8220;Compensation Discussion and Analysis&#8221; required to be included in the Company&#8217;s proxy statement and annual report on Form 10-K by the rules and regulations of the SEC with management, and produce a compensation committee report on executive compensation for inclusion in the Company&#8217;s annual proxy statement in accordance with the SEC proxy and disclosure rules;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Review and recommend to the Board for approval the frequency with which the Company will conduct say-on-pay votes, taking into account the results of the most recent stockholder advisory vote on frequency of say-on-pay votes required by Section 14A of the Exchange Act;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Review and approve all Senior Officer employment contracts and other compensatory, severance and change-in-control arrangements for current and former Senior Officers;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Establish and review periodically policies and procedures with respect to perquisites;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Review the Company's incentive compensation arrangements to determine whether they encourage excessive risk-taking, review and discuss at least annually the relationship between risk management policies and practices and compensation, and evaluate compensation policies and practices that could mitigate any such risk;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Review the Company&#8217;s human capital management strategies and matters related to talent attraction, development and retention, culture, inclusion and diversity;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Review and assess the adequacy of the committee's charter and submit any changes to the Board for approval on an annual basis;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Maintain minutes of the committee's meetings and report its actions and any recommendations to the Board on a periodic basis; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Annually perform, or participate in, an evaluation of the performance of the committee against the requirements of this Compensation Committee charter, the results of which shall be presented to the Board.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compensation Committee currently consists of Brent Turner, John A. Deane, T. Devin O'Reilly (chair) and Andrew T. Kaplan, each of whom the Board has determined is independent under SEC and Nasdaq rules. The Compensation Committee met five times during 2023.</span></div><div id="i227833c13def44249bd1572bf17f4242_55"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purpose of the Governance Committee is to (i) identify and recommend individuals qualified to serve as directors of the Company, (ii) review the composition of the Board, (iii) review performance of Board members, (iv) review senior management succession plans, (v) assist the Board in the oversight of environmental, social and governance (&#8220;ESG&#8221;) matters, (vi) monitor significant developments in the law and practice of corporate governance and of the duties and responsibilities of directors of public companies, and (vii) carry out such other responsibilities delegated by the Board relating to the Company&#8217;s director nominations process and procedures and governance matters. Our Board has adopted a written charter under which the Governance Committee operates. A copy of the Governance Committee charter is available on the "Investors - Governance" page of our website at www.surgerypartners.com. The Nominating and Corporate Governance Committee periodically reviews and assesses the adequacy of its charter.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Governance Committee currently consists of Patricia A. Maryland, Dr.PH, T. Devin O'Reilly and Blair E. Hendrix (chair), each of whom the Board has determined is independent under SEC and Nasdaq rules. The Governance Committee met once during 2023.</span></div><div id="i227833c13def44249bd1572bf17f4242_58"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance and Ethics Committee</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purpose of the Compliance and Ethics Committee is to assist the Board in discharging its responsibilities relating to our compliance with laws, regulations, internal procedures and industry standards that may cause significant business, regulatory, or reputational damage to us, as well as legal and business trends and public policy issues. The Compliance and Ethics Committee, among other things, oversees the activities of, and receives regular reports from, our Chief Compliance Officer, and reports to the Board on the effectiveness of the Company&#8217;s compliance, ethics and quality programs. Our Board has adopted a written charter under which the Compliance and Ethics Committee operates. A copy of the Compliance and Ethics Committee charter is available on the "Investors - Governance" page of our website at www.surgerypartners.com. The Compliance and Ethics Committee periodically reviews and assesses the adequacy of its charter.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compliance and Ethics Committee currently consists of Teresa DeLuca, M.D. (chair), Clifford G. Adlerz, John A. Deane and Patricia A. Maryland, Dr.PH. The Compliance and Ethics Committee met four times during 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Compensation Committee Interlocks and Insider Participation</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No member of our Compensation Committee is or has at any time during the past year been an officer or employee of ours or any of our subsidiaries. None of our executive officers currently serves or in the past year has served as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving on our Board or Compensation Committee. Our CEO has participated in discussions related to compensation of certain of our executive officers, but has not participated in any discussions regarding his own compensation. We have also retained a compensation consultant since our initial public offering to review the compensation of executive officers at peer group companies and assist in benchmarking appropriate compensation of our executive officers on a forward-looking basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Employee, Officer and Director Hedging</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s Insider Trading Policy expressly prohibits our employees, officers or directors from engaging in transactions that involve the purchase of financial instruments, including prepaid variable forward contracts, instruments for the short sale or purchase or sale of call or put options, equity swaps, collars, or units of exchangeable funds, that are designed to or that may reasonably be expected to have the effect of hedging or offsetting a decrease in the market value of any securities of the Company. In addition, all of our employees, officers and directors are subject to the Company's Code of Conduct, which includes conflicts of interest provisions broadly prohibiting actions or activities that involve obtaining improper personal gain or advantage, or adversely affecting the interests of the Company.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Stock Ownership Guidelines</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compensation Committee adopted share ownership and retention guidelines applicable to the Company&#8217;s named executive officers and non-employee directors. Please refer to "Compensation Discussion and Analysis -- Compensation Policies and Practices" for more information.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">16</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_61"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 2: ADVISORY VOTE ON EXECUTIVE COMPENSATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In accordance with Section 14A of the Exchange Act, the Board is asking stockholders to approve a non-binding, advisory resolution on the compensation of the Company's executive officers who are named in the Summary Compensation Table appearing in this Proxy Statement (our "named executive officers" or "NEOs"). The compensation of our named executive officers is described in the "Compensation Discussion and Analysis" and "Executive Compensation" sections of this Proxy Statement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The compensation program for our named executive officers is designed to attract and retain highly qualified individuals and to motivate and reward them for performance that benefits Surgery Partners and its stockholders. The Compensation Committee and the Board believe that the policies and procedures detailed in "Compensation Discussion and Analysis" achieve these goals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This advisory resolution, commonly referred to as a "Say-On-Pay" resolution, is non-binding on the Board. Although non-binding, the Board and the Compensation Committee value the views of the Company's stockholders and will review and consider the voting results when (i) evaluating the effectiveness of the Company's compensation policies and practices and (ii) making future compensation decisions for our named executive officers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are requesting your vote on the following resolution:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">"RESOLVED, that the Company's stockholders approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Company's Proxy Statement for the 2024 annual meeting of stockholders pursuant to the compensation disclosure rules of the SEC, including the "Compensation Discussion and Analysis" and "Executive Compensation" sections and the other related tables and disclosure."</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE "FOR" THE APPROVAL OF THE ADVISORY RESOLUTION ON EXECUTIVE COMPENSATION.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">17</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_64"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.540%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayne S. DeVeydt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Chairman and Class I Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Class III Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Administrative and Development Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Strategy Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danielle Burkhalter</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Human Resources Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harrison R. Bane</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, American Group</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anthony W. Taparo</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Growth Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, National Group</span></div></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Wayne S. DeVeydt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as Executive Chairman of Surgery Partners since January 2020 and director of Surgery Partners </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">since January 2018. Mr. DeVeydt&#8217;s biography is included elsewhere in this Proxy Statement under the heading "Proposal No. 1: </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Election of Directors - Directors Continuing in Office."</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">J. Eric Evans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as Chief Executive Officer and director of Surgery Partners since January 2020. Mr. Evans&#8217; biography is included elsewhere in this Proxy Statement under the heading "Proposal No. 1: Election of Directors - Directors Continuing in Office."</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">David T. Doherty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as our Executive Vice President and Chief Financial Officer since February 1, 2022. Previously, Mr. Doherty was our Senior Vice President of Corporate Finance and Controller. Prior to joining Surgery Partners in 2018, Mr. Doherty held various senior financial management roles at Aetna Inc., including leading Aetna&#8217;s internal audit organization, planning and risk management, and serving as Aetna&#8217;s assistant controller. Mr. Doherty earned his CPA while working at Arthur Andersen, LLP. Mr. Doherty holds a bachelor's degree in Accounting from the University of Connecticut.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Jennifer B. Baldock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">has served as our Executive Vice President and Chief Administrative and Development Officer since February 2020. Previously, Ms. Baldock served as our Executive Vice President and Chief Legal Officer from May 2018 to February 2020 and, prior to that, Ms. Baldock served in various senior management roles for both Surgery Partners, Inc. and Symbion, Inc. prior to our acquisition of Symbion in November 2014. Prior to joining Symbion in 2010, she served as Assistant General Counsel for both Ambulatory Services of America and Renal Care Group. Prior to that, Ms. Baldock practiced law with Waller Lansden Dortch and Davis in Nashville, Tennessee, concentrating in corporate law with an emphasis on healthcare mergers and acquisitions. She is also a Certified Public Accountant (inactive). Ms. Baldock holds a B.A. in Economics and Accounting from Lipscomb University and a J.D. from the University of Alabama.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Marissa A. Brittenham</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as our Executive Vice President and Chief Strategy Officer since January 2022. Previously, Ms. Brittenham led Growth at Cityblock Health and Medicaid Partnerships at Evolent Health (NYSE: EVH) and was an Associate Partner at McKinsey &amp; Company. She received a bachelor&#8217;s degree in Ethics, Politics and Economics from Yale University and earned her JD/ MBA from University of Pennsylvania Carey Law School and the Wharton School.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Danielle Burkhalter </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">has served as Chief Human Resources Officer since February 2023 and became an Executive Vice President in March 2024. Prior to this role, Ms. Burkhalter was our Vice President of Talent leading talent initiatives across the Company. Prior to joining Surgery Partners in 2018, Ms. Burkhalter held various Human Resources roles at UnityPoint Health, one of the nation&#8217;s most integrated health systems with numerous clinics, hospitals and home care areas of service in metropolitan and rural communities throughout Iowa, Illinois, and Wisconsin. Ms. Burkhalter graduated from Simpson College and earned her master&#8217;s from The University of Alabama.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Harrison R. Bane </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">has served as President of the American Group since September 2022. Prior to joining Surgery Partners, from September 2020 to August 2022, Mr. Bane served as president for Steward Health Care&#8217;s North Region, encompassing 14 acute care hospitals, a large multispecialty physician group, and an ACO with nearly 500,000 lives. From February 2018 to August 2020, he served as president of a Steward Health Care hospital. From July 2016 to January 2018, he led the system wide integration of value-based care at fourteen skilled nursing facilities, three adult day health centers and two assisted living facilities for a private, for-profit system. Mr. Bane is a graduate of Middlebury College, and earned his master&#8217;s from the Tuck School of Business and Geisel School of Medicine at Dartmouth.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Anthony W. Taparo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as our Chief Growth Officer since August 2019. Previously, Mr. Taparo served as our Atlantic Group President from our acquisition of Symbion in November 2014 to August 2019. Mr. Taparo previously served as President of Symbion's Atlantic Group since 2006 and as Regional Vice President for Symbion from 1999 to 2006. Prior to joining Symbion, Mr. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Taparo served as Chief Operating Officer of Columbia Physician Services. Mr. Taparo holds a B.A. in Accounting from Indiana State University.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Bradley R.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Owens</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> has served as our National Group President since December 2019. Previously, Mr. Owens served as the Senior Vice President Operations - CFO for Arete Health from April 2019 to December 2019. He previously held several positions at LifePoint Hospitals, including Western Group Chief Operating Officer (COO), Vice President Clinical and Business Informatics, COO of the Continental Division, Operations CFO and American Division Chief Financial Officer (CFO). Prior to his time at LifePoint Hospitals, he worked at HCA Healthcare as CFO for three east coast hospitals. Mr. Owens holds a B.S. in Accounting from Marshall University and a Master of Health Administration degree from Ohio University.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">19</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_67"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION DISCUSSION AND ANALYSIS</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Compensation Discussion and Analysis ("CD&amp;A") is designed to provide an overview of our compensation philosophy and objectives, our compensation programs, and our decision making processes as they relate to our named executive officers for the year ended December 31, 2023.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This discussion is intended to, among other things, help our stockholders understand the information provided in the compensation tables included in this Proxy Statement, and to put that information in the context of our overall compensation program for our NEOs.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to SEC rules, our NEOs for 2023 were: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.678%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Named Executive Officer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Administrative and Development Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Strategy Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, National Group</span></div></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of 2023 Company Performance</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary of the Company's performance is intended to provide additional context for the compensation of the NEOs in 2023. We ended 2023 and entered 2024 with strong momentum and continued confidence in the Company's long-term growth potential. Our NEOs were instrumental in helping us drive Company performance results in 2023, and in assessing our competitive position and shaping a plan that will best position us for continued growth in 2024 and beyond.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We present below key business highlights to assist our stockholders in understanding the compensation decisions made with respect to our NEOs that relate to 2023 performance. Key performance highlights from 2023 include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Revenues increased 8.0% over 2022 to $2.74 billion.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Days adjusted same-facility revenues increased 11.3% from 2022.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Net loss attributable to common stockholders of $11.9 million, resulting in a net loss per share of $0.09.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Adjusted EBITDA increased 15.2% from 2022 to $438.1 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Overview of Our Executive Compensation Objectives and Pay-for-Performance Philosophy</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our executive compensation program reflects the Company&#8217;s commitment to pay-for-performance and to align the interests of the Company&#8217;s management with those of our stockholders. In addition, our executive compensation program is designed to encourage our executives to take actions that support the Company&#8217;s short-term financial goals while sustaining the incentive to achieve strong stockholder value creation over the long term.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our long-term success is based on achieving key strategic, financial and operational goals each year. To drive achievement of and align focus with these goals, our executive compensation program is designed to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Attract, retain and motivate talented executives with significant industry knowledge and the experience and leadership capability necessary for our corporate success.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Align the interests of our NEOs with those of our stockholders by delivering a substantial portion of each officer's compensation through incentives that drive long-term enterprise value.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Provide a strong link between pay and performance by weighting total direct compensation toward performance-based incentive compensation that promotes achievement of short-term performance with annual cash incentive awards and supports long-term business objectives with performance-based equity grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Compensation Policies and Practices</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We maintain the following compensation policies and practices that reflect our pay-for-performance philosophy and support long-term stockholder value:</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Well-Balanced Compensation Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The structure of our executive compensation program includes a balanced mix of cash and equity compensation with a strong emphasis on performance-based and at-risk compensation.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Capped Annual Incentive Award Opportunities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The value of our NEOs' incentive awards is determined by performance-based metrics that promote long-term stockholder value. Additionally, for 2023, although there is not a specific performance metric tied to clinical quality, the Compensation Committee used its discretionary authority to emphasize clinical quality in determining the level of award payout achieved by our NEOs.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Performance-Based Long-Term Incentives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. To align pay with performance, 50% of our long-term incentive awards for NEOs granted in 2023 were subject to vesting based on key financial performance objectives.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Multi-Year Vesting Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. To enhance retention and alignment with stockholders' interests, our long-term incentive awards are comprised of time-based and performance-based equity awards that vest over multiple years, including recent performance-based equity awards that cliff vest after three years.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Independent Decision Makers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Members of our Compensation Committee are independent and the committee works closely with an independent compensation consultant to monitor trends and best practices.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Competitive Compensation Practices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The competitiveness of our executive compensation program is determined by comparison to a group of peer companies that are comparable based on industry, revenue, market capitalization and other factors.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Double-Trigger Change in Control Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Options and restricted stock grants are subject to "double-trigger" vesting in connection with a change in control (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, awards that require a qualifying termination of employment in addition to a change in control in order to become fully vested).</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Limited Perquisites</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. We provide our NEOs with limited perquisites that are narrowly tailored to enhance our retention of talent over the long term.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Share Ownership and Retention Guidelines.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> In order to demonstrate alignment of the interests of management and the directors with the stockholders of the Company, we have share ownership and retention guidelines applicable to the NEOs and non-employee directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Clawback Policy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> We adopted an Executive Compensation Recovery Policy regarding the recovery of erroneously awarded incentive-based compensation received by executive officers under certain circumstances which is administered by the Compensation Committee.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Compensation Framework and Process</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Role of the Compensation Committee in Compensation Decisions</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Compensation Committee oversees our total compensation philosophy, compensation programs, equity incentive programs and benefit plans, and is responsible for reviewing and approving, or recommending that the Board approve, as applicable, all components of our executive compensation program. Our Compensation Committee reviews and recommends the compensation of our Chief Executive Officer. After considering the assessment and recommendation of the Chief Executive Officer, our Compensation Committee determines and approves compensation decisions relating to our other NEOs.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Role of the Independent Compensation Consultant</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For 2023, our Compensation Committee retained Frederic W. Cook &amp; Co., Inc. ("FW Cook"), an independent compensation consulting firm, to provide advice on executive compensation matters, including the types, levels and the competitiveness of our programs. FW Cook reports directly to our Compensation Committee and interacts with management at the Compensation Committee's direction. Our Compensation Committee and its chairperson have regular opportunities to meet with FW Cook in executive sessions without management present. The Compensation Committee considered the independence of FW Cook in light of current SEC rules and Nasdaq listing standards and concluded that no conflict of interest exists that would prevent FW Cook from independently advising the Compensation Committee.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Role of our Chief Executive Officer</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Chief Executive Officer annually reviews the performance of the other NEOs, after which the Chief Executive Officer presents his conclusions and recommendations to the Compensation Committee for approval. Our Compensation Committee has absolute discretion as to whether it approves the recommendations of the Chief Executive Officer or makes adjustments, as it deems </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">appropriate. The Chief Executive Officer may also work with the Compensation Committee to gather and compile data needed for benchmarking purposes or for other analysis conducted by the Compensation Committee's independent consultants and advisors.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Benchmarking</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Compensation Committee reviews competitive data for comparable executive positions in the market. External market data is used by the Compensation Committee as a point of reference in its executive pay decisions in conjunction with financial and individual performance data. The Compensation Committee reviews compensation information disclosed by a peer group of comparably sized companies with which we compete for business and executive talent and information derived from published survey data that compares the elements of each executive officer's target total direct compensation to the market information for executives with similar roles. FW Cook compiles this information for the Compensation Committee and size-adjusts the published survey data to reflect our size in relation to the survey participants to more accurately reflect the scope of responsibility for each NEO.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compensation Committee, in consultation with FW Cook, annually reviews and selects the peer companies, which generally consist of publicly-traded healthcare companies. The peer group companies selected for purposes of analyzing and determining the compensation of our executive officers, including our NEOs, were selected primarily based upon the following criteria: (i) similar business operations/industry/competitors for investor capital, (ii) comparable sales, market capitalization and profitability levels, and (iii) competitors for executive talent.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compensation Committee worked with FW Cook to evaluate our peer group and selected the following companies as our peer group for 2023 primarily because they are similar healthcare companies with revenues between approximately 1/3 and three times our pro-forma sales estimate of $2 billion:</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.805%"><tr><td style="width:1.0%"/><td style="width:32.328%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acadia Healthcare Company, Inc.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Encompass Health Corporation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premier, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amedisys, Inc.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Ensign Group, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RadNet, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMN Healthcare Services, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ModivCare Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Select Medical Holdings Corp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brookdale Senior Living Inc.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option Care Health, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemed Corporation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pediatrix Medical Group, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elements of Named Executive Officer Compensation</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of the primary elements of compensation for each of our NEOs for 2023, which consisted of the following:</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.493%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.493%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.073%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Element</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Primary Objectives</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base Salary</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Fixed cash payments paid over the fiscal year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Attract and retain key talent</span></div><div style="padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Provide competitive compensation</span></div><div style="margin-bottom:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Recognize experience and performance</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-Term Incentives</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Performance-based annual cash and equity incentives</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Promote and reward achievement of the Company's annual financial and strategic objectives</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Incentives</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Restricted stock</span></div><div style="padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Performance restricted stock units</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Retain and motivate senior management over a multi-year vesting period</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Tie value earned to achievement of the Company's long-term goals</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement and Welfare Benefits</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   401(k) Plan</span></div><div style="padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Supplemental executive retirement plan</span></div><div style="margin-bottom:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Medical, dental, vision, life insurance and disability insurance</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Provide tax-efficient retirement savings</span></div><div style="padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Provide tax-efficient opportunity to supplement retirement savings</span></div><div style="margin-bottom:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Provide competitive health and welfare benefits</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perquisites</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Cell phone allowance</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Provide competitive ancillary benefits</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance Benefits</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Cash and non-cash payments and benefits upon an involuntary termination of employment</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:11.25pt;padding-right:2.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#9679;   Provide protection in the event of an involuntary termination of employment</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compensation Committee does not have a pre-established policy for the allocation between fixed compensation, such as base salary, and variable or "at risk" compensation, such as short-term cash and equity incentives. However, our Compensation Committee places a significant portion of total direct compensation for the NEOs at risk. At risk compensation under the Company&#8217;s annual cash incentives plan (the "Cash Incentive Plan") incentivizes our NEOs to reach or exceed desired financial operating goals. Moreover, at risk equity compensation under the Company's 2015 Omnibus Incentive Plan, as amended and restated effective January 1, 2020, as amended (the "Omnibus Incentive Plan"), incentivizes our NEOs because the full benefit of equity-based compensation cannot be realized unless our NEOs are able to grow the value of our stock over multiple years.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Base Salary</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is a part of the Company's compensation philosophy that employees be paid a base salary that is competitive with the salaries paid by comparable companies based on each employee's experience, performance and any other unique factors or qualifications. Generally, the Company has chosen to position cash compensation in a range around market median levels in order to remain competitive in attracting and retaining executive talent. FW Cook provides the Compensation Committee with benchmarking data, and our NEOs are provided with a base salary within the market benchmarked range based on their unique situation. Actual base salaries paid vary within a range based on performance over time. Our Compensation Committee reviews the base salaries of our NEOs on an annual basis, and takes into consideration the following factors when determining whether such amounts should be adjusted:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the executive's performance; </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the performance of the Company;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the impact of the executive's performance on the individual businesses or corporate functions for which the executive is responsible;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the nature and importance of the executive's position and role within the Company;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the scope of the executive's responsibility;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the market data provided by the independent compensation consultant; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the current compensation package in place for the executive, including the executive's current annual salary and potential bonus awards under the Company's bonus plan.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The annual base salaries for applicable NEOs for 2022 and 2023 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:68.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.505%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Named Executive Officer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 Base Salary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Base Salary</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,050,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,050,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">515,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">580,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">535,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">580,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">475,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500,000</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Ms. Brittenham was not a named executive officer in 2022. Therefore, in accordance with SEC rules, her compensation is only disclosed for the year ended December 31, 2023. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2024, the Compensation Committee determined that the 2024 base salary for Mr. Evans would remain the same as 2023, and the 2024 base salaries for the other NEOs would be set at the following amounts: Mr. Doherty - $650,000, Ms. Baldock - $600,000, Ms. Brittenham - $500,000 and Mr. Owens - $550,000. The Compensation Committee believes that the base salary for each NEO is competitive and reasonable compared to the peer group and survey benchmark data.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Special Cash Bonuses</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In acknowledgment of his efforts in connection with the successful completion of certain transactions in 2023, the Compensation Committee awarded Mr. Doherty a discretionary transaction bonus of $200,000 in cash for 2023. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Short-Term Incentive Awards</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company maintains the Cash Incentive Plan under which our Compensation Committee determines annual cash incentives for the Company's key employees, including our NEOs, based on achievement of pre-established annual financial goals. We provide </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">an annual award opportunity under the Cash Incentive Plan in order to tie a significant part of the overall compensation of each of our executive officers to short-term corporate goals and objectives. Payments under the Cash Incentive Plan can be paid in cash or in common stock issued under the Omnibus Incentive Plan.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2023 Awards</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The target bonus opportunity for each of our NEOs is based on a percentage of base salary, is established based on each NEO's respective level of management responsibility and is based on the achievement of certain established goals. For 2023, the target bonus opportunity as a percentage of base salary for each of our NEOs was as follows: Mr. Evans - 120%, Mr. Doherty - 85%, Ms. Baldock - 85%, Ms. Brittenham - 60% and Mr. Owens - 65%. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For 2023, the Compensation Committee determined that the primary financial metric to be measured for purposes of determining the annual cash awards payable to our NEOs would be Adjusted EBITDA. In addition to Adjusted EBITDA, other metrics are applicable to certain NEOs as described below. In February 2023, the Compensation Committee established 2023 Adjusted EBITDA performance levels. Performance levels were set relative to the prior fiscal year's actual results and current fiscal year projections. The threshold performance level is the minimum performance level required for a payout under the Cash Incentive Plan, and the maximum performance level is the maximum payout. Performance targets are set with the intent that achievement will enhance stockholder value.</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:53.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.059%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.059%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.062%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Cash Incentive Plan Performance Goals</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Threshold</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA (in millions)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$399.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$420.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$436.8</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payout</span></div></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200%</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the Company's Adjusted EBITDA for 2023 is equal to or greater than $399.0 million, but less than $420.0 million, then the percentage of the target award that may be earned will be determined using a straight line interpolation between 25% and 100%. If the Company&#8217;s Adjusted EBITDA is equal to or greater than $420.0 million, but less than $436.8 million, the percentage of the target award that shall become earned will be determined using a straight line interpolation between 100% and 200%.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">With respect to Messrs. Evans and Doherty and Ms. Brittenham, the target bonus opportunity for 2023 is earned solely based on the Company's Adjusted EBITDA performance goals. With respect to Ms. Baldock&#8217;s target bonus opportunity for 2023, 50% is earned based on the Company&#8217;s Adjusted EBITDA performance goals and 50% is earned based on the achievement of certain goals associated with the Company&#8217;s acquisition and divestiture activity. With respect to Mr. Owens target bonus opportunity for 2023, 50% is earned based on the Company&#8217;s Adjusted EBITDA performance goals and 50% is earned based on the achievement of performance goals specific to the National Group over which Mr. Owens is President. Similar to the Adjusted EBITDA performance goal, each of Ms. Baldock and Mr. Owens may earn above the target award applicable to their specific roles. Notwithstanding the foregoing, if the Company's Adjusted EBITDA is less than the threshold, no cash incentive award may be earned by the NEOs.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For 2023, the Company's Adjusted EBITDA was $438.1 million. However, after evaluating the Company's 2023 performance, the Compensation Committee determined that, while the Company's Adjusted EBITDA exceeded the targeted and maximum level of performance, the varying levels of performance across the Company justified aggregate incentive payments below the targeted amounts (rather than 100%). As a result, the NEOs earned the following incentive payments:</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.095%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Named Executive Officer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Cash Incentive Award Earned</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519,050</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,000</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Awards</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2024, the Compensation Committee established incentive award opportunities for 2024 for our NEOs under the Cash Incentive Plan. The Compensation Committee determined that 70% of the award would be based on the Company's Adjusted EBITDA, 15% of the award would be based on the Company's Net Revenue and 15% of the award would be based on the Company's Free Cash Flow, as well as other metrics applicable to certain NEOs described below. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The target amount that may be earned by each NEO for 2024 under the Cash Incentive Plan is set forth below:</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.095%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Named Executive Officer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 Short-Term Incentive Award Target</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,260,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,000</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the Company's Adjusted EBITDA, Net Revenue and Free Cash Flow for the year ending December 31, 2024 is equal to or greater than the threshold for each metric, but less than the target range for each metric, then the percentage of the target award related to Adjusted EBITDA, Net Revenue and Free Cash Flow that may be earned will be determined using a straight line interpolation between 25% and 100% of the target award for each metric. Additionally, up to 200% of the target award related to Adjusted EBITDA, Net Revenue and Free Cash Flow can be earned depending on the extent to which the Company's Adjusted EBITDA, Net Revenue and Free Cash Flow exceeds the target for each metric. If the Company's Adjusted EBITDA, Net Revenue or Free Cash Flow is less than the applicable threshold for such metric, then the portion of the cash incentive award related to such metric would not be earned.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Each of Mr. Evans', Mr. Doherty's, Ms. Baldock's and Ms. Brittenham's target bonus opportunity for 2024 is earned solely based on the Company's Adjusted EBITDA, Net Revenue and Free Cash Flow performance goals. As described above, if the Company's Adjusted EBITDA, Net Revenue or Free Cash Flow is less than the applicable threshold for such metric, then the portion of the cash incentive award related to such metric would not be earned.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">With respect to Mr. Owens target bonus opportunity for 2024, 50% is earned based on the Company&#8217;s Adjusted EBITDA, Net Revenue and Free Cash Flow performance as described above and 50% is earned based on the achievement of performance goals specific to the National Group over which Mr. Owens is President. As described above, if the Company's Adjusted EBITDA, Net Revenue or Free Cash Flow is less than the applicable threshold for such metric, then the portion of the cash incentive award related to such metric would not be earned. Additionally, with respect to the 50% portion of the cash incentive award related to Mr. Owens' performance-specific target as President of National Group, no cash incentive award may be earned if at least 25% of the target is not achieved.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Incentive Awards</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our long-term equity incentive program is designed to reward our NEOs for Company performance, drive sustainable, long-term growth for our Company and our stockholders, and reinforce retention.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2023 Annual Awards</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Each of our NEOs received equity grants in 2023 under the Omnibus Incentive Plan. Except as otherwise described herein, the long-term incentive award opportunity for each of our NEOs for 2023 is shown in the table below:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.742%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Named Executive Officer</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Time-based restricted stock</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs (at Threshold)</span></div></td></tr><tr style="height:23pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"># shares of common stock</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"># units of common stock</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,950</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,950</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,302</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,302</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,259</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,259</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,172</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,172</span></td></tr></table></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For our annual grants in 2023, the Compensation Committee generally determined that 50% of the grant date value to be delivered under the Company's long-term equity incentive program would consist of time-based restricted stock and the remaining 50% would consist of Performance Stock Units ("PSUs").</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The time-based restricted stock awards vest in increments of one-third on each of the first, second and third anniversaries of the date of grant, generally subject to the executive's continued employment. The Compensation Committee believes that grants of time-based restricted stock foster employee share ownership, align the interests of our NEOs with those of our stockholders, and enhance retention by requiring continued employment over a period of years.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The PSUs provide our NEOs with the opportunity to earn a specified number of shares of common stock based on a one-time vesting on the third anniversary of the grant date if certain performance criterion is achieved during the three-year period. This creates a three-year incentive and alignment period.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the PSUs awarded during 2023, the Compensation Committee set the threshold performance level as Adjusted EBITDA of $535.9 million by December 31, 2025 (the &#8220;Performance Period End Date&#8221;). If Adjusted EBITDA on the Performance Period End Date is equal to or greater than $535.9 million, but less than $550.2 million, then 100% of the award may be earned. If Adjusted EBITDA on the Performance Period End Date is equal to or greater than $550.2 million, but less than $564.9 million, then 200% of the award may be earned. If Adjusted EBITDA is $564.9 million or more on the Performance Period End Date, then 300% of the award may be earned. The number of shares earned by the NEOs pursuant to the PSUs awarded during 2023 will not be determinable until the Performance Period End Date.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2023 Special Awards</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2023, the Compensation Committee determined to grant additional special long-term equity-based incentive awards to Mr. Doherty, Ms. Baldock and Ms. Brittenham as a further retention incentive based on their key roles in the Company. The special long-term incentive award opportunity provided for a time-based restricted stock award of $1,000,000 for Mr. Doherty granting him 30,432 shares of common stock, $750,000 for Ms. Baldock granting her 22,824 shares of common stock and $500,000 for Ms. Brittenham granting her 15,216 shares of common stock. The time-based restricted stock awards have a one-time vesting on the third anniversary of the grant date, generally subject to continued employment.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2024 Annual Awards</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2024, the Compensation Committee utilized long-term equity-based incentive awards consisting of (i) three-year time vesting restricted stock awards (40%) and (ii) PSUs subject to Company performance with a one-time vesting on the third anniversary of the grant date if the performance criterion is achieved during the three-year period (60%). The long-term incentive award opportunity for each of our NEOs for 2024 is shown in the table below:</span></div><div style="margin-bottom:12pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.742%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Named Executive Officer</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Time-based restricted stock</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs (at Threshold)</span></div></td></tr><tr style="height:23pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"># shares of common stock</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"># units of common stock</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,760,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,446</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,640,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,669</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,657</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,486</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,243</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,864</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,697</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,545</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,262</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,394</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As with the 2023 awards, the 2024 time-based restricted stock awards vest in one-third increments on each anniversary of the date of grant, generally subject to the executive&#8217;s continued employment. With respect to the 2024 PSUs, performance is determined with respect to the achievement of an Adjusted EBITDA goal by the third anniversary of the grant date. If the Company&#8217;s Adjusted EBITDA is equal to or greater than the threshold, then the percentage of the award that may be paid out to the NEOs is 100%, and up to 300%, subject to varying levels of performance in excess of the threshold and a potential positive or negative modification by 10% based on the Company's Total Shareholder Return ("TSR") during the performance period. No shares are earned for performance below threshold. The shares that are earned will be subject to a one-time cliff vesting on the third anniversary of the grant date.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2024 Special Awards</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2024, the Compensation Committee also granted a one-time special time-based restricted stock award of 2,886 shares of common stock (which had a value of $90,000 as of the grant date) to Ms. Brittenham as a further retention incentive based on her key role in the Company. The time-based restricted stock award will vest over two years in equal increments on each anniversary of the grant date, generally subject to continued employment.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"> Retirement and Welfare Benefits and Perquisites</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All of our full-time employees, including our NEOs, are eligible to participate in our health and welfare plans, including medical, dental, vision, life and disability insurance. Our NEOs participate in these plans on the same basis as other eligible employees. We do not maintain any supplemental health and welfare plans for our NEOs.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the Company maintains a 401(k) plan in which eligible employees are permitted to participate. The Company&#8217;s 401(k) plan is a tax-qualified defined contribution retirement plan under which eligible employees may defer their eligible </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">compensation, subject to the limits imposed by the Internal Revenue Code, and under which the Company may make discretionary matching contributions.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also maintain the Symbion, Inc. Supplemental Executive Retirement Plan (the "SERP"), a nonqualified deferred compensation plan, for certain former management of Symbion, Inc., including Ms. Baldock. Under the SERP, participants may elect to defer up to 25% of annual base salary and up to 50% of bonus each year. Eligible employees who elect to defer are also entitled to an annual Company contribution under the SERP equal to 2% of base salary.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Severance Arrangements</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company provides severance protection to each of our NEOs pursuant to employment agreements in the event that his or her employment is terminated by the Company without cause or he or she resigns for good reason. For a description of the severance protections provided to our NEOs please see "Executive Compensation - Potential Payments upon Termination or Change in Control" below.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Non-GAAP Financial Metrics in our Executive Compensation Program</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe that presenting certain non-GAAP measures can be helpful to investors who may wish to use some or all of this information to analyze the Company&#8217;s performance, prospects, and valuation. The items excluded from these non-GAAP metrics are significant components in understanding and evaluating our financial performance. We believe such adjustments are appropriate, as the magnitude and frequency of such items can vary significantly and are not related to the assessment of normal operating performance. We believe that the non-GAAP measures discussed below are appropriate for evaluating the performance of the Company for compensation-related purposes.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adjusted EBITDA</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For compensation purposes, &#8220;Adjusted EBITDA&#8221; is calculated as income before income taxes, adjusted for net income attributable to noncontrolling interests; depreciation and amortization; interest expense, net; equity-based compensation expense; transaction, integration and acquisition costs; net loss (gain) on disposals, consolidations and deconsolidations; litigation settlements and other litigation costs and other adjustments that are not related to the assessment of normal operating performance. We use Adjusted EBITDA as a measure of financial performance. Adjusted EBITDA is a key measure used by our management to assess operating performance, make business decisions and allocate resources. The Committee may consider such other adjustments to the calculation of Adjusted EBITDA as it reasonably determines are appropriate in accordance with the discretion provided to the Committee under the Incentive Plan.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A reconciliation of Adjusted EBITDA to income before income taxes, the most directly comparable GAAP financial measure can be found in "Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations - Certain Non-GAAP Measures" in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2023.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For purposes of the calculation of 2024 Adjusted EBITDA, the Compensation Committee intends to make adjustments, in its reasonable discretion, that are appropriate to account for extraordinary corporate events. The accretive earnings resulting from any acquisitions completed during 2024 will result in an adjustment that increases the performance goal, as calculated by the Compensation Committee in its discretion. Additionally, the Compensation Committee may consider such other adjustments to the calculation of Adjusted EBITDA as it reasonably determines are appropriate in accordance with the discretion provided to the Compensation Committee under the Omnibus Incentive Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risk Management and Compensation</span></div><div><span><br/></span></div><div style="text-indent:18.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Compensation Committee believes that the Company&#8217;s compensation policies and practices are an integral part of the Board&#8217;s risk management. Our Compensation Committee considers various features of our compensation policies and practices that discourage excessive or unnecessary risk taking, including but not limited to the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Appropriate pay philosophy, peer group and other market comparability data and market positioning to align with and support business objectives;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Effective balance in:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Cash and equity pay mix, including the use of restricted stock, PSUs and stock options, used to focus employees on mitigating downside risk while generating long-term gains;</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Short- and longer-term performance focus;</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Management and Board discretion to manage pay as it deems appropriate in light of Company and industry developments; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Compensation Committee oversight of our compensation policies and practices to determine whether they encourage excessive risk-taking and evaluate compensation policies and practices that could mitigate any such risk.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Compensation Committee believes that the Company's executive compensation program does not encourage inappropriate risk-taking and the level of risk associated with the Company's compensation programs is not reasonably likely to have a material adverse effect on the Company.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Stock Ownership Guidelines</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compensation Committee believes that, in order to demonstrate alignment of the interests of management and the directors with the stockholders of the Company, NEO&#8217;s and non-employee directors should have and maintain a significant equity stake in the Company. As a result, we have adopted share ownership and retention guidelines applicable to the NEOs and non-employee directors, which require:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The CEO to hold shares of Company common stock with a fair market value equal to five times their current base salary;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Other named executive officers to hold shares of Company common stock with a fair market value equal to three times their current base salary; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Non-employee directors and the Executive Chairman of the Company to hold shares of Company common stock with a fair market value equal to five times their annual retainer.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The guidelines provide that all owned stock, restricted stock awards and vested performance stock unit awards count towards the ownership guidelines.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compensation Committee will monitor compliance with these guidelines on an annual basis. Until the minimum share ownership requirement applicable to an NEO or non-employee director is satisfied, and thereafter whenever the minimum share ownership requirement is not satisfied, such NEO or non-employee director must retain 50% of the net shares received by such person as a result of the exercise of stock options, payout of performance unit awards, or any other award under the Omnibus Incentive Plan. As of March 30, 2024, all of the Company&#8217;s NEOs and non-employee directors (other than the directors associated with Bain Capital) met the minimum share ownership guidelines, except for Ms. Brittenham, who became an NEO in 2023 and Dr. Maryland, who became a member of our Board in February 2021. The NEOs and non-employee directors (other than the directors associated with Bain Capital) must make good faith efforts to satisfy the minimum share ownership requirements described above; however, there is no specific time period in which an NEO or non-employee director must satisfy the minimum share ownership requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Say-on-Pay Feedback from Stockholders</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Each year, the Compensation Committee considers the results of the prior year's advisory vote as it reviews and determines the compensation packages of our NEOs. In 2023, we received support for our executive compensation program, as approximately 94% of total votes cast on the advisory vote on executive compensation voted to approve the proposal.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">28</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_70"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF THE COMPENSATION COMMITTEE</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy Statement with the Company's management and, based on such review and discussions, has recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement. &#160;&#160;&#160;&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Submitted by the Compensation Committee:</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;T. Devin O'Reilly, Chairman</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Brent Turner</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Andrew T. Kaplan</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;John A. Deane</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">29</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_73"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION</span></div><div><span><br/></span></div><div id="i227833c13def44249bd1572bf17f4242_76"></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Compensation Table</span></div><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes information regarding the compensation awarded to, earned by or paid to our named executive officers during the years ended December 31, 2023, 2022 and 2021.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:22.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.662%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and Principal Position</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Salary</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bonus</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)(6)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Equity Incentive Plan Compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Pension Value and Nonqualified Deferred Compensation Earnings</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">All Other Compensation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">J. Eric Evans</span></div><div style="margin-bottom:2pt;padding-left:13.5pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Chief Executive Officer</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$1,050,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$4,400,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$1,000,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$7,600</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$6,457,600</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,050,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,645,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">390,500</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,325</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,092,825</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,050,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,500,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">750,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,123</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,307,123</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">David T. Doherty</span></div><div style="margin-bottom:2pt;padding-left:13.5pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Executive Vice President and Chief Financial Officer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">567,500</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">200,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,400,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">345,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,600</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,519,100</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">499,394</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">250,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,000,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">274,238</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,907</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,030,539</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;padding-right:2.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jennifer B. Baldock</span></div><div style="padding-left:13.5pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Executive Vice President, Chief Administrative and Development Officer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">571,346</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,950,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">519,050</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29,999</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18,300</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,088,695</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">508,461</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">800,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">525,940</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(34,802)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15,725</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,815,324</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">420,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">600,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">452,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34,036</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16,100</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,522,136</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Marissa A. Brittenham</span></div><div style="margin-bottom:2pt;padding-left:13.5pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Executive Vice President and Chief Strategy Officer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">470,192</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,000,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">200,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,100</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,677,292</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bradley R. Owens</span></div><div style="margin-bottom:2pt;padding-left:13.5pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">President, National Group</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">500,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">800,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">300,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,600</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,607,600</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">476,923</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,300,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">200,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,100</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,984,023</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">391,923</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">600,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">390,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,800</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,388,723</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Mr. Doherty was not a named executive officer until 2022. Therefore, in accordance with SEC rules, his compensation is only disclosed for the years ended December 31, 2023 and 2022.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Ms. Brittenham was not a named executive officer until 2023. Therefore, in accordance with SEC rules, her compensation is only disclosed for the year ended December 31, 2023.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects a transaction bonus paid to Mr. Doherty in acknowledgment of his efforts in connection with the successful completion of certain transactions in 2023.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects a transaction bonus paid to Mr. Doherty in acknowledgment of his efforts in connection with the successful completion of the Company&#8217;s public equity offering in November 2022.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects the dollar amounts of the aggregate grant date fair value of stock and PSUs granted to our NEOs, as determined in accordance with FASB ASC Topic 718. These amounts do not reflect the actual amounts that may be paid or realized by our NEOs and exclude the effect of estimated forfeitures. The aggregate grant date fair value of the time-based restricted stock awards was calculated using the closing price of our common stock on the grant date. The aggregate grant date fair value of the PSUs was determined based on the probable outcome of the applicable performance conditions associated with such award. The PSU awards were valued based on a grant date fair value of $32.86 per share (for awards granted in 2023), $54.03 per share (for awards granted in 2022), $42.04 per share (for awards granted in 2021), except that the PSU awards granted to Mr. Doherty on February 1, 2022 had a grant date fair value of $44.80 per share.</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Assuming that the maximum performance goals are attained for the PSUs granted in 2023, 2022 and 2021, the aggregate grant date fair value of the annual grants of PSUs would have been: </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.222%"><tr><td style="width:1.0%"/><td style="width:48.749%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.713%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.713%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 PSU Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 PSU Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 PSU Awards</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6,600,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6,000,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt 0 3.25pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,875,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,100,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,200,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 3.25pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,800,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,200,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 3.25pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 3.25pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,200,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,200,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 3.25pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">400,000</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The underlying valuation assumptions for PSUs are further disclosed in footnotes to our consolidated financial statements filed with our annual reports on Form 10-K for the years ended December 31, 2023, 2022 and 2021.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">In connection with our public equity offering on November 21, 2022, Mr. Evans agreed to receive $500,000 of any 2022 annual cash incentive bonus earned in shares of our common stock, valued at the public offering price paid by purchasers in the offering ($24.50 per share). As a result, upon the Board&#8217;s determination that Mr. Evans had earned an aggregate annual cash incentive award of $890,500, the award was settled on March 24, 2023 with (i) the payment of $390,500 in cash and (ii) the issuance of 20,408 shares of common stock ($500,000 divided by $24.50) with a grant date fair value of approximately $645,000. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects the dollar amounts of cash incentives earned by our NEOs under our Cash Incentive Plan. Please refer to the section titled "Compensation Discussion and Analysis - Elements of Named Executive Officer Compensation - Short-Term Incentive Awards" above for additional details regarding our cash incentive program. Does not include awards under the Cash Incentive Plan for which shares of common stock have been issued in lieu of cash incentive payments, which awards are included in the &#8220;Stock Awards&#8221; column of the Summary Compensation Table.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects the items set forth in the table below, as applicable to each NEO:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company </span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">401(k) match contributions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company contributions under the SERP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6,600</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$7,600</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,100</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,225</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,325</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,800</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,323</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,123</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,600</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,600</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,907</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,907</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,600</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,700</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,300</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,100</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,400</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,225</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,725</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,800</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,400</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,900</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,100</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,600</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,100</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,600</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,600</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,100</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,100</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,800</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,800</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.91pt">Reflects Company matching contributions to the Company's 401(k) Plan which is a broad-based tax-qualified defined contribution plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects Company contributions to the Symbion, Inc. Supplemental Executive Retirement Plan, a nonqualified deferred compensation plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.91pt">Reflects cell phone reimbursement and Company contributions to the NEOs health savings accounts for the applicable year.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">31</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Grants of Plan-Based Awards</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth information regarding grants of non-equity and equity-based awards granted to each of our NEOs during the year ended December 31, 2023. </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:14.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.403%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Future Payouts Under Non-Equity Incentive Plan Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Future Payouts Under Equity Incentive Plan Awards</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">All other stock awards: Number of shares of stock (# of shares)</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date fair value of stock and option awards</span></div></td></tr><tr style="height:59pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Type of Award</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Threshold</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:3.37pt;padding-right:3.37pt;text-align:center;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Target</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Threshold (# of shares)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Target (# of shares)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum (# of shares)</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash Incentive</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$315,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$1,260,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$2,520,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">66,950</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,200,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSUs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">66,950</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">133,900</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">200,850</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,200,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="4" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash Incentive</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">123,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">493,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">986,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30,432</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21,302</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">700,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSUs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21,302</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">42,604</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">63,906</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">700,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="4" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash Incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">123,250</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">493,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">986,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22,824</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18,259</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSUs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18,258</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36,518</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">54,777</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash Incentive</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">71,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">285,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">570,000</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15,216</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,608</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSUs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7,608</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15,216</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22,824</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bradley R. Owens</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash Incentive</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">81,250</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">325,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">650,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,172</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">PSUs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3/2/23</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,172</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24,344</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36,516</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects annual cash incentive opportunities granted under our Cash Incentive Plan. Each NEO was eligible to receive a target annual bonus that is equal to a percentage of his or her annual base salary. For 2023, the target bonus opportunity as a percentage of base salary for each of our NEOs was as follows: Mr. Evans - 120%, Mr. Doherty - 85%, Ms. Baldock - 85%, Ms. Brittenham - 60% and Mr. Owens - 65%. See "Compensation Discussion and Analysis - Elements of Named Executive Officer Compensation - Short-Term Incentive Awards" for additional information.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects grants of restricted stock awards to our NEOs under our equity incentive plan, as described in "Compensation Discussion and Analysis - Elements of Named Executive Officer Compensation - Long-Term Incentive Awards - 2023 Annual Awards" above. Each restricted stock award will vest as to one-third of the award on each of the first, second and third anniversaries of the date of grant, generally contingent upon continued employment through each such vesting date (except as expressly provided in the award agreement evidencing the grant of such restricted stock award).</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects the threshold, target and maximum future payouts under the PSUs granted to our NEOs under our equity incentive plan. PSUs provide our NEOs with the opportunity to earn a specified number of shares of common stock subject to a cliff vesting based on achievement of certain Company performance objectives over a three-year period, thereby creating a three-year incentive and alignment period. For a description of the PSU vesting terms, see "Compensation Discussion and Analysis - Elements of Named Executive Officer Compensation - Long-Term Incentive Awards - 2023 Annual Awards."</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects grants of restricted stock awards to the NEO under our equity incentive plan, as described in "Compensation Discussion and Analysis - Long-Term Incentive Awards - 2023 Special Awards" above. Each restricted stock award is subject to a one-time vesting on the third anniversary of the grant date, generally contingent upon continued employment through such vesting date (except as expressly provided in the award agreement evidencing the grant of such restricted stock award).</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects the aggregate grant date fair value of time-based restricted stock awards granted to our NEOs in 2023, as determined in accordance with FASB ASC Topic 718. These amounts do not reflect the actual amounts that may be paid or realized by our NEOs and exclude the effect of estimated forfeitures. The aggregate grant date fair value of the time-based restricted stock awards was calculated using the closing price of a share of the Company's common stock on the date of grant.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects the aggregate grant date fair value of PSUs granted to NEOs in 2023, as determined in accordance with FASB ASC Topic 718. These amounts do not reflect the actual amounts that may be paid or realized by our NEOs and exclude the effect of estimated forfeitures. The aggregate grant date fair value of the PSUs was determined based on the probable outcome of the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">applicable performance conditions associated with such award. The award was valued using the closing price of a share of the Company's common stock on the date of grant.</span></div><div id="i227833c13def44249bd1572bf17f4242_82"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Narrative Disclosure to Summary Compensation Table and 2023 Grants of Plan-Based Awards Table</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have entered into employment agreements with each of our NEOs. A summary of certain terms follows:</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">J. Eric Evans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Pursuant to Mr. Evans' employment agreement, as amended, an annual base salary was established, subject to adjustment at the discretion of our Compensation Committee, and he is eligible to receive an annual bonus with a target amount equal to $750,000. For information regarding Mr. Evans' base salary and bonus eligibility in 2023, please see "Compensation Discussion and Analysis." Mr. Evans is eligible to participate in the Company's employee benefit programs for senior executives. Mr. Evans is entitled to benefits upon certain terminations of employment, as described in "Executive Compensation - Potential Payments upon Termination or Change in Control" below. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">David T. Doherty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Pursuant to Mr. Doherty&#8217;s employment agreement, an annual base salary was established, subject to adjustment at the discretion of the Board or our Compensation Committee, and he is eligible to receive an annual bonus with a target amount equal to 75% of his base salary. For information regarding Mr. Doherty&#8217;s base salary and bonus eligibility in 2023, please see "Compensation Discussion and Analysis." Mr. Doherty&#8217;s is eligible to participate in the Company&#8217;s employee benefit programs for senior executives. For a description of the payments and benefits Mr. Doherty may be entitled to in connection with a termination of employment, see "- Potential Payments upon Termination or Change in Control" below.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Jennifer B. Baldock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Pursuant to Ms. Baldock's amended and restated employment agreement, an annual base salary was established, subject to adjustment at the discretion of the Board or the Compensation Committee. Ms. Baldock is also eligible to earn an annual cash bonus based on the achievement of certain performance goals with a target of 60% of her base salary. For information regarding Ms. Baldock&#8217;s base salary and bonus eligibility in 2023, please see "Compensation Discussion and Analysis." Ms. Baldock is eligible to participate in our employee benefit plans, as may be in effect from time to time. For a description of the payments and benefits Ms. Baldock may be entitled to in connection with a termination of employment, see "- Potential Payments upon Termination or Change in Control" below. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Marissa A. Brittenham</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Pursuant to Ms. Brittenham&#8217;s employment agreement, an annual base salary was established, subject to adjustment at the discretion of the Board or the Compensation Committee. Ms. Brittenham is also eligible to earn an annual cash bonus based on the achievement of certain performance goals with a target of 60% of his base salary. For information regarding Ms. Brittenham&#8217;s base salary and bonus eligibility in 2023, please see "Compensation Discussion and Analysis." Ms. Brittenham is eligible to participate in our employee benefit plans, as may be in effect from time to time. For a description of the payments and benefits Ms. Brittenham may be entitled to in connection with a termination of employment, see "-Potential Payments upon Termination or Change in Control" below.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Bradley R. Owens</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Pursuant to Mr. Owens' employment agreement, an annual base salary was established, subject to adjustment at the discretion of the Board or the Compensation Committee. Mr. Owens is eligible to earn an annual cash bonus based on the achievement of certain performance goals with a target of 60% of his base salary. For information regarding Mr. Owens&#8217; base salary and bonus eligibility in 2023, please see "Compensation Discussion and Analysis." Mr. Owens is eligible to participate in the Company&#8217;s employee benefit plans, as may be in effect from time to time. For a description of the payments and benefits Mr. Owens may be entitled to in connection with a termination of employment, see "-Potential Payments upon Termination or Change in Control" below.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, each of our NEOs received equity grants under the Omnibus Incentive Plan, as described in "Short-Term Incentive Awards" and "Long-Term Incentive Awards" in the "Compensation Discussion and Analysis" section above.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">33</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at Fiscal Year-End</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table sets forth information regarding equity awards held by our NEOs as of December 31, 2023. </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"/><td style="width:10.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.228%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Awards</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Securities Underlying Unexercised Options (#) Exercisable</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Securities Underlying Unexercised Options (#) Unexercisable</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Exercise Price</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Expiration Date</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of shares or units of stock that have not vested (#)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Market value of shares or units of stock that have not vested </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(14)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: Number of unearned shares, units or other rights that have not yet vested (#)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: Market or payout value of unearned shares, units or other rights that have not yet vested </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(14)</span></div></td></tr><tr style="height:12pt"><td colspan="3" rowspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$11.54</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/1/2029</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,956 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,542</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,433 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,782</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,433 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,782</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,678 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">789,449</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,950 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,141,731</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,016 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,184,142</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,950 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,141,731</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="7" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,487 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,569</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,230 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,338</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,928 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,607</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,302 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681,451</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,432 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">973,520</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,928 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(12)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,607</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,302 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">681,451</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="8" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,500 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.42</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/15/2029</span></div></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,784 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,070</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,676 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,605</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,936 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,903</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,259 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584,105</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,824 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">730,140</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,403 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236,822</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,259 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584,105</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="5" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,068 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226,105</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,608 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,380</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,216 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">486,760</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,370 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(12)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267,756</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,608 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,380</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="7" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bradley R. Owens</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,586 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,736</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,379 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,104</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,936 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,903</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,254 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296,035</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,172 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">389,382</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,403 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236,822</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,172 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">389,382</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents non-qualified stock options granted on April 1, 2019 to Mr. Evans in connection with the commencement of his employment with the Company, which became fully vested on December 31, 2022.  </span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents non-qualified stock options granted on March 15, 2019, in exchange for the cancellation of previously issued LPUs. The non-qualified stock options became fully vested on December 31, 2022. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents remaining one-third of restricted stock awards granted on March 10, 2021, of which one-third of the original award vests upon the first, second and third anniversaries of the date of grant, generally subject to continued employment through each vesting date.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents remaining one-half of PSUs granted on March 10, 2021, which were deemed earned on February 10, 2022 of which one-half vest on each February 10, 2023 and 2024.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents remaining one-half of special PSUs granted on March 10, 2021, which were deemed earned on February 10, 2022 of which one-half vest on each February 10, 2023 and 2024.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents remaining two-thirds of restricted stock awards granted on March 11, 2022, of which one-third of the original award vests upon the first, second and third anniversaries of the date of grant, generally subject to continued employment through each vesting date.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents remaining two-thirds of restricted stock awards granted on February 1, 2022, of which one-third of the original award vests upon the first, second and third anniversaries of the date of grant, generally subject to continued employment through each vesting date.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents special restricted stock awards granted on March 11, 2022, of which one-half of the original award vests upon the second and third anniversaries of the date of grant, generally subject to continued employment through each vesting date.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents restricted stock awards granted on March 2, 2023, of which one-third of the original award vests upon the first, second and third anniversaries of the date of grant, generally subject to continued employment through each vesting date.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.34pt">Represents special restricted stock awards granted on March 2, 2023, which are subject to a one-time cliff vesting on the third anniversary of the date of grant, generally subject to continued employment through the vesting date.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.34pt">Represents PSUs granted (at target) on March 11, 2022, which vest on the third anniversary of the grant date if certain performance criterion is achieved during the three-year period.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.34pt">Represents PSUs granted (at target) on February 1, 2022, which vest on the third anniversary of the grant date if certain performance criterion is achieved during the three-year period.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:1.34pt">Represents PSUs granted on March 2, 2023, which vest as set forth in the section titled "Compensation Discussion and Analysis - Elements of Named Executive Officer Compensation - Long-Term Incentive Awards - 2023 Annual Awards."</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.34pt">Based on the closing price of a share of our common stock on December 29, 2023 of $31.99, except as otherwise indicated.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Option Exercises and Stock Vested</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table sets forth information regarding stock awards that vested for our NEOs during the year ended December 31, 2023. No options were exercised by our NEOs during the year ended December 31, 2023.</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:56.281%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.932%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Awards</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares Acquired on Vesting (#)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value Realized on Vesting</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,603 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$987,545</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,905 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707,763</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,123</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,433 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,700</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,433 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,222</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,433 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,222</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,338 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373,718</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,408 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645,913</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,521 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,521</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,781 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,553</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,654</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,153</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,170</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,464 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,205</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,737 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,514</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614,802</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,571</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,571</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,004</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,725</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,534 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,329</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,520 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288,361</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,280 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498,658</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,292</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,438</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,092</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,725</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents one-third of the award of restricted stock granted on March 13, 2020 that vested on March 13, 2023. The closing price per share of our common stock on March 10, 2023 (the last trading date prior to the vesting date) was $30.29.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents PSUs granted on March 13, 2020 that became earned as of February 24, 2021, and of which one-half vested on February 24, 2023. The closing price per share of our common stock on February 23, 2023 (the last trading date prior to the vesting date) was $34.92.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents one-third of the award of restricted stock granted on March 10, 2021 that vested on March 10, 2023. The closing price per share of our common stock on March 9, 2023 (the last trading date prior to the vesting date) was $31.71.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents one-half of the award of restricted stock granted on March 10, 2021 that vested on March 10, 2023. The closing price per share of our common stock on March 9, 2023 (the last trading date prior to the vesting date) was $31.71.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents PSUs granted on March 10, 2021 that became earned as of February 10, 2022, and of which one-half vested on February 10, 2023. The closing price per share of our common stock on February 9, 2023 (the last trading date prior to the vesting date) was $33.26.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents special PSUs granted on March 10, 2021 that became earned as of February 10, 2022, and of which one-half vested on February 10, 2023. The closing price per share of our common stock on February 9, 2023 (the last trading date prior to the vesting date) was $33.26.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents one-third of the award of restricted stock granted on March 11, 2022 that vested on March 11, 2023. The closing price per share of our common stock on March 10, 2023 (the last trading date prior to the vesting date) was $30.29.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents unrestricted common stock granted on March 24, 2023. In connection with our public equity offering on November 21, 2022, Mr. Evans agreed to receive $500,000 of any 2022 annual cash incentive bonus earned in shares of our common stock, valued at the public offering price paid by purchasers in the offering ($24.50 per share). The closing price per share of our common stock on March 23, 2023 (the last trading date prior to the grant date) was $31.65.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents one-third of the award of restricted stock granted on August 28, 2020 that vested on August 28, 2023. The closing price per share of our common stock on August 25, 2023 (the last trading date prior to the vesting date) was $34.00.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.34pt">Represents one-third of the award of restricted stock granted on February 1, 2022 that vested on February 1, 2023. The closing price per share of our common stock on January 31, 2023 (the last trading date prior to the vesting date) was $33.20.</span></div><div id="i227833c13def44249bd1572bf17f4242_88"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nonqualified Deferred Compensation</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding the value of accumulated benefits of our NEOs under our nonqualified deferred compensation arrangements as of December 31, 2023.</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:20.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive contributions in last fiscal year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company contributions in last fiscal year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate earnings in last fiscal year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate withdrawals/ distributions</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate balance at last fiscal year end</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,427</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,700</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,999</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,192</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Reflects contributions by each of our NEOs to the Symbion, Inc. Supplemental Executive Retirement Plan (the "SERP") during 2023.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Reflects Company contributions to the SERP on behalf of each of our NEOs during 2023.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Reflects aggregate earnings accrued on the accounts of each of our NEOs during 2023.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Ms. Baldock has participated in the SERP, a nonqualified deferred compensation plan sponsored by Symbion, which is an unfunded plan available to executives and certain key employees and directors of Symbion, an indirect subsidiary of the Company. Under the SERP, participants are permitted to defer up to 25% of their annual base salary and up to 50% of their bonus each year. Symbion makes a matching contribution for each participant who contributed at least 2% of base salary earned during such plan year and who was employed as of the last day of the plan year. Each Symbion contribution is subject to forfeiture for one year following the contribution. Symbion does not provide above-market or preferential earnings on deferred compensation.</span></div><div id="i227833c13def44249bd1572bf17f4242_91"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Potential Payments upon Termination or Change in Control</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Employment Agreement-Related Severance Benefits for our NEOs Employed at the End of 2023</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described above under the heading "Executive Compensation - Narrative Disclosure to Summary Compensation Table and 2023 Grants of Plan-Based Awards Table," we have entered into employment agreements with each of our continuing NEOs, which were amended and restated effective March 8, 2022 (except for Mr. Evans and Mr. Doherty). Each of our NEOs is entitled to receive certain benefits upon a qualifying termination of employment and/or upon certain change in control transactions accompanied by a qualifying termination of employment within a certain period of time following such transaction. The following discussion is based on the employment agreements in effect as of December 31, 2023. The employment agreements provide for severance upon a termination of employment by us without cause or by the executive for good reason, in each case conditioned on the executive's timely and effective execution of a release of claims acceptable to the Company, and other customary terms and conditions.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Each of our NEOs (except Mr. Evans) is entitled to severance consisting of 12 months of continued base salary, an amount equal to their target bonus payable within three months following the end of the fiscal year of termination, and continued health and welfare plan benefits at the same cost to such NEO as if the NEO were an active employee of the Company during the severance period. Under the employment agreements with each of our NEOs, if a qualifying termination occurs within the 90 days prior to or 12 months </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">following a change in control, the executive is entitled to be paid the severance benefits described above in a single lump-sum payment no later than 30 days following termination. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Mr. Evans is entitled to severance consisting of 12 months of continued base salary, an amount equal to his target bonus payable when such bonuses are paid to employees, and 12 months of COBRA coverage following the date of such termination at no cost to Mr. Evans during the severance period.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, if Ms. Baldock&#8217;s, Ms. Brittenham's, Mr. Owens&#8217; or Mr. Doherty&#8217;s employment is terminated without cause or for good reason such NEO is entitled to accelerated vesting of time-based restricted stock awards and of earned PSUs to the vesting event next following the date on which the employment period is terminated. Furthermore, with respect to PSU awards granted after December 31, 2021, held by such as of the date on which the employment is terminated without cause or for good reason that have not been converted to earned PSUs, such NEO&#8217;s rights under the award will be fully vested based on the number of shares that would be earned under the award based on performance measured through the end of the employment period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Equity-Related Severance and Change of Control Benefits</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Restricted Stock Awards</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In accordance with our NEOs' restricted stock award agreements, unvested restricted stock is forfeited upon a termination of employment, except that the vesting of any unvested restricted stock will become immediately accelerated in full (1) on a termination of employment by the NEO due to death or disability, or (2) on a termination of employment by the Company without "cause" or resignation by the executive for "good reason" (each as defined in the applicable award agreement) within 90 days prior to or 18 months following a change in control. If, in connection with a change in control, unvested shares of restricted stock are not assumed or continued, or a new award substituted for the unvested shares of restricted stock, such unvested shares will automatically vest in full.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Performance Stock Units</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In accordance with our NEOs' PSU award agreements, upon a termination of employment for any reason, (1) any PSUs that are not yet earned are immediately forfeited, and (2) any PSUs that are earned but unvested are immediately forfeited, except that the vesting of any unvested earned PSUs will become immediately accelerated in full (a) on a termination of employment by the NEO due to death or disability, or (b) on a termination of employment by the Company without "cause" or resignation by the executive for "good reason" (each as defined in the applicable award agreement) within 90 days prior to or 18 months following a change in control.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If a change in control occurs during the performance period, the Compensation Committee will determine the extent to which the performance criteria has been satisfied and the number of PSUs that have been earned based on such performance criteria as of the change in control (which is prorated based on the number of days that have elapsed during the performance period). Thereafter, earned PSUs, if any, continue to vest solely based on time in accordance with the terms of the award agreement. If, in connection with a change in control, earned PSUs are not assumed or continued, or a new award substituted for the earned PSUs, the earned PSUs will automatically vest in full.</span></div><div><span><br/></span></div><div style="text-indent:18.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Stock Option Awards</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In accordance with our NEOs' stock option award agreements, if any of our continuing NEOs employment is terminated without cause or for good reason by such NEO within 90 days prior to or 18 months following a change in control, then the stock option awards, to the extent outstanding and which have not previously vested in accordance with Time Condition shall automatically be deemed to have vested immediately prior to such NEO&#8217;s cessation of employment with the Company; provided, however, that the performance vesting requirements of such stock option awards shall remain in full force and effect. For purposes of satisfying the "Time Condition" portion of the stock option awards vesting, one-third (1/3) vested in three equal installments on each of December 31, 2020, December 31, 2021, and December 31, 2022, generally contingent upon continued employment through each applicable vesting date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Terms and Conditions</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to their respective employment agreements, our NEOs are bound by certain restrictive covenants, including covenants relating to confidentiality and assignment of intellectual property rights, as well as covenants not to compete with us or to solicit our employees or other service providers during employment and for a specified period following termination of employment. Each of our  NEOs is bound by a non-competition covenant for one year following termination of employment, and by a non-solicitation covenant for two years following termination of employment.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the payments that would have been made to our continuing NEOs upon the occurrence of a termination of employment or a change in control, assuming that each NEO's termination of employment with the Company or a change in control occurred on December 31, 2023. Amounts shown do not include (i) accrued but unpaid salary, and (ii) other benefits </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">earned or accrued by the continuing NEO during his or her employment that are available to all salaried employees and that do not discriminate in scope, terms or operations in favor of executive officers.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:22.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.265%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.781%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.954%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.957%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Death/Disability</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination Without Cause / Resignation</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">for Good</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reason</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Without Cause / Resignation for Good Reason In</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Connection with a</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Control</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Eric Evans</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash&#160;Severance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,310,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,310,000</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Payout / Acceleration</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,565,286 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,565,286 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,544</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,544</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash&#160;Severance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073,000</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Payout / Acceleration</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059,484 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488,861 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059,484 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,467</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,467</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash&#160;Severance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073,000</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Payout / Acceleration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614,823 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416,329 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614,823 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,544</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,544</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marissa A. Brittenham</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash&#160;Severance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760,000</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Payout / Acceleration</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956,245 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,179 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956,245 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,960</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,960</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley R. Owens</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash&#160;Severance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825,000</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Payout / Acceleration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970,161 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,603 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970,161 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,722</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,722</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Represents an amount equal to (a) 12 months of base salary continuation, and (b) the executive's target bonus for the year of termination. Under each of the continuing NEO's employment agreements, if a qualifying termination occurs within 12 months following a change in control, the executive is entitled to be paid the severance benefits described above in a single lump-sum payment no later than 30 days following termination.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Represents the dollar value of 12 months Company-paid continued health and welfare benefits.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Represents the value of the unvested portion of the NEO's time-based restricted stock awards and the value of the unvested portion of the NEO's earned PSUs, in each case, as of December 31, 2023. The value of the awards is calculated by multiplying the number of shares of Company stock subject to acceleration by $31.99, the closing price of our common stock on December 29, 2023.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Represents an amount equal to the value of the NEO's restricted stock awards and earned PSUs that are subject to time-vesting conditions, in each case, as if vesting occurred on December 31, 2023 (but not with respect to awards with time-vesting conditions that would be satisfied after December 31, 2024). The value of the restricted stock awards and PSUs is calculated by multiplying the number of shares of Company stock subject to acceleration by $31.99, the closing price of our common stock on December 29, 2023.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Represents an amount equal to the value of the unvested portion of all of the NEO's time-based restricted stock awards and earned PSUs. The value of the restricted stock awards and PSUs is calculated by multiplying the number of shares of Company stock subject to acceleration by $31.99, the closing price of our common stock on December 29, 2023.</span></div><div id="i227833c13def44249bd1572bf17f4242_94"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CEO Pay Ratio</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K, we are providing the following information regarding the ratio of total annual compensation for Mr. Evans, our Chief Executive Officer, to the median of the annual total compensation of all our employees (other than the Chief Executive Officer) (the "CEO Pay Ratio"). For 2023:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Total annual compensation for Mr. Evans: $6,457,600</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Median annual total compensation of all employees (other than Chief Executive Officer): $53,792</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ratio of the annual total compensation of the Chief Executive Officer to the median of the annual total compensation of all employees (other than the Chief Executive Officer): 120:1</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In determining the median employee, we chose December 31, 2023 as the date to identify our median employee, and we identified </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">our median employee using a consistently applied compensation measure which included total gross payroll wages received in 2023. Our total employee population as of December 31, 2023 was approximately 13,500. After we identified our median employee, we measured the annual total compensation under SEC rules using: base salary earned in 2023, annual cash bonus earned for the 2023 performance year, the grant date value of any equity awards he or she received in 2023, and the 401(k) match provided by the Company in 2023, in each case, to the extent applicable. Pay was annualized for permanent employees not employed for a full year in 2023. We calculated the median employee's total annual compensation using the same methodology we used to calculate Mr. Evans&#8217; annual total compensation, as reflected in the "Total" column of the Summary Compensation Table. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This pay ratio is a reasonable estimate calculated in a manner consistent with SEC rules based on our records and the methodology described above. The SEC rules for identifying the median compensated employee and calculating the pay ratio based on that employee's annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their compensation practices. As such, the pay ratio reported by other companies may not be comparable to the pay ratio reported above.</span></div><div id="i227833c13def44249bd1572bf17f4242_97"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following sets forth certain information regarding compensation actually paid to our NEOs compared to certain measures of our financial performance for the years ended 2023, 2022, 2021 and 2020:</span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-5" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.211%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based On:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Summary Comp. Table Total for CEO (Evans)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comp. Actually Paid to CEO (Evans)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Summary Comp. Table Total for CEO (DeVeydt)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comp. Actually Paid to CEO (DeVeydt)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average Summary Comp. Table Total for Non-CEO NEOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average Comp. Actually Paid to Non-CEO NEOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">TSR</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Peer Group TSR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted EBITDA (in millions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-6">6,457,600</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-7">7,260,168</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-8">2,473,172</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-9">2,646,951</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="1" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-10">204.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="1" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-11">142.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-12">135.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-13">438.1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">6,092,825</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">3,342,023</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">1,670,372</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-17">1,192,139</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="1" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-18">178.0</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="1" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-19">147.8</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-20">87.0</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-21">380.2</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">4,307,123</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-23">14,217,126</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-24">1,541,025</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-25">6,060,779</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="1" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-26">341.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="1" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-27">146.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-28">70.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-29">339.6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-30">3,541,863</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-31">16,996,689</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">559,528</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-33">13,280,517</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-34">1,284,162</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-35">6,249,898</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="1" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-36">185.3</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="1" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-37">111.9</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-38">1.3</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-39">256.6</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-40" continuedAt="f-40-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects compensation amounts reported in the Summary Compensation Table for our CEO for the respective years shown. Until his appointment as Executive Chairman on January 13, 2020, <ix:nonNumeric contextRef="c-8" name="ecd:PeoName" id="f-41">Mr. DeVeydt</ix:nonNumeric> served as Chief Executive Officer of the Company. <ix:nonNumeric contextRef="c-7" name="ecd:PeoName" id="f-42"><ix:nonNumeric contextRef="c-5" name="ecd:PeoName" id="f-43"><ix:nonNumeric contextRef="c-2" name="ecd:PeoName" id="f-44"><ix:nonNumeric contextRef="c-3" name="ecd:PeoName" id="f-45">Mr. Evans</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>, who previously served as Executive Vice President and Chief Operating Officer, was appointed to replace Mr. DeVeydt as the Chief Executive Officer of the Company effective January 13, 2020.</span></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-46" continuedAt="f-46-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">&#8220;Compensation Actually Paid to CEO&#8221; in each of 2023, 2022, 2021 and 2020 reflects the respective Summary Compensation Table total  adjusted as set forth in the table below, as determined in accordance with SEC rules.</span></ix:nonNumeric></div><ix:continuation id="f-46-1"><div style="margin-bottom:9pt;margin-top:3pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"/><td style="width:49.331%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.813%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.813%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.813%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.813%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CEO</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DeVeydt</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-47">3,541,863</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-48">559,528</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-49">4,307,123</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-50">6,092,825</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-51">6,457,600</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Equity Award Amounts Reported in Summary Compensation Table</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-52">2,250,000</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-53">125,000</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-54">2,500,000</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-55">4,645,000</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-56">4,400,000</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Fair Value of Current Year Equity Awards Outstanding/Unvested at Year End</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-57">8,512,317</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-58">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-59">3,175,972</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-60">2,062,532</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-61">4,283,461</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-62">375,000</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-63">125,000</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-64">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-65">645,000</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-66">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Value of Prior Years&#8217; Awards Outstanding/Unvested at Year End</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-67">4,977,917</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-68">10,794,029</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-69">8,437,390</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-70">3,285,321</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-71">336,661</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Value of Prior Years&#8217; Awards That Vested in the Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-72">1,839,592</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-73">1,926,960</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-74">4,620,973</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-75">4,212,059</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-76">582,446</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Fair Value of Prior Years' Awards Forfeited in the Year</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-77">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-78">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-79">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-80">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-81">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Fair Value of Prior Years' Awards Failing to Meet Vesting Conditions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-82">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-83">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-84">3,824,332</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-85">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-86">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-87">16,996,689</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-88">13,280,517</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-89">14,217,126</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-90">3,342,023</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-91">7,260,168</ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fair value or change in fair value, as applicable, of equity awards was determined as follows: (1) for restricted stock awards and earned PSU awards, the closing price on applicable year-end date or, in the case of vesting, the closing price as of each vest date, (2) for unearned PSU awards, closing price on applicable year-end date multiplied by the probability of achievement as of each such date, and (3) for option and SSAR awards, a Black-Scholes value as of the applicable year-end or vesting date(s), determined based on the same methodology as used to determine grant date fair value for the applicable grant.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(3)</span><ix:continuation id="f-40-1" continuedAt="f-40-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects average compensation amounts reported in the Summary Compensation Table for our non-CEO NEOs for the respective years shown. The following non-CEO NEOs are included in the average figures shown: </span></ix:continuation></div><ix:continuation id="f-40-2" continuedAt="f-40-3"><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023: David T. Doherty, Jennifer B. Baldock, Marissa A. Brittenham, Bradley R. Owens</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="f-40-3"><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022: David T. Doherty, Thomas F. Cowhey, Jennifer B. Baldock, Harrison R. Bane, Bradley R. Owens</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021: Thomas F. Cowhey, Jennifer B. Baldock, Anthony W. Taparo, Bradley R. Owens</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2020: Thomas F. Cowhey, Jennifer B. Baldock, George M. Goodwin, Anthony W. Taparo</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(4)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-92" continuedAt="f-92-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">&#8220;Average Compensation Actually Paid to non-CEO NEOs&#8221; in each of 2023, 2022, 2021 and 2020 reflects the respective average Summary Compensation Table total adjusted as set forth in the table below, as determined in accordance with SEC rules.</span></ix:nonNumeric></div><ix:continuation id="f-92-1" continuedAt="f-92-2"><div style="margin-bottom:9pt;margin-top:3pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"/><td style="width:60.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.528%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-93">1,284,162</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-94">1,541,025</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-95">1,670,372</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-96">2,473,172</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Equity Award Amounts Reported in Summary Compensation Table</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-97">654,625</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-98">661,875</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-99">1,020,000</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-100">1,537,500</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Fair Value of Current Year Equity Awards Outstanding/Unvested at Year End</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-101">2,326,667</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-102">840,847</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-103">768,546</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-104">1,496,764</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-105">142,125</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-106">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-107">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-108">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Value of Prior Years&#8217; Awards Outstanding/Unvested at Year End</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-109">2,251,193</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-110">3,008,559</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-111">502,425</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-112">81,948</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Value of Prior Years&#8217; Awards That Vested in the Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-113">900,376</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-114">1,714,650</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-115">401,924</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-116">132,567</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Fair Value of Prior Years' Awards Forfeited in the Year</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-117">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-118">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-119">1,706,708</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-120">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Fair Value of Prior Years' Awards Failing to Meet Vesting Conditions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-121">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-122">382,427</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-123">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-124">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-125">6,249,898</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-126">6,060,779</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-127">1,192,139</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-128">2,646,951</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-92-2">Fair value or change in fair value, as applicable, of equity awards was determined as follows: (1) for restricted stock awards and earned PSU awards, the closing price on applicable year-end date or, in the case of vesting, the closing price as of each vest date, (2) for unearned PSU awards, closing price on applicable year-end date multiplied by the probability of achievement as of each such date, and (3) for option and SSAR awards, a Black-Scholes value as of the applicable year-end or vesting date(s), determined based on the same methodology as used to determine grant date fair value for the applicable grant.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(5)</span><ix:nonNumeric contextRef="c-1" name="ecd:PeerGroupIssuersFnTextBlock" id="f-129" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects the cumulative total shareholder return for the Dow Jones U.S. Health Care Providers Index.</span></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(6)</span><ix:nonNumeric contextRef="c-1" name="ecd:Additional402vDisclosureTextBlock" id="f-130" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">For compensation purposes, "<ix:nonNumeric contextRef="c-1" name="ecd:CoSelectedMeasureName" id="f-131">Adjusted EBITDA</ix:nonNumeric>" is calculated as income before income taxes, adjusted for net income attributable to noncontrolling interests; depreciation and amortization; interest expense, net; equity-based compensation expense; transaction, integration and acquisition costs; net loss (gain) on disposals, consolidations and deconsolidations; litigation settlements and other litigation costs and other adjustments that are not related to the assessment of normal operating performance. We use Adjusted EBITDA as a measure of financial performance. Adjusted EBITDA is a key measure used by our management to assess operating performance, make business decisions and allocate resources. Adjusted EBITDA is the core long-term metric we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled "Compensation Discussion and Analysis - Elements of Named Executive Officer Compensation."</span></ix:nonNumeric></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Relationship between Pay and Performance</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-132" continuedAt="f-132-1" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in more detail in the sections entitled "Compensation Discussion and Analysis" and "Executive Compensation," the Company&#8217;s executive compensation program reflects a variable pay-for-performance philosophy, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">with a significant emphasis on long-term performance and stockholder value creation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. While the Company utilizes several performance measures to align executive compensation with Company performance, all of those Company measures are not presented in the Pay versus Performance table. Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not specifically align the Company&#8217;s performance measures with "Compensation Actually Paid" for a particular year. We believe the "Compensation Actually Paid" in each of the years reported above and over the three-year cumulative period are reflective of the Compensation Committee&#8217;s emphasis on "pay-for-performance" as the "Compensation Actually Paid" fluctuated year-over-year, primarily due to the result of our stock performance and our varying levels of achievement against pre-established performance goals. </span></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="f-132-1"><div style="text-align:center;text-indent:18pt"><img src="sgry-20240425_g2.jpg" alt="9.2 Pay v Performance - 1TSR graph.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div></ix:continuation><div style="text-align:center;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-134" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="f-133" escape="true"><div style="text-align:center;text-indent:18pt"><img src="sgry-20240425_g3.jpg" alt="9.3 Pay v Performance - 2Fin Perf graph.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Performance Measures</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following financial performance measure reflects the Company's most important performance measure for the most recently completed fiscal year used by the Company to link compensation actually paid to our NEOs, to the Company&#8217;s performance:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><ix:nonNumeric contextRef="c-1" name="ecd:TabularListTableTextBlock" id="f-136" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:32.5pt"><ix:nonNumeric contextRef="c-73" name="ecd:MeasureName" id="f-135">Adjusted EBITDA</ix:nonNumeric></span></ix:nonNumeric></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">42</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_100"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTOR COMPENSATION</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table sets forth information concerning the compensation earned by our directors for the year ended December 31, 2023.</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.325%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fees Earned or Paid in Cash</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayne S. DeVeydt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$250,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$250,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brent Turner</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teresa DeLuca, M.D.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John A. Deane</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clifford G. Adlerz</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">T. Devin O'Reilly&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew T. Kaplan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patricia A. Maryland, Dr.PH</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blair E. Hendrix </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Mr. DeVeydt received a cash retainer for serving as our Executive Chairman.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Messrs. O'Reilly, Kaplan and Hendrix did not receive compensation for their service on the Board because they are associated with Bain Capital.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">Amounts reflect the aggregate grant date fair value of restricted stock awards granted on June 1, 2023, determined in accordance with FASB ASC Topic 718. The assumptions used in the valuation of share awards are set forth in Note 10 to our consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2023. As of December 31, 2023, each of Dr. DeLuca, Dr. Maryland and Messrs. Adlerz, Dean and Turner held unvested restricted stock awards of 4,192 shares. Also, Mr. Turner held</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> 4,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> shares of common stock underlying stock options exercisable as of December 31, 2023.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">With respect to 2023, each member of our Board who was not an employee and who was not associated with Bain Capital (other than Mr. DeVeydt), was eligible to receive an annual cash retainer payment of $100,000 and an annual award of restricted stock having an aggregate grant date fair value equal to $160,000. The restricted stock awards vest in full on the first anniversary of the grant date. Mr. DeVeydt was eligible to receive an annual cash retainer payment of $250,000 for serving as Executive Chairman. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the chair of the Audit Committee is entitled to an additional cash retainer payment of $25,000, the chair of the Compensation Committee is entitled to an additional cash retainer payment of $20,000, the chair of the Compliance and Ethics Committee is entitled to an additional cash retainer payment of $20,000 and the chair of the Nominating and Corporate Governance Committee is entitled to an additional cash retainer payment of $20,000.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">43</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_103"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 3: APPROVAL OF EMPLOYEE STOCK PURCHASE PLAN</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Board adopted, subject to approval of the Company's stockholders, an employee stock purchase plan (the &#8220;ESPP&#8221;) including the reservation of 1,500,000 shares of our common stock for issuance under the ESPP. The Board believes that the adoption of this proposal is in the best interests of the Company for the reasons discussed below. The following description of the ESPP is qualified in its entirety by the full text of the ESPP attached to this Proxy Statement as Appendix A.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Background and Purpose of the Proposal</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The ESPP was adopted by the Board to be effective within 12 months following approval by the Company&#8217;s stockholders. The ESPP is a broad-based plan that provides an opportunity for eligible employees of the Company and its designated affiliates to purchase common stock at a discount from the market price. The ESPP is designed to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Internal Revenue Code.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company believes that employee participation in stock ownership through the ESPP will help to achieve the unity of purpose conducive to the continued growth of the Company and to the mutual benefit of its stockholders and the employees of the Company and its affiliates. Participation in the ESPP will be entirely voluntary by our employees.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event that the ESPP is approved by stockholders, the Company expects to register the shares available under the ESPP with the SEC on a registration statement on Form S-8.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Consequences of Failing to Approve the Proposal</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the ESPP is not approved by our stockholders, the employees will not be able to acquire our Company&#8217;s stock through the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Summary of the ESPP</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following description of the ESPP is only a summary of the material features and does not describe all of its provisions. This summary is qualified in its entirety by reference to the text of the ESPP, attached as Appendix A.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Purpose</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purpose of the ESPP is to provide an added incentive for eligible employees of the Company to promote the Company&#8217;s best interests by providing an opportunity for those employees to purchase shares of common stock at below-market prices through payroll deductions. The ESPP is intended to align the interests of the Company&#8217;s stockholders and employees by increasing the proprietary interest of employees in the Company&#8217;s growth and success, advance the interests of the Company by attracting and retaining employees and motivate employees to act in the long-term best interests of the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Administration</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The ESPP is administered by the Compensation Committee, which has full discretionary authority to make determinations regarding the interpretation and application of the provisions of the ESPP and to adopt rules, policies and procedures for administering the ESPP as it deems necessary. The Compensation Committee also has the discretion to identify affiliates of the Company whose employees are included in ESPP participation. Any such determinations will be made by the Compensation Committee in its sole discretion and will be final and conclusive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Eligibility</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Generally, any person who is employed by the Company, or by an affiliate of the Company that has been designated by the Compensation Committee for participation, may participate in the ESPP; provided, however, the following individuals may not participate: (1) a person employed for less than 90 days; (2) an employee who is customarily employed less than 20 hours per week; (3) an employee whose customary employment is for five months or less in a calendar year; or (4)  an employee who would own, immediately after such grant, more than 5% of our outstanding capital stock, including stock that may be acquired through outstanding options, stock held in a business entity or trust and stock held by certain family members. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of April 25, 2024, it is anticipated that approximately 10,000 individuals would be eligible to participate in the ESPP when it becomes effective.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Shares Available for Issuance</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If approved by the Company&#8217;s stockholders at the Annual Meeting, the maximum number of shares of common stock that may be purchased under the ESPP will be 1,500,000 shares, subject to adjustment for stock dividends, stock splits or combinations of shares of the Company&#8217;s stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Offering Periods</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If approved, the ESPP will offer an option to purchase our common stock on the first day of each calendar quarter following effectiveness of the ESPP. Each offering period will continue for a period of three months that ends on the last day of such calendar quarter. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Participation in the Plan</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">An eligible employee may become a participant in the ESPP by giving instructions to the plan recordkeeper authorizing payroll deductions, and payroll deductions for each participant will begin after such instructions are received in good order, subject to compliance with the Company&#8217;s insider trading policies and such rules and procedures as may be established by the Compensation Committee. An employee&#8217;s payroll deductions or other contributions under the ESPP may not exceed $6,250 in each calendar quarter. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The option exercise price or purchase price for the common stock under the ESPP is 90% of the average market value of our common stock on the first and last day of each three-month offering period, based on the closing price on those two dates. However, the exercise price cannot be less than 85% of the market value of our common stock on the last or first trading day of the offering period. At the end of each offering period, the Company will apply the funds that have been withheld from each participant&#8217;s payroll to purchase the largest number of whole shares of common stock at the exercise price. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A participant&#8217;s payroll deduction election will automatically remain in effect for successive offering periods until the participant provides new instructions or terminates employment. A participant may modify his or her payroll deductions during an offering period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Withdrawal from the Plan</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A participant may elect to withdraw and terminate payroll deductions from the ESPP at any time. Upon withdrawal, all payroll deductions credited to the participant during the offering period will be returned to the participant in cash, without interest. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Upon a participant&#8217;s termination of employment, unless due to death or disability, payroll deductions that have not yet been used to exercise the option will be returned without interest to the participant. Upon a termination due to death or disability, the participant (or personal representative) may elect to remain in the ESPP until the end of the offering period or withdraw from the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Restrictions on Transfer</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Rights to acquire common stock that are granted under the ESPP are not transferable by a participant other than by will or the laws of descent and distribution following the participant&#8217;s death.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Duration, Amendment and Termination</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Board has the power to amend or terminate the ESPP at any time. However, stockholder approval is required within 12 months before or after the Board adopts an amendment to increase the maximum number of shares that may be issued under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Adjustments Upon Changes in Capitalization</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the event of any increase or decrease in the number of issued shares of common stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification or other extraordinary corporate event, the Compensation Committee shall proportionally adjust the maximum number of shares issuable under the ESPP, the price per share and the number of shares of common stock covered by each option under the ESPP that has not yet been exercised in order to prevent dilution or enlargement of the rights of participants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Participation by the Company&#8217;s Named Executive Officers</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s named executive officers will be eligible to participate in the ESPP on the same terms and conditions as all other participants and will continue to remain eligible, conditioned on approval of the ESPP by our stockholders.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Federal Income Tax Consequences</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary describes U.S. federal income tax consequences of participation in the ESPP, but is not a complete description of all U.S. federal tax laws or regulations that may apply and does not address any state or local laws. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No taxable income is realized by a participant on the grant of an option under the ESPP or upon the purchase of common stock at the end of an offering period. The stock purchased under the ESPP is eligible for long-term capital gain treatment if it is held for at least two years after the grant date and at least one year from the purchase date. If the exercise price is less than the market value of the common stock at the beginning of the offering period, the participant will recognize ordinary income on a portion of the proceeds. In that situation, the amount of ordinary income is the lesser of (a) the market value of the stock at the time of the disposition, less the exercise price and (b) the market value of the common stock at the beginning of the offering period, minus the exercise price. The participant&#8217;s tax basis in the shares is the amount paid to exercise the option plus the amount of any ordinary income that is recognized upon disposition. Any additional amount of gain recognized on the disposition of the shares will be long-term capital gain. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If an employee disposes of the shares prior to the holding periods described above, the transaction is a disqualifying disposition and the participant will recognize ordinary income in the year of disposition. The taxable amount will be equal to the difference between the fair market value of the common stock at the end of the offering period and the exercise price paid. The amount of such ordinary income will be added to the participant&#8217;s tax basis in the shares. Any subsequent gain at the time of disposition will be taxed as a capital gain.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company will generally be entitled to a deduction in the year of a disqualifying disposition equal to the amount of ordinary income realized by the participant as a result of such disposition, subject to the satisfaction of any tax-reporting obligations. In all other cases, no deduction is allowed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">New Plan Benefits</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The benefits to be received pursuant to the ESPP by the Company&#8217;s employees are not currently determinable as they will depend on the purchase price of our common stock in offering periods after the implementation of the ESPP, the market value of our shares on various future dates, the amount of contributions that eligible employees elect to make under the ESPP, and similar factors. As of the date of this Proxy Statement, no employee has been granted an option to purchase shares under the ESPP, as the implementation is conditioned on approval of the ESPP by our stockholders.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Securities Authorized for Issuance under the Company&#8217;s Equity Compensation Plans</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table represents securities authorized for issuance under the Company's equity compensation plans as of December 31, 2023:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted- Average Exercise Price of Outstanding Options, Warrants and Rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in the First Column) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Compensation Plans Approved by Security Holders</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,095,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,270,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Compensation Plans Not Approved by Security Holders</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,095,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,270,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes shares available for future issuance under the Omnibus Incentive Plan.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE APPROVAL OF THE EMPLOYEE STOCK PURCHASE PLAN.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">46</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_106"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 4: RATIFICATION OF THE AUDIT COMMITTEE&#8217;S APPOINTMENT OF THE</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Audit Committee selected Deloitte &amp; Touche LLP ("Deloitte") as the Company's principal independent registered public accounting firm for the year ending December 31, 2024. Such selection of Deloitte was approved by the Board, and the Company seeks ratification of the appointment by the stockholders.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Audit Committee annually reviews the independent registered public accounting firm's independence, including reviewing all relationships between the independent registered public accounting firm and us and any disclosed relationships or services that may impact the objectivity and independence of the independent registered public accounting firm, and the independent registered public accounting firm's performance.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although ratification of the selection of Deloitte is not required by our bylaws or otherwise, the Board is submitting the selection of Deloitte to our stockholders for ratification as a matter of good corporate governance. If the selection is not ratified, the Audit Committee will consider whether it is appropriate to select another independent registered public accounting firm. Even if the selection is ratified, the Audit Committee in its discretion may select a different registered public accounting firm at any time during the year if the committee determines that such a change would be in the best interests of the Company and our stockholders.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A representative of Deloitte is expected to attend the Annual Meeting and will have an opportunity to make a statement if he or she so chooses. The representative will also be available to respond to appropriate questions from stockholders. </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE "FOR"</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE RATIFICATION OF THE AUDIT COMMITTEE&#8217;S APPOINTMENT OF DELOITTE AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">47</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_109"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FEES PAID TO INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deloitte served as Surgery Partners' independent registered public accounting firm for the fiscal years ended December 31, 2023 and December 31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Audit Committee pre-approves all auditing services and permitted non-audit services (including the fees and terms thereof) to be performed by the Company's independent registered public accounting firm, subject to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> exception for non-audit services that are approved by the Audit Committee prior to the completion of an audit. Each member of the Audit Committee has been delegated the authority to pre-approve any audit services, provided that such approvals must be presented to the full Audit Committee at its next scheduled meeting. The Audit Committee pre-approved all services performed by Deloitte during 2023.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit and Other Fees for Past Two Fiscal Years</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the years ended December 31, 2023 and 2022, the Company incurred the following fees for services performed by Deloitte:</span></div><div style="margin-top:14pt;padding-left:31.5pt;padding-right:31.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.694%"><tr><td style="width:1.0%"/><td style="width:62.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,975,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit-Related Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,727,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,170,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Audit Fees include fees for the last two years for professional services rendered by Deloitte in connection with (i) the audits of the Company's annual consolidated financial statements, (ii) the audits of the Company's internal control over financial reporting, (iii) the review of the Company's quarterly condensed consolidated financial statements, and (iv) services that are provided by Deloitte related to regulatory filings and private placement debt offerings, including billings for out-of-pocket expenses incurred.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Audit-related fees during 2023 and 2022 relate to audits performed for grant funds received.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Tax related services performed during 2023 and 2022.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">All Other Fees encompasses any services provided other than the services reported as Audit Fees, Audit-Related Fees or Tax Fees, which in 2023 and 2022 were related to accounting research services.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">48</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_112"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF THE AUDIT COMMITTEE</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Audit Committee of the Board is currently composed of the three directors named below, each of whom is an independent director (as independence is defined in the Nasdaq rules and Rule 10A-3 under the Exchange Act). Each member of the Audit Committee who served at any time during the fiscal year ended December 31, 2023 is financially literate (as that qualification has been interpreted by the Board in its business judgment), and at least one member of the Audit Committee qualifies as an "audit committee financial expert" as such term is defined by the SEC. The Audit Committee operates under a written charter.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Audit Committee hereby submits the following report:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The Audit Committee has reviewed and discussed with management the Company's audited consolidated financial statements as of, and for, the year ended December 31, 2023.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The Audit Committee has discussed with the Company's independent registered public accounting firm, Deloitte, the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (the "PCAOB") and the SEC.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The Audit Committee has received and reviewed the written disclosures and the letter from Deloitte required by applicable requirements of the PCAOB regarding Deloitte's communications with the Audit Committee concerning independence, and has discussed with Deloitte such firm's independence.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Based on the foregoing review and discussions, the Audit Committee recommended to the Board that the financial statements referred to above be included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 for filing with the SEC.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Submitted by the Audit Committee:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Brent Turner, Chairman</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Teresa DeLuca, M.D.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;John A. Deane</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">49</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_118"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RELATED PERSON TRANSACTIONS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Related Person Transaction Policy</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have adopted a formal written policy with respect to the review, approval and ratification of related person transactions. Under the policy, our Audit Committee is responsible for reviewing and approving related person transactions. In the course of its review and approval of related person transactions, our Audit Committee considers the relevant facts and circumstances to decide whether to approve such transactions, including, but not limited to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the impact on a director's independence in the event the related person is a director or an immediate family member of the director;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the benefits to us of the proposed transaction;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">if applicable, the availability of other sources of comparable products or services;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the terms of the transaction; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the terms available to an unrelated third party or to employees generally.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Audit Committee may also consider such factors as: the related person's relationship to us and interest in the transaction, and the material facts of the proposed transaction, including the proposed aggregate value of the transaction. The Audit Committee may approve only those transactions that are in, or are not inconsistent with, our best interests and those of our stockholders, as the Audit Committee determines in good faith.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Registration Rights Agreement</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 31, 2017, the Company entered into an Amended and Restated Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;) with certain securityholders of the Company and certain other parties thereto, including Bain Capital. Pursuant to the Registration Rights Agreement, among other things, and subject to certain limitations, the Company agreed to use commercially reasonable efforts to effect the registration under the Securities Act of 1933, as amended, of the registrable shares held by the parties to the Registration Rights Agreement. The Company also agreed to provide, with certain exceptions, certain piggyback registration rights with respect to such registrable shares, as described in the Registration Rights Agreement. Additionally, in connection with the private issuance and sale of our common stock to certain affiliates of Bain Capital on December 22, 2022 (the &#8220;Private Placement&#8221;), the Registration Rights Agreement was amended to extend the registration rights granted thereunder to the shares purchased in the Private Placement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Indemnification Agreements</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We enter into indemnification agreements with each of our directors and executive officers. These agreements require us to indemnify these individuals and, in certain cases, affiliates of such individuals, to the fullest extent permissible under Delaware law against liabilities that may arise by reason of their service to us or at our direction, and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified.</span></div><div id="i227833c13def44249bd1572bf17f4242_121"></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL MATTERS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Code of Conduct and Corporate Governance Guidelines</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have adopted a Code of Conduct which is applicable to all our directors, officers and employees (the "Code of Conduct"). To the extent required pursuant to applicable SEC regulations, we intend to post amendments to, or waivers from, our Code of Conduct on our website.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Copies of our Code of Conduct and Corporate Governance Guidelines are available, free of charge, on the "Investors - Governance" page of our website at www.surgerypartners.com, or by sending a written request to our Chief Administrative and Development Officer at Surgery Partners, Inc., 340 Seven Springs Way, Suite 600, Brentwood, Tennessee 37027.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Availability of Certain Documents</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Householding is a program adopted by the SEC that permits companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for annual reports, proxy statements and the notices of internet availability of proxy materials sent to multiple stockholders of record who have the same address by delivering a single annual report, proxy statement or notice of internet availability of proxy materials to that address. Householding is designed to reduce a company's printing costs and postage fees. Brokers with account holders who are stockholders of the Company may be householding the Company's proxy materials. If your </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">household participates in the householding program, you will receive one Notice of Internet Availability. If you are a beneficial holder, you can request information about householding from your broker, bank or other nominee. If at any time you no longer wish to participate in householding and would prefer to receive a separate proxy statement, annual report or notice of internet availability of proxy materials, please notify your broker if your shares are held in a brokerage account or us if you are a stockholder of record. We will undertake to deliver promptly, upon written or oral request, a separate copy to a stockholder at a shared address. You may notify us either by calling us at (615) 234-5900 or by writing to us at Surgery Partners, Inc., 340 Seven Springs Way, Suite 600, Brentwood, Tennessee 37027, Attn: Chief Administrative and Development Officer, and providing your name, your shared address, and the address to which we should direct the additional copy of the annual report or proxy materials. Multiple stockholders sharing an address who have received one copy of a mailing and would prefer us to mail each stockholder a separate copy of future mailings should contact us at our principal executive office. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, if current stockholders with a shared address received multiple copies of a mailing and would prefer us to mail one copy of future mailings to stockholders at the shared address, notification of that request may also be made through our principal executive offices. Stockholders who participate in householding will continue to have access to and utilize separate proxy voting instructions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Stockholder Proposals and Nominations</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Requirements for Stockholder Proposals to be Considered for Inclusion in our Proxy Materials.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> To be considered for inclusion in next year's Proxy Statement, stockholder proposals must be received by our Secretary at our principal executive offices no later than the close of business on December 26, 2024, which is 120 days prior to the date that is one year from April 25, 2024 (the date this year's Proxy Statement was first made available to stockholders).</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Requirements for Stockholder Proposals or Director Nominations to be Brought Before an Annual Meeting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Our bylaws provide that, for stockholder nominations to the Board or other proposals to be considered at an annual meeting, the stockholder must have given timely notice thereof in writing to the Company's Secretary at 340 Seven Springs Way, Suite 600, Brentwood, Tennessee 37027. The Board does not have a written policy regarding stockholder nominations, but has determined that it is the practice of the Board to consider candidates proposed by stockholders if made in accordance with our bylaws. To be timely for the 2025 annual meeting, although not included in the Proxy Statement, the stockholder's notice must be delivered to or mailed and received by us not earlier than the close of business on the 120th day nor later than the close of business on the 90th day prior to the anniversary date of the prior year's annual meeting, except that if the annual meeting is set for a date that is not within 30 days before or after such anniversary date, we must receive the notice not later than the close of business on the tenth day following the day on which we first provide notice or public disclosure of the date of the meeting. Assuming the date of our 2025 annual meeting is not so advanced or delayed, stockholders who wish to make a proposal at the 2025 annual meeting must notify us no earlier than February 6, 2025 and no later than March 8, 2025. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Such notice must provide the information required by our bylaws with respect to each matter the stockholder proposes to bring before the 2025 annual meeting.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to satisfying the foregoing advance notice requirements under our bylaws, to comply with the universal proxy rules for the 2025 annual meeting, stockholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Securities Exchange Act of 1934, as amended, no later than April 7, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Contacting the Board of Directors</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Stockholders wishing to communicate with the Board may do so by writing to the Board or to the non-employee members of the Board as a group, at:</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Surgery Partners, Inc.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">340 Seven Springs Way, Suite 600</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Brentwood, TN 37027</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Attention: Chief Administrative and Development Officer</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The communication must prominently display the legend "BOARD COMMUNICATION" in order to indicate to the Chief Administrative and Development Officer that it is a communication for the Board. Upon receiving such a communication, the Chief Administrative and Development Officer will forward the communication to the relevant individual or group to which it is addressed as appropriate depending on the facts and circumstances outlined in the communication received. Certain items that are unrelated to the Board's duties and responsibilities may be excluded, such as spam, junk mail and mass mailings, resumes and other forms of job inquiries, surveys and business solicitations or advertisements. The Chief Administrative and Development Officer will not forward any communication determined in his or her good faith belief to be frivolous, unduly hostile, threatening, illegal or similarly unsuitable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other Matters</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of the date of this Proxy Statement, the Board does not intend to present any matters other than those described herein at the Annual Meeting and is unaware of any matters to be presented by other parties. If other matters are properly brought before the meeting for action by the stockholders, proxies will be voted in accordance with the recommendation of the Board or, in the absence of such a recommendation, in accordance with the judgment of the proxy holder.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Attendance at Annual Meeting</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We invite all stockholders to attend the Annual Meeting, which will be held solely by remote communication in a virtual meeting format on Thursday, June 6, 2024, at 2:00 p.m. Central Daylight Time (CDT) and any adjournments of the annual meeting. You can attend the meeting by visiting www.meetnow.global/MFATQXS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and entering the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-digit control number found on the proxy card or voting instruction form. However, even if you plan to attend virtually, please vote your shares promptly to ensure they are represented at the Annual Meeting. If you decide to attend the Annual Meeting and wish to change your proxy, you may do so by voting during the meeting. If you have any questions on how to attend the Annual Meeting, please contact Investor Relations at 340 Seven Springs Way, Suite 600, Brentwood, Tennessee 37027, (615) 234-5900 or email ir@surgerypartners.com.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Electronic Access to Proxy Statement and Annual Report to Stockholders</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have elected to provide this Proxy Statement, the proxy card and our Annual Report to Stockholders over the internet through a &#8220;notice and access&#8221; model. The Notice of Internet Availability provides instructions on how you may access these proxy materials on the internet at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">www.investorvote.com/SGRY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or request a printed copy at no charge. In addition, the Notice of Internet Availability provides instructions on how you may request to receive, at no charge, all future proxy materials in printed form by mail or electronically by email. Your election to receive proxy materials by mail or email will remain in effect until you revoke it. Choosing to receive future proxy materials by email will save us the cost of printing and mailing documents to stockholders and will reduce the impact of our annual meetings on the environment.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">52</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_1169"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">APPENDIX A</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EMPLOYEE STOCK PURCHASE PLAN</span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective [&#9679;]</span></div><div style="margin-bottom:12pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_1302"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.<br/>EMPLOYEE STOCK PURCHASE PLAN</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Page</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.206%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> PURPOSE OF PLAN</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> DEFINITIONS</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Affiliate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agreement</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Board</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Code</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Committee</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.7</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.8</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Eligible Employee</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exchange Act</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.10</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exercise Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.11</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fair Market Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.12</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grant Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.13</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Option</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.14</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.15</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payroll Account</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.16</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.17</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> GRANT AND EXERCISE OF OPTIONS</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Conditions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Right to Exercise</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Method of Exercise</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payment of Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.5</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Issuance of Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.6</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nontransferability</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stockholder Rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.8</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Issuance and Delivery of Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE IV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> STOCK SUBJECT TO PLAN</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Source of Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Maximum Number of Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Forfeitures</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> ADMINISTRATION OF THE PLAN</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Authority</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Persons Subject to Section 16(b)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Designation of Affiliates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE VI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> ADJUSTMENT UPON CORPORATE CHANGES</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Adjustments to Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Substitution of Options on Merger or Acquisition</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Preemptive Rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.4</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fractional Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE VII</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> LEGAL COMPLIANCE CONDITIONS</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.2</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock Holding Periods</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.3</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock Legends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Representations by Participants</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE VIII</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> GENERAL PROVISIONS</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Effect on Employment</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.2</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unfunded Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.3</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Rules of Construction</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.4</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Governing Law</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.5</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Compliance With Section 16 of the Exchange Act</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.6</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amendment</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.7</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Effective Date of Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_1336"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.<br/>EMPLOYEE STOCK PURCHASE PLAN</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RECITALS: </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Surgery Partners, Inc. (the &#8220;Company&#8221;) desires to establish a plan through which employees of the Company and its affiliates may purchase from the Company shares of its common stock; and</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Company intends that the plan be an &#8220;employee stock purchase plan&#8221; within the meaning of section 423 of the Internal Revenue Code of 1986, and has designed the plan to conform to the provisions of Rule 16b-3 of the Exchange Act;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOW, THEREFORE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Company hereby establishes the Surgery Partners, Inc. Employee Stock Purchase Plan (the &#8220;Plan&#8221;), effective </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">[&#9679;]</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE I<br/>PURPOSE OF PLAN</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The purpose of the Plan is to secure for the Company and its stockholders the benefits of the incentive inherent in the ownership of the Company&#8217;s common stock by present and future employees of the Company and its Affiliates.</span></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE II<br/>DEFINITIONS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Affiliate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Entities that are subsidiaries of the Company, as described in section 423 of the Code,  and designated as an Affiliate by the Company pursuant to Section 5.3. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An agreement between a Participant and the Company or an Affiliate through which the Participant elects to exercise the Options granted to him hereunder and authorizes payment of the Option exercise price.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The board of directors of the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Internal Revenue Code of 1986, as amended.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The committee designated by the Board as the &#8220;compensation committee&#8221; or is otherwise designated by the Board to administer the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Surgery Partners, Inc. and its successors and assigns.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An employee&#8217;s annual rate of compensation earned from employment with the Company or one of its Affiliates, including regular earnings, overtime, bonuses, commissions, amounts elected under a salary reduction agreement pursuant to a plan described in section&#160;125 of the Code or a deferred compensation plan, and amounts excluded from taxable income under section 402(g) of the Code.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Eligible Employee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An employee of the Company or an Affiliate, except for the following:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">An employee who has been employed by the Company or Affiliate for less than 90 days.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">An employee whose customary employment is 20 hours or less per week.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">An employee whose customary employment is for five months or less in a calendar year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">An employee who would own more than 5% of the total combined voting power of all classes of stock of the Company or an Affiliate at the time such employee would be granted an Option. For the purpose of determining if an employee owns more than 5% of such stock, he shall be deemed to own (i) any stock owned (directly or indirectly) by or for his brothers and sisters (whether by whole or half blood), spouse, ancestors or lineal descendants, (ii) any stock owned (directly or indirectly) by or for a corporation, partnership, estate or trust of which such individual is a stockholder, partner or beneficiary in proportion to his interest in such corporation, partnership, estate or trust, and (iii) any stock the individual may purchase under an outstanding stock option.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Exchange Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Securities Exchange Act of 1934, as amended.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.75pt;text-decoration:underline">Exercise Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The period during which an Eligible Employee may elect to exercise an Option and make payment through payroll deduction, pursuant to Article III. The initial Exercise Period shall be the period that begins on the initial Grant Date hereunder and expires on the last day of the calendar quarter that includes the initial Grant Date. Thereafter, the Exercise Period shall begin with each successive Grant Date and expire on the last day of the calendar quarter that includes such Grant Date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.75pt;text-decoration:underline">Fair Market Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. On any given date, Fair Market Value shall be the applicable description below (unless, where appropriate, the Committee determines in good faith the fair market value of the Stock to be otherwise):</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">If the Stock is traded on a national securities exchange or over-the-counter national market system, Fair Market Value shall be determined by reference to the price of the Stock on such exchange or market with respect to the date for which Fair Market Value is being determined (unless the Committee determines in good faith the fair market value of the Stock to be otherwise).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">If the Stock is not traded on a national securities exchange but on an over-the-counter national market system, Fair Market Value shall be the value determined by reference to the price of the Stock on the over-the-counter national market system with respect to the date for which Fair Value is being determined (unless the Committee determines in good faith the fair market value of the Stock to be otherwise).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">If the Stock is not traded on an national securities exchange or an over-the-counter market system, Fair Market Value shall be determined by the Board in good faith and consistently with the applicable requirements of section 1.409A-1(b)(5)(iv) of the Treasury Regulations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.75pt;text-decoration:underline">Grant Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The initial Grant Date shall be </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">[&#9679;]</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Thereafter, the Grant Date shall be each the first day of each calendar quarter (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, January 1, April 1, July 1 and October 1) of each calendar year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.75pt;text-decoration:underline">Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The right that is granted hereunder to a Participant to purchase from the Company a stated number of shares of Stock at the Fair Market Value on the last day of each respective Exercise Period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.75pt;text-decoration:underline">Participant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An Eligible Employee who has elected to exercise an Option and participate in the Plan in accordance with Article III.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.75pt;text-decoration:underline">Payroll Account</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A bookkeeping account to which is added the amounts withheld on behalf of each Participant under regular payroll deductions authorized by Participants hereunder, and reduced by amounts due to the Company to pay the exercise price of Options exercised hereunder.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.75pt;text-decoration:underline">Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Surgery Partners, Inc. Employee Stock Purchase Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.75pt;text-decoration:underline">Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The common stock of the Company, $0.01 par value.</span></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE III<br/>GRANT AND EXERCISE OF OPTIONS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">General Conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. On each Grant Date, each employee who is an Eligible Employee on such date shall, without further action of the Committee, be granted an Option to purchase a number of whole shares of Stock in each Exercise Period in an amount that does not exceed $6,250, based on the Fair Market Value of Stock on the Grant Date. The right to purchase Stock under the Plan and all other employee stock purchase plans (described in section 423(b) of the Code) of the Company and its Affiliates may in no case accrue at a rate that exceeds $25,000 for such Stock (determined on the date that the Option is granted) for each calendar year in which such Option is outstanding at any time. Each Option grant is further subject to the following terms and conditions:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The exercise price of each Option shall be 90% of Fair Market Value of each share of Stock that is subject to the Option, based on the average of the Stock&#8217;s Fair Market Value reported on the first and last trading day during the Exercise Period. However, in no event will the exercise price be less than 85% of the Fair Market Value on the Grant Date or less than 85% of the Fair Market Value on the Exercise Date. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Each Option, or portion thereof, that is not exercised during an Exercise Period shall expire at the end of the Exercise Period in which the Option was granted, unless it expires sooner pursuant to Section&#160;3.1(c). </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Option that has not yet expired pursuant to Section 3.1(b) shall expire on the date that the Eligible Employee terminates employment with the Company and all of its Affiliates or revokes his election pursuant to Section 3.3; provided, however, if termination is due to the death or disability (as determined in the discretion of the Committee by reference to any disability benefit plan of the Company) of the Eligible Employee, the Participant (or his personal representative) may elect to revoke his election pursuant to Section&#160;3.3.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">A right to purchase Stock which has accrued under one Option granted hereunder may not be carried over to any other Option.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Right to Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An Option shall be exercisable on the last day of the Exercise Period that includes the Grant Date on which the Option was granted. An Eligible Employee must exercise an Option while he is an employee of the Company or an Affiliate or within the periods that are specified herein after termination of employment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Method of Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To exercise an Option, an Eligible Employee shall notify the Company in writing of his election to so exercise and execute an Agreement in the form and manner prescribed by the Committee. An Eligible Employee may revoke his election by giving written notification of such revocation to the Committee in a timely manner and prior to the last day of the applicable Exercise Period. The amount credited to the Eligible Employee&#8217;s Payroll Account shall be refunded as soon as administratively feasible following such a revocation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Payment of Exercise Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. An Eligible Employee who desires to exercise an Option must timely execute an Agreement in the form and manner prescribed by the Committee prior to or during the applicable Exercise Period. The Agreement shall provide for authorization of deductions from the Eligible Employee&#8217;s regular payroll that is credited to a Payroll Account. Amounts credited to a Participant&#8217;s Payroll Account shall be accumulated and reserved for payment of the exercise price of Options granted hereunder.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">A Participant may modify his election to participate in the Plan at any time by timely providing the Committee written notice in the form prescribed by the Committee. Such modification shall be effective on the first payroll date following such written notice or, if later, the date specified in the notice.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">An Agreement to begin or modify participation in the Plan must be executed by the Participant within the time prescribed by the Committee prior to the last payroll date in the Exercise Period for which it is to be effective. If the Agreement is not timely executed, it shall take effect upon the next following Exercise Period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each Participant&#8217;s election specified under an Agreement shall remain in effect for successive Exercise Periods until modified or revoked by the Participant in accordance with Section 3.4.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Issuance of Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall issue whole shares of Stock to a Participant, unless the Participant timely revoked an election to exercise the Option pursuant to Section 3.3, as follows:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Company shall determine the number of whole shares of Stock to be issued to each Participant for each Exercise Period by dividing the balance of such Participant&#8217;s Payroll Account by the applicable exercise price of the Option.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Company shall deduct from a Participant&#8217;s Payroll Account the amount necessary to purchase the greatest number of whole shares of Stock that can be acquired under the applicable Option.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Any amounts remaining in the Payroll Account after deducting the exercise price for whole shares of Stock shall generally be held for use in a subsequent Exercise Period. However, a Participant who has made contributions to a Payroll Account and has revoked his election to exercise an Option under the terms of Section 3.3 may obtain payment of the amounts held in his Payroll Account from the Company by requesting such payment in writing to the Committee in the time and manner specified by the Committee. A Participant who has terminated employment shall be paid any amounts remaining in his Payroll Account after the expiration of all Options hereunder.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Nontransferability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Option granted under this Plan shall not be transferable except by will or by the laws of descent and distribution. Only the Participant to whom an Option is granted may exercise such Option, unless he is deceased. No right or interest of a Participant in any Option shall be liable for, or subject to, any lien, obligation or liability of such Participant.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Stockholder Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No Participant shall have any rights as a stockholder with respect to shares subject to his Option prior to the time that such Option is exercised.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Issuance and Delivery of Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Shares of Stock issued pursuant to the exercise of Options hereunder shall be delivered to Participants by the Company (or its transfer agent) as soon as administratively feasible after a Participant exercises an Option hereunder and executes any applicable stockholder agreement that the Company requires at the time of exercise.</span></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE IV<br/>STOCK SUBJECT TO PLAN</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Source of Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Upon the exercise of an Option, the Company may deliver to the Participant authorized but unissued shares of Stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Maximum Number of Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The maximum aggregate number of shares of Stock that may be issued pursuant to the exercise of Options is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1,500,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">subject to increases and adjustments as provided in Article VI.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Forfeitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If an Option is terminated, in whole or in part, the number of shares of Stock allocated to such Option or portion thereof may be reallocated to other Options to be granted under this Plan.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE V<br/>ADMINISTRATION OF THE PLAN</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">General Authority</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Plan shall be administered by the Committee. The express grant in the Plan of any specific power to the Committee shall not be construed as limiting any power or authority of the Committee. No member of the Committee shall be liable for any act done in good faith with respect to this Plan or any Agreement or Option. The Company shall bear all expenses of Plan administration. The interpretation and construction by the Committee of any terms or provisions of this Plan or of any rule or regulation promulgated in connection herewith, shall be conclusive and binding on all persons. In addition to all other authority vested with the Committee under the Plan, the Committee shall have complete authority to do the following:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Interpret all provisions of this Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Prescribe the form of any Agreement and notice and manner for executing or giving the same.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Adopt, amend, and rescind rules for Plan administration.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Make all determinations it deems advisable for the administration of this Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Persons Subject to Section 16(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in the Plan to the contrary, the Board, in its absolute discretion, may bifurcate the Plan so as to restrict, limit or condition the use of any provision of the Plan to Participants who are members of the Committee subject to Section 16(b) of the Exchange Act without so restricting, limiting or conditioning the Plan with respect to other Participants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Designation of Affiliates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may from time to time designate a &#8220;parent corporation,&#8221; as defined in section 424(e) of the Code, or &#8220;subsidiary corporation,&#8221; as defined in section 424(f) of the Code, to be a participating corporation in a manner that is consistent with Treasury Regulation &#167; 1.423-2(c)(4). Corporations that are so designated shall be Affiliates for purposes of this Plan. Such designation shall be evidenced by the express inclusion of the corporation as an Affiliate within Section 2.1, the intentional act of the Company or the Committee to communicate in writing the grant of Options hereunder to employees of a corporation, or such other written document that is intended to evidence such designation. The Company or Committee may rescind the designation of a corporation as an Affiliate by adopting a writing that is intended to evidence such rescission.</span></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE VI<br/>ADJUSTMENT UPON CORPORATE CHANGES</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Adjustments to Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The maximum number and kind of shares of stock with respect to which Options hereunder may be granted and which are the subject of outstanding Options shall be adjusted by way of increase or decrease as the Committee determines (in its sole discretion) to be appropriate, in the event that:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the Company or an Affiliate effects one or more stock dividends, stock splits, reverse stock splits, subdivisions, consolidations or other similar events;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the Company or an Affiliate engages in a transaction to which section&#160;424 of the Code applies; or</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">there occurs any other event which in the judgment of the Committee necessitates such action.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Provided, however, that if an event described in paragraph (a) or (b) occurs, the Committee shall make adjustments to the limits on Options and on the award of Options specified hereunder that are proportionate to the modifications of the Stock that are on account of such corporate changes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Substitution of Options on Merger or Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Committee may grant Options in substitution for stock awards, stock options, stock appreciation rights or similar awards held by an individual who becomes an employee of the Company or an Affiliate in connection with a transaction to which section 424(a) of the Code applies. The terms of such substituted Options shall be determined by the Committee in its sole discretion, subject only to the limitations of Article IV.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">No Preemptive Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, for cash or property, or for labor or services rendered, either upon direct sale or upon the exercise of rights or warrants to subscribe therefor, or upon conversion of shares or obligations of the Company convertible into such shares or other securities, shall not affect, and no adjustment by reason thereof shall be made with respect to, outstanding Options.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Fractional Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Only whole shares of Stock may be acquired through the exercise of an Option. The Company will return to each Participant&#8217;s Payroll Account any amount tendered in the exercise of an Option remaining after the maximum number of whole shares have been purchased.</span></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE VII<br/>LEGAL COMPLIANCE CONDITIONS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No Option shall be exercisable, no Stock shall be issued, no certificates for shares of Stock shall be delivered, and no payment shall be made under this Plan except in compliance with all federal and state laws and regulations (including, without limitation, withholding tax requirements), federal and state securities laws and regulations and the rules of all national securities exchanges or self-regulatory organizations on which the Company&#8217;s shares may be listed. The Company shall have the right to rely on an opinion of its counsel as to such compliance. No Option shall be exercisable, no Stock shall be issued, no certificate for shares shall be delivered and no payment shall be made under this Plan until the Company has obtained such consent or approval as the Committee may deem advisable from any regulatory bodies having jurisdiction over such matters.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Stock Holding Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In order for tax treatment under section 421(a) of the Code to apply to Stock acquired hereunder, the Participant is generally required to hold such shares of Stock for two years after the Grant Date of an Option through which shares of Stock were acquired and for one year after the transfer of Stock to the Participant. A person holding Stock acquired hereunder who disposes of shares prior to the expiration of such holding periods shall notify the Company of such disposition in writing.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Stock Legends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any certificate issued to evidence shares of Stock for which an Option is exercised may bear such legends and statements as the Company or Committee may deem advisable to assure compliance with federal and state laws and regulations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Representations by Participants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As a condition to the exercise of an Option, the Company may require a Participant to represent and warrant at the time of any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares. At the option of the Company, a stop transfer order against any shares of stock may be placed on the official stock books and records of the Company, and a legend indicating that the stock may not be pledged, sold or otherwise transferred unless an opinion of counsel was provided (concurred in by counsel for the Company) and stating that such transfer is not in violation of any applicable law or regulation may be stamped on the stock certificate in order to assure exemption from registration. The Committee may also require such other action or agreement by the Participants as may from time to time be necessary to comply with the federal and state securities laws. This provision shall not obligate the Company or any Affiliate to undertake registration of options or stock hereunder.</span></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ARTICLE VIII<br/>GENERAL PROVISIONS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Effect on Employment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Neither the adoption of this Plan, its operation, nor any documents describing or referring to this Plan (or any part thereof) shall confer upon any employee any right to continue in the employ of the Company or an Affiliate or in any way affect any right and power of the Company or an Affiliate to terminate the employment of any employee at any time with or without assigning a reason therefor.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Unfunded Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Plan, insofar as it provides for grants, shall be unfunded, and the Company shall not be required to segregate any assets that may at any time be represented by grants under this Plan. Any liability of the Company to any person with respect to any grant under this Plan shall be based solely upon contractual obligations that may be created hereunder. No such obligation of the Company shall be deemed to be secured by any pledge of, or other encumbrance on, any property of the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Rules of Construction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Headings are given to the articles and sections of this Plan solely as a convenience to facilitate reference. The masculine gender when used herein refers to both masculine and feminine. The reference to any statute, regulation or other provision of law shall be construed to refer to any amendment to or successor of such provision of law.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Governing Law</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The internal laws of the State of Tennessee shall apply to all matters arising under this Plan, to the extent that federal law does not preempt state law.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Compliance With Section 16 of the Exchange Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. With respect to persons subject to Section 16 of the Exchange Act, transactions under this Plan are intended to comply with all applicable conditions of Rule 16b-3 or its successors under the Exchange Act. To the extent any provision of this Plan or action by Committee fails to so comply, it shall be deemed null and void to the extent permitted by law and deemed advisable by the Committee.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Amendment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Board may amend or terminate this Plan at any time; provided, however, an amendment that would have a material adverse effect on the rights of a Participant under an outstanding Option is not valid with respect to such Option without the Participant&#8217;s consent, except as necessary for Options to maintain qualification under the Code; and provided further that, to the extent that such approval is required for compliance with Rule 16b-3 of the Exchange Act, the provisions of the Plan relating to the number of shares granted to persons subject to section 16(b) of the Exchange Act, the timing of such grants and the determination of the exercise price shall not be amended more than once every six months, other than to comport with changes in the Code or the regulations and rulings issued thereunder. Provided further that the stockholders of the Company must, within 12 months before of after the adoption thereof, approve any amendment that increases the number of shares of Stock that may be issued pursuant to Options granted under the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Effective Date of Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Plan shall be effective and Options may be granted under this Plan on and after the date of its adoption by the Board, provided that no Option will be effective or exercisable unless and until this Plan is approved by stockholders of the Company in a manner that satisfies Treasury Regulation &#167; 1.423-2 within 12 months of the date that the Board took action to adopt the Plan. All Options granted under the Plan will become void immediately following the 12-month anniversary of the date the Board adopted the Plan if such approval by stockholders has not yet been obtained.</span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">[Signature Page Follows]</span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i227833c13def44249bd1572bf17f4242_13">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the undersigned officer has executed this Plan on this the ___ day of _______________, 2024.</span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.089%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Surgery Partners, Inc.</span></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Its: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i227833c13def44249bd1572bf17f4242_124"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><img src="sgry-20240425_g4.jpg" alt="2024proxycard1.jpg" style="height:944px;margin-bottom:5pt;vertical-align:text-bottom;width:729px"/></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><img src="sgry-20240425_g5.jpg" alt="2024proxycard2.jpg" style="height:944px;margin-bottom:5pt;vertical-align:text-bottom;width:729px"/></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>sgry-20240425.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:070e72ad-b5ec-4d42-99f8-3fee09a3b359,g:667ac803-2758-4174-bee1-6fa36ced4494-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgry="http://www.surgerypartners.com/20240425" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.surgerypartners.com/20240425">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20240425_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20240425_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20240425_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember" abstract="true" name="FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgry_EvansMember" abstract="true" name="EvansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgry_DeVeydtMember" abstract="true" name="DeVeydtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember" abstract="true" name="FairValueOfPriorYearsAwardsForfeitedInTheYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>sgry-20240425_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:070e72ad-b5ec-4d42-99f8-3fee09a3b359,g:667ac803-2758-4174-bee1-6fa36ced4494-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember_8aa6faf9-836f-4650-a2c9-13d0f7f3bd39" xlink:href="sgry-20240425.xsd#sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember_8aa6faf9-836f-4650-a2c9-13d0f7f3bd39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember_59564c33-e109-4ef2-8165-1a8a28ad50a8" xlink:href="sgry-20240425.xsd#sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember_59564c33-e109-4ef2-8165-1a8a28ad50a8" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EvansMember_852c6d7e-d54e-417c-a8a4-ffd6b35e3213" xlink:href="sgry-20240425.xsd#sgry_EvansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_sgry_EvansMember_852c6d7e-d54e-417c-a8a4-ffd6b35e3213" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeVeydtMember_57a8ade2-7a03-4c52-85e1-cb5b7ce6a5a2" xlink:href="sgry-20240425.xsd#sgry_DeVeydtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_sgry_DeVeydtMember_57a8ade2-7a03-4c52-85e1-cb5b7ce6a5a2" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>sgry-20240425_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:070e72ad-b5ec-4d42-99f8-3fee09a3b359,g:667ac803-2758-4174-bee1-6fa36ced4494-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember_label_en-US" xlink:label="lab_sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Prior Years' Awards Forfeited in the Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember" xlink:href="sgry-20240425.xsd#sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember" xlink:to="lab_sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DeVeydtMember_label_en-US" xlink:label="lab_sgry_DeVeydtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">DeVeydt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeVeydtMember" xlink:href="sgry-20240425.xsd#sgry_DeVeydtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DeVeydtMember" xlink:to="lab_sgry_DeVeydtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_EvansMember_label_en-US" xlink:label="lab_sgry_EvansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Evans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EvansMember" xlink:href="sgry-20240425.xsd#sgry_EvansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_EvansMember" xlink:to="lab_sgry_EvansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember_label_en-US" xlink:label="lab_sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember" xlink:href="sgry-20240425.xsd#sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember" xlink:to="lab_sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>sgry-20240425_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:070e72ad-b5ec-4d42-99f8-3fee09a3b359,g:667ac803-2758-4174-bee1-6fa36ced4494-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember" xlink:href="sgry-20240425.xsd#sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember" xlink:href="sgry-20240425.xsd#sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EvansMember" xlink:href="sgry-20240425.xsd#sgry_EvansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_sgry_EvansMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeVeydtMember" xlink:href="sgry-20240425.xsd#sgry_DeVeydtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_sgry_DeVeydtMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>sgry-20240425_g1.jpg
<TEXT>
begin 644 sgry-20240425_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &K#!X# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X/XL_Y&?5?^OA_P"=
M>\5X/XL_Y&?5?^OA_P"=;TMSFK[(R:***Z3E"BBB@ KI_AO=-;^*[= <+,CQ
MM]-I8?JHKF*W? G_ "-VG?[[?^@M4RV94?B1[C7BO[5^JR:;\*S!$2!?7\-L
M^/[H#/\ SC%>U5X3^V!_R333?^PO'_Z(FK+#?QH>I>-;6&G;L?']%%%?6'P
M4444 %&1110!]S_LU_\ )%?#G_;S_P"E,M>GUYA^S7_R17PY_P!O/_I3+7I]
M?(5_XL_5GZ'A?X%/T7Y!1116)U!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KP?Q9_P C/JO_ %\/_.O>*\'\6?\
M(SZK_P!?#_SK>EN<U;9&0M+1172<H4444 %;O@3_ )&[3O\ ?;_T%JPJW? ?
M_(V:=_O-_P"@FE+9E1^)'N->$?M@?\DST[_L+Q?^B9J]WKPC]L#_ ))GIW_8
M7B_]$S5CA?XT?4K'?[M/T/D"BBBOK#X$#Z=Z/K110 4444 ?<_[-?_)%?#G_
M &\_^E,M>GUYA^S7_P D5\.?]O/_ *4RUZ?7R%?^+/U9^AX7^!3]%^04445B
M=04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %>#^+/^1FU3_KX?\ G7O%>#^+/^1GU7_KX?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)=V5U&T4T,@RKJPP0?PH Y3_ (7O\._^ATT7_P #$_QH_P"%[_#O_H=-%_\
M Q/\:^!_CI\'[SX/>-)]/8/+I%SNFT^[;^.//W2?[RYP?P. "*\ZH _4?1?B
MQX,\2ZI%IVE>)]*O[^;/EV]O<JSM@$G !R< $UV-?D?INHW6CZA;W]E<26UY
M;2"6&:,X9&4Y5@?4&OT?^ ?QDM?C%X-CO#M@UJSVPZC:KT5R.)%']U@"1Z'(
MYQD@'J-%%% !1110 4444 %%%% !1110 4444 %<7J?QA\$:+J$]A?\ BO2K
M.]@;9+;S7:J\;#J",\$>E<9^TI\<(OA%X5^SV,JR>)-21DLX^#Y"]&F8>@Z*
M#U;U ./SQN+B6[N)9YY&EGE8N\DA)9F)R22>22>IH _3K_A>_P ._P#H=-%_
M\#$_QH_X7O\ #O\ Z'31?_ Q/\:_,*O9/V:O@;+\7/%)N]0C9/#&FN&O).1Y
M[=5@4^IZL1T7N"10!^@NDZM::YIMOJ&GW*7=E<*'BGB.Y'4]"#W!]:OU5M[>
M*SMXH88EBAC4(D<:A550,  #H .,"K5 !1110 4444 %%%% !1110 5PG_"]
M_AW_ -#IHO\ X&)_C7=U^0] 'Z>_\+W^'?\ T.FB_P#@8G^-'_"]_AW_ -#I
MHO\ X&)_C7YA44 ?I[_PO?X=_P#0Z:+_ .!B?XT?\+W^'?\ T.FB_P#@8G^-
M?F%10!^GO_"]_AW_ -#IHO\ X&)_C1_PO?X=_P#0Z:+_ .!B?XU^85% 'Z>_
M\+W^'?\ T.FB_P#@8G^-7+?XN>!KI@L/C/P_*Q&=JZI 3^6_-?EM10!^LFG^
M(M*UG'V#4K.]W $?9YU?.1GL3VYK4K\AZZ#1OB%XI\.D'2_$FK:>!_#;7LB+
MUS@@'!'L: /U8HK\\/#?[7WQ*\/R()]4M]9A7_EEJ%JK9'^^FUOS)KVGP3^W
M7HM^\<'BC1+C2G/!N[%O/B^K(0&4>PW&@#ZFHK \*^-=#\;Z6+_0-4MM4M6X
M+V\F2I/9AU4^Q /M6_0 4444 %%%% !1110 4444 %%%% %#5=6LM#T^XO\
M4+F*RLK=2\MQ.P5$4=R3T%<G_P +W^'?_0Z:+_X&)_C7A7[;_P 3!8Z7I_@B
MSF(GO"+V_"GI$I/EH?JP+$=MBGH:^-Z /T]_X7O\._\ H=-%_P# Q/\ &NJT
M76K#Q%IL&HZ;=PWUE,-T5Q;N'1P"02".#R"/PK\F*^OOV&_B69;?4O!%W*VZ
M/=?6&X_PD@2QCZ$A@!ZN>U 'UU1110 4444 %%%% !1110 4444 %%%% &3K
MWB'3/"^FR:CJ]];Z;8QD![BYD"(I)P 2?4G KFO^%[_#O_H=-%_\#$_QKD/V
MPO\ D@^M_P#7:V_]'I7YXT ?I[_PO?X=_P#0Z:+_ .!B?XT?\+W^'?\ T.FB
M_P#@8G^-?F%10!^GO_"]_AW_ -#IHO\ X&)_C1_PO?X=_P#0Z:+_ .!B?XU^
M85% 'Z>_\+W^'?\ T.FB_P#@8G^-'_"]_AW_ -#IHO\ X&)_C7YA44 ?I_!\
M</A[.VQ/&N@@XS^\U")!^9(%7[3XG>#;['V;Q;H=P2VT>5J4+?-Z<.>>>E?E
MC10!^M5EJUEJ2%[.[@ND_O0RJX].Q/>KU?D1'(T4@='*.IR&4X(/L:ZK1/BU
MXU\-L/[-\5ZQ;(O2);QS'_WP20?Q% 'ZFT5\ ^%?VT?'^A,JZFUEXA@X!^U0
M"*3'L\>T9]R#7T'\.?VQ/!?C22*TU02>%]1<@!;Y@UNS'L)@ !]7"CWH ][H
MJ"&9)HU=&#JP#!E.00>A!]*GH **** "N-UKXM^"_#NISZ=J7BC2K"_@.);>
MXND1T) (!!.1P0:[*OS9_:@_Y+UXM_Z[Q_\ HB.@#[K_ .%[_#O_ *'31?\
MP,3_ !H_X7O\._\ H=-%_P# Q/\ &OS"HH _3W_A>_P[_P"ATT7_ ,#$_P :
M/^%[_#O_ *'31?\ P,3_ !K\PJ* /T]_X7O\._\ H=-%_P# Q/\ &C_A>_P[
M_P"ATT7_ ,#$_P :_,*B@#]/?^%[_#O_ *'31?\ P,3_ !H_X7O\._\ H=-%
M_P# Q/\ &OS"HH _3W_A>_P[_P"ATT7_ ,#$_P :/^%[_#O_ *'31?\ P,3_
M !K\PJ* /T]_X7O\._\ H=-%_P# Q/\ &C_A>_P[_P"ATT7_ ,#$_P :_,*B
M@#]/?^%[_#O_ *'31?\ P,3_ !H_X7O\._\ H=-%_P# Q/\ &OS"HH _3W_A
M>_P[_P"ATT7_ ,#$_P :/^%[_#O_ *'31?\ P,3_ !K\PJ* /T]_X7O\._\
MH=-%_P# Q/\ &NPL[R'4+2"ZMIEF@F19(Y(SE75AD$'N"#D5^25?JG\-_P#D
MG7A7_L%6G_HE* .EHHHH *Y/Q!\4O"'A746L-9\1Z;IEZJAS;W5PJ.%/0X)S
M@UUE?GW^VC_R7"Y_Z\;?_P!!- 'V3_PO?X=_]#IHO_@8G^-'_"]_AW_T.FB_
M^!B?XU^85% 'ZVVEY!J%K%<6\R3P2H)(Y(V#*ZD9# CJ".0:MU\5_LD?M!C0
MKBW\$>([D#39GVZ9=RG_ %$A/^J8G^%C]T]B<=",?:E !1110 4444 %%%%
M!1110 4444 %<)_PO?X=_P#0Z:+_ .!B?XUW=?D/0!^GO_"]_AW_ -#IHO\
MX&)_C6_X:\6Z-XRL9+W0]3M=4M8Y#$TUI*)%#@ E21W 8''N*_*.ONK]A/\
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MW_T%+K_OZ:0^+=9/!U2Z_P"_IH]DQ>V78]>\1>(K;PY8M-,P,A!\J'/S.?\
M#U/:O#[B>2ZN))Y#F21B['U).32SW$MU(99I9)9#U:1BQ/XFHZUA#E,9SY@H
MHHK0S"D^M+10 5O> O\ D;=._P!YO_036#6[X#_Y&S3O]]O_ $$TI;,J/Q(]
MQKPC]L#_ ))GIW_87B_]$S5[O7A'[8'_ "3/3O\ L+Q?^B9JQPO\:/J5CO\
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M*RH?P8$4 ?DO17Z$>-?V0OA_XL622TL)/#UVW(ETR3:F>V8VRN/90OUKYO\
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MY'!R&'/4&@#OZ*** "BBB@ KY9_;V_Y%'PM_U_2?^BZ^IJ^6?V]O^11\+?\
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M+T7_ , T_P * /S"HK]/?^%$?#O_ *$O1?\ P#3_  H_X41\._\ H2]%_P#
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M%6G_ *)2LG_A1'P[_P"A+T7_ , T_P *["SLX=/M(+6VB6&"%%CCCC&%15&
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M?%% 'YZW?['/Q-MDW1Z99W9Q]V.^C!X_WB!S]?K7*ZQ^SO\ $G0E)N?!VI2
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M&S3O]YO_ $$TI;,<?B1[C7A'[8'_ "3/3O\ L+Q?^B9J]WKPG]L#_DFFF_\
M87C_ /1$U8X7^-'U+QW^[3]#X_HHHKZP^!"BANE% !1D444 %%%% !10O2B@
M HHH;I0 4444 %%%% !1110 5^@?P>_Y);X4_P"P=#_Z"*_/ROT#^#W_ "2W
MPI_V#H?_ $$5Y&9?!'U/?R?^+/T_4[.BBBO!/K@HHHH **** "BBB@ HHHH
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M0 4444 %%%% !7Y4_$O_ )*-XJ_["MW_ .C7K]5J_*GXE_\ )1O%7_85N_\
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MQY/^RW\!S\4/$1UG5[<GPQIL@\Q7'%U,.1$/51P6]L#OD?H JB-0JC"C@#L
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MGL !FOS#^,/Q!E^)_P 1=8U]]XMYY/+M8F_@@7Y4&.Q(&3[EC7V#^V5\2O\
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M:3 'VB,9)@<^Y)*D]#Z DU^?%U:S6-S+;7,307$+F.2*0%61@<,I!Y!!X(-
M&[X!\=ZK\-_%5EK^CS^5=VS<JW*31G[\;CNI'![CJ"" 1^DOPN^)&E?%+PC:
M:YI3_*_RSV[L"]O*!\T;?3J#W!![U^7->C? WXQW_P &_%R7\?F7&D7.V*_L
M5/$B9X90>-ZYR#]1D F@#],J*RO#VO6'BC1;+5M+N5O;"\C$L-Q&<AE/\B#P
M0>000>16K0 4444 %%%% !1110 5^0]?KQ7Y#T %?=7["?\ R235_P#L.3?^
MD]O7PK7W5^PG_P DCU?_ +#DW_I/;T ?1U%%% !1110 5^>'[87_ "7C6O\
MKA;?^B4K]#Z_._\ ;$_Y+QK?_7"V_P#1*4 >+U] ?L0_\EFG_P"P5/\ ^AQ5
M\_U] ?L0_P#)9I_^P5/_ .AQ4 ??%%%% !1110 4444 %%%% !1110 4444
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M+P?IPR$CBN;@^Y9HU'?MM/;O^0!\G445<T6Q&JZQ861?8+F>.$LO;<P7/ZT
M?=/[(WP>M_ _@N#Q+>P Z[K40E5V',%L<%$&>A888^N5':OH.J]O;QVL$<,2
M+''&H1%7H% P /H*L4 %%%% !1110 4444 %%%% !7E_Q:^ 7A;XO6[O?VPL
M-9"XBU6V4"9<#@..CJ/0\^A'6O4** /GG]EGX/>(?@[K'C>TUJ*-[6Z:S^QW
MD+ QW"KY^X@=5(WKD$#D\9'-?0U%% !1110 4444 %%%% !1110 4444 %%%
M% 'BGQ#_ .1QU'_MG_Z+2N<KI_B3:O;^++AVZ3)'(OT"A?YJ:YBNZ/PH\Z7Q
M,****HD**** "BBB@ HHHH *3Z4;J6@ I/K2T4 %%%(M "TG%+10 5O> P6\
M7:<!R-S'\E:L&NN^%]BUUXD^T ?);1EBWN1M _$$_E4RT3+CK)'L%>$_M@?\
MDTTW_L+Q_P#HB:O=J\B_:8\/R>(/A/?21+YDFG31WH4#)VKE7/X*[$^P-8X=
MVK1;[EXV+EAYI=CXFHHHKZT_/PH^E%% !1110 4444 %&T444 %%%% !1110
M 4444 %%%% !7Z!_![_DEOA3_L'0_P#H(K\_*_1/P#I+Z#X)T#3I1LEM;&"*
M1>?OB,!NOOFO'S)^Y%>9]#DR?M)OR.CHHHKPCZP**** "BBB@ HHHH ****
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MT^HHHH **** "BBB@#\M/C%_R5SQQ_V'+[_THDKDJZ[XQ_\ )7O&W_8<O?\
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M+^SE,4T+=58?S!Z@C@C!'%4*^Y?VMO@./&VBOXNT2#.NZ;%_I4,8^:Z@49R
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MRXS^]NKIAE;>$$;G/J>< =R0.!DCF-'TB\U[5;33=.MY+R^NI!###$,L[$X
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M10 4444 %%%% !7Y#U^O%?D/0 5]U?L)?\DCU?\ [#DW_I/;U\*U]U?L)_\
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M'_GP'_?Z/_&C_A7OB'_GP'_?Z/\ QHYH]PY9=CF]U+71?\*[\0?\^'_D:/\
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M%>F_\,U_$C_H71_X'6W_ ,<H_P"&:?B/_P!"[_Y/6W_QRCV]+^=?>'U7$?\
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M%?0W[)_P%_X6!K8\4:Y;[_#NGR_N89!\MY..0N#U1>K=B<#D;@ #U?\ 9&^
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MK0!H>'-%F\1^(=,TF 9GO[J.U3;_ 'G8*/U-?K!;6T=G;Q01+LBB0(BCL ,
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M_P"/T ?==%?"G_#=?C[_ *!/AS_P%N/_ (_1_P -U^/O^@3X<_\  6X_^/T
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M9I)-MW&HX^^<AQ[-S_M5\]T4 ?I=X"_:"\#?$58DTS7(;>]?'^@7Y$$^3_"
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MX; \&_\ 0-US_OQ!_P#'J/JM?^1A]?PW\Z/=J*\)_P"&P?!O_0.UW_OQ#_\
M'J/^&P?!O_0.UW_OQ#_\>H^JUOY6'U_#?SH]VHKPG_AL'P;_ - [7?\ OQ#_
M /'J/^&P?!O_ $#M=_[\0_\ QZCZK6_E8?7\-_.CW:BO"8_VOO!K, =/UQ03
MC<T$.!^4IKO_  ;\7/"?CYO*TC5HY+O&?LDP,4WOA6 W8[E<@>M1*A5@KRB:
M4\70J/EA--G;T445@=84444 %%%% !1110 4444 %%%% !2$;N#TI:* /F_X
MQ?L=Z)XTDEU/PM+%X<U9LL]N5/V28GV',9/JH(_V<\U\B>/OA/XK^&MT8=?T
M>XLXMVU+M1OMY/I(,@GVSD=P*_4NJUW:Q7MM)!<11SPR*5>.10RL#U!!X(^M
M 'Y(45^B/C/]D_X=>,&:2/2FT*Z8D^=I+B$?]^R"F/HH/O7B?BS]A#5[7S)/
M#GB*TOTY*V^H1- _TWKN#'W(4?2@#Y:HKT+Q5^SW\0_!V]K_ ,+WTD"<FXL5
M%S'CU)C)VC_>Q7GKQM&Y1PR,I(*L,$$=010 5T/A?XB>*/!3@Z%K^H:6H.?*
MMYV$9[\IG:?Q!KGJ* /H;PG^VYXXT4HFL6^G^((!]YI(_L\Q^C)A1^*FO</!
M7[:'@7Q)LBU<7GAJZ;K]I3S8<^@= 3^)4#WKX)HH _671?$&F^)+%+S2K^VU
M*S?[MQ:3+*A]L@D9]JTZ_)[PQXPUOP5J OM"U2ZTJZX!DM92NX#LP'##V((]
MJ^G_ (5_MO2+);Z?X\LU=#A?[8L$QCWDB'7W*8]E- 'V%167H6O:=XCTNVU'
M2KV'4+&X7='<6[AE8?4=QT(/(/!K4H **** "BBB@ K\J?B7_P E&\5?]A6[
M_P#1KU^JU?E3\2_^2C>*O^PK=_\ HUZ .=KZ[_X)_P#7QY_VX?\ MQ7R)7UW
M_P $_P#KX\_[</\ VXH ^O:*** "BBB@ HHHH **** "BBB@ HHHH *^9OV\
M?^2=>'_^PJ/_ $5)7TS7S-^WC_R3KP__ -A4?^BI* /B"NZ^!/\ R6;P7_V%
M;?\ ]#%<+7=? G_DLW@O_L*V_P#Z&* /T^HHHH **** "BBB@#\M?C%_R5OQ
MQ_V'+[_THDKD:Z[XP_\ )7/''_8<OO\ THDKD: .Y^&'QH\2?"'^T_\ A'9;
M:/\ M'R_/^T0B3.S?LQGI]]LUWO_  VA\2O^?K3?_ )?\:\)HH ]U_X;2^)7
M_/SIW_@$O^-'_#:7Q*_Y^=._\ E_QKPJB@#W7_AM+XE?\_.G?^ 2_P"-,D_;
M.^);(0+S3T)R RV2Y'N,DC\Z\-HH ]>O?VM/BE>#:/$JVZD %8;&W7H<YR8R
M1^!KD]8^,WCO7LI>^+M9E1N#&MX\:'/JBD _E7&T4 .FE>>1Y)7,DC'+,Q))
M/N33:*Z/PC\-O%'CR81Z!H5[J@+;3+#$?*4_[4APJ_B10!SE=/\ #WX;>(/B
M=KT>EZ#9-<R\&69AB&!3_$[=%'ZGH 3Q7T3\-?V';J9X[SQQJ2P1?>_LS36W
M.?9Y2,+[A0<CHP-?57A'P;HW@718M*T'3X=-L8^D<(Y8_P!YF.2S'N223ZT
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M%?(=% 'UY_P\ _ZD/_RL?_:*/^'@'_4A_P#E8_\ M%?(=% 'UY_P\ _ZD/\
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M$BU6WS-I]VPYCDQ]TGKM; ##Z'J!7YNZSH]YX?U6ZT[4;=K2^M)3#-#(,,K
MX(/^>>HK];:^8OVO/@6OBG3)/&6BV^[6+"/_ $^&,<W$"C_68'5D'7N5^@!
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M2O\ GZTW_P  E_QI/^&T/B5_S]:;_P" 2_XUX510![M_PVA\2O\ GZTW_P
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MLMJ';!8L<L3SR37DM% 'NO\ PVA\2O\ GZT[_P  E_QI?^&S_B7_ ,_6F_\
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MS&,,,8\OWSFO6O\ A@6__P"ARM__  7M_P#'*M_\$_\ KX\_[</_ &XKZ]H
M^-_^&!;_ /Z'*W_\%[?_ !RD_P"&!-0_Z'.W_P#!>W_QROLFB@#XW_X8%O\
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M$EK,\+*W!W*Q4_RJK7I7[1_AD^%?C5XIM@F(KBZ-['C^)9@)3CV#,1^%>:T
M>_?L2ZXNE_&1[)VP-2TZ:!5]74K*/_'8WK[ZK\KOA?XM/@3XB>']>)/EV5Y'
M)-MZF(G;(![E2PK]2H9DFC5T8.K ,&4Y!!Z$'TH GHHHH **** "BBB@ KC/
MC!I5WKOPM\5:=86[7=[=:=-%##']YV*D!1[DUV=% 'YF?\,Y_$K_ *$[4O\
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M?=,?["_@(."=5\1N <[6NH,'\H16C:_L6_#BW8F1-5N1D'$MY@<=OE4'G_\
M50!\"T5^C>F_LJ_"_3,,GA>.X<?Q7-U/+GKV+D=_2NXT/X<>%?#,BOI/AS2M
M.D7D26UG&C_]] 9_6@#\W/"GP>\:^-C'_8WAK4+N)\8N&A,<//\ TT?"_K7O
M7P__ &%]0NI([CQAK$=E#P38Z9^\E(]&D8;5/T#?6OLZB@#E/ WPW\._#?2Q
M8>'M+AT^(X\R0#=+*1W=SEF/)QDX'0 #BNKHHH **** "BBB@ KX(_;*^)@\
M7?$0>'K64/IN@@Q-M/#7+8,A_P" X"8[%6]:^O\ XQ?$*+X7_#W5M>?:;B&/
MR[6-OXYVX08[@$Y/L#7YAW-S+>7,MQ/(TL\KF221CEF8G))/<D]: (ZZ7X:^
M$5\=>.-'T66XCM+6XG'VBXDD5%CB'S.V3P#M!QGJ<#O7-44 ?JKI_B'PQI-A
M;6=KJVEV]K;QK##$EW&%1% 55'/0 8%6_P#A,M!_Z#FF_P#@7'_C7Y/T4 ?K
M!_PF6@_]!S3?_ N/_&C_ (3+0?\ H.:;_P"!<?\ C7Y/T4 ?K!_PF6@_]!S3
M?_ N/_&C_A,M!_Z#FF_^!<?^-?D_10!^L'_"9:#_ -!S3?\ P+C_ ,:Y[QVW
MA7Q[X1U?P_?:WIHM[^W:(L+N/*-U5QSU5@"/<5^8%% %K5M,FT;5+S3[C:;B
MUF>"1HV#*65BIVL.",C@CJ.:JT44 ?1O[%?Q,_X1KQQ<^%KN<I8:T,P*W1;E
M1D?3<N1[D**^ZZ_(_3-2N=&U*TO[*5K>[M95GAE7K&RL&5A]",U^H?PP\=6W
MQ(\"Z/XAML#[9"#+&#_JY1\LB?@P('J,'O0!UM%%% !1110 4444 >*_MA_\
MD%UO_KM;?^CTK\\:_0W]L+_D@^M_]=[;_P!'I7YY4 %?3WAW]AV]\1>'],U1
M?%MO M]:QW(B-BQ*AT#;<[QG&<9KYAK]4_AO_P DZ\*_]@JT_P#1*4 ?+G_#
M M__ -#E;_\ @O;_ ..4?\,"W_\ T.5O_P""]O\ XY7V110!\;_\,"W_ /T.
M5O\ ^"]O_CE'_# M_P#]#E;_ /@O;_XY7V110!\@6W[ 9RC7'CC_ 'EBTO\
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M_P"ARM__  7M_P#'*^R** /C?_A@6_\ ^ARM_P#P7M_\<H_X8%O_ /H<K?\
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MC@M[Q%G=CC$3YCD/X*S4 ?J-12 YZ=*6@ HHHH **** "BBB@ HHHH ****
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MW^%']C7_ /SY7/\ WY;_  K];:* /R2_L?4/^?&X_P"_+?X4?V/J'_/C<?\
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M[$%X)@!OC;W&<@]P0>]?F;XQ_P"1LUS_ *_I_P#T8U &57W5^PG_ ,DCU?\
M[#DW_I/;U\*U]U?L)?\ )(]7_P"PY-_Z3V] 'T=1110 4444 %?GA^V%_P E
MXUK_ *X6W_HE*_0^OSP_;"_Y+QK7_7"V_P#1*4 >+5] ?L0_\EFG_P"P5/\
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MUM>V\EM*I&?E=2IX^AK\F: "ON/]ACQ(^I?#G5])E9G.FWY:(-_#'*H;:/\
M@2N?QKX<KZ[_ ."?_7QY_P!N'_MQ0!]>T444 %%%% !1110 4444 %%%% !1
M110!XI\1/^1PO_I'_P"BUKG*Z/XB?\CA?_2/_P!%K7.5W1^%'G2^)A1115$A
M1110 44=** "BBB@ HHHH **** "BBB@ HHHH *W? ?_ "-FF_[[?^@&L*M[
MP'_R-FG_ .\W_H+4I;,J/Q(]PKPC]L#_ ))GIW_87B_]$S5[O7A/[8'_ "33
M3?\ L+Q_^B)JQPO\:/J5CO\ =I^A\?T445]8? A1110 4444 %%%% !1110
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M9<O_ *-(?5)3C;GT?'H": /?Z*BCD6:-71@R,,AE.00>A!J6@ HHHH ****
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MM381WB]1 W19@/;HV.JYX) K]#(9DN(4EB99(W7<K*00P(R"".H- %BBBB@
MHHHH *^)/VS/@RV@ZU_PG&EP_P#$OU!PFH+&.(K@\"0^BN.I_O#DY85]MUE>
M(=!L/$VBWNE:G;+>6%Y$89H7Z,I_D1U!'((!'- 'Y.45Z-\</@SJ/P;\5/9S
M;KG2+DE]/OL#]X@ZJ<='7(!'?@C@BO.: /H#]F7]I!OAG<CP_P"(99)?#$[Y
MCE W-8R$\L!U*'JP&2#R!G(/W997D&I6L-S:SI<V\R"2.:)@R.I&0P(X(([B
MOR3KUSX)?M':]\()H[)]VK^'&;,FG2/@QY/+0L<[3W(^Z><@$Y !^CE%</\
M#CXP>%OBI8BXT'4DEG5<RV,V$N8O]Y"<X]QE3V)KN* "BBB@ HHHH **** "
MBBB@ KC_ (Q?\DD\;_\ 8#OO_2>2NPKCOC'_ ,DA\<?]@.^_])WH _+BBBB@
M#[@_8/\ ^2<Z_P#]A4_^B8Z^F*^9_P!@_P#Y)SK_ /V%3_Z)CKZ8H **** "
MBBB@#\DM8_Y"][_UWD_]"-5*MZS_ ,A>^_Z[2?\ H1JI0!]O?L&_\DZ\0?\
M85/_ *)CKZ:KYE_8-_Y)UX@_["I_]$QU]-4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7RS^WM_P BCX6_Z_I/_1=?4U?+/[>W_(H^%O\ K^D_]%T
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M "3OPM_V"K7_ -$K7Y65^J?PU_Y)WX6_[!5K_P"B5H Z6BBB@ HHHH ****
M"O+_ (]?!^V^,'@F:P4+%K-J3-IURW\,F,%">NUAP?0X/.!7J%% 'Y'ZCI]S
MI-_<V-Y!);7=O(8IH91AD93AE([$&J]?8?[9'P/%Y;OX^T2W_?0J%U:&,<N@
MX$^!U(& WM@]B:^/* /HK]D?XY'P1KX\*:Q<8T'4I0+>20_+:W)P!SV5NA[
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M&(HHQDA5 P!DDGCWK1HJ93G/XG<TA2IT]812] HHHJ#4**** "BBB@ HHHH
M*\)_;0_Y(?=?]?UO_P"A&O=JXWXH?#G3_BIX.O/#VI2RVT,I$B7$!&Z-U.5;
M!X(SU!ZCT/( /RYHKT?XM? 7Q1\([QSJ%H;S2"V(=5M5+0L#T#]T;V/?H2.:
M\XH [OX?_'+QI\-"D>C:U*+('FQNOWUN?HISM^JD'WKZ,\%_MX6$ZQQ>*O#T
MUI)T:ZTIA(A/J8W(*CZ,Q]J^.** /TN\,_M"?#OQ9&GV+Q78PRMQY-](;5\^
MF) N3],^U>@VMU#>P)-!+'/$XRLD;!E(]B.#7Y(5<TS6M0T:;S=/O[BPE_YZ
M6LS1M^8(- 'ZV45^7^G_ !T^(.EJ%@\9:UM' 66\>4 >GSDUKI^TY\3XXPH\
M776!TW0PD\>I*9/XT ?I317YJS?M-?$Z>,HWB^[ /]V*)3^80$5CZA\;_'^I
M*5N/&6M!6ZK%>O&#QC&%(&/:@#]-=2U2STBU:YO[N"RMU^]+<2"-!]22!7D'
MCC]K7P#X-CD2VU/_ (2*]7@6^E#S$)[9E/R8]P2?:OS[U#4[S59O.O;NXO)O
M^>EQ*SM^9)-5Z /5?C)^T5XF^,#&UN"NEZ"K[H],M6.#CH9'X,C#Z #J%!YK
MRJBG0PR7,T<44;22R,$2.,$L[$X  '))/04 , RV!R37WW^R;\%9?ASX2EUK
M5K?R?$&L*K-&WWK>W'*1D=F)^9A_N@\@UQ?[-?[*TFDW%MXK\;6B_:UQ)8Z/
M*,^2>HDF4\;AU"]NIYX'UE0 4444 %%%% !1110!\K?M>_ 27Q!"_CC0+8S:
MA;Q[=2M8ERTL:C E '5E'##NH!_A.?C"OUXKY,_:&_9);5KBY\2^!H%2Y<F6
MZT5<*KGJ6AZ $]2AX/;!P" ?'5:/A[Q)JGA+58-3T:_N--OX3\EQ;R%6]P<=
M5/<'(/0@U3O+.?3[J6UNX);:YB8I)#,I1T8<$%3@@CN#45 'U=\.?VY+NSBA
MM/&ND_;PN =1TP*DA]WB)"D^I!4>@KZ$\*?'[P!XVC3^SO$]E%.W'V>\D^S2
MY] LF-Q^F17YFT4 ?KG'(LT89"&5@"&4Y!!Z$&I:_)O1O%NN>'6SI.LZAI9Z
M_P"A73P]\_PD=ZZZQ_:$^(^GA1%XQU1PIR#<2>=VQSN!S^- 'Z;45^;/_#4'
MQ1_Z&VY_\!X/_B*S=0_:"^(VIAQ+XRU5 W4V\WD]1CC:!C\* /TQN)X[>%Y)
MI%BC499G( 'U)XKS3QE^TE\//!*NMUXBM[ZZ4'_1=,/VER1V)7*J?]XBOSKU
MCQ-K'B%M^JZK?:FV<YN[AY3GU^8FLV@#Z5^)O[;&O^($ELO"5G_PCUHV1]LG
MQ+=./]G^&/(Z\,1U#"OG"]OKG4[J6[N[B6[NIF+R332%W=CU+,<DD^IJ&B@
MJYHNBWWB/5;33-,M);V_NI!'#;QC+,Q[#^9)X Y/%;?P_P#AIXB^)VM)IOA^
MPDNY,CS;AOEA@4_Q._11[=3T )XK[U^!_P"SWHGP=L?..W4_$4RXN-2DCQMS
MUCB!R57UYRW4]@ ";X _!6T^#OA-8&\NXUR]"R:A>*."P'$:GKM7)QZDD\9
M'JU%% !1110 4444 %%%% 'Y;?&+_DKGC;_L.7W_ *425R%==\8O^2M^./\
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M((/(K\GJ^COV0_CA_P (;KR>$-:N-FB:E+_HLTA^6VN#P 2>BOT/HVT\ L:
M/NJBBB@ HHHH **** "BBB@ HHHH ^??VW_^2,P?]A6#_P! EKX)K[V_;?\
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M\<#<2+CN=I)'H0#VH _4BBJEG>0:C9P7-M*LUO/&LL<J'*LC#(8'T(.15N@
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MF'0 5^DO[,'_ "07PC_UPD_]'R5^;5?I+^S!_P D%\(_]<)/_1\E 'J=%%%
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M#5_Y3KO_ .-4?\-:_"G_ *&K_P IUW_\:K\YJ* /T9_X:U^%/_0U?^4Z[_\
MC5'_  UK\*?^AJ_\IUW_ /&J_.:B@#]&?^&M/A3_ -#5_P"4Z[_^-5O^!/C?
MX)^)FK2Z9X;UO^TK^* W+Q&UGBQ&&52V711U=1@'//3K7YCU]&_L)_\ )7-7
M_P"P'-_Z/MZ /NNBBB@ HHHH \W_ &C/^2(^,?\ KQ;_ -"6OS/K],/VC/\
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M]VGZ'Q_D4445]8? A1M%%% !1110!]S_ +-?_)%?#G_;S_Z4RUZ?7F'[-?\
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M?_!=#_\ $TG_  K?PE_T*NB_^"Z'_P"(H _*RBOU4_X5KX1_Z%71?_!=#_\
M$TG_  K?PE_T*NB_^"Z'_P"(H _*RBOU3_X5OX2_Z%71?_!=#_\ $4?\*W\)
M?]"KHO\ X+H?_B* /%?V$_\ DD>K?]AR;_T1;U]'UF:3H6G:!;R6^F6-MIT#
MOYC0VL2Q*6( +$* ,X &?85IT %%%% !7RS^WM_R*/A;_K^D_P#1=?4U96K>
M'M+\01QQZGIUKJ4<9W(MW LH4G@D!@<&@#\G*UO!W_(W:'_U_0?^C%K]/?\
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M_P#@NA_^)JQI/A'1-!N3<:9H^GZ=<%#&TEI:I$S*2"5)4 XR <>PH W****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7@_BS_D9]5_Z^'_G7O%>#^+/^1GU7_KX?^=;TMSGK;(R:
M***Z3D"BBB@ KH?A_&9/%NGXZ NQ_!&KGJ[_ .%6BLUQ<:I(,1J##%N[YP2?
MP''XGTJ)NT67!7DCT^O"_P!KZ-I/AGI[*,A-6B9CZ#RIAG\R*]TKB?BQX/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\'\6?\ (SZK_P!?#_SKWBLN30-,N)'DET^UDD8Y
M9W@4DD]R2.:TA+E=S*I'F5CP6BO>O^$:TC_H%6/_ (#I_A1_PC6D?] JQ_\
M =/\*U]LNQE[%]SP6@#M7O7_  C6D?\ 0*L?_ =/\*EMM%T^SDWV]C;P/_>C
MA53^8%+VR[![%]SRGPSX!OM:D66Y1K.RZEF&&8?[(/KZGCZUZU96<.GVL5O;
MQ^7#&NU5 Z"K=%92DY&T8*&P4445!H?/WQV_9W_X3"XEU_PTD<6L-\US9L0J
M7)_O@G[K^N< ]20<D_*^L:+J'A^_DLM3LKBPNT^]#<1E&^N#U!['H:_2FL[5
M-'L-:M_(U"RM[Z'O'=1+(OY$&O2H8Z=)<LE='B8K*X5Y.<'9_@?FU17Z&_\
M"K_!W_0HZ#_X+8?_ (BD_P"%7^#?^A2T+_P6P_\ Q%=?]I0_E9YW]C3_ )T?
MGG17Z&_\*O\ !W_0HZ#_ ."V'_XBC_A6'@[_ *%+0O\ P6P__$4?VE#^5A_8
MU3^=',_LU_\ )%?#G_;S_P"E,M>GUFZ=I-GH=C'9:?:06-K%G9!;1K'&N22<
M*  ,DDG ZG-:5>+4ESS<N[/IZ,/9TXP?1)!1114&H4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>sgry-20240425_g2.jpg
<TEXT>
begin 644 sgry-20240425_g2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ') OD# 2(  A$! Q$!_\0
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M%_WP*EHH B^S0?\ /&+_ +X%'V:#_GC%_P!\"I:* (OLT'_/&+_O@4?9H/\
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MLT'_ #QB_P"^!1]F@_YXQ?\ ? J6B@"+[-!_SQB_[X%'V:#_ )XQ?]\"I:*
M(OLT'_/&+_O@4?9H/^>,7_? J6B@"+[-!_SQB_[X%'V:#_GC%_WP*EHH B^S
M0?\ /&+_ +X%'V:#_GC%_P!\"I:* (OLT'_/&+_O@4?9H/\ GC%_WP*EHH B
M^S0?\\8O^^!1]F@_YXQ?]\"I:* (OLT'_/&+_O@4?9H/^>,7_? J6B@"+[-!
M_P \8O\ O@4?9H/^>,7_ 'P*EHH B^S0?\\8O^^!1]F@_P">,7_? J6B@"+[
M-!_SQB_[X%'V:#_GC%_WP*EHH B^S0?\\8O^^!1]F@_YXQ?]\"I:* (OLT'_
M #QB_P"^!1]F@_YXQ?\ ? J6B@"+[-!_SQB_[X%<K77UR- '4V?_ !Z0_P"X
MO\JEJ*S_ ./2'_<7^52T %%%% !1110 4444 %%%% !7&>(-7U6_\4+X;\.S
M16DL< N;R^DC\SR5)PJJIX+'KSVKLZ\\CO(= ^+6IMJDBV]OK%K"UM-(=J%X
MQM*9/&>_Y>HH Z/0+'7]/O9%U75X-3L&C)5VMQ#*CY''R_*5QGWZ56/Q \,"
MZ\@ZHGW_ "_-\M_*W>GF8V_K1XOU:VN] UO3M+O89M4.GS2+#"X9PNW&>.G4
M8K DU#0_^%*[1-;?9SI?E+'N&?.V8QC^]O\ UYH [/6?$&E:+);IJEY';&X5
MVC+@X8(,MSTZ$?7M6;#X]\-36<]RFIH$@<(Z-&ZR;CT 0C<<X/0=JY22S<ZO
M\+;?5(@\T=M+YB2#.'6!",Y[@@?B*UEM8'^-CR-#&9%T42*Q49#>=MS]<<9]
M* .ETWQ)I.I:-/JME>++8P!C*^U@8]HRV5(R"!SC%9Q\?^&1<PPG58]TNW:^
MQ]@+#(#/C:IYZ$@CO7,1J$E^*:( J>7NP.F3;L2?QJI+?Z&?@3Y44MJ<V*Q&
M)"-WVG XV]=V_G]: /2-<US3M#MTFU2Y6%9&V1C:69V]%4 DGZ"H]&\1:7K-
MM<3Z=="5+?B92C(\?&?F5@"/RKS[4H]1@\9>$EGOH+&;^R#%'-=P^:OVCCS
M!N7#$8YS[=ZWK'1IK?6M9U.]UJSO;R;3_)D@MX!%@#)5V&]CGJ* +S?$+PNK
M0 ZK'B8*5;RWVKNZ;CC"_P# L5KZYK^FZ'%"^I7/E^<VV)%1I'D/?:J@D_E7
MG^EVENO[/\P6&,!]/EE;"CYGR3N/OP.?85K3Z8VHZ=X6O;#5H+'7;.R5X1,
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MSE?PV-3LUS>Z1.E_%[[#\P^FW/Y4 ='<:K9V^J6NG2S 7MTKO%$%)+*H^8Y
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MSB;5D\W+91"-ZYS_ '21G-:VLZA:7?Q9\+V]M<1S2P071E5&W;-R#&??@\4
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M(UUU<C0!U-G_ ,>D/^XO\JEJ*S_X](?]Q?Y5+0 4444 %%%% !1110 4444
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M>8G]Y?SI/)C_ .>:?]\BCR8_^>:?]\B@!?,3^\OYT>8G]Y?SI/)C_P">:?\
M?(H\F/\ YYI_WR* %\Q/[R_G1YB?WE_.D\F/_GFG_?(H\F/_ )YI_P!\B@!?
M,3^\OYT>8G]Y?SI/)C_YYI_WR*/)C_YYI_WR* %\Q/[R_G1YB?WE_.D\F/\
MYYI_WR*/)C_YYI_WR* %\Q/[R_G1YB?WE_.D\F/_ )YI_P!\BCR8_P#GFG_?
M(H 7S$_O+^='F)_>7\Z3R8_^>:?]\BCR8_\ GFG_ 'R* %\Q/[R_G1YB?WE_
M.D\F/_GFG_?(H\F/_GFG_?(H 7S$_O+^='F)_>7\Z3R8_P#GFG_?(H\F/_GF
MG_?(H 7S$_O+^='F)_>7\Z3R8_\ GFG_ 'R*/)C_ .>:?]\B@!?,3^\OYT>8
MG]Y?SI/)C_YYI_WR*/)C_P">:?\ ?(H 7S$_O+^='F)_>7\Z3R8_^>:?]\BC
MR8_^>:?]\B@!?,3^\OYT>8G]Y?SI/)C_ .>:?]\BCR8_^>:?]\B@!?,3^\OY
MT>8G]Y?SI/)C_P">:?\ ?(H\F/\ YYI_WR* %\Q/[R_G1YB?WE_.D\F/_GFG
M_?(H\F/_ )YI_P!\B@!?,3^\OYT>8G]Y?SI/)C_YYI_WR*/)C_YYI_WR* %\
MQ/[R_G1YB?WE_.D\F/\ YYI_WR*/)C_YYI_WR* %\Q/[R_G1YB?WE_.D\F/_
M )YI_P!\BCR8_P#GFG_?(H 7S$_O+^='F)_>7\Z3R8_^>:?]\BCR8_\ GFG_
M 'R* %\Q/[R_G1YB?WE_.D\F/_GFG_?(H\F/_GFG_?(H 7S$_O+^='F)_>7\
MZ3R8_P#GFG_?(H\F/_GFG_?(H 7S$_O+^='F)_>7\Z3R8_\ GFG_ 'R*/)C_
M .>:?]\B@!?,3^\OYT>8G]Y?SI/)C_YYI_WR*/)C_P">:?\ ?(H 7S$_O+^=
M'F)_>7\Z3R8_^>:?]\BCR8_^>:?]\B@!?,3^\OYT>8G]Y?SI/)C_ .>:?]\B
MCR8_^>:?]\B@!?,3^\OYT>8G]Y?SI/)C_P">:?\ ?(H\F/\ YYI_WR* %\Q/
M[R_G1YB?WE_.D\F/_GFG_?(H\F/_ )YI_P!\B@!?,3^\OYT>8G]Y?SI/)C_Y
MYI_WR*/)C_YYI_WR* %\Q/[R_G1YB?WE_.D\F/\ YYI_WR*/)C_YYI_WR* %
M\Q/[R_G1YB?WE_.D\F/_ )YI_P!\BCR8_P#GFG_?(H 7S$_O+^='F)_>7\Z3
MR8_^>:?]\BCR8_\ GFG_ 'R* %\Q/[R_G1YB?WE_.D\F/_GFG_?(H\F/_GFG
M_?(H 7S$_O+^='F)_>7\Z3R8_P#GFG_?(H\F/_GFG_?(H 7S$_O+^='F)_>7
M\Z3R8_\ GFG_ 'R*/)C_ .>:?]\B@!=Z?WE_.G4SRH_^>:?]\T^@# U_6)[+
M5+&RMQ:QF?Y_-NI3&CX('EJ=IRYSG'\^S;[Q,EIK;6?D%[:*"66:X#?=9%#%
M ,<G:03SW'OBQXATB;6%%L;QXM/F0QW,(1#O4@_=)4D'WSTZ8/-0W7A/3)[]
M;HK*IQ,'196VN91\Q(S@=^GK0!4_X2:]CDCMKC3X4OKA87MT6X)0B0L"&;;P
M5"DG .>U;6AZ@^HVDCS1+#/#-)!*BMN4,K8R#@9!&#T[UECPME5>74;F2\B$
M2P7#*F8Q&25XQ@YW'<>^>U:^D:>NG6IB$CS.\CS22/C+NQ))XX'7@>@% %VB
MH[FXAM;=Y[F6.&&,;GDD8*JCU)/2N:;QUH[D_8EU"_4=9+.QEE3_ +Z"X/X4
M =316)H_BK1]6N?LMK=A;S&?LTZ-#+^"N 3^%;= !7(UUU<C0!U-G_QZ0_[B
M_P JEJ*S_P"/2'_<7^52T %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!3UAX8M+NYKF$3PPQ-*T94-NVC=C!^E<OIT7B[5+"WOU
MUG2[))XUECMX[(S*JL,@%RXSP>H%==>SQ6UG//<<0Q1L\AQGY0,G]*\J@T#5
M+Z%+K1M%N=.TZ8>9';#798=RMR/D4%4SGH#Q0!W?AJ\FU/[5%K$%H=1TRY,#
M20C*$E%8,F>5RKX(SZUT%<WX#-I'I<]I:Z<^FSVL[1W5N\GF,)2 Q8OD[\AE
M.X_TKI* "N1KKJY&@#J;/_CTA_W%_E4M16?_ !Z0_P"XO\JEH S]>,JZ5.\.
MH)INP;GNG0,(U'4_,<=.YR!Z5PK'PI*=UUX[O9I3_'_;/EX^BH0H_*O1+VU@
MOK.:UNXUEMYD,<B-T92,$5YQK45EX4F$.CZM!-/_  :1=PF\9O0*5!E7\<B@
M#I_"UJ<K<Z;XDFU;2F!79.R3D,/[LHP>/0YKIJR?"MU<7NBP3WFE'2IGR6M2
M0=OOP!U]P#6M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 45S?B3Q&^CWL<"VRRAHP^2^,<D>GM65_PG,G_/BG_?
MT_X5O'#5)KF2,I5X1=FSN:*X;_A.9/\ GQ3_ +^G_"KVA^*GU/4X;1K18Q)N
M^8/G& 3Z>U.6%JQ5VA*O3;LF=71117.;!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A('4@=N:6N0\;N
MEO<PWES,);6TC,KVB7;02@[AB1 "-YX("G /;GBDOIFA\76IBNBD%P)HF*WK
M29<1EL-$?EC"[3\PSSC.-U '845YS:W$EI;1Z5<W$H=9K1;R\CU&6=75]PX=
ML&,LR#('9QSS75^$)6DTV<><\\,=W-'!([ERT:N0/F/)QR,GTH U[B..:WEB
MG4-$ZE7#="I'.:XQ-#O[.-+?2O&DUO91C;'%+##,R*.@#D9P.V<UVEQ%'/!)
M%,H:*12KJ>A!&"*X6T\+^#=%\.I<ZE#H]Q9IG9>R0I\Z$_("W.XXP,CKC- &
MYX-@L[:+4H;6ZN+VX2[Q=W4Y!:64QHV1CC 4J !TQBNAKGO!>GZ99V5W/H,U
MM)IU]<?:8EMU 2/Y$0J,>Z$]N3CM70T %<C775R- '4V?_'I#_N+_*I:BL_^
M/2'_ '%_E4M &?XAA2?0M0BFNVLHG@</<JVTQ+M.6SVQUKSS^Q(O!NF0SQ^+
MY;*"Y($9BTR%Y)B1GLA9N.<G-=QXPT:TUW1)[*]D\GS%9(I-Y78[ @'@C=UZ
M'K6?HFCZO-KL6J>)&L?,M+<V]K#:%F52V-\A+ 8)P!CL* -7PK(9M#MYO[5.
MK++ETNC&J;AGIA0 ,=/7UK6KF?".EW.D-<_;KXA[NXGG2Q!0I$&D9OE. Q."
M,\XY-;FHZA::; )KZ>.")G6,,YQEF( 'YF@"U149GB$RQ&5!*REE3<-Q ZD#
MTY'YU%:ZA9WDDB6EW;SO']]8I Q7Z@'B@"S1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 >>?$3_D,0?]>X_]":N6KJ?B)_R&
M(/\ KW'_ *$U<M7N8;^%$\JO_$85N>"_^1DM/H__ * :PZW/!?\ R,EI]'_]
M -56_AR]":7QKU/4****\$]<**** "BBB@ HHHH **** "BBL?Q%KD6D0A0/
M-NY.(H1U)]3[4 /\0:W!H]MN?]Y</Q%$.K'_  K*T3Q#<K>BQU^(6UQ)AHFQ
MM!!Z#Z__ *NM2>']#E-R=4UH^;?ORJ'I$.WX_P JU-=TBWUBS,,XPXYCD Y0
M_P">U &E17*:%J]QI]X-(UPXF'$,Y/$@[<_U_#K75T %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 5[BRMKBXMYYX4>:W8M$S#E"1CBG+:VZSO,L$0F<;7
MD"#<P]">]344 5TLK5+=K=+:!8&^]&(P%/U'2IHT2*-4C5411A548 'M3J*
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M6-X-(UP[9UXAG)XD';G^OX=:ZN@ HHHH **** "BBB@ HHHH **** "BBB@
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MF.0#E#_A[5C:#K%Q97@TC7#MN%XAG)XD';G^O]:ZNLW7M'M]8LS%,-LB\QR
M<H?\/:@#2HKE=!UBXLKP:/KAVW"\0S$\2#MS_7^M=50 4444 %%%% !1110
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MK.(TSG:@)(49QP/0>@K3HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *^*M1_P"0A=?]=6_F:^U:^*M1_P"0A=?]=6_F:]'+]Y'#C=D5
MZ***]0X#T?X<?\@.?_KY;_T%:ZJN5^''_(#G_P"OEO\ T%:ZJI*"MSP7_P C
M):?1_P#T UAUN>"_^1DM/H__ * :RK?PY>AI2^->IZA0< 9/2D8A5)8@ #))
M[5QVH7]SXEO'T[2&,=BIQ<7/9AZ#V_G]*\$]<=JFIW.O7C:7HC;8!Q<70Z8]
M ?3^?TKHM'TNWTJS6"U7 ZLQZN?4T_2M.M],LUM[1-J#DGNQ]3[U;H ****
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M  CH#WQFNEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "OBK4?^0A=?]=6_F:^U:^*M1_Y"%U_UU;^9KT<OWD<.-V17HHHKU#@/
M1_AQ_P @.?\ Z^6_]!6NJKE?AQ_R Y_^OEO_ $%:ZJI*"MKP<ZQ^(;9W8*JA
MR23@ ;#6+5O0[+^U=6AM-YCC<G<PZX )/\JY\1-1@UU9M1@Y23['77EW=>*K
MMK'36:'3$.)KC'W_ &'^'YUU6G6,&G6B6]H@2-?S)]3[TZQM(+&U2WM8Q'$@
MP /Y_6IZ\0]4**** "BBB@ HHHH **** "N(^)'WM/\ I)_[+7;UQ'Q(^]I_
MTD_]EKHPG\5&&(_ALXJBBBO:/,-#P]_R'+#_ *[+_.O7*\C\/?\ (<L/^NR_
MSKURO+Q_QH[\)\+"BBBN$ZPHHHH **** "BBB@#,U[1[?6+/RIOEE7F.4#E#
M_A[5D:#K%Q:7G]D:Y\MRO$,Q/$H[<^OO_6NJK,U[1[?6+3RIOEE7F.4#E#_A
M[4 :=%<KH&L7%I>?V1KGRW*\13$\2CMSZ^_?ZUU5 !1110 4444 %%%% !11
M10 4457N+VUMO^/BYAB_WW"_SH L45B7'BG1X.&O%<^D:EOU Q5!O&EH[;;*
MSO+EO]E, _S/Z4 =517*?VWK]S_QYZ&8_>=B/Y[:CF'BAXS)<WECI\0ZDD<?
MB0?YT =?1D5P_P#9OVC_ (_O%8<'JD<P _\ 0OZ5JZ%:Z+HS2O;ZE'(\H 9I
M+A3T^E5R2[$\R[G1T53_ +5T_P#Y_K3_ +_+_C5M&#J&4@J1D$'((I--;C33
MV%HHHI#"BBB@ HHHH ;)(D>WS'5=Q"C<<9)Z"G5QOCB2WM[VVN9IK:X>&(E-
M.EE*/,<@AH<=9., 8/7J*@U*YM9O$ET-'N(X]3MH)O,'G_O)Y3'\D80GD+]X
MG& 0 /XL '<T5YBLMF'A^PW);162S_M!_-)0,6?.\YX8_+OSVQNKL?!ISI4W
ME,7M/M4PM6)R#%O.W!_N]<>V,<8H W:X*/6-=FU[4TF\)2W$,8B$2M- -O#9
M.XGYL\<9./:N]KS/QYJ(L/$0EU2_O+2.*6S>R5)'2!U\X>>6V\,P&<ANW04
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M_;EK_=E_[Y'^-</)+L=/M8=S5HJ*UG6Y@66/.UNF>M2U)HG?5!1110 4444
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M1110 R2&.22.1T5GC)*$CE21@X_"GT44 &!1110!!J%Q]DL+FY*[A#$TF/7
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MR_\ CO\ A7F'<2T5%Y+?\]Y?_'?\*/);_GO+_P"._P"% $M%1>4W_/:7]/\
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M;LBO1117J' >C_#C_D!S_P#7RW_H*UU5<K\./^0'/_U\M_Z"M=54E!5W1O\
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ME]J2F5@SWH"RQ,, QE0JXQZ$9YK>H *Y&NNKD: .IL_^/2'_ '%_E4M16?\
MQZ0_[B_RJ6@ KA?$%[IDD.M6QTS[1=W%_#:+ +@QM<3;$97R/N;01\PYPF?2
MNZKB+J6ZN_%5]<:'X<TR>ZL6%M)?W<WER,Q0,0N$)P%8#)]: -;P(;==",%O
M9?8GMYY89X3*9?WH8[CO/+9/.3SS70UE^'+>XM]-VWEG:V<[2O(\=M(9%)9B
M2VX@$DDDFM2@ HHHH **** "BBB@ HHHH **** "BBB@ HK+UC7K#25Q<RYE
M[1)RQ_#M^-8?F:]XA_U8_LNP;^(_ZQA_/^0^M &OK/B.PTO*22>;<=!#%RV?
M?TK'\G7O$/-PW]F6#?P+]]A[]_SQ]*V=&\/6&E8:*/S)^\TG+?AZ?A6Q0!F:
M/H=CI*C[+"/,Q@RORY_'M^%:=%% !1103CK0 5\5:C_R$+K_ *ZM_,U]E76I
M6-J,W5Y;0C_II*J_S-?%.J:KIZ7]R7OK51YK=9E]3[UZ& :3E<XL8F[6)**R
MY/$.DQ_>U" _[K9_E563Q;HJ?\OF[Z1L?Z5Z+JTUO)'&J<WT/9?AQ_R Y_\
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M%%%<XSK-$_Y!D/T/\S5ZJ.B?\@R'Z'^9J]7'+=GJ4_A04445)84444 %%%%
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MM)]N_:#O?^89X7T_/JP;'_C[U[W10!X)_P (Y\?[OF7QCX<LU/\ #' &(_\
M(!_G2CX:?%N]_P"0C\4S!GK]EMS_ $V5[U10!X)_PHOQ5<G.I_%OQ).#U5#(
MH_68C]*/^&:M(NO^0QXM\3WOK_I"#/\ WTK5[W10!X=:_LQ^ 86S*=8N?7S;
ML#/_ 'RHKY[N?!VB07<T:V9*H[*-TKG@'ZU]ZU\5:C_R$+K_ *ZM_,UWX&$9
M.7,KG'BYRBE9F#'X=TB/[MA ?]X9_G5F/2M/C^Y86J_2%?\ "KM%>FJ<%LCA
M<Y/=GH/PUMH$T6<I!$I^T,,A /X5KL*Y7X<?\@.?_KY;_P!!6NJH *NZ-_R$
M8_H?Y&J57=&_Y",?T/\ (U-3X6".EHHHKS2PKM+/_CUA_P!Q?Y5Q==I9_P#'
MK#_N+_*L*W0Z\+NR:BBBL#L"BBB@ HHHH *XCXD?>T_Z2?\ LM=O7$?$C[VG
M_23_ -EKHPG\5&&(_ALXJBBBO:/,+&G_ /']!_OBNJKE=/\ ^/Z#_?%=57'B
M?B12"BBBN<9UFB?\@R'Z'^9J]5'1/^09#]#_ #-7JXY;L]2G\*"BBBI+"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L/QM_R+=U]4_P#0
MA6Y6'XV_Y%NZ^J?^A"M*/\2/JB*OP,\OHHHKWCR KKK?_CWB_P!T?RKD:ZZW
M_P"/>+_='\JYL3LAQ)****Y"CH/#'^IG_P!X?RK:K%\,?ZF?_>'\JVJY*GQ,
M]*C\""BBBH-3F_%-_>6=W:D3&STY09);K[.TP# C"O@C:A&<L>/<=WWVK7=C
MK%ZDPA>SAL'NXT13O)4C.3G'//0?G5W5]$@U6:)KF6X$(!26!)G6.92#\K*"
M 1SZ<]#Q2R:+:2:H;^0SM,T9B*F9BA0]5V9QC\.M '/MK6KP75O8336KW-XE
MN\<RPD+%O+;QC=S@)\O/4\UO^';R>\LYQ>%&GM[B6W9T7:K[6P&QDXR,9]\U
M!'X8TV.W>(+<'=Y861KAV=!&24"L3D!23T]3G.:TM.LH-/M1;VJL(PS.2S%F
M9F)+$D\DDDG- %FO-O&VK-8^),WVKW&G1P2V;6L*R^5%.AF F9C_ !8&<C.
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MJ?ZUH^:__/"7\U_QJ6BH;N[LUC%15D1>:W_/"3\U_P :EHHI%!1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .3^(O_ ""[;_KM_P"RFO/Z] ^(O_(+MO\
MKM_[*:\_KV,'_"/-Q/\ $"G)]]?K3:=']]?K74SG/3?[ _Z>?_'/_KT?\(__
M -//_CG_ ->MVBO!]I+N>I["GV,+_A'_ /IY_P#'/_KUIZ=:?8[?RM^_YLYQ
MBK5%2YN6C*C2C%W2"BBBI- HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-'+;RS>8P?:ISG<>"",<].>]=/7)_#R6TFM=4DL;FYOD-X=U].P8W)\M/F&
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MD'J":T?!!O9TNYK^61S W]GQDOD2"$LK2_5F)S_NB@#;T_5=/U%G6PO;>Y9
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M5<PB(8)')XR3@=<=JRKWPQ=6FAVD-L(9I8;:PM"H0E6,5PK,Q'=<9/YUW5%
M''S>&+R287KR0M=//++) DTD4>'1%P'7YL@1@].=S<"K(\,E%D6$PQJ9+%D
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M<)-?QS6\B3R Y94C6.0-[L-Q'H2*ZVBB@ HHHH **** "BBB@ HHHH ****
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M&A(,<0=@S;?E!YPO7.,8&!0!+9ZG?7EQ<SPQVRZ;;SR0-O+>8^PD.PQP,,"
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MG&1Z]: +UCJT%]?7-M;+(_V? >7C;DJK =<]&!Z8]ZSFUV8:?-<>4FY-36Q
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K%<C10!UU%<C10!UU%<C10!UU%<C10!UU%<C10!UU%<C10!UU<A2TR@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>sgry-20240425_g3.jpg
<TEXT>
begin 644 sgry-20240425_g3.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" '* OL# 2(  A$! Q$!_\0
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M%_WP*EHH B^S0?\ /&+_ +X%'V:#_GC%_P!\"I:* (OLT'_/&+_O@4?9H/\
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MLT'_ #QB_P"^!1]F@_YXQ?\ ? J6B@"+[-!_SQB_[X%'V:#_ )XQ?]\"I:*
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M:5HPT^Q>*SCN9[F^C+.RMT55!7IGDD\9KEO#[&7X9_$ B6*XS>7I\R!<1O\
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M5 )CX&7P._>JGA'PM%9V^F7ZZKK,K"!&\F:]9XCE.FSI@9X_"N83_D5?B?\
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M,S=2?K5JB@"OI]E;:=9QVMC"D%M&,)'&,*O?@4FGV%IIT!AL;>.WB9S(5C7
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M\B+_ )Y1_P#?(H\B+_GE'_WR* '[U_O#\Z-Z_P!X?G3/(B_YY1_]\BCR(O\
MGE'_ -\B@!^]?[P_.C>O]X?G3/(B_P">4?\ WR*/(B_YY1_]\B@!^]?[P_.C
M>O\ >'YTSR(O^>4?_?(H\B+_ )Y1_P#?(H ?O7^\/SHWK_>'YTSR(O\ GE'_
M -\BCR(O^>4?_?(H ?O7^\/SHWK_ 'A^=,\B+_GE'_WR*/(B_P">4?\ WR*
M'[U_O#\Z-Z_WA^=,\B+_ )Y1_P#?(H\B+_GE'_WR* '[U_O#\Z-Z_P!X?G3/
M(B_YY1_]\BCR(O\ GE'_ -\B@!^]?[P_.C>O]X?G3/(B_P">4?\ WR*/(B_Y
MY1_]\B@!^]?[P_.C>O\ >'YTSR(O^>4?_?(H\B+_ )Y1_P#?(H ?O7^\/SHW
MK_>'YTSR(O\ GE'_ -\BCR(O^>4?_?(H ?O7^\/SHWK_ 'A^=,\B+_GE'_WR
M*/(B_P">4?\ WR* '[U_O#\Z-Z_WA^=,\B+_ )Y1_P#?(H\B+_GE'_WR* '[
MU_O#\Z-Z_P!X?G3/(B_YY1_]\BCR(O\ GE'_ -\B@!^]?[P_.C>O]X?G3/(B
M_P">4?\ WR*/(B_YY1_]\B@!^]?[P_.C>O\ >'YTSR(O^>4?_?(H\B+_ )Y1
M_P#?(H ?O7^\/SHWK_>'YTSR(O\ GE'_ -\BCR(O^>4?_?(H ?O7^\/SHWK_
M 'A^=,\B+_GE'_WR*/(B_P">4?\ WR* '[U_O#\Z-Z_WA^=,\B+_ )Y1_P#?
M(H\B+_GE'_WR* '[U_O#\Z-Z_P!X?G3/(B_YY1_]\BCR(O\ GE'_ -\B@!^]
M?[P_.C>O]X?G3/(B_P">4?\ WR*/(B_YY1_]\B@!^]?[P_.C>O\ >'YTSR(O
M^>4?_?(H\B+_ )Y1_P#?(H ?O7^\/SHWK_>'YTSR(O\ GE'_ -\BCR(O^>4?
M_?(H ?O7^\/SHWK_ 'A^=,\B+_GE'_WR*/(B_P">4?\ WR* '[U_O#\Z7KTJ
M/R(O^>4?_?(J0 *,  #T% &3XGU1])TPSQK'O=Q$))GV11$]'=L'"CZ=Q]:H
M7/B.:UO=.M)8]-5[F$2-+)?%$)W ;8SL.\G.1TK8U>"\GL]NG7*V\X8$,Z!E
M8=P01T^G<"LE_# _L==)COI%T]E99H_*7=)N8LV#CY<Y(X' QC% $=QXJ^S2
M///:*NEK/-;"<2DN7B5V8[-N-N8W .[.0..:OZ+JMS=W<EK?V<=K.(([E1'-
MY@*.6&"=HPP*\]1R.:J2^%89Y94GN97L'EEG%KM  DE5E<[NI'SN0/4_2KNC
MZ0]A/)/<WDEY.T20!V0+B-,D<#N2Q)/?C@4 :U%%<U=>-=(CF>&S^V:G,APR
MZ?:O<!3Z;E&W]: .EHKF(/'&D&58[];[2W8X7^T+5X%/_ F&W]:Z?KTH *YS
M5O\ D(2_A_(5T=<YJW_(0E_#^0H WK/_ (](?]Q?Y5+45G_QZ0_[B_RJ6@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-)I_EO(TT]DT#I(9,A,D#>""QZ<8'/-=;10 4QQ)GY"@'N,T^B@"+$_]Z/\
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MM[G/5J^U=[!1116QF%>V#I7B=>V#I7G8_P"S\SMP?4****\X[0HHHH ****
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M]\,DL >C:G,1@?\  C%2_P!C_'W7!FYU_P /Z!$WWHX(P[CZ'8__ *%7OE%
M'@8^!GB?5?F\5?%'7KM6^_!;;D3\,N1_X[6CI?[-/@&UDWWR:KJ;DY8W5V1G
M_OV%->UT4 <3HWPH\!Z/C[#X5TG<O(:: 3L/Q?)KLH(8K>%8K>)(HE&%1%"@
M?0"I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **HZQJ*Z;:B0QO--(PBAA3K)(0<+D\#H>35:[U
MQ+*U@GNK.[2-POF-L!$)+!?FYR>3_#GUZ4 :]%946MPR7%XGD7"P6;,LURVT
M1J54,?XMW0^E/TG6(=2D>-(;B"58TF"3H%+1OG:PP3P=IX/(QR!0!I5Q5MK
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M%K>6H+%?+NXC&_'?![5>J&SNK>]MUGLYXIX6^[)$X93]"*FH **** "BBB@
MHHHH \B_:/\ ^1<TK_K[/_H!KY_KZ _:/_Y%S2O^OL_^@&OG^O:P7\)'EXK^
M(PHHHKK.8W/!7_(S67U?_P! :O5:\J\%?\C-9?5__0&KU6I92"BBBD,*]L'2
MO$Z]L'2O.Q_V?F=N#ZA1117G':%%%% !1110 4444 %%%% !1110 5B>-/\
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M&,9]:VJYKP"BC1IY1?6E[-<7<L\SV;;H5D8Y*H>X''/KFNEH **** "BBB@
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M_C\@_P"NB_SI2V8UN>RBB@45\\>R%%%% !1110 4444 %%%% !1110 4444
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M-_;\7_/%_P Q1_;\7_/%_P Q7![.78Z_;0[FS16-_;\7_/%_S%:EK,+BW24
M@,,X-)Q<=RHU(RT3):***DL**** "BBB@ HHHH *Q/&G_(MW?_ /_0Q6W6)X
MT_Y%N[_X!_Z&*TH_Q(^J(J_ SRZBBBO>/("I[+_C\@_ZZ+_.H*FLSMNX2>@=
M3^M*6S!;GLPHK._MFS_OM_WR:/[9L_[[?]\FO Y)=CU_:0[FC16=_;-G_?;_
M +Y-']LV?]]O^^31R2[![2'<T:*;$XDC5UY5@"/I3JDL**** "BBB@ HHHH
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MPU6QU"21+*YCF:,X?9SCG'\Q6'?)=IXJ4Z7!>12R-$]T[-&;::(<$D$[@X'
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M )[-_P!\BCRY/^>S?]\B@"6BHO+D_P">S?\ ?(H\N3_GLW_?(H EHJ+RY/\
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M\Q9QPV>#D=L5T59'AB*2+3Y&GTTZ;-+/)+)"9Q,2S');</7T[=*UZ "BBB@
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MSW<LL'^K+.<X3_9 P!],UM4 %%%% !1110 4444 >1?M'_\ (N:5_P!?9_\
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M_P#CPM_^N:_RJ>N)[GJQV04444B@HHHH **** "BBB@ HHHH **** "BBB@
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M_5H''_V?=_\ /"3\JZ+3G\FRBCD20.HP1L)J]14RFY;ETZ,:;NB+SU_NR_\
M?L_X4>>O]V7_ +]G_"I:*@U(O/7^[+_W[/\ A1YZ_P!V7_OV?\*EHH B\]?[
MLO\ W[/^%'GK_=E_[]G_  J6B@"+SU_NR_\ ?L_X4>>O]V7_ +]G_"I:* (O
M/7^[+_W[/^%97B9)+[1;BWMHI'E?;M&PC.&![UM44XR<6I(4ES*S/*O^$<U;
M_GS?\Q1_PCFK?\^;_F*]5HKL^O5.R.?ZI \J_P"$<U;_ )\W_,4^+P[JJRH3
M9O@,">17J5%+Z]4[(/JD#C_[/N_^>$GY4?V?=_\ /"3\J["BL/;2']6@<?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBHKFY@M4WW,T<2^KL%'ZT 2T5SMYXPTJ [87DN9.@6),\_4XJK_;.
MOZA_R#M)%NA_Y:7!_7G']: .LJE>:M861Q=7<,;?W2W/Y=:P/^$?UB_YU;6'
M53UCMQ@'^0_0U=L?"6D6N";<SM_>F;=^G3]* '/XMT5/^7S/TC<_TJO)XTTA
M?NO,_P#NQG^M:Z:1IJ?=L+0?]L5_PJQ':6\?^K@B7Z(!0!S7_"<:>?\ 56UZ
M_P!$'^-+_P )>[_ZC1[Z3_@/^ -=5TZ44 <I_P )+JK_ .J\/77U8L/_ &6C
M^V/$<G^JT1%_WW_^N*ZNB@#E/M7BU^EC91_5@?\ V:E\OQ=)_P MK&+\,_T-
M=510!RG]G>*9/]9J]N@_V$'_ ,2*/[ UR3_6Z_*O^XI_Q%=710!RG_"*7;?Z
M[7KU_P 2/_9J7_A"[9_]??WTG_ Q_@:ZJB@#ET\#Z4OWFN7^L@_H*G3P=HJ]
M;9V^LK?T-=#10!C)X8T9.EC&?J2?YFK$>B:6GW=/M?QB!K1HH Y7QM96MOH+
M-!;0Q'S%&4C"_P J\]KTKQY_R+[?]=%KS6O6P/\ #^9YV*^,****[#F+.F(9
M=2M(QP6E103[D5Z#_8,W_/6/]:X+1/\ D-6'_7Q'_P"A"O7Z\[&S<9*QUX:G
M&:?,<[_8,W_/6/\ 6C^P9O\ GK'^M=%17%[61T?5X'._V#-_SUC_ %K>MT,<
M$:'DJH7\A4E%3*;EN7"G&'PA1114F@4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%-FD2&)Y)6"H@+,Q.  .IH5U900PPPR.>M #
MJ*3(SC(SZ4M !7+>.-0NK2;2;>#4X])M[N9HYKQE5BF%)51N^4;CQD^WK74U
MR&O1:Y?73QOX:T34+2-SY+7=SDX]=IC.#0!9\,J5OWSXL;6?W9_T<^1\O(^;
MY #[>G-=-7*>%;"\M=1=[GPWHNE(8B!-9."['(^4X1>._7L*ZN@ KG-6_P"0
MA+^'\A71USFK?\A"7\/Y"@#>L_\ CTA_W%_E4M16?_'I#_N+_*I: ,GQ:UXO
MA?56TO?]N%K(8=GWMVTXQ[^GO4&C:_HLFAVT\&JV[6R0J#)-<#<,#^,DYW>N
M>:W:QKKPMH-U=FZN=&TZ6X)W&1[="S'U/'- %/X?74EYH<TQDEEM6O)_LDDI
M)9X/,.PY/)'7&>V*Z6D151 J *JC  & !2T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !15&^U>PL<_:KN&-A_#NRWY#FL2;QE;
MR2&/3+.ZO9.VU< _S/Z4 =32,P12S$ #J2<5RGG>*M1_U<-OIT1Z%^6_K_(4
MJ^$6N6WZOJ=S='KM!PH_//\ 2@#3OO$VDV>0]XCL/X8OG/Z<5E_\)3=WO&C:
M1<3 ])).%_3C]:V+'0-+LL>19Q;A_$XWG\S6ITZ4 <G]A\3ZC_Q]WT5C&>J0
MC+#\O_BJEMO!M@'\R^EN+R4]3(^ ?RY_6NGHH JV>GV=DN+2VAB]U4 G\:M4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <[X\_Y%]O
M^NBUYK7J?BRQGU#2#!:H'D+J<$@<#ZUQ7_")ZO\ \^Z_]_%_QKT\'4A&G:3Z
MG!B82E.Z1@T5O?\ ")ZO_P ^Z_\ ?Q?\:/\ A$]7_P"?=?\ OXO^-=?MZ?\
M,CG]E/L9VB?\AJP_Z^(__0A7K]>=:7X9U2WU.TFE@41QS(['S%. "">]>BUY
MV-G&4ERNYVX6+BG=!1117$=04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!@^-(K:72$%Y<1V\:S(X,T)FB8C.%D4=5
M/N1SCOBN6O5C:VTW4/L%DE]# T<&ERV3.)/WG!BZ;"=N1D?*",BO198TE0I*
MBNAZJPR#3J .#L85/B* ^2PUA=5N'N)/+.[[,4D"9;'*;3$ ,XR!W%=Y110
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MB@"GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,%+)STRR_>QPP/3FA_$MI'IK7DL%XNR<V\D7E;GC<'!W8)4#D'.<<C% &OY
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MB@ KG-6_Y"$OX?R%='7.:M_R$)?P_D* -ZS_ ./2'_<7^52U%9_\>D/^XO\
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MD7;(1]9-X^BBL/2=,NM&\.VU]Y;I<7%I:6S0VD31% N<M(0&8M\V"0N1C\:
M/0-Z^9LW#?C.W/./6DCECD:18W5C&VUP#G:< X/H<$'\17!Q7>MG35G=+H7
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M$VG3KI\ %^H_NW$BF/'IC:KM]9*MQ:"9-:U"\NWD,;727$$._P#=EEAC4,P
MSD,IXSC@'%=#10!P6E>'-2C\UI;:"W,DEA(T<6Q$W13%Y"H4#C&,9RQP,GM5
MSPOH-UI^L6T]Q901-%:S03W2."UU(TD;!R,9Y"D\\Y)'IGL:* .7F\*2R3._
M]LWPW,3C=T_6F?\ "(R_]!J^_P"^C_C75T4 <I_PB,O_ $&K[_OH_P"-+=^&
MKB/0=5M8;Z>[ENH#&BS-\H-=510!PEYX6U$76KQV<B"QFA1;8;L$ R^9)$<@
MC!^8#((PX&,"IK'PU]GO=+NAI^\0W$CLD_D[H0P7#*$4* "N<#G))ZFNUHH
MY?6]"FU#4KEVCCDM9FLLJYX98I79P1]&'UJC!X>N+6\A+Z;;7EE&]P(8&90M
MOOFWHR@C ^7CCD8&*[:B@#AF\.7K2SXM8([C-V9+T.-UTLH<(AXS@;ESG@;!
MC(I__"(K#.TMK9VT;J;)XF7 *NDF9F'H2H )ZMC!KMJ* .2\-Z#/8:W-=72R
MF4M-F<-'LE5WW+G"AR0,?>) Q@<5UM%% !1110 4444 %%%% !1110 4444
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M: .IHKEOM,__ #WE_P"^S1]IG_Y[R_\ ?9H ZFBN6^TS_P#/>7_OLT?:9_\
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M#J:*Y;[3/_SWE_[[-'VF?_GO+_WV: .IHKEOM,__ #WE_P"^S1]IG_Y[R_\
M?9H ZFBN6^TS_P#/>7_OLT?:9_\ GO+_ -]F@#J:*Y;[3/\ \]Y?^^S1]IG_
M .>\O_?9H ZFBN6^TS_\]Y?^^S1]IG_Y[R_]]F@#J:*Y;[3/_P ]Y?\ OLT?
M:9_^>\O_ 'V: .IHKEOM,_\ SWE_[[-'VF?_ )[R_P#?9H ZFBN6^TS_ //>
M7_OLT?:9_P#GO+_WV: .IHKEOM,__/>7_OLT?:9_^>\O_?9H ZFBN6^TS_\
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MY;[3/_SWE_[[-'VF?_GO+_WV: .IHKEOM,__ #WE_P"^S1]IG_Y[R_\ ?9H
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="$OX?R%0_:9_^>\O_?9J&1V=RSL68]23DT ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>sgry-20240425_g4.jpg
<TEXT>
begin 644 sgry-20240425_g4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ,A FL# 2(  A$! Q$!_\0
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M !11FC- !111F@ HHS10 449HS0 449HS0 449HS0 449HS0 4449H ****
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MNM"\=S:)9'6[Y1:+IR3 ,)FRVXL#S7T!8Q2PV<$=Q,9YD15>4KMWL!RV.V:
M+5%%% !1110 4444 %9EUK.GV;3"YNXH_)4O)N;[H&,D_P#?2_G6@#S7D'C[
M/VOQ)_UZ7'_H%O5PBI.QU83#K$3Y&[?\.>CIXDTAQ(5U" ^62K'=T(QG^8_.
ME?Q'I,=P8)+^!905!4MSE@2OY@$UX?8?ZK5_^N\O_H4%2:K_ ,C?)_UVL?\
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M>6@=V+-@!?4UWW@_P_!X6T*'2K2YO+J&)F82WDWFRG<Q/+8&>M;E% !1110
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M^.&&:U)%W*P]L4N]?[PZXZT;ASR..O-9-N]SBDW*3D]V<W#I=X]G]GNXK0+
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MY.:FCM)Q<R-=VT[*)'-\3$S"4>=F/M\X"9Z9P.*W8_%320Y%B?,V"?RS*/\
M5;=P;..O;'J.M/C\4"68I%:[O,9E@)DP)=K[&SQQ@_7BMKR[':Y5?Y?Q.:2S
MO=SA8+@3X)C8QMQ:^00$STSO_AZYJ86DAO@UM:7"P&1#8CR641?O%,O&/DR
M>N,C/K6ZOBQ.2;0K&N8V;?R)1'YA3&.F._Z4[_A)BL_E2VFUXF5;C$F1'N8*
MN./FSN]L8-%Y=@YJO\OXF9ID<D=C?1Q07"/+;)&X\IEWW #F0].XV_-T/ SF
MJ4EI(;J%K6TN%@\T&S A91$?,C+DC'R@@'KC(W>O/4V>OB6WNI9+8IY<*W"
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MD2.-GD8*BC+,3@ 4 /HK.T/5[#7=,BU'2;E+JSE+".:/.&VL5./Q4C\*T<T
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MM[N_N(HKN&\CFF:,(&VLT9()4CO_ 'J^@&\!^%S<7$[:%8M)<6RVDF8\AHE
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M(V<S2%-C8PWR%.F:YS21XLL=+:YNO[<O)GMMCQ2,V5+0PEF4 9W*[2XQS\I
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MF*6@ HHHH *#110!Y+\3O[4_X2!/L,%_)%Y"_-!8I*N<G^(L#GIQ7)?\3_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;3O*G-D3.,F1&/DY'N"?IN-:.@_#/QOI?A/Q)HLNF6]T^K1K&+M[Y08E0^8
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M ]NMI"UHDD;IEYC/(R9!SQM"YZ'O5;P)XMO=6CU.;4=K064"2NP@,3*Q#,5
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MO2TE+3 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** $(S5)M+L2Q)M("3U/EBKM+1<:DULRLMI;J %B0
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MQ,"Y)VBM#_A _"O_ $+^F_\ ?A: +7@W6?\ A(?#=CJAA$#SJ=\8;<%=6*L
M>XR#@^E;M<3\'8TB^'.DQQ*%13.JJ.@ FDP*[:@#R'XX^.==\(:EH-OX>\AW
MO5F9HI+=IFE9-FU%"\Y.2*P="^.-U!:W5MXBT*Y.L&X9+6"W=<2YE= F3TVE
M&!)SG%>MZUIND-KVD:WJ4RPW=CYD5JSS!%)E&",'J2!Q7*:S\*/"%S)+-?\
MVB*29FVR_:MC([2O+E#V.YW_  H&<XW[0>C+,[MI5_\ 8?(+QSAURTH1&,17
ML1O )SC->B?#?QA9^./#,>KV,4D \QH989""8W7J,CJ,$$'T(KFW^$7@B801
MFW?RW0K%$+@X8&)$)'<G;&ISZ\]ZZ[PYI.F^$]%M])M9W$,89E:ZGWR/EN22
M>O+#VY H$=#157[7 +S[+Y\?VG9YGE;QOVYQG'7'O5G- "T5#),D;1J[HID.
MU 3@L<9P/7@&H7OK5+H6K7,"W)0R"$R .5]<=<>] %RBLTZQIWV:.X^WVGV>
M1_+23SEVLW]T'."?:K4UQ';J'GD2-20H9V !)X ^N: +%%9CZUI:-.'U&S4V
M_P#K@9U'E\X^;GCGUJS]J@VQ-YT6V;_5G<,/QGCUXR: +5%9C:SIJ[]VH68V
M1B5\SJ-J'HQYX!R.:(=;TRXFABM]1LY99ANB1)U8R#GE0#ST/Y4 :=%4KK4+
M2SR;RZ@@"E03+(%QGIU/?!_*EFO[6%G66X@1DC,K!I "J#^(^@]Z +E%9ZZM
MIY:W5;ZU+7"EH0)E_>@=2O//X5;AE26-9(F5XV&Y64Y##U% $M%59;N"*3RY
M9HTDP&VLP!P3@'\R!0UW;JJEIX@&D\I3O'+YQM'OD=* +5%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*0%(8<^6N?J3WJ4:'XDL]6D:Q^W+:37;3NGVG*C]_(<A2W&4*D@=>.]>JT4
M<GX%LM3L+6ZBU66[DRT31M<SF5LF%-XR23C?NX_+BNK-+2&@!:*** "BBB@
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MFBEM/M$+QN7RDI^;*HI!]1B-/RK7OK^UL(T>]N8+9'8(K32! S'H 3W]JMT
M8FH>'+"_U:+4)Q-YR;,A92$DV,63<O0[221]:S9O FB74TLM_%/?22 @M=3-
M+P5*CKZ!FP>HR:ZVB@#$DT*WGTB[TZ]EGN;6X^7;)(<HN   >HQC.?7FJJ^$
M-/6&&+?>F-)C<.IN&(FD+A]TG]X[@#^&.E=+10!@:GX7L-1O9KN;SUN)1$"T
M<A7!C8LC#W!9OP)%2_\ "/V&Z1F61GDEAF=F<Y+Q8V'_ ,='UK:JA=ZG86GG
M"ZO;:#R4$DOF2JNQ2< MD\ GC)H RKOP?I-TTK2QS9E617Q*1G?()"?J' (]
M*6W\(Z5;VDUND<I29564M(2SXD:3)/J69B3[UT>:* .<F\)V$NGW-DTET+2X
M<N\0E^7DDE1[$L?T]!4VH>&K"^U."]F$PFA5% 60A6"-N7([X)-;M0W$\=O
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS5)X+$1ZM(DMO$$<AW D/S9SSWR!GKQFH8_"VI1Z'?VD.JM#>7,\<HND9R5
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M#^- :ENV^$'A2ZB\VVU#59H^F^.^##\P*E_X4OX:_P"?K6?_  ,_^M7-Z_\
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M+^&O^?K6?_ S_P"M7IE% 7/,_P#A2_AK_GZUG_P,_P#K4?\ "E_#7_/UK/\
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M\EP1YB%R^&]<,2>U=7HOAK3M&BU&.R20+J$IFGW/G+$!3CTX%9'_  HK2O\
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MO2O^AG\6?^!R_P#Q%'_"B]*_Z&?Q9_X'+_\ $47"QV-%<=_PHO2?^AG\6?\
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M?\*+TK_H:/%G_@>O_P 11<+'8T5QW_"B])_Z&CQ9_P"!R_\ Q%'_  HO2?\
MH9_%G_@<O_Q%%PL=C17'?\*+TG_H9_%G_@<O_P 11_PHO2?^AH\5_P#@>O\
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M 'BHQP33-273[^RU"VDT[Q,D=].+B4I:$'( &!QTX%7_ /A1>E?]#/XK_P#
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M<O\ \11_PHK2O^AG\5_^!R__ !%%PL=C17'?\**TK_H9_%?_ ('+_P#$4?\
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M0?:(< ^;'@G .X<T>?'EAO3*\L,]/K3L%F3XHQ4'GQ';^\3YON_,.?I1]HA
M)\V/"G!.X<46"S)LT5%YT>X+O7<1D#/)J/[9;_\ /Q%_WV*+,+/HBHNB::+<
M0"QMO(#^8$\H;=V,9QZU(VF63S2S-:PF65/+D;8,LIXP3W%:-)BB['S2[F=_
M8^GB.!!9V^V!MT0\L8C.<Y'IS0VCZ>WVC=9VY^T',V8Q^\.<_-ZU\Q?&SQQX
MOTWXM:EH^A:U>V\&ZW2"WB8 !GB0\<=V)_.N?^(/BKXB>"O$TVC7_BR\GEC1
M)!)&V%8,,]Q^%%V.[[GU^-+LA)!)]EAWP+LB;8,H/0>E1_V+II@>'[#;>2[[
MV3RAM+>I'K7G.K^/9_#7@K1-3O$NK^>\\F )&P#-(\9;))X_A/YU#IGQA\,W
MMA%<3:TMI(T?F-!."'3G&.!@GV'.*+L7,^YZ@VF61F,[6L)E9/++E!DKC&,^
MF*9_8VG>1'#]BM_*C;>B>6,*WJ!V-</_ ,+)\/\ VJ2W/B&U$L<7GL"^!LVA
ML@]#P0>.U+#\1] F:W$?B&U)GB:>,;^J+G<3Z8VMP>>#Z478<S[G<MI5BSSL
MUI 7N!B4F,9D'OZT#2; ?9\6D'^C_P"I^0?N_P#=]*\S'Q<T(ZD(EU1#8BT:
MY:]W':I$BQ^7MQNW9;/3I76+X@A-O!/_ &E"(9T$D3M( '4]"/4478<S[F^=
M&T\Q31&SM_+F;?(OEC#GU/J:4:99">.;[+")8T\M'V#*KTV@^G)_.O/?&'CV
M\\/7.G1V^EWVII?,(X9;:1-ID()"<GJ0I/I5;1/BWH&I:&FI3:Q%9 N(WAF?
M#QL<X!'T&<CCWHNPYGW/2/[$TW[.+?[#;>0&WB/RQMW>N/6I/[+LC--+]EA,
MLR[)'V#+KZ$]QP*\Q\=?%.'PAJ5E;74-W=)<Q>>98&7")NQG!Z_A6G)\2?#\
M<5W(_B"V"VCB.;YB2K'.!C'/0],]#1=AS/N=Q_8^GA;=!9V^VW;="/+'[L]<
MKZ<BE.D6!6X!LX,7!S,/+'[P]>?6O.=5^+'ARPM[MO[=BGFMXO-$,9),N1E0
MIQ@YR/SK3F\=Z?9V.EW&J:G'8MJ**\$<K\G(!Q^N,]*+L.9]SM%TJQ6:"5;6
M$20+LB<(,HOH/0<TS^Q=.-N\!LK?R7;>R>6-I;UQZUY/'\8(9?!]QX@@L[R6
MW2_^PQ1*Z[Y2<8;VSGH>:GTWXPZ/<IYM[<R:?;>4C;[@\B0LZF,J,G(,;<],
M478<S[GJO]F6?VAI_LT/G,GEL^P;BN,8SZ4P:+IPBBB%E;B.)M\:B,85O4>A
MKAF^)7AQ;>><^(K3RH91#(1)G#GH,=2.#STX/I6=H_Q;T+4$F>;58K,+>-:1
M>;(/WN,8<?[)SU_.B[#FEW/3#I-@6N&-I!NN!B8^6/W@]_6A=)L%:W9;2 -;
MC$1$8_=CV]*X*'XF^'9;\64?B" W1F\@1G(._.,=/7C/3-2ZQ\1="T;4)K'4
M]<AMKN%0\D;YR <$=!UY''6B[#F?<[;^QM.,<R&RMRDS;Y%\L8=O4^IIZZ;9
M+.MP+:$3(GEJ^P95>F ?2N&E^(N@12.DGB*S#I +EAYH.(R 0?Q!''7D55N/
MBKX8M_+\WQ);#S(Q*I&XY4_0?IUHNPYI=SOAHFF"W6$6-L(5?S GE# ;UQZU
M*=+LFFFE-K"99D\N1B@RZ^A/<5P"_$[PXU^+(>(K<W+2+$$R>6/09QC\:)OB
M?X<A@>9_$5MY22^0S*Q;#XSC@>QYZ<'FB[#F?<[U=(T]5@46EN!;G,0\L?NS
MG/'I2-H^GLMP&L[<BX(:;]V/WA!R-WKS7F]S\5]#M]>ETYM4C,=O;M//=!\Q
MQD,JA..K'<.E;FH>-M+TZSL+J^UF&&VOL?9I&;Y9,XP0?3D<].:+L.9]SL%T
MRR6:&46L(DA79&VP91?0>@J+^Q--%L;?[#:^0S^88_*&TMZX]:Y74_&>FZ7<
M/#J.L0VTJ% PD;&-X8K^81C_ ,!-8/\ PMC0&U:SM(=6BDAN+>6<W(?"1[#T
M;N"<,>>RT78<S[GIC:99-,TYM83*Z>4SE!N*]-N?2F?V-IWDPQ?8K?RX6WQK
MY8PA]1Z5P>L?$.UL_"7_  D&G3-JEH94A06[@%F9PN.>A!/>N8?XVV\,TT=W
MINHP>3&Y=V9"HE6,R>5D'J0.OJ11=AS/N>RMI-BS7!:TMR;CB4F,?O/][UH&
ME6(-N1:0 VXQ"=@S&/\ 9]*\\\)_$BWUW1]0U"X,VFQV!'V@7+J0BE0P;(XP
M0:H77Q9L!K6FV.GM+?1WS0K'<1. H,CNG(/.1Y;9'THNPYGW/4/[&TXPRPFR
MM_*E;>Z>6,,WJ1ZT_P#LRR\]9?LL/FJGE*VP9"XQMSZ8[5YYXM^)FD>&H[U+
MG4!+J%I&)&LD<>8V2,#GCN#ZXYK*UOXNVFBVNE2WR3(VH6+7RH)%.T!<A,C@
MDG@=J+L.9]SU0Z+IIMEMS8VQ@5_,$?EC:&]<>M2-I=DTTTK6D)DG7;*Q09<>
MA]>@K@-+^)>A7]GILRZY;QO?D)%$[X;?W4@CC!..:N7WCO2+#6#I5]K4-O?J
MGF&*1MN%QGDGCISUHNPYGW.P_L>P_P!&'V.WQ;'="/+'[LYSE?3H*7^R-/*3
MJ;.WVSG=*/+&)#ZGUKS^3XI^&8X8)7\1VPCGW>6<MSCKGCC\<53'Q;T%+^>&
MYU:*"W58FAN3(&6?>N> ,D8Z'(%%V'-+N>FKI=BDT,PM8!+$GEQN(QE%YX![
M#D_G3/[$TW[,;?[#;>0S^88_*&TMZX]:XJ;XBZ#"UZLGB&T4V8!G_>?=ST^O
MX9JSI_C?2=2U--/L-9@N+QXA.L4;Y)0C(/Y'..N*+L.9]SL/[-LOM$D_V:+S
MI$\MWV#++TP3Z<4Q='TX1PH+*V"0MOC7RQA#UR/0UYGXJ^*!\/\ B";37L;V
MY6WMUNIYXG4".,YR<'DXP>E8MY\<8K2"%I]*U1)R\BS0,55X0BHV2#URK@\4
M78<S[GM!TFQ)N";2 FX_UV8Q^\_WO6A=)L%D@D6T@#P#;$PC&8QZ#TKS'Q7\
M5(?#W]ER207ES:WUO]K,L>!Y465&XJ>3]\<"KUK\4?#5RT2P^([4F63RD#,5
MRV <<CW'/3FB[#F?<[[^QM.\F6+[%;^5*V^1/+&&;U([FGKIMDMP)Q;0B8)Y
M8DV#<%Z8SZ5P"?%#PV]K+<#Q':^3%*(78L1ACT&",GH>1QP:?<?$KP];M="7
MQ%:@VNWS</NVYZ8P.?PS1=AS/N=P-%TU8$A%C;B)'\Q4\L85O4#UJ1M+L3+/
M(;2$R3KLE;8,NOH?45YYI_Q$_M.QUVZTNWN[Y-,E$*K;D,UR< Y3VYK0\*^,
M6\1>'O[5B6XMPK2(\,A!960D$9'!Z478<S[G8KI&GKY&VTMQ]G_U/[L?N^_'
MI2-H^G,MPIL[<K<,&E'EC]X0<@GUYKQ5?CHGV2WN'T;5!'.&DCVO&V8UY=\
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M>B>6,*WJ!V-/.E6)>=S:P%[@;96\L9D'H?6M"BB[%S2[F<NDV"FW*VD -O\
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M'"RM;LC?:&D+ +'SR1L)/3 H ])HH!S10 4444 %%%% !1110 4444 %%%%
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MX2N]$-T;47)3,H3?MVL&Z9'I6]IMM]CL+:VW;O)B6/=C&< #^E$=+@^A;%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MET^.0DJS>602_? [?GUH'H>A^+/$AT'P)?Z_(D8EM[/STC9MRF0K\JDCJ"Q
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MI: $-1QQK$FV-%5<]%&!S4M% "8J)8D$QE5%\PJ%+8Y(&<#/IR:FHH ****
M.*T\@?%W6\G'_$HM/_1L]=1K##^R;[D?ZA^_^R:P?$W@'PSXGU!;[7-+6[NE
MC$0D,LBG:"2!\K =2:R_^%/>!/\ H 1_^!$W_P 70!J_"O\ Y)KX5_[!EO\
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MFSWJW^B6CV<04X"HX0$CN#\@P<^M9^F>!]/T[3Y+6WN+L^8T;&1BFX%)3*"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSDDH&+'.1P#S6YX9\8WVK3RF>UMO(6&1H_)9BSLB1-D$_P +>9Q[#OFI]/\
M&;:K<)9VFGM'?$2.Z2-N54CD*.<CKRN![D5)/XQ\K0K/5/LA43>;OMB?G4HC
M':3QM;*X.0:-T'6QE^&_$^KZ[J%\\=Q9_9K>Q=HQ;KOCEE)X8$\X7!4C/4&L
M6T^(.L6VEO<7)L;Q9%A"2_<6-C%;EV8Y VYE/<8/<#IL3?$C%W;"/37,+Q.'
M4OEO.#1J$&.W[SK@YJ=OB+$@BW:3>!IFVPQY&]L E@5QE2,=.Y]* \QOC/Q]
M+H!M%CBMO/ELS<O%*W3Y&888-R 4(. >HY'&<_\ X63>?:)X]FF,L<*OYJNV
MU07"^>>?]5@YS^M6[_QY#>VYM!I)?SYQ R7# H8?-$;,1ZY/"TQOB!;I9RZA
M9:+.LEP.9)2$WX5?+;U8'>H..G/7%'F'0IS>/=9FAE^S6UO$[VOG#S06:-FA
M#*%'&0&]>M.;X@:O;Q23"WT^[MHMJ9B+;Y240Y!R1C+^_ KI=:\6MI-K8M<V
M#223VOVB18Y!A#NC0*..<M(H^F:H2?$$,S)!IER"C1J5< NS'RMR!<@@XE7!
M/?M0'4Q+[Q_K4NE336XTR%51<7"-YB\ECO!#%=NU#D9.,]>*VO&_BK4=.O$T
M[36MEFGM@Z2X+."0Y\Q5Z%%V '/=U_&-/B%)NGD?3#+!^[6-()"\A8J[.I&.
MHV$8P#G@X[6)/'Z1LF_2KHK(C2*5;=A<L%+<84$H1STR/?!T!%/Q'XHU#2/$
M\UM#/]J^SV"7'V':N91Y<Y=^F1S'&/3YO>J]OX^U SV1EALREV4"XD#(V6VX
MC92<LP.X D\*:VY/&,EGH]G>WUB2TT\T<J12#]TJ2[,\_>/3IUYK,U'XBO;F
M\:UT\-!;V@E+._*NT:.G ZK\X!QSWH?7R!:KU,G2_'.L&W-U/=64RJCR"U*@
M2M_HJ2*N01U)8].@;TXV-4\:26NF^&+R]E6V2_G83"W:-TD0<#:S$C!)4X!)
MVD\_*:W?#OB4ZK?7%L;8?Z,I::;(55)=U4!<DGA#DUEP?$&*<WODV$KK9J7E
M82 #;@%"NX G=N'L.O(H!=R'Q9XEU#0/$LBI<1O:/!$RQW( C1CYIP"!NW-Y
M0503U;OTJ"T^($U[<K;HMC;/YLD,C2N?D=2?W7_70XR ?0\5J7?CJ.SNWM[O
M3Y4=)%A8K*K#S,1DCZ 2KSWYJJOCZ2ZN%BL].V@2@,\L@.4*RDL .X,1X[YI
M=+#14\)>-M2O[_2-.O+>U:6X1C/*KA"^%)W(I/..-P /WL\=[%IXSB^WV\%Q
MJ]DLANK^UDC:1 P=)2(4([-CH.I]Z(OB,K6\+-ILA>5"R$2*H8*'+MWQCRS@
M<YR*MZ]XONM)U:\62UBDT^!8P@7/F2,T;N1G. /E Z&F]["7<SO^$HU?0OA_
M_;.N-')<3,C6PE"\J8P<.5*J,D/CGNHY/!LW7BR\G\.ZI=6L]C;SV6I16S./
MGCCB,J*=S9QG:QSTV\C@C-7;'QFUQKD&FSZ7)")9VMO.\Y6 =?,[8Z9B8?E6
M<GQ EMA?#4-.+M;S3(/)< ?*\JHO)Y)$+$G@#(XH J:?XZU:._T^PNX;.9KJ
M7B<MY892V @R0"^,D8ZA>G>O414,!=HD:5 CD LH.<'TSWJ:@#@O$WB'6CXJ
MDT/1/#MEJOV:VBO7DN+P0["SN%P"IY!3.:SOM_C"Q,MXG@'18G7?*\D>IH&.
M1ECD1YR<#/KBMO3?^2NZY_V"+3_T;/73ZQ_R";[_ *X/_P"@F@"GX5U4Z[X8
MTK5C"(&OK6.Y,0;=LWJ&QGC.,UC_ !(73]/\)ZSJ=SI-M?NL0+QL C2'[@^?
M!((#<'M4WPK_ .2:^%?^P9;_ /HM:K_&#_DF^M_]<T_]&+0!Q^C:3K6F:?:V
MUC\,="$4$82-I-31WVYW<L8R3R2>O4UL^&)VN_%$^C:_X-TK2Y_L1N5>&5)]
MZ,VPJ<(,9Q^E>B6__'O'_NC^5<A_S6+_ +@0_P#1YH ZN>TM[BW$$\$4D/'[
MMT!7CIQTXKS&_O[BX\7^(-+T#P'HVHBQ,,=S<S7$<+2^8BR@$&,Y&3ZGIFO5
MZX/P7_R4SXB?]=['_P!)5H YS7K_ %W3],O-4U+X;:"T%G$]S*YOXW8*J_,1
M^ZZ[5Q^&*])T"WLUL;>YLK&WM#<0H[+%&%X(W8R ,X+'\S6;\4/^2:^*O^P7
M<_\ HIJU_#O_ "+^F?\ 7K%_Z * -&BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!P%Q\+=$N;>2&XO_ !!+#(I1XY-6G96!X((+<CVKN+6!+6UA@B!$<2"-03G
M P*GHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN.Q=_P"%;^'Q#+$-'TP1RC:X$ ^89W>GKS5JW\$Z9;7D5U;Z?8Q7$7^KD2(
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MW=8I"4)'3)8Y'(4''&,YHOI</(KW7P_T6[FNYKK2M.EEN@!.[0@F3!!Y./4
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M>B1I([ZC"%CC69CSPC $'IZ$'\:GMM<L+JZNHHYE_P!'3S&D8X0KEE)!]BK
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M^M0?\)CH C#G4X I#-D@C 49.>...1GKVS0!MV\$5M D-O&D448"HB*%51V
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M9525FM9#YR@YPP\GUW'C'WV]L>M[%_NC\J-B_P!T?E0M ..'Q,\)C_F)2_\
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M7-AK^J+(R)'*&M9&$RH,*&_<]N3QCJ:]:V+_ '1^5&Q?[H_*@#CO^%F^$_\
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MJ_\ V'-2_P#2J2@"#XD?\AOP+_V'%_\ 1$U=S7#?$C_D-^!?^PXO_HB:NYH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .?^(?\
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M?^@)I?\ X"1_X4 4O^$]\)_]#)I/_@4G^-'_  GOA/MXCTG_ ,"D_P :N_\
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M$C_PH I?\)[X3_Z&32?_  *3_&C_ (3WPG_T,FD_^!2?XU=_X1G0?^@)I?\
MX"1_X4?\(SH/_0$TO_P$C_PH I?\)[X3_P"ADTG_ ,"D_P :/^$]\)_]#)I/
M_@4G^-7?^$9T'_H":7_X"1_X4?\ ",Z#_P! 32__  $C_P * *7_  GOA/\
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M9C:WC9I.77. ,]LUVW@_X>^%M,M]*U&UT*TM]2CA1Q,%(=7*\GKUY-=W10M
M>H"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)U?6(=*>!9HY9#*<#RP
M./F51G)]64?C6M52\TZTOFC-W;QS&,Y0N,[?I0!SZ^,[$VZ3_9[D0NBN'PN
M"C.>_4*A)'N/6M#2O$-OJ&J7&GK#/#=01K(ZR <!@".A/J*D7P_I*<+I]N!D
M-@(,9 QG\CBK%EI5C83-+9VD,,C*$+(N"0.@_04 7Z*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  T
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>sgry-20240425_g5.jpg
<TEXT>
begin 644 sgry-20240425_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ,A FL# 2(  A$! Q$!_\0
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MLDAEYS\ORYS4VF^%];76M!OOL^+2VN6EECN7594D<.99=J$I\Q8  '@#IR:
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MU5DDL9U:-HI9&<*A&"JY/ QV%)[ 0^$=9;7-&CNY1&D^[$L*!AY+<$(=P!R
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M:/"UVK6A(A/VER50[<Q]?N?*OR].*:W@W2//298I4E1TD5UF8$%'=QW]97_
MXI]0,^'Q_ILCZ8&MKR$:C(8[<R^4"V#C=M#[MI/&0#[XIESXS-GX+T[5#9/+
M>7EH9X[> #:N$W,3DC"CCW] :TU\&Z0LEDR13)]D54C"S, 0KEU##/S88D\^
MM/O/".E7>EV6GR1S+;6<9BB$<S*P0KM*D@Y((ZYH#T,]?'^CC4;RRE,JRV90
M3."C(N[/.0Q(P5(.0#G'%4;+Q_'+<7C7$$L=O$Q\J(1YED'EV[*#\V Q:<#'
M3W&*MZI\/=)NK+4((%>/[<RB;?(SJ$$WFL%!/&26Z=VK0OO!^EW)O95A*W%S
MN8OYC8#$1C. 1C'E1],=/>D!@6_Q%CN+JZ6+3;SRA!NAW*H82CSLH_S<']R<
M8R/4BM.?Q3<Q:3X7NQITK/J\\44L>5S$&C9B?O?[/J>,T[P_X%T_3-/@BN2]
MU=*,RSEF7>W[SG&3Q^]?UZ\UJMX?L6L--LSYQBT^1)+<^:VY64$#)ZG@D<]C
M3 Y6/XE6*6:R36.I7&V+S))H(45 -A<\&3(PJD]^GK6YX?\ &.DZ[K5_IFGR
ML]S9D[\E<-AMIP 21@\<@9[9'-(G@?0DLWM5M7$+H8V7S6Y4QF/U_NL1^-6X
M/#=M:%OL$US;(\ZW#QI*Q4D-N8 $\!CUQUS0#*&O>,+/3&U"V(F%W:KO;]WO
M&W8&W8W#(YQU'-9UQX_5;NR:'2[XZ?*UV))W5 2( =S*-_3((YQTKH-3\+Z5
MJ=]<7EY;E[BXM?L<C"1ES%NW8X/7/?K3'\)Z4]O:PM"_EV[3,BB1O^6V[S >
M>0=QXI:CT,VZ^(&D6T=J\JW 6XNEM%SL!#L$(."V2/WB] 2/2L^P^(<4>G_;
M-7MVCB:)7!@7=\Q61MO)[B/ ]S6K'X T-(X8PET1%)Y@+7+DL04(W'/(S$G'
MM3[CP5IC6<%K;1".*.>"4AF+Y$3%E')]S^=,18UKQ+9Z-)!!<13+/<A3$JH#
MN)8*1UZC()]@:J:+XST_4=4L-+P[7MS9K>*V$"X*JQ&T.64X8'D8]S6SJ>A6
M&IWME=WD/F3V9<PMN(V[UVMP.O'K5+3?".E:;J,%[:1RI+#'Y48,S%5&Q4SM
M)QG:BC/M2 Y^'Q[*MU$+S2KE+=I[J%W0*2JQ2K&'^]]WYN>^1P*V?#OC/2O$
M4VJ0Z5*9); XD#8P>6 (P3@91NN#QTP15C_A$M*+2EXY6$C2L096POF,K.!S
MP"R@_G5S2]%M-*AGALQ*L,K,YC:0LJ$DD[0?NC)/ HZ!U..;XDP_V7-ML+EM
M1CLA<8"KY+OY22%%.[/"R \@=#5RY^(^CVMY<V4T5W]MMXT=X%$;/N8H-F-_
M4&1>N!UP3BM'_A!]#V,HMI &C,9(F;[IB6+U_NHH_#/6K#^%--=9UD^TNDYC
M:1&G?:S(5(;&?O?(N3WQ[FGU R;GXA:5:3W\5[;7ULUFI9S*J*K,/+RH;?C(
M,R=<#GKQ4OA7QE'XDURYM[*VD^P)9PW,=P=O+,TBLIPQZ%,#&1PW.,9T+GPA
MI%S=7-S) XGN&9W=96!W-Y>2.>#^YCQZ8JW9Z%:6FH->Q&9KA[=;9V>5FWHI
M8KNSU(W-SUYH!G-KX^M[O5+.STRTGGWZC]AG?=&P0>6[A@5<_P!SIUP#QTR:
MOXW?3=6UNP:PED>SA\RW= -LC"$R%&)((. >V..N:U;+P;I-FT#0+<!H)DFB
M)G<["BLJ@<_=VNPQTYJQ>>%]+O+RXN;B!FFN,^81(P!S&8^F?[I(I!I<Q(_&
M[QM=_:]'U#$30)$D0C+NTD6\CE\9'/\ ]>KVC^,['69IX]-M;V?RO)+,%0?+
M* 0V"V[: V22.QQG%&I>#;2[6-8KBZA_>1/*PF;<XC0J.<\'!Y/M4\?A'3H&
MWVKW<#K"D$;1W##RHU((5>>G XZ&F!@WWC=[2V%[(N^T>\N"BQ)N<VL(VLPR
M0"3)C'LPJ6?XF:/:V4]S?6U_:"-E15G6-3(2[H0IWXX,;YR1TXSQ6HO@O2S;
MK;S"66W6Q73UC9L;8PVYB",'<Q"Y/^R*FF\'Z1+R894D#;UD29E9&WL^5(/!
MR[?@<=*0'-ZW\4=*@M;Q=)#WE[%:+=1)E<."JMTW!A\K@\@#K@DC%:O_  G>
MGK=WMM)9Z@DUK\I#1I^\?,8*+AOO9E0<X'/7BM*[\*Z;=+?K,+@QWT?ESH)V
M"MP!NQGAL*.>O%1/X.TB1YW>*4RS%F>3SFW;F\LE@<\',2'/M0!EO\2M#CVK
M(MY',V0(6B&_<,Y7KUW*5^H_&I?%GCBWT22ZM8[:XENXX'=7VCR1((GE",<Y
MR50G@58;P%X?:XM9WLRTUN$V.TK$Y60R@DYY.\DDGKGFJVJ> [/4=:MKJ:>7
M[*D+QSPM([-.6C:,$MNXPKL,XSTYXH KZUX^BLU$=I8W4T_VF*%04 6<&9(Y
M/+.[JI<#YL#)':F:S\2-.M;55LTDDO)[)KR!9"NW@9VL VX' /;'O6O=>"-&
MN999)([@/(XD!2X=?+8.),I@_*2RJ3CJ14<O@#092FZWFV+%Y(03N%QLV9QG
MKMXS3 QM=\=S:-K+O<Q(VC&\^P^8!\R,L6YGSZ;V1/;!JKIGQ!O+G3SJ%Q#;
M6]O#I2ZC-'Y<C$DA_E#_ '5Y4=>3FNO;PGIDUBEK>Q&Z19)9?WIZM(26R!@=
M^*2/PCHZ6$MD+8FVECCB=&D8ADC8LH//3).?6ET&<S#XTU62PL[_ ,K3S ^G
M37<T2EBPEB(5D5@<8W'KCH*E7Q?K$.K:?IMU:6+3SWC63R1NP4,%24, 3G!C
M+>OS =C721>%-(BADACM0L+I-$8PQ"A96#. .P)';IVJE9^ ]$M&A9(KB22&
M0S1R2W#NZN65BV2>N44?08Z4^HNA-X-UFZUB.\^W_9XKF";8]O&&5X>/NN&Z
MGT(X(Y%=)6)IOANRT^^>[@>[-P[;G>2Y=]X ("G)Y W' ['FMN@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M CN)H[>"2:>1(H8U+N[MM55')))Z"J^EZI8:O:_:=+O;:\M]Q7S;>42+D=1D
M$BK4J[HV&,Y&,5YMH&AZ_8:AH,;6]S%!!''YK)<J(HU D\Q&0-\S,2F" >G4
M8H6X'I=%>8:_IWBZY\1:K+:0W*6)0*BPW 03('B)"DRY#E!*,[4 SUYS4NJ:
M;XAD34!86FI1RO;P_97>]#+&@\O?"P\T9D.'^;(Z_?&:5]+CL>E5%-/'"R"6
M1$,C;$#'&YL9P/4X!_*O,AH_B9&*'^UIEETMHGE\Y$,,N25$:^<<MR =Q/ '
MSUN2:;J=YH7A5[ZQE%[:744MQ#%<Y,8VLI)8O\V,@D;F[CGNQ'96\\=Q"LL$
MB21.,JZ'(/T-/8X&3TKQL^%_%]I:P6U@]Y!:YB+HLXD*,4<,5'FIPK;3C=CO
MAL8KM_$FEZQ<:YH<NGSS?8QE+X++LX4JZMC/.2I4X[-Z4KZ =*+ZV-K'<BXA
M-O+M\N3>-K;B N#WR2 /K5DUY8OAK7)]'N6U2&]N+I;C3WBB^V=4C\HRX^?:
M#D/UQDCZ56O].\:M_:T4-K>M&S>7"YND8L/.G</&/-7'RM$/F(X'0XQ38(]7
M@N(9VE6&5)&A?RY K [&P#@^AP1^=2UY_I>B:U%X:UJ"=)8[Z[NXI04G =E\
MN%7.X'@_*XZYX^E<]+X<\8P07,=K)?&%I(VVM=>:Q :X!VYF0\*8#C>.@ZD$
M4=; >N3SQ6\9DGD2- 0"S' R3@?J11;W$5QO\F1)-C%&VG.UAU!]Z\IU#PUX
MIN;K61?37=[:E(S#$CJ@G"M"< ^;\KC8_P#"!\Q^8Y%7M1T7Q/-?Q3VIO(UB
MN=\8^V  (;B(_,-V&'E"3@Y[]\4(#TVBO.?AW?7\%S/:7]MJ#2M,D$KRS^<J
M2+$6D?(9@%+#@<<D<"J>I6OB&[U?7H;22\N+.RNH2D,-QY;S1R%9)$5B0 0,
M <C@D9&: /4J*\[\.67BFWUC2HM32ZD@C59+BX-PICS]GV%"-VXG?STQWS56
MY\.^(VU-KN%[X.;PN/\ 33L$?VG^[OQCRB>,?K1U ].-5?MUM]F6X\^'R"P4
M2;QM))V@9^O%>96%AXN%GIC7-GJ)N+>ZMUDBDO$V2(L2)([%9,XW!F'4D]5Y
MK8M_#UXW@%=(-I<1SK>(S(UP"607"L65@QP-HR.0?;-+I<#OP<T5Y%:Z)XSF
MDM[:Y^UP1QV4D/VA;D$EBC;"Q\WE@VWHG09+=JT='T?Q8->T2XU">Y2#RO.N
ME5Q(J2%I&>-CYH&/F11A'^Z,$8IH#T(W]J)C%]HA\WS/*V;QG?MW;<>NWG'I
M5G->9:QX7U&ZU[4I(K.Z"2WZW2W"700%?LC(-N'!!#X!X'!'4=+_ (/TOQ-;
M^*[RYUJYG-F80$3(:-LK'@9\PX92K]$&<D[CD4+5 =Q#=P30-/%-&\*E@75L
MJ-IP>?;!HL;N"^M8[FSF2>WD&Y)$.58>H->8W/A_Q1<:I)))]L-NP:/;]L 4
MHQNLY7=Z-![CC'0X@O\ P]XJ1&MM-2^14M%C21;T!-ODJOE ;\[Q("V[T[]J
M2[C/7*BFGCA*"5T3>P1=QQN8]A[UYKJGAK7SK&H2V;ZA]G4M]DQJ# 8$4.S@
MO_?$G7\>HJO!H_B>[UN[N=7L;DVRZC!-#%#<@+A7E#,N92<;6C)SM[@+Q3ZB
M/4K:XBN8EEMY$DC;.&0Y!YQ1=7$5K"9;F5(HEQEW; &3@<_6O+;[1O&3W2>2
M;S/V=@L@O%"(-DP*%=W+EFB(;'&.HQ6KJGA_4YO VL::T5S<2FX22WC:YW.Z
M QL0'+>H;J12Z =Y;W$5QYGD2I)Y;F-]C9VL.H/O0MS"\TL2RH98@#(@8$IG
MID=LUY?_ &#XCL3K,VG6EQB\DE81-<@\-+'M(7S%&_9YA^\.1R:T_AOHVLZ=
M<7,VN6]R+R>PM5>=[A7#2(A5E(#'YLX.>GO30'?6T\5S DUO(DL4BAD=#D,#
MW!J6N#\(V.OVGB!&U**[:U;3XTEEFN RI,H4$( YSGDDE>".&.<5@^'-+U_4
MM4$T_P#:<>DM>GS?,O"/,"O<Y90'W!.81CC..F!FD@?4]1AO;::U^TPSQ/;X
M)\U6!7C.>?;!J6&5)X4EA=7CD4,K*<A@>A%>72>&_$US @N#>%BK0N#>?*48
M7 .1NP?O0^_3T.*^G:!XNA(6)KRTMTTI8H(3*K;9!!M*,WFX!\SY@0A[?,.E
M 'J9U"T$;/\ :8=BR^26WC DR!M^N2!CWJ>:1(8GDE=4C12S,QP !U)K@_#N
MD:M:^%I84M+JTN9=6^TB*2X5I!"9E8[F#$'Y<Y&34.@:#KD?AW7['4_M+M=V
M:+$)KKS"93&P< [CCG;Z"F]&".^M[F&=G6&5)&3!8*V<9&1GZBIZ\GN_#7B,
M037&B1W=C=RP")1)=@[0+4J-P#D%A)@9Y/?.*V7TS7A\-WMBVH2ZN9/,2-&5
M) /,W",DS'Y<<']YG'?-%P.ZCGCE>18I$=HVVN%.2IP#@^AP1^=)-<PPO$LT
MJ1M,_EQAFP7;!.!ZG )_ UYC>:+XH@NKR^L+.4372.)H1=[DY2W *CS%RPVR
MX.5SCDX-9LWAWQC</I!DANS=6\)*7#W2;+=_)N$^9=YRQ9X^1NX[\4 >P7%S
M%;1^9<2QQ)N5=SL%&2< ?4D@?C2K/&T[PK(AE0!F0'D YP2/P/Y5Y)<>'O%,
M]GHL=S#?7*+<++)$9EC%N5N(6W.#,^]=J28^9CD]!6WXKTSQ WC!K_0[*9S]
MG0"8W(2%]J39C==X8DL\>#CCU&* /1:*\\\#Z1K\>H6,VN"\6&%+DA9+CHS.
MFS<HD?/R[\9+8]J]#H#J%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 &*,444 (17(:GXP72_$5]87%K+.L44+Q);J#(VY96<G) P%B
MS_C785A:MX4TG5;J6YO()#<2A%:2.9XVPH8  J1@8=P?4'FD!0D\::='I^H7
MPAG^PV;!6N"8XTD<XRJEG'(W#KCVS6&GQ/L((KZ]O[>6'31) MK(Q1#+YD(E
M^8LX (&?3H ,GBNHD\(Z0_VC;%/$L[I(RQ7$B*KKC#* WRG@9(QGO4,?@C0X
MHPD%O/$%$6PQW,BE#&FQ2"&R#M^4GJ1US3 JV/C&/4O%5GIUA"[64MO+*URX
M #,HB8!><])><CTQWJ.\^(&GV@?=8Z@Y\S9$%1/WPRXW+EAQF-NN#TXYK:M_
M#>FV^NMJ\44GVYE92QF<K\P4,=I.W)")DXSQ5;_A#-#,SR-:R,S2>;\T[D*?
MGX49^4?O'.!QDT@(-9\3R6QT=[&U:>#4(99]Y &P+%O7(R#S^-8]E\4-)%K8
M#4HYK6]G=87B<QKM<K&V1E_F'[U" ,M@].#763Z!I\UO80/$XBLD*0!967"E
M-A!(/(V\<U5M_"&CVUQ'/;0S0S(X</'<2*3A$3!PW*XC3@\<4^H,K^(?&FGZ
M#<W<5[#<&.U@CGEF78(U$CE$&68<DJ?8=215!OB9H2V<=S_I!ADA,X8!"-@5
MB6SNQ@%"N<XR1VYKH=0\/:;J$MW)=0%I+J..*1A(RG$;%DQ@_*0S$@C!_*H+
MCPMI-S*);FW>:86ALO,DF=F,1()&<YSD [NOO2 Q8?B/I5Q9RW5K;7MQ!#:O
M=RO#Y;JBJ[(1D/@G*GD9&.<XJY:^.]'N?$-GHJNRWUU$LJ*7C;&4+@<,2?E!
M.X K[UHKX;T]1(?]*,LEN+5IC=2&0QABP&_=G.6//6C2?#.F:3-%+I\<T)CB
M$(43OL90, LN<,?<C-,#(O/&UG'?30*)8OLEZMK.716SE&;@!]RC"Y#$<]@>
MHS/^%G:=9WC1:Q%+9>;<B*WCD*!]GEQ-N;Y\'F4<+DX[<&NDN/"&CW.I2W]S
M;R37,C*Q:2=V P&  !. /G;@<<U'9^#-&LI89;>.Z6>)_,64W<I<Y"@J6+9*
MX1/E/'RCBDO,&-\0^+K31[[[&\-Q+.8U;>BC8A?<(PQ)!^8H0,#ZXJE8^)-0
M.@>%[NXLS)<:K+&DRHJJ(U9&;(&\],#N>.V>*VM2\-:7J>I17][;M)<1*%!$
MC*I SC*@X)&YB,],G%3/HEBUEI]KY;K#8,CVX21E*%!A>0<GCCGKWIH#C[#X
MB12V]LUY;7$$ZHTD\2PAO,40O("A#\#Y#U&>,8'6M?5_$TI\/Z3J&DP[O[0N
M8HANV2;$8G+?*^T\#LQZU;C\':+%-'+%;21RQH$1TGD4J C(,$'KM=N?>K5G
MX=TRTTVTL(8&%M:R^?$K2,2'W%MQ).3RQ//K2#J8UIX\L;JZM+:&QU!I[IP(
ME*(-R%&<2??^[A&]^.E+X;\>6.OW<$-O8ZA )@"DLZH%.4W@<,3RO/3M5_3_
M  CHVGW45S;6SB:%R\;/,[[,H4P,GA0K, O09XI+7P=HMI"L5K;20A5"*4GD
M#*!'Y8P<Y!V\9_'K3 Z#KTH P.*2-0BA1G &.3FG4 %%%% !1110 8HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY/\ XU1]I\5?] S1_P#P/D_^-5T-% '/?:?%7_0,T?\ \#Y/_C5'VGQ5_P!
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M+OPOX?O9-.N-4ALTO)]@6X!SN11N^5^, GCK7ML9RH)&#CIZ4 8'VGQ5_P!
MS1__  /D_P#C5'VGQ5_T#-'_ / ^3_XU70T4 <]]I\5?] S1_P#P/D_^-4?:
M?%7_ $#-'_\  ^3_ .-5T-% '/?:?%7_ $#-'_\  ^3_ .-4?:?%7_0,T?\
M\#Y/_C5=#10!SWVGQ5_T#-'_ / ^3_XU1]I\5?\ 0,T?_P #Y/\ XU70T4 <
M]]I\5?\ 0,T?_P #Y/\ XU1]I\5?] S1_P#P/D_^-5T-% '/?:?%7_0,T?\
M\#Y/_C5'VGQ5_P! S1__  /D_P#C5=#10!SWVGQ5_P! S1__  /D_P#C5'VG
MQ5_T#-'_ / ^3_XU70UB>(/%&DZ!+;P:A<G[7<Y\BUAC:6:7'7;&H+$>^,4
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M1MJ GL,G)/8 U#X5\.6_A^VDNKN;[7J]PNZ^U&;[\IZD9/W4'91P!^)J#Q<
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M9"+^5<9J]OXATK1=2U$7E[/J41M8[8/,5CF.R-&_=!BH)<MGKSWK>U&.^N?
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M]M1>)O\ D;O!_P#U]7'_ *325U%<OXF_Y&[P?_U]7'_I-)0!U%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
M.>--+U'4?[%GT@6K7&GZ@+LI<R,BNOE2H1E58Y_> ].U='10!S7VCQ?_ - W
M0O\ P/E_^,T?:/%__0-T+_P/E_\ C-=+10!S7VCQ?_T#="_\#Y?_ (S1]H\7
M_P#0-T+_ ,#Y?_C-=+10!S7VCQ?_ - W0O\ P/E_^,T?:/%__0-T+_P/E_\
MC-=+10!S7VCQ?_T#="_\#Y?_ (S1]H\7_P#0-T+_ ,#Y?_C-=+FC- '-?:/%
M_P#T#="_\#Y?_C-'VCQ?_P! W0O_  /E_P#C-=+FC- '-?:/%_\ T#="_P#
M^7_XS1]H\7_] W0O_ ^7_P",UTM% '-?:/%__0-T+_P/E_\ C-(;CQ?WTW0O
M_ ^7_P",UTV:,T <S]H\7_\ 0-T+_P #Y?\ XS1Y_B[_ *!NA?\ @?+_ /&:
MZ;-&: .8:;Q:W73-!(Z\WTO_ ,9I?M'B[_H&Z%_X'R__ !FNFS1F@#F#-XN.
M,Z7H)P<C-]+_ /&:7[1XO_Z!NA?^!\O_ ,9KILT9H YCS_%Q.?[,T+/K]NE_
M^,TOVCQ=_P! S0O_  /E_P#C-=-FC(H YG[1XN_Z!NA?^!\O_P 9H^T>+_\
MH&Z%_P"!\O\ \9KILT9% ',_:/%__0-T+_P/E_\ C-'VCQ=_T#-"_P# ^7_X
MS739HR* .9\_Q?\ ] S0O_ ^7_XS1Y_B_P#Z!NA?^!\O_P 9KILT9H YG[1X
MO_Z!NA?^!\O_ ,:H\_Q?_P! W0O_  /E_P#C5=-FC- ',_:/%_\ T#="_P#
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M<27@2*,?O5B:1"6'E@J79<D<8YY!K/O_ (A>,+6;4/LLJ7EK8.9HYTAC;[;
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MV5MY<S;Y%\L8<^I]:=_9=D)HYA:0":-/+1]@RJ]-H/IR:R?^$[\)?]#-HO\
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ML;8I,V^1?+&';U/J:D73;-;A;A;6$3(GEJ^P95>F ?2LC_A._"?_ $,VB_\
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M<_: &4-&6**YX7).,G^[]: LSWC_ (5GX-_Z%^R_(_XT?\*S\&_]"_9?D?\
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M6?@W_H7[+\C_ (UV%% ''_\ "L_!O_0OV7Y'_&C_ (5GX-_Z%^R_(_XUV%%
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MX-_Z%^R_(_XUV%% ''_\*S\&_P#0OV7Y'_&C_A6?@W_H7[+\C_C7844 <?\
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MXD2,(IZ)C<<XR>>.O2MW_A2?P_\ ^A?3_P ")O\ XNC_ (4G\/\ _H7T_P#
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MLM$\!60MOLD6B1&WG^TQ%94RLG][.<_@>!@5TG]NZ1_T%;#_ ,"$_P :K?\
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M_P"!"?XT?V[I'_05L/\ P(3_ !JM_P *3^'_ /T+Z?\ @1-_\71_PI/X?_\
M0OI_X$3?_%T 6?[=TC_H*V'_ ($)_C1_;ND?]!6P_P# A/\ &JW_  I/X?\
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MW_Q= %G^W=(_Z"MA_P"!"?XT?V[I'_05L/\ P(3_ !JM_P *3^'_ /T+Z?\
M@1-_\71_PI/X?_\ 0OI_X$3?_%T 6?[=TC_H*V'_ ($)_C1_;ND?]!6P_P#
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M ($3?_%T?\*3^'__ $+Z?^!$W_Q= %G^W=(_Z"MA_P"!"?XT?V[I'_05L/\
MP(3_ !JM_P *3^'_ /T+Z?\ @1-_\71_PI/X?_\ 0OI_X$3?_%T 6?[=TC_H
M*V'_ ($)_C1_;ND?]!6P_P# A/\ &JW_  I/X?\ _0OI_P"!$W_Q='_"D_A_
M_P!"^G_@1-_\70!9_MW2/^@K8?\ @0G^-']NZ1_T%;#_ ,"$_P :K?\ "D_A
M_P#]"^G_ ($3?_%T?\*3^'__ $+Z?^!$W_Q= %G^W=(_Z"MA_P"!"?XT?V[I
M'_05L/\ P(3_ !JM_P *3^'_ /T+Z?\ @1-_\71_PI/X?_\ 0OI_X$3?_%T
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M)EB9<@\<MG\*!'T91FOGFY^*GBVWUS5)&;3GTJ+4M1TR*'R")%:&(NCDYY[
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M=,L$LN,>8Z]VP3GGG)]:[6B@#S2P^#/AJR2%(I=2:."622%'N2RQ!U8%5!'
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M^#SQBN\50BA5& !@#TI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO"%$+YW #L?F//6@1XOJWQUUZTUS45@L-*DTN.:>"V)63S2R1[E9COP1R,X
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MR6K1HY$AG@E,6[>6'& >,8![]L5ZC/\ !KP;+9-;?89XPUR;H21W#*ZNP 8
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MF"J<#L21S7G\G@76(FUYK6YMGEO9RT;23;1)&TID97'E-M(S@-E^/[O9FG>
M=4M]%ETVY329_-CM,W3,QDS'Y(>/E/N8B)!SSGH.M) >FB>+RED,L?EMR&W#
M![]:S]2U_3M-*?;+@1H[*H?:2NYG5%&1QDEA_/I7-W/@ZZG\ 6^@&>".>.7)
MD4G:(S(=P'&?]6Q XZ^U9(^'M_%H]E;+)8W,MJ5;]\S8<K<I(,G:?X$VYQU]
MJ /0-+U6SU2.9[&=91%*\+XX*LC%2".O53]:@L?$.EWTL$=K>1N\R%XQTW -
MM./?/:L+P=X4NM#UK4;R9K79=B0D0DY+-<2R G('\,BCZ@]JR3X"O9+>S3;I
MT$EJRB-XF.0!<B0L/D&&*#&/7C..: /18[B&2-G26-D7(9@P(&.N:8M[;,L;
M+<PE9#M0B088^@]:X?PYX4OM"\#ZS83[)KR:W>-/)DWB3$6Q3C8NTG'(^;_>
M/6L72? 6L1V]G)-'ID3R2;Y81(Q%F,PG=%\G+GRCG[HRW4XY8'J?VJ#9N$\6
MT#).\8QC.?RYI4N8'D5%FB9V7>JAP25]0/2O)O\ A5VJH-16+4;?R9$/V>,L
MV RRJ8PV5(QY2*AX/?@CKV?A#PN^BW/GSK"7^R10*0_F,A#2,P#;5^7YQC '
M3H,4 :^M:]I^D6QFO+@8$J0;(QO?>YPJX'.35Z2Z@B8)+-&CD%@K. 2!U->=
M/X!OYM>>[F.G?9UOH[A>6+SJ+@S$R#;C<H.U>O?D=*T/&_A34M<U1I=/:S@B
MFL9;2:6:0LQW(X4!-AQAF!W!@<9&#2'U.MDU6SCU&*Q>YC%S*C.B$_>"D \]
M,Y(XZU6O/$6F6EQ'#)=HTTD<LJ)&"Y81@%\8[C(XZFN#G\#Z[>SV4UVFDK)Y
M[2SLL\C&$&>.4>6?+&XD1E3G;][O38_ &L?98XRFEJ(X;VUB0RLQB2:-%0[_
M "@6(93U&0&ZG'+0CT/3=;L-16?[+<HQ@<Q2!OE*L "00?8TRUU_3[J=HK>?
MS"LLD+L%.U'C'S!CT'X]>U<%<>!=;2"Y2Q72M\DTI#O,ZEDE@$9+8C/*L,@<
MYR>14FH^ =2NH+F&!]/A5KFYG4AF_>"15PK@+Z@J>3P<^U(#T<7ENS1JMQ"6
ME&8P'&7'J/6GSSQ6ZAIY4C4G +L ,^G->;IX'U.&6ROL:?\ :;:1)UB1V(CQ
M/)(T:':.,.%'3..0*UO'NA:WXG\)065JUI;W<J?Z2DLA5%+1D?*VQSPQ'0#.
M.HH Z\WML&*FYAW!@A'F#(8]OK[5!-JEI!JEOI\TZI=SQM+&AXW*I4'!Z9RP
MXZUY_>_#Z]EAM-DEKYBWMS-<!9-A>.5\JP<QL=ZCV'4X85M>,O"ESKNL:;>6
M[VRBT50#*3N4BXAD)7 /\,;#ZD=LTP.L-[:XR;F'&_R_]8/O?W?K[5!<:O8P
M3V\4MU$K3NT<?S<%@,D9Z UP6A_#^]M+BP>^DM7%M=M(S"3?YBB&1$<+Y:X?
M+@\ECQ]XUG6_PWU:WT".R7^SKBXW/&[SSL5VF'RA,H$0P_?'.<#Y^] ,]:CF
MCD.(Y$8XS\K ^W\ZC6\MV4LEQ$P4D$AP<$=?RKE?!.@SZ5J6ONY<0M<>7:%Q
MTC.9&Q[>9))^5<G;^ O$\5G?F6?2Y;N[>17)G94VO"(V?Y8A@Y7.W&.<;N](
M#T*W\4:1<7D=M#?1M-)+-"H((!>(@.,GC@D?7/&:TWO;90Y:YA78=K9<#:?0
M^AKS2]^'FH7#.$_LU%2YNYXGW-G,KQNI(V<%=K#C/;UXLV_@._;6X[FZ&FFU
MBO%F(#,S7"!IFW."N-^9% '/0\]!3ZAT.]L]4M+H#RY@K,64))\CG:Q4G:><
M9!Y].:;?:O8V4$,T]U&(YI$BC(.[>S,% &.O)'TKSR?P'K-QYMK*=,%J8+U(
M;A)7$L4D\DC!]OE_-A7 QN&,MUXIT7@/5(XM*"IIY,<RRW'F7!?R2MPDI,.(
ME'S!2,87&>]):[@ST ZQ8KJ=Q8-<QK=6\*SRHQQM1B0#D\?PG_)JW)<PQQ++
M)-&D;=&9@ <].:XCQ5X4OM1UZ[O[.+3I$F@M0%N'92S0S,^QL*?D8-@GL5'!
MJY_PB\\F@^';"<VTG]GW4<\ZMDH54/E5!'."PQG' I@=2][;(K,]S"JJVQB9
M  &]#[T->6P+ W,(*D!@9!P3T!^M>3R> =6LHF2*&SU&6>];F><^6T>R?#R
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M=)< @E9LJI$C1#G'(,@4 ^C9K:L1X2N9WO5BM9;C7)7MV-Q;XDE*KAHB&7<
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M_,=RJJS*WRH?O!>,97GDC!KMKC1M,N5B6XTZSE6&4S1AX5(20G)8<<-DDYJ
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M_BF.FVD,8 M;*=ED9A);%F?V(D(7_@5?2VJ>%=#U6[:ZU'2K2YN&4(9)$R2
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MWH5A+>SY\V9H@6?*[3D^X.#0(\]^&?Q;U+QGXQU#2Y-)BM]/2&1HIHW+.A3
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M0/F9D 3UQQTKZ6Q1B@#Y)\-?![Q7?^&4OUL;*)[@>4MA=L4."DJ?:'&.'4R
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M<RHH17EC#$#<K8_[Z53]0*KS>%M#FTF+2Y=*LGTZ)_,2V:(&-6R3D+T[G\Z
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ML['[262.*)GVB24Y[8)../RKT6X\':%+9O;Q:=;6V6D=)((E5HG==K.G& V
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M&EC8QZI<:E]@._+0NNUSO7#?[..O4-7J4/@GPS"JK%H.FJJAE %NO0J%/;N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME@67=@J=P"YW8)P>@]*YY/AUJ<DVG&ZU* YA9+YTAQ\NR!%1!NZXBY8GKV[
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** *EQJ=A;RF*XO;6*1>J/*JD?@34?]M:7_P!!*R_[_K_C7R1\:=)DU_\
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M7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?7\Z/,3^^OYURE%
M7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?W
MU_.N4HH"YU?F)_?7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?
M7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?7\Z/,3^^OYURE%
M7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?W
MU_.N4HH"YU?F)_?7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?
M7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?7\Z/,3^^OYURE%
M7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?W
MU_.N4HH"YU?F)_?7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?
M7\Z/,3^^OYURE% 7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?7\Z/,3^^OYURE%
M7.K\Q/[Z_G1YB?WU_.N4HH"YU?F)_?7\Z=UKDJZFV_X]HO\ <'\J0R2BBB@
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M W9P-Z_G[5L:%XQLM9O(;:"&>*2:%IE\TH/NL59>#G<".1VR,XIL"3[!<_\
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M-O\ OYW<+SGM6]JDVEZK+;R:A\*]?GDM[8VD3-;QY6$J5V?ZSI@G'IFO8Z*
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MZ[[%% ' _P#"P-1_Z$3Q5_WYB_\ BZ/^%@:C_P!")XJ_[\Q?_%UWU% ' _\
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M_H1/%7_?F+_XNN^HH X'_A8&H_\ 0B>*O^_,7_Q='_"P-1_Z$3Q5_P!^8O\
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MNSHQ0!YEXAU*/0OC)!J=];7[6+Z"UL);:SEG'F&X#;3L4XX!-;?_  L?0O\
MGEK7_@GNO_C==E10!QO_  L?0O\ GEK7_@GNO_C='_"Q]"_YY:U_X)[K_P"-
MUV5% '&_\+'T+_GEK7_@GNO_ (W1_P +'T+_ )Y:U_X)[K_XW7944 <;_P +
M'T+_ )Y:U_X)[K_XW1_PL?0O^>6M?^">Z_\ C==E10!QO_"Q]"_YY:U_X)[K
M_P"-T?\ "Q]"_P">6M?^">Z_^-UV5% '&_\ "Q]"_P">6M?^">Z_^-T?\+'T
M+_GEK7_@GNO_ (W7944 <;_PL?0O^>6M?^">Z_\ C='_  L?0O\ GEK7_@GN
MO_C==E10!QO_  L?0O\ GEK7_@GNO_C='_"Q]"_YY:U_X)[K_P"-UV5% '&_
M\+'T+_GEK7_@GNO_ (W1_P +'T+_ )Y:U_X)[K_XW7944 <;_P +'T+_ )Y:
MU_X)[K_XW1_PL?0O^>6M?^">Z_\ C==E10!QO_"Q]"_YY:U_X)[K_P"-T?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "FNH=2K#((P13J* /#_C7\-_#MC\/-
M4NO#_AR!=35HS&UO&S2<NN< 9[9KM_!WP]\+:7!I6I6N@VEOJ44*.)@I#JY7
MD]>O)KN:*%H#U 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
2%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140271361390592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Surgery Partners, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001638833<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140271253914320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based On:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Summary Comp. Table Total for CEO (Evans)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comp. Actually Paid to CEO (Evans)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Summary Comp. Table Total for CEO (DeVeydt)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Comp. Actually Paid to CEO (DeVeydt)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average Summary Comp. Table Total for Non-CEO NEOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average Comp. Actually Paid to Non-CEO NEOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">TSR</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Peer Group TSR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted EBITDA (in millions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6,457,600</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,260,168</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,473,172</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,646,951</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$204.3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$142.1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$135.3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$438.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,092,825</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,342,023)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,670,372</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,192,139)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178.0</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.0</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,307,123</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,217,126</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,541,025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,060,779</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341.2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146.1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.7</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,541,863</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,996,689</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559,528</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,280,517</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,284,162</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,249,898</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256.6</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureName', window );">Company Selected Measure Name</a></td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects compensation amounts reported in the Summary Compensation Table for our CEO for the respective years shown. Until his appointment as Executive Chairman on January 13, 2020, Mr. DeVeydt served as Chief Executive Officer of the Company. Mr. Evans, who previously served as Executive Vice President and Chief Operating Officer, was appointed to replace Mr. DeVeydt as the Chief Executive Officer of the Company effective January 13, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects average compensation amounts reported in the Summary Compensation Table for our non-CEO NEOs for the respective years shown. The following non-CEO NEOs are included in the average figures shown: </span><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023: David T. Doherty, Jennifer B. Baldock, Marissa A. Brittenham, Bradley R. Owens</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022: David T. Doherty, Thomas F. Cowhey, Jennifer B. Baldock, Harrison R. Bane, Bradley R. Owens</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021: Thomas F. Cowhey, Jennifer B. Baldock, Anthony W. Taparo, Bradley R. Owens</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2020: Thomas F. Cowhey, Jennifer B. Baldock, George M. Goodwin, Anthony W. Taparo</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupIssuersFnTextBlock', window );">Peer Group Issuers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Reflects the cumulative total shareholder return for the Dow Jones U.S. Health Care Providers Index.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">&#8220;Compensation Actually Paid to CEO&#8221; in each of 2023, 2022, 2021 and 2020 reflects the respective Summary Compensation Table total  adjusted as set forth in the table below, as determined in accordance with SEC rules.</span><div style="margin-bottom:9pt;margin-top:3pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:49.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CEO</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DeVeydt</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,541,863</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$559,528</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,307,123</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$6,092,825</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$6,457,600</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Equity Award Amounts Reported in Summary Compensation Table</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,250,000)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(125,000)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,500,000)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,645,000)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,400,000)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Fair Value of Current Year Equity Awards Outstanding/Unvested at Year End</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,512,317</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,175,972</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,062,532</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,283,461</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">645,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Value of Prior Years&#8217; Awards Outstanding/Unvested at Year End</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,977,917</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,794,029</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,437,390</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,285,321)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">336,661</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Value of Prior Years&#8217; Awards That Vested in the Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,839,592</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,926,960</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,620,973</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,212,059)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">582,446</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Fair Value of Prior Years' Awards Forfeited in the Year</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Fair Value of Prior Years' Awards Failing to Meet Vesting Conditions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,824,332)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$16,996,689</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$13,280,517</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$14,217,126</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$(3,342,023)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$7,260,168</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fair value or change in fair value, as applicable, of equity awards was determined as follows: (1) for restricted stock awards and earned PSU awards, the closing price on applicable year-end date or, in the case of vesting, the closing price as of each vest date, (2) for unearned PSU awards, closing price on applicable year-end date multiplied by the probability of achievement as of each such date, and (3) for option and SSAR awards, a Black-Scholes value as of the applicable year-end or vesting date(s), determined based on the same methodology as used to determine grant date fair value for the applicable grant.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 2,473,172<span></span>
</td>
<td class="nump">$ 1,670,372<span></span>
</td>
<td class="nump">$ 1,541,025<span></span>
</td>
<td class="nump">$ 1,284,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 2,646,951<span></span>
</td>
<td class="num">(1,192,139)<span></span>
</td>
<td class="nump">6,060,779<span></span>
</td>
<td class="nump">6,249,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">&#8220;Average Compensation Actually Paid to non-CEO NEOs&#8221; in each of 2023, 2022, 2021 and 2020 reflects the respective average Summary Compensation Table total adjusted as set forth in the table below, as determined in accordance with SEC rules.</span><div style="margin-bottom:9pt;margin-top:3pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:60.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.528%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,284,162</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,541,025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,670,372</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,473,172</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Equity Award Amounts Reported in Summary Compensation Table</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(654,625)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(661,875)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,020,000)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,537,500)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Fair Value of Current Year Equity Awards Outstanding/Unvested at Year End</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,326,667</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">840,847</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">768,546</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,496,764</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142,125</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Value of Prior Years&#8217; Awards Outstanding/Unvested at Year End</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,251,193</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,008,559</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(502,425)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81,948</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Value of Prior Years&#8217; Awards That Vested in the Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">900,376</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,714,650</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(401,924)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132,567</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Fair Value of Prior Years' Awards Forfeited in the Year</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,706,708)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Fair Value of Prior Years' Awards Failing to Meet Vesting Conditions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(382,427)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$6,249,898</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$6,060,779</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$(1,192,139)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,646,951</span></td></tr></table></div>Fair value or change in fair value, as applicable, of equity awards was determined as follows: (1) for restricted stock awards and earned PSU awards, the closing price on applicable year-end date or, in the case of vesting, the closing price as of each vest date, (2) for unearned PSU awards, closing price on applicable year-end date multiplied by the probability of achievement as of each such date, and (3) for option and SSAR awards, a Black-Scholes value as of the applicable year-end or vesting date(s), determined based on the same methodology as used to determine grant date fair value for the applicable grant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in more detail in the sections entitled "Compensation Discussion and Analysis" and "Executive Compensation," the Company&#8217;s executive compensation program reflects a variable pay-for-performance philosophy, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">with a significant emphasis on long-term performance and stockholder value creation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. While the Company utilizes several performance measures to align executive compensation with Company performance, all of those Company measures are not presented in the Pay versus Performance table. Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not specifically align the Company&#8217;s performance measures with "Compensation Actually Paid" for a particular year. We believe the "Compensation Actually Paid" in each of the years reported above and over the three-year cumulative period are reflective of the Compensation Committee&#8217;s emphasis on "pay-for-performance" as the "Compensation Actually Paid" fluctuated year-over-year, primarily due to the result of our stock performance and our varying levels of achievement against pre-established performance goals. </span></div><div style="text-align:center;text-indent:18pt"><img alt="9.2 Pay v Performance - 1TSR graph.jpg" src="sgry-20240425_g2.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><div style="text-align:center;text-indent:18pt"><img alt="9.3 Pay v Performance - 2Fin Perf graph.jpg" src="sgry-20240425_g3.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure</a></td>
<td class="text"><div style="text-align:center;text-indent:18pt"><img alt="9.3 Pay v Performance - 2Fin Perf graph.jpg" src="sgry-20240425_g3.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List, Table</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:32.5pt">Adjusted EBITDA</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 204.3<span></span>
</td>
<td class="nump">178.0<span></span>
</td>
<td class="nump">341.2<span></span>
</td>
<td class="nump">185.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">142.1<span></span>
</td>
<td class="nump">147.8<span></span>
</td>
<td class="nump">146.1<span></span>
</td>
<td class="nump">111.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 135,300,000<span></span>
</td>
<td class="nump">$ 87,000,000.0<span></span>
</td>
<td class="nump">$ 70,700,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="nump">438,100,000<span></span>
</td>
<td class="nump">380,200,000<span></span>
</td>
<td class="nump">339,600,000<span></span>
</td>
<td class="nump">256,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Additional402vDisclosureTextBlock', window );">Additional 402(v) Disclosure</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">For compensation purposes, "Adjusted EBITDA" is calculated as income before income taxes, adjusted for net income attributable to noncontrolling interests; depreciation and amortization; interest expense, net; equity-based compensation expense; transaction, integration and acquisition costs; net loss (gain) on disposals, consolidations and deconsolidations; litigation settlements and other litigation costs and other adjustments that are not related to the assessment of normal operating performance. We use Adjusted EBITDA as a measure of financial performance. Adjusted EBITDA is a key measure used by our management to assess operating performance, make business decisions and allocate resources. Adjusted EBITDA is the core long-term metric we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled "Compensation Discussion and Analysis - Elements of Named Executive Officer Compensation."</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure:: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=sgry_EvansMember', window );">Evans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 6,457,600<span></span>
</td>
<td class="nump">$ 6,092,825<span></span>
</td>
<td class="nump">$ 4,307,123<span></span>
</td>
<td class="nump">$ 3,541,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 7,260,168<span></span>
</td>
<td class="num">$ (3,342,023)<span></span>
</td>
<td class="nump">$ 14,217,126<span></span>
</td>
<td class="nump">$ 16,996,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Mr. Evans<span></span>
</td>
<td class="text">Mr. Evans<span></span>
</td>
<td class="text">Mr. Evans<span></span>
</td>
<td class="text">Mr. Evans<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=sgry_DeVeydtMember', window );">DeVeydt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 559,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,280,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mr. DeVeydt<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Evans [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (4,400,000)<span></span>
</td>
<td class="num">$ (4,645,000)<span></span>
</td>
<td class="num">$ (2,500,000)<span></span>
</td>
<td class="num">$ (2,250,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Evans [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">4,283,461<span></span>
</td>
<td class="nump">2,062,532<span></span>
</td>
<td class="nump">3,175,972<span></span>
</td>
<td class="nump">8,512,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Evans [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">336,661<span></span>
</td>
<td class="num">(3,285,321)<span></span>
</td>
<td class="nump">8,437,390<span></span>
</td>
<td class="nump">4,977,917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Evans [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">582,446<span></span>
</td>
<td class="num">(4,212,059)<span></span>
</td>
<td class="nump">4,620,973<span></span>
</td>
<td class="nump">1,839,592<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Evans [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,824,332)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Evans [Member] | Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">645,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Evans [Member] | Fair Value of Prior Years' Awards Forfeited in the Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | DeVeydt [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | DeVeydt [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | DeVeydt [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,794,029<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | DeVeydt [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,926,960<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | DeVeydt [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | DeVeydt [Member] | Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | DeVeydt [Member] | Fair Value of Prior Years' Awards Forfeited in the Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(1,537,500)<span></span>
</td>
<td class="num">(1,020,000)<span></span>
</td>
<td class="num">(661,875)<span></span>
</td>
<td class="num">(654,625)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,496,764<span></span>
</td>
<td class="nump">768,546<span></span>
</td>
<td class="nump">840,847<span></span>
</td>
<td class="nump">2,326,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">81,948<span></span>
</td>
<td class="num">(502,425)<span></span>
</td>
<td class="nump">3,008,559<span></span>
</td>
<td class="nump">2,251,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">132,567<span></span>
</td>
<td class="num">(401,924)<span></span>
</td>
<td class="nump">1,714,650<span></span>
</td>
<td class="nump">900,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(382,427)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">142,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Fair Value of Prior Years' Awards Forfeited in the Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,706,708)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Additional402vDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Additional402vDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupIssuersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupIssuersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=sgry_EvansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=sgry_EvansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=sgry_DeVeydtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=sgry_DeVeydtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>73</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>12</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="sgry-20240425.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sgry-20240425.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="sgry-20240425.htm">sgry-20240425.htm</File>
    <File>sgry-20240425.xsd</File>
    <File>sgry-20240425_def.xml</File>
    <File>sgry-20240425_lab.xml</File>
    <File>sgry-20240425_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>sgry-20240425_g1.jpg</File>
    <File>sgry-20240425_g2.jpg</File>
    <File>sgry-20240425_g3.jpg</File>
    <File>sgry-20240425_g4.jpg</File>
    <File>sgry-20240425_g5.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="128">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sgry-20240425.htm": {
   "nsprefix": "sgry",
   "nsuri": "http://www.surgerypartners.com/20240425",
   "dts": {
    "inline": {
     "local": [
      "sgry-20240425.htm"
     ]
    },
    "schema": {
     "local": [
      "sgry-20240425.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "sgry-20240425_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "sgry-20240425_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgry-20240425_pre.xml"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 4,
   "axisCustom": 0,
   "memberStandard": 8,
   "memberCustom": 4,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 73,
   "entityCount": 1,
   "segmentCount": 12,
   "elementCount": 270,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 128,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgry-20240425.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgry-20240425.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgry-20240425.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgry-20240425.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "sgry_DeVeydtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.surgerypartners.com/20240425",
     "localname": "DeVeydtMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DeVeydt [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "sgry_EvansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.surgerypartners.com/20240425",
     "localname": "EvansMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Evans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "sgry_FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.surgerypartners.com/20240425",
     "localname": "FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sgry_FairValueOfPriorYearsAwardsForfeitedInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.surgerypartners.com/20240425",
     "localname": "FairValueOfPriorYearsAwardsForfeitedInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Prior Years' Awards Forfeited in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001638833-24-000106-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001638833-24-000106-xbrl.zip
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MH9T=#R*J_#MPXQ $?\8M59"0:ZSE.S1@V2I ]PEV,%=5FG/C^YX[U:7([F6
ME=D,--?XHHF-E6#0$NTB^(9<<Y>)4UA":=<L^TY5(>$&6)@LS==0=R?(H^<%
M[&0T#5'B*VQC^5P5N=8,'8H:;,Y%;EVC$J^]JDE)!"XMN#9;!?[)Y6AUY=?G
MJ+Y*>.N&_LQ69TK@I54X&0IZ-3E &)?B9>+%S1(7VVB'Z4G=KH7JUG()U+1U
MC^,!/;&Y(0]!^X+:N923O[/GF!11S5>NQ:+.2"4<:9O?+=&J9Z,/XW?5N$4R
M6U TN"]=N*\O$[3(#O,"DB(2((&D%3&7%8DJXBNU!8%3LKBH)5'4P8";@Z5D
M,6G^@3^&D86-=' 45UIW5"$3^Y'P3YIE#49R\!V.IB*NN%XE%WJF9YE*I9G3
M0WX:1[CSM$\H7YLPZ0^R^:+9J0]264J%"@LNYVCX3-'FKBK:O-8RG%'SVB)1
MRBA];TI5.TY%5LJ+Z0;^E"WO6\Z6"=[E 6R?&@ ]$WB+T#>#L>I]W?(KPQV2
MGBJZ</ C"X2N["37J7KY0R>U3/7R8LEP_:N7;^MBKTM=[#4CJO//+QSYL4NG
MPMV)F K&H3;E)/T6GM@P?2T L,@!=:*P88.W5WK_P0_NF8-(A=M#$.X8GS4-
MQ5;GU$.-".\8)3A]/0P:5<;CI[_IS_\[,"D(5N_>8#@]@ 8;CP49:K\Z9_CJ
MG"$S8&DV_T:EUN9YY+?.]1?C7%^3.SC'Y6((0^M.1:XJEQ5QXO\0S4:U6EO[
MU0;^G0.+0(/;=5=4ZT?-ZMY3%OXH%V>MKH,W5@\!K3 _K (9-LUL4W'5_23?
M>&2C+2=4X/@K:M3.4'2Y>4H$BB=2%C99S3%_)^!:>U-)D7UO GP<;=/HJQW&
MJ/>JKB2HFPT"'Y1'$ CO0W+!GO=$Q[Z%F_,!9/^A_P,4+]#-E<;9LX96X+ ?
MU)9W#H!,[-@R_ Z'#&3-M2;\#PKD ]4"WQM(P"UJ>!R"LAM[7N(P\4%-C">
M('O8@UC<P?Q*0;,F$SA,+CCM#Z-[LOS 6!,W!I0*$XN*A^X,,I%H8XOH_)@
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M?&LC];Y_Q7X0C\GI ;0S,7IN6-:MU@'G[$;%M1>%6:#42&'F%L?#)WFP#B8
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M1+Y/ N?.&DQ5 ';6"L^=D52JM#+&*_$KWSM Z(AY!Q,P,'   ^1 ^YM$%"N
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M=,O+MC;/QX.DY=D!C'13$?^P)G#O-M'N>?0Z[9[4(+/^;O4<>@O>9P?O5BQ
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MB[!D'@ V#T.*@5.;W][L]4+A@5NQ]KU&BHD!6DI%]UA\E%0!H4L2MZ%[S&]
MLJZ'6;S/#W)LN?+%;>O\)6[JM9S54_GL7 +[,X+^*BCLPTSW%T)C#3E.?0L'
M@L/36AV_/#AL\:$('UZR( :2V*D<Z\9=XB0YW$=PPT+]_[>]]NJ96FO(>=I)
MPK8?B!,7MKV]S*Q6;>% </BI%N(O" Y;?"C"A\<QN;4FB%]'3K3)VMS3T7:S
M=K2,U+U9.WKI9Z2(1"Y@I\9]>!>ZCQ8["1^0^5[O&(M;"&<]ZT=PH.H79$]'
M^2[*Z.;/!&[LK2@&H_ZWC"OR]T^?A<M!I=%$.'0]2FD:4*2#$8[A4]<,^Y$U
MQK=5< HCWNHY!W0N8LJQ_RH]'(A5?UO:ALF]_#"Y536^OKR^NKQNW73$Q\LO
MG>N+UD6[L^ZYXPOCW=)HXS16G'JCAQ$'A4LO3:"OB%;$46\6%T@;2TGICY@K
ME%9DH:HX7$ 0'J3I]_>.ZXJ^%!*[@TM=NB0"Y)%[4TR!Q80@BF>.4:.R5:R<
M$05./>$Q>8A'OZ<4:T[HQR!E3'W"L&8GH"3+FU&V3@U%S.%L_+D*189?G4#G
M.E)E;-6\7-@6]93GA&RN)Q#.5@HH.E D'\N%/6:X#5&=-4$,JNUV\&YUV34Y
M :59(4F2$F144X@$-?Y@S"'\HN.7.JMK,9XBKO4E%VU2#1O>;<]W7<[WEQSP
MP3N\]-M#7IM#_B6G?/AN?H/<IQWQFAQH"YL>)4WX4M"-G FV6D[Z#&+N$65@
M#3"5+$GH\9(0LUFN;&.JF]./D3-SRM LOPR-Q#5/4J4 K)OLAZ'3QQX9)!LH
MWHS#*DF"0MLQYGOD<&I7AK'/,NHD#![KFOJY-5!I@C"R;F]E0#)"1GP(Q=B:
M"AO4I*GP.<N,RKR(P<CRN% MCFXT.B$A1#VEGE-496YS4VD?%/<&F/],&7C4
M.5NEE\T7T^;>09+&S'O(I<0!!9(L-#T&C8FOP7>8S:JR]C -#-O+8(8FRGS4
M-@%3T_34,&"2Z<9X@KO-9K\Z6!L$SYX21^6/@1MCAQ/ S?Z4RHC\D\N=Y/&.
MQ45,J.8EX61WU@!STI1HZ,E[%(?A"N%BLI<MDZU(58&P3<Q/S ^WYP[_'@H7
M"ZC!H6 ]G7_%?A"/RP@E&BW$6HF!Q)+:9FTKK(P^D).(*D;3);2PN#F=+.8_
M\K[2O:@B,S"0?V>YW!$G31V<SAXM]?*S8B EX<B"L_0]W)_>=9F*OBBZA.08
MY^0\P#L?"ZS@/^\=K(<DTR1,U[HOX__R*\,"6!&$L!V/KAD^4$4(:&V"P@-=
MSH&D050?.%B:.IY$EC=)7L'=7LZVT*B5'FMIJ]57WBA.=('L3#"DTBOH#[=&
M! IM?S?)G<)\)LP1EO=*$W2,;6@ZGEZFI-8?I_WJ8M=I57U!2$2UJ+BQDVW]
MJR).TL\</5_9N-D&9:'+)%5:UBGR+56RFTIJZ:(]] =<8'YN82\27;>BK/)W
MRZ)ENS+XWW+2/A8_2OLHIAN-S):O.K%+)X4MO<>N!Q?K.[<@,XBE*AV5,EOB
MUK;BJGA55;HYT;O,[KD)BN=[>ZI=LLQ4V0O3VOYMHU,CT0TB"D,+RX-0F1<G
M&,3CD%J/A,9:;"FQ9A>L05(Q2\=+UJUZJ3E!!B/,:C81%=OWY-"A]&)JPD E
MBQ369*D(R8TZG:]P3ZJ! \M797$O,\82>'MJ-C.@3+O"TU'$#\6.D,9,J*%J
M^9;:F-4P04SEXW#1)E:DP$9VC, )Y*TJW10.1M*.F17I?.Z0J^U33YG[D8.'
MB/2[>$AD9B WA9B-_F1*V=PD2CG32*(7!?$ J]&M,[G4\EP?",]]J,4YN.H_
MG'$\%D-7_G#Z#G4W4G5^M4PML/! R%U5\RT/E4!#M4;F5")A02PW+=$'$.)&
M2IQA05RK97"]; >;SR"J3:2/U?I4ZP*RYTVH+0WI%0;%58*(RHB]H:(!QJXL
MLL@9JX9M)E]C#0BB-4[$-%51A3#B9@F2U9(\C<*;EM<MX8KW<40BBEC/D8S7
M"ZJT%,-4+<'8+P/R)X:DLBU&C8^)A20G4Z>7B8<JH3UGAC+7QYA,L!!C#NZ9
M^A+%1=$S6\Q6"KN9RTB-)28E_K(5*1Y>M[BEXH4C9XSEBCUJY\A%"A770#!K
MLZZY#QQZ=B]/IW:'FT3M>J90C&/.1KZO*;5+L8ED-6H]BH8'TDZP/HO'U1@Y
M)Y^5EF2S15H-<6WF?%@>*8[2JBUS:5\WTH6:_ D((W[N"N24Z7#DQT#_T$3"
M6AT01-@14I^)ZERG"@,9+7& <#D#JF,:R=M EY8!12V6JOEYGTK;L/,9,9L:
M'R+'UN*/ZWNW>V1.T]0NS)&[/T*4%K]+!0OSKF8+SV0U^MR&+$4=DTI!W)*K
MG-M0MFV7;99:0XF;" ^:E- $@-0#MH1B4RAE;LFZO19)M5KC+".1SRXZHNI]
M1!]E0,VGK$B9M_2VJ.G<G'T1)PKD4-DAX',G"C5>H80P@&.!+5D5JLL?H-CI
M3DW%00O3?.;*B#%0]9LR!CB&B%K& !5==CS!?7. M<:DSZI.3L3# A\%%;)4
MP;W$P7!Q/M7J<S,E)91_RX"?XA;<.B"FCIV>E#:*HP5E@M+MC+*<F2"H..L8
M*P(BM<4ZH5AAVS0E*:DXK<:M6K:1J2@M('I<7%B4!8+L<-EZIJ%SZQ%@O4QM
M4@V!,$%4W7VMKXO:8V,R/^)BCMS\%TV"JN(@0\X7JN@'PU^UWS+GH7.-5#,#
M_O1=6LYH]L:E990RY5;3=G7<L8W+M"4*6%D)[43U%&N#Q9'2D)A&BN\)U^;"
M&F;R=OI.^&D!Z1R4X3"9FQJ("9<8V^9AJX#L7(B_# SXJXPHX))60R(EU28C
MC6/^JO2*6.;B16';/M" WXD V] 9%EISI86 (%*!?$(#'$<(4<N<OX1W:?VI
M-U;:6L.<*W-$F4,=&F7BTC)6 ;4+HWT$/E(RN=S)T5U ZFY%L^M-=56EDI2-
M&;$,,JN32N[1"S US7<F#CB#I KQPW!-KO\?VC12Q$-X7&4R!2+B /(8.KK&
MC;0,,NO1SUZM\O4%3#7F!TQM8Y]>5NS3.@G?5!Y>49A"&1&D4]HGZ>,VMR0-
M8Q2@B:]A<R)\)K&]CU1.$;A.;!L(4.>SE(W7<!#9,?%99>$U"+H<6>XP4\P:
MI&)%64$>,@P:1@BG$IZE]F>Q0*G\!QD#L ^3>G[$H@UV6J(VTJX#WVMJG;I5
MS=J'2?%)U0$A(_11A3$FNH;G!4TF0(4JXI-_C_*IN9#4H6K+H'#:HGEV4*;$
M=02T;S9&4F<$'UN;[Y87UWW/[,0A4V2Z;.!RB79-VA>6YP^3&K4@4KH12-6W
MHR)PHM@8(D )DC@L^GG0DI3QLY%H3Q_!CS[(>O_+"!/&?>J[CER0\(E/5/%"
M0@#%Q RA/>NS4Q(H6J)S2AO(-NA-0NPABQ9-@#)23D49QB[ZOQ2G0RF"#IP9
ML-).E;A9!H!S*3;V4L,A@<9&]AK57%>7[^:E*^&"#\>9*.89E5-\?:JQHEG=
M)&,%G]6Y<CJW$NBLNZGB,QGTJ=%4X@GXF'H"/L: Z?@5($;6\LXHR5H](X-!
MQ?3ALZBE_T@<0HJFA5F+1')CX2=5;#?3]CKKV _ST345<1J3/,>-C%FQOI=4
MI/Y'YBNC>N&%GVB:"7'CW6#<I[PG"@:G<KC_-[U8Z_8VD+>J'<>.L\L.8*J,
ME!*Z_)[3J[SC+/')/!#I-KHH#_M I'C#"=0,*T%1J>* J43*4S@(J8$$T#75
MUY%?.( *L" JHY9%58P?B'I*X,G.07KIZ52AL2%4H9Y4W4O,QM<8$P$PI_;E
MEUH77'<*<9F6"Z4RRH =KE06FX"X)EIU4HPM*X^XP5>F">)F-."<_DR2#8Y%
MOZ=OHM_!=/_J J*Y*=!NCLUVAE,<1+JZPZ12LTU%/5%[@8.B849%\"0J(+L6
MC ^X#0U(DMH(,XP]LM:JGB1Z&*,J-O6- BQTL+2T :@6R'X1MR]'<)6U_9 K
M6Z.6!M^%<N\>10R0! ,?158TG68W44[73I'H$VH!3@1J,$(#XU@5O3?[1**3
MF=JXHP7%%$53K=M\CH:E,3K.3#MM;CQ3$"91Q1LI#W]" M@B_/0K?[!)5[Y=
M3+K7_99_E4IQ\&8QU"(M!K0@%8G1CETRR%*'.O:1)F^+'=6-W?PD?:PZL6,M
M?N"]B2.$/(=%\L?LN$4/]:C:'8RA#DZ"D1WR4AA#)=;>O DZ+PSC%1L$3E_:
M7+M853M.&2A;!.%%%1>1Q"RRW3GD"WS'],00.VZ($[+S![!$9D<E:E/LY$PZ
M&*C 1);H'XY)+,/[*EP/9"N2WT"/<F3 H762I(. "$K.8\&.)J4)<[M>5*8<
M;LNJ45WYT&6(:9Y..$I"15*I9,8#1<T/,GH*S!J0U14G "T<MA/&A>UBEJ0<
M1VM&.6C$I?J5$BW)W<2-H2&)AQ^=_=IZG-M,!E?0[47N*;JT=#]["F4:.];N
MSO[;W9W6KD:?S@\5!MT:1'R7)G% 6KIZ(3\5=8(PJHP7O:-N+H^7>_A'J)CY
M5%MW"JD%I7;Y3^S1NC@W8U5ISFN<G-%B"LF$:^):Z!T8:*;#E+_8-6M&DUEX
MT'XPFTVU/;-?<F8AI5F8QL)HE'B%,ZZQ-*9@QI53Y%<JY]U1J0Q <[B@LKOJ
MVF($(C9[RWB?RKG8W00W_@AS7O%R-L*79 Y\584\*/W<M [G\2]""<;EKQ)5
M(OFX"#\+D\&V./HK</2*S)TJBHX<E:2]DJY$B3].WK*O[!]7@?]CRAUC66DT
MXF9U'D/LIGI!K]-^9#V&->/W!9RR*.")=%(FUJRX#C+:1"#1P<0AW@D14%YB
MI.K\C3-,1<5R8;Q"_LX4<G(T9N\IH3PD@R6]S7U(=$-<M&=C  D%+6&@-5_4
MY(6=; 3W4.H,;;*8D^'1'^ZJ;#]%"E(<6'JI[,G6<3?A($[3RDS3Q'RJ48RF
M]##5#U#H 3$M]O3O<[WV+,J' ]='=UAH"/BADM62/)=2VB@,)C[EQ6L:UP+:
M-PT=N@<?DLG:OF>GFM@UN][QE;27>&GNU<ONA6\M\@E7MR]7]\TT>9A;09,K
M\!J*(#&"+,B'1C$X>*:.5WQ.RLV8'E8&O\BQ+]E#0DW& /$''-E2(/7J$%_E
MO>-KP"./T8X:A,F *NXAA<7<F<S1<D$1TQ!.F"*S-%-2>85EXLHI+E .1!&(
M./)&Q_LE$.-X!KPARG+%H38)RIJ&K/1,!E-4B>4@)L9/T3$OCT06%[ P6X6*
MG0&&^NZ6Q0V&1%HJ@:<LSBNG%0+?W_V1)UHJ<R??G),\>)15.YLVH9O_E9BF
MI4:']*@IW"8JS4GIZ2+"-*N'^.]K%J40Q7I[_S#Z*U(79-K#')4L9V0X#;))
M2H':F3"ZO!>E@#QVB<47>$RZ81R0>2,TO"( GLETGE*I%$8=DL2V9T4L3!=^
M)M5)T2':):?.E,E,=&<Y+H=<\&Y*NIEF*/8,>UA)3*PT.?A>]D,GHN3S^_O[
M2LA]7">JC6L%SG;;IS -0FK.#T):WJ*T7]]6;7IYD4N;8Q%<WA"_"9PQ9[8K
M=AE0%H./\D/6= !D6L6U4-/H*)PUR)E"R(R!P=1"9M)TRT92(N>)J5AKCF#2
MF9>I8&S--&'&\3BY4\G/J M&TSU. ,[,#N+B;6"-0[.I+GHY+=N?D*@N[@.$
MA9?X%UCV3AW_<T"G_1,_RZ3RO'#.='IUOY*C$0>?,S]K Z0!&-(X"9YZR^3$
M'4QU,H*V^FZ\D%D,D:WA>@T-3-<<H6YHBIDL;$MEG:2.^)E8]SSIRBIU\Y(0
M=^@:MCN7I=V$;"6T+9=BBB% ROC%--%-DG-A@"1+7OED]2C*#\L1$4-*P $J
MK3TYM8,B!P[H.K[K\DYU9E*I)SWL/Z]6'I9VRSKQ0,ZUKZIE,8'.#8#+<%/B
MCSRG$-#P)\SDT!"62AK3I!34 _^64W43DP)/5JR;["0I03DG[F[9R/XUL*#,
MK@R<4GIV)J^!2Q#2:SKJ-X,#+B:YA(FU;3$L^IE2$CJA ^6)9%\8\]=/,G H
MJ<_GV"Y/3Z!L[,D2V-H%&JT=JTHZ&%,;)>M1>7];3\OO(3+GUG>9(I,ZR Q*
M67U]/'ER4EPO8WMROY\]**%2YDVY"T1)UT(/E6$@=CS4NYT[6?"B2A<<RB H
M'"BA*'D:PB:\Y5#,PL=L1N::J2-C<A;*0,Q5N(?,QX/M+[^6+5[^+KPLY$Q4
M02LI7'.;Q(O/.ZZR5J&T?*)*F!72G+)VQC@^IN=0@G&2H(Y,/)V.!5N]1%0
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M1GD<I H]2A]7(]%NUEKV=MU 2\L16K5ZNW^(0W7LRA9)[#-?N\@!U;??+R6
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M$/8A'&6D= 5")@G$F0"X6>*"C4S)QRC 44+8GMPAI&]+>QL<KQZB29)3$ ]
M&)-SO,5-@*Y"2P&&.Q[\&O1+(*B+NE^ !5DE:5J%!REQY:HA19=Y%,, 3EFP
M\J-8HD"(O"C!WUZ/\,DNP=N>14DRQ8,3"LT28$<$1Y7?IO)4GL-2@K6HUX""
MUG\@>%6IN= 8;'8E6_T+V&:_UF[V=M7;O=O:$2[;X0ZU$2Y;+CD' T5G2\$F
MT(#R[[:Y@=[Z!KIS&#P[F-HF'.Q<>NC@TZ'#B<X@F5'#R:TX>7WS1\A>@4^;
MX-X5(6 5;W2[6;31LR;@P#,"]LK['R2JZ>;W=(:EZUCZ-\0?"21^L0ZX;GAL
MQ/: 6?HWAK[[)E)K$K2JGZ!5L5MUVRJJK#I19G0Z5K]M.&'$8JU8G%CJT7-E
M+Q[^VG>?L TJ2;#=L)IU^W3H-0ML<G%-+NZ3<W&/FN!&S[+;_=.AURSPR7EX
M)YY<;A<DEQ\UP5VK4^^=#KEF?4VMQ*D8L];)66_;:G0?=V2M)+UF@3?$?J+(
M8T+>_O/+/JD40=5L-9M-MA+CZ$YXU 9[L80YU$[K46@\-D)H:;K$4SU@1\)U
M8#4S':G3K.,-LB9ENN\0VPZ'LB]W>89&TEHT$%,NV\OB#)>&T#L9WM"#?] E
MV:LS3%HX>WV$&?0)!LLJ[LG6N]A[ .4"UB(0$AD<$_XPJ6[B!&G+:+7P8R<(
M(XN% A@\4BN /P,YPY4/P;>7M^;X8Y(/^#M)BZ5)5CBGCNAQMG;25!V$!,:-
M' ^;FHOIS/4)/WPE,M8 9$X %5)&E:"OD9RQ'Q(B/+T!QJ#+?N8_P/S"B3.S
M&&FBI,,L/A]F>T[+Y@Y^*.*/EW-OX_:S2>8M(M[('KHHJT6$R@1_ZH#M^",<
M&@OQ"K#]#<A5(<A5VX!<[7TJ)P5R16EO8+SNG9%8T@XBDT\-NDXV'(F+?&#G
M>W,JK 7RB].-TNHA+E4RS)\TME:SF=>_BP(;[:1]:O2:HV'@1*AI"%@KKC9A
MHWD0]\C XAYQ+EN)DTI"30R_'5+%+W:$T'ZA)9.C:4!U0#I-/7E\5M96?E84
M"P*9U)2#:UTMQ#++UDLO=T?GR]U$8'U_:#?;M7[<Z@0-2[Y*N\U>X=!8Z&;7
MW^D^T+4T+I?8"PI6D7[1>/>::G&77B5E;,7CJUN#9::YU!JLW:[7[%Q/-+UF
MNJ!RZGEFF9U'?I:=EDX#S=)^Q"QA"MFQ<")3'QV/M?-7KVVN>RWJI"6ELMPL
MB,WF03CG7N*!E8FOK(17Y7?Q>8!4]ARVNKMNVM7=](\I0+I!O5Y>@71@%*Y#
MQ?W" W#[U^HP_9#H*YO#D_I,:>O@O_FSG_+,<P5(85R(J9(_K.4.7IER<]2.
MG(WG <''IHYV.JQ>?NL$[+M8R.Y=<=V2.IW*G;,\V54%4LKLR\)7OOZL17H[
MZ5%!3VFD2M;AOILX4]CH5JMIEW@%%ONAV]8&T5B4#@+\L&VK9[?*7 ODY@_M
M>FZ<E+69H1IMRVYT2H:2S-O@K#GAR,BG>#(EA\C"0^,)Z9[6FN+' R-P=X#<
M<S!",/9H8_VBXD(D=6/VRGFM>[ 9H2P3XE>M^H^O:?>\<N!QLIR:*!84]<KS
MP),]>(6"\P3OG;WJ4"^WVYT4@;:>5 2JP@R$!F7J0BM5S&GJ0@\A9\S4A3X?
M%TU=J*D+K3[O38&=J0NM((^-V)JZ4%,7>E+ _0VK6X#;?[K\:'>L5JMCF*$*
M1#LM(QPI/WHMJ],YZ0J"D^YPT3NY*L*VU6EW3X?>QI,*XBM)<K-GM7J=IZDT
M4RAJ"D5/*5&];]FMYNG0VS^U!;9[5J_3.F4W[]0+19]PZJDDP5VKTS\A/Z_Y
MA)!')0EN-*QVJ_T<7EY5--II=]6R3\R"-^J6W3FE8M'>J2UPVVKV"URT0V\3
M=Z&5J%#FLDQML^(/6ML4#J:E@GH)H:H:+$AJV[HH,.G54UP:F.\4E-" J0=6
M)F..>G(DZ<I%?6-R#7I@:?)9_-BG)TZEWR!Q+]_AK*SQT.8]]5;VQ),9?'I'
MNQEWL#E(0B%E\,'+4()EG:+L-M>D?VMK< _T8"8AE:&$^79%L/#8WBU,:CW3
M&A:J_F$SGY*Q@2!91WA/C84\<4?5AVSJC["K#H_K(AOU'\O:@-WZ$8QR@_?N
MLKZ2?1/1//#8J[/;FV]GK_641WV*<<725S^^M,<B3U4,@3F,^H\I:3$E0N6#
MR\>(G=JS<7= C5E:<N?0=<;C1Z1XGE:^\II:B:J0OKM,9NZ&JGP"^W:EXA37
M)&Q47F!;O5Y9ECY[)1N'33B.+ZOVL2*A+RL >+@LDJ^I'..Q%1?X@[C>HK#<
M8CU)M-/(T%!A=/3@RX)H4C^D+3>S.3LJ(#@PX2O==TM)("2.J#8=R2S2T7\*
M=XQ:[3TP9(S9(?CAM0C^.W= 88LCW907(%$JF7T\=UVYR6(@ / 70*#<N>R)
MJO+=+:G[P=UTJ.&=#S85?5!G1HGY'OUP(KB+2?[ P@?%UYD+T]0'G(H1>JX6
M0Q[@?^^!T5A2"!9#%LV.G) /'%=B8X3S $T3'!7CQ/O<>T&R0_6:V,Z$?$H[
M$"L"5".H=.8)E> T@1_F4UT?0F=083 6+83SV<PE"8&M5492TGX,YU1=J[5.
M=<=%;):NN!)VH19LU1NOOK\FIN!R2/6ZS&T2GQEZG9%J-:BM8PIMH3N'F9&I
MS)K_=8[Z3I:-CV"_HB."6BMP!G/2P$&ZN^DYB<!2.BET#V$<"=+B:%)BX"02
M.(E.[A;-P$F\_%2>#TYB/YIEJ+E_5O[,ZSI3-,3.%#9+6K']&?< %M/&'5H_
M^".ASF[:)L^J*?S_[P(MRA U@^^A.S3E$1QP%?A,K#F.58?_J9SJQ,(A@VX6
MTP%Q_K,WK+$;W=ZE13.:HX2]%262PMG-Y;?KL]? =[";7D89BR @;:PY]JB"
M+;*4,? &'C5AK8 L4!AQ@"$S'=U7T(IZ:^R/!$P+YV"E]@/=7EQJX2HADAI=
M]8^7?645 ACZV> >N"@&Z:E?07K)9LKD/:-_76.7RP;C8>+GWX.&C5B,KG_D
M2N/&O?B5L3!FS-0\0TL:\[#E1-)95E<JM_3+;V!7DZ?'+@+XKQ2.(_6^-6<G
MKI\/69@P #Z*0,)03@@N)U=XJJ-6:*!9_"X0Z@RH=CGJR4C&;1"NQ@_H,*H]
M A\J+(LHU;/QQ# PB!&S(9^'0CZ,?X8$-8<M?:4+?.?[>'#EH>_5V"?" )#]
M5F=ZV^DBXL(4.P"C?0EYV \:GP!EDRJC3+S@G%TG<;5KOI!$SV?PS:TB1^&*
M?)B@)"$_T!+"$?Q,AKAVM:M>O(Z!Q.</B;?VU??.?[FXN&:?@&*/PB-?J%UX
M&!_'2MAW+6$&#_U@O\ZL*<@[*> SD$DAD1IB4^/%_)F"0,TQ%C2$>0X$"+([
M@U,O2IWC85S%#Z1B1R/RX(03_ :%/O2G)/-<GI8CW$7427K*X]T)=LQ=_)\H
M#&YG.EJ#K%.,7<'B8>2)!I%''R<2TQ!CR6#X,"X;^%-UL-6HD&N+Y@:W'P6.
M81.CP?6]>-^380DC> 6R@@#XU*O467Z<"(LV/3H*Q_RDQO.< O-R9Y&!FP$!
ML\"AX!$/B=XIAUE$,&%ZSQA!_80WI' 3C2&)0J9C%%V?M"NM+PZ,IV^M_SR%
M[\-0A&'L''@X1^ _3%=2439OD@-\?GGAT?^;A^1,4H0[1Y$L\$_YE(^A^YG+
M"^G/:!OJ/)X_:&9T61^+5'BPMCEW2W/HU*V%A,WZJ&K1K!@E+$>M0@9#8SGD
M[G NEYKC;ANB?AB(,:)7J7]%_"\<BL=CC.FZ)XJ_YI'T ;F*H8&H#J5E<E'P
M$IC-=V!$0:7!/J4YTF:9^N#O_A]]\"[Y)>@,) 4V);SE71;V(T.F^MT[%H$=
M#OE0GKQPF+M >\E0QCWQWT.?)H*S=_TP9*_N0*N^QA@;XDOXX)\"H8@D@E4D
M7%IT"M^)[(?OX$ 7.7?R):&((E>Y*?AC&9S3?D!OU;[2%5%R!?5TI8'J/7_Y
M2$%]I3-PD!)567!GR2G$'S\Z5Z=65+?:00>M!4VR>%J6/*H.YB'(;(AWM$,*
MC(8*2-#UAZBJ8-%AW"&&+Y4;J:Y.T'@1K@N>+$C_%C!0\BJ68^6@%?#!B91/
M!X*J02 OV0(T.7PX](-1"O%"U]O)@3OCY$69&:>'H,_)O0F>-*M[YED=<P>6
MP@(-'=<I93VY).5JA:PN;!#@+XR%9A3W. ](G9#)2V4VED;E](PQSP27Z^Q+
M(I*)I_)1VL=8"UR@4X/1<YAAZER""RUCP?2;;R*<N[*8]DJ*,XKJ.?N@O*_$
M._VBC/!9[O8KS0&0Y^1O @%W4+V BIZR1OW\?TE[XB.$WB,\E*(\PF/S2*4%
M[51LFF(')+=O)>155H)6WJZBMO<DO!SI&DTU6(1^#>N9;'M]$UNIZM4W/VHT
MV/QS4&[D0?T%M@54@4-1-E *,PQDJG.HTE?P>QSR7J81@ K$-Z(DH38DMQ<]
M+,T,A23BKH@RD(PM>2DJ'R4EY&G4R-G2I2@/1;CDSV'V"GFQFD'73K^%G"/F
MI!Q!,Q##^[F+E5ROD&(N!!=+M/35U /?)5RKK0_PR/S-";^S5/&1!M/IW85+
M6^ONI?:)Z,/+T8V0X8L4<-8=!L=MB.CUR*)9@([B,!8O+_8770J^QFKIO<^#
M43):@*Q.W1YY<5LRMWA;A'A"='R0K;'@T5SE;:#_M,G<B# 4;'@ L\!D2I;*
MM9I[GL!_HDJBJ47\.R@1/<J,2+?H4=*]0[H?QN"4^P^8A_DXZ<B4R]%UERXO
MYWNT+72DZ;R+9_[R4\B6$C9:-=HY%YKZFH'2G$T<.'CXL\D"$Q@%I@/Z\YEV
M-ICRX+N($A](I@S J8/3;]2W\8TK'>Q]U=- 8A'"C_"N']V.Q.WVZ2H*A"=\
M9Y;]19;]<CR6'&<#[JJTREULN:Y]4+SO=^OV(?&^U4%F?."AW BJ&0WNNZGS
MEZX>41?.9<@YGZ!F*<AL+TY8\RGJ#]XDG8%ANXW](=ZI)?=GH,6GZK /0X_\
M!S( 4C,_P'Z/.^_0URDZ)X8>=K(AC5!L(!0W$U")Y[2LN 2(&(*+H+O0M*Z/
M7)#32Z'I9GEA4FB.*H7&*)K'*IK<B8P.$OH1E0(5^!.R2_+X.Q)XJY0[ZKKX
M)KE<\HZ&4[!K!,?G (_)]\+U9W34?H=?&<_N13R[DE,?9K&'\8)M?,CSTV@'
M> J"#@#PQX();_G@A_[$N3SIZ9>@8O/SY) :Z"E?1:B\X.&$1C[X^[V=QPI^
M"M-*M!P/5<_"D0^/X2DZ70['TW=I?DDHTX^:^Z!CB?X?#T,?;[SBJK3L^XO>
M2C5<\C(HB8FYSG?A4J,IU6AABB5D&,#F(Q0\$!,Z<.1*K*J=$B([.E[%K?O8
M+W,'NU!ZQUJ_L&DG1 IK$^B=5"!3.)Q$%)1..W.I*%:FQ>$T:YADY!2O7"A5
M)!9.O=MA+DG PF2F)":&8V!60M)J,1TLG)"BD;)*48NX$B&3Y:&.9V&$<?M\
M&=$%WD#*6+C%'H0:; 2',3RH9;LZTDO2BJ6[1%#0I((ZC&^FDRK)\KE;*N56
M=G,4Y<T.'B=JQMQN:6YI4UQ>D>K#$M2T B[-0=4JX50_CC%WDDB:K(=+LE''
MJ.TCFK8LCQC.@P#WA):@:J)D+[.X5^3P>-38(#7%OFQL$.YNS:E=RMI%-T[T
MBRW\UV*[$9LE+<=S JL*4\BGJSV?.E 9[F!-P&")X$AOXE&M:F8R[G,J;\0Q
M,_3!2^.A93@1E/,IZ#)7#Z/)WR L>=J::4ZY0JH1W$0WW>DL:JR\0JWRS"YQ
M[.C&'^35B50*G^MD[K;#S#+YGE:#0;6@6$$2=VN$4Z0SG4^7G"/ERDC'+^,/
MP6#@#A%Z0]&&I"Y0,.,0JV&L>'?"L00C>7A>]<2]ND;?Y-WJ6*.-2(?/E3.8
MSL-([46]23WF[ZFM#S\4SKU,=J#Q0!1#9%3J/\9/@8D)AHZ,^N="^S.^P+J
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M8 ,A91H,32# 0_\_>.=@D4R'YBK^&KKSD:!Q0*9Q2*!%A)$SY9&T4F/A1/-
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M^?]NEC:?2X@YDDS)SL%E2GY>SG;%]2M)8/7U!%:5\V514AA=&3)^%PB9*!;
M@F+._0\*F0CW'_<6\:J2= QY. %Q0WV./Y4YNR 4*I.2,L3"HFQ!*\ZR4PE8
M:K;)-&6:(65*#A;P;3"<<. 9Y?;B[Y,?OOK!;M7:6D+:ZQJ[P%QB>/'<C2PV
MGZD$PO<^#T9)?F^<9B@W%R6"I4S '#A%!:QQFL153#7EV%%N7*]?Q_[R*O>+
M/L:4QE!$D2MS">$D/IPPNZ4J2VBU7CFO)0_X(LYF_J$I1Z)49GP;[J)7COHA
MG.7GE*(&O[3K5JO>TSB=R<E\E2P>[#=G)'--)<=>RY>O2/7CLUG@_T4YIRX\
MU9'=O6OE:6B5VLC=@]O(:U*>LU*7;#,]>9@,!_WS _[X<R*BUR[W:O"G@$V$
M:<KP*]CAE!2O]$;DD(B>?= +9#Z"29F'(9D?$, +C[N+T G9.;MTE=6 B7VE
M(IT4FC@&'LX,=<YN)F!(SF]AUVD3DZDA9XP/0"F174'.*,P[V*/<<4.&NR\8
MD?9"-9+=?2"C(,%3O/43LFP(OJ/T:97[*IE".?[+3*%7/DP<V)0E6RC)OZ1M
M)_6:ZXCY\I+$&SBTU(AJ FBDU9Q&L?Y"/637W]W0*R03Z*/&.SR<S*=)7<+-
M?#K%]-P,,\D?.A*#VCOL?>B >T0:'"4EFL3K)]-D!\+U'ZB"0,M"AXTE.*P^
M[,BW6RR1EF?4+SIFOGAN+IQB:G5YDMDJ.;=9Z]>+O]HVY;1=:W<ZNTE>;<+:
MMG8SE%VK]W<T5'UG!'9K_>9JIE<E.?>%8@//FYM[0BS[%_@A^V79J@S-1JUA
M+W%0?7@H'%2EAYOZU<= <JO>>/7]-8.C!1A*.+U&@3.8R]C&LW@#'<)\7C>O
MLN84$C&ZO#D%WTES"K,!LH*0^NTWE]^NJR@7@SW+1>4$X8H"F15<Z:%9Z>U6
M^M:/N%O L^K4A1QZGN$+%8*LX>\!)LL_M:O T10-=)Z*X'TTG-@!"MW1\*+Q
M;*4[5>-$*=[[X>?O[%O!'@,X_(;4'DL/T@W)/1[ SLVST8ZB^_NFN=)6,T>N
M47HGA+J](;7M(X&Q-4JO%+CW*$#5-U9ZC>+N 1L&<:I2!_2("NEJ+62UVBEO
M[&%N=DZO%E65ZV-[XG0M2^&&.G+7F$;[5C 5:FR^L3?7KW>/CJICW8B;!NBJ
M155G208-JD354"7VK9E/Z,3RY+N;:I';J%O=DZ+W2)I ;4IN#UMPFJBCN6HQ
M5RTIN3VK=4KDGMA%2Z-M=<U-B[EI,3<M)ZWS^B=%[K(%/\Z+EL<"KE5K.<UM
M2V6H.M9@:/L(UZJ[K9+<U#I417N68L8=O8$T0<PC)O<$LXA.*HII\L5-$-,$
M,8W2.S&EMVMG]624GHEB'BNY1ND=-[F=)7%>C;&<S2?J[R--B.;];_F_QZ.2
M9=*@6O5:$DDX!"0Y?D!(<OU&!DDN1C@AP!L$,LQ"G2@L1O6KGT*F\'$(H5!B
M"3J(:3H(?#Y2'=PC_M?Y?^>P&<8._&LDQM2A6A^7S1#U\7&+O00:>&B+/3B@
MQ<[!!A;#V:@UOEE,!_!O"W$H:^QF/IM))$WN:@B:WT3D!/0QB8 %2^_Y7F:U
M11#0<FNHD,>\W,,#6N[<WAX*UV6SB>\ALJHS'<R#4"X=0J:NE 7";)T([D83
M%O)[> 5L\N%0(K[&&-L:LB3";9<O\.D!^3>RO,@!P3-G](^S]?CRW?Z90?\_
M&O3_4H]+UW:(A/3RN$=)@)_]@HC;A#2,VOW\/=GS7)/L/$&Z)MZ3(K9_E.T)
MQK[K^@_HQ2A 6B'5%:'CPG^GTAREJ,UW";U@Q<X5(CUJ1_E7Y= HM&3ZL42@
M)QA=!1Y/NG(T)\SWN/5 6>>!]1#E) 6MHG/&B\/L]ONU%JFSK5!V&ZU:JV[O
M"M"VT>GM"+"W4V_N",^VT=H-B#"X9SMB5+?6:O0/;*1VK=O:%<?M[F[FU*G5
M[=UPO ="OIHZ%6S,^4!VEQ3D3NH2G_*S_OYP/UNUY1*E5NU%@(/7.@?D(%V&
M$;66&+%/\V@>"';-%_X<S,0?A/OY%2S%I;04.<3^K*'<Z<S;-7N#N9>!1-JU
MWK+"UT B&^M (I]97 X'6GHG$K*)=)07OP7^@_R[_7Q,;^29OE=DSLV8?@&'
M69]@6&7["^F5O65?Y^1B@3>6]LE0/6;^EGZZ 0SJ2S#^L"!1-V,\'0K8Q^4V
M/&H=P%WV9[(36)F(%QO#=G\#8W@4Q;*;,;HZ&/_[X<_M8D9R1YJT&HPZO#V\
M>?7U?H&+*Z 8;R=@6":^N[DL[IFGS5JSN\13]>'RO68FQ$X>^I[8#$2)J"H\
MKH#<?N%_.=/YU'!T]YI@6Y_3<'@K)6#8^[PJ82U_BQUY=6U1=IYZX2X),$A5
M_-R#[I!0Q-OG26Y:RQ:ZH<HVR7P6(/@U''G)A*_-1.44^@-L)AT_-!OMHV\0
ML"$K&I;=J1MF2&;85MM^/F94B1_/KC$,,PPS##..38$6L6*;<\ Z/CW6!=4\
M_(/PW8E;WT08@>^.=X.RA?H+70<7S>:QU\'V%B?K%UC4PSM#%ZN,YAO[C58D
M7W5TTQ?3DX9>0Z^AU]!KZ'T&?Z33L?KMYRJ W-225Z@Q^&929%MVG6(*>W/O
MGI#MUWYJ8/^D'/KKFS_"*CKQ3>/$&R?>&$5#[VG1^_Q.S^&1VV@VCP2M=S-Z
MT??JG<;ZOL#V-4Y\%9WXSLZR<UH[@+26*3=[6,/=]@VM?,;+D:JUJI EK;'=
MM.R-K%.ER&KUF]5J[[<96?U>Y\C(.M*]9<@R9!TN68\(GS[!)3>9#8_TFEN;
M!T4K)9*YJ.614'5"^L.09<@R9!FR2FQOLVZUFINT(MA!G.] HG,$W%S5Z-RN
MKMB-CWC0V:]5T2'&1S1D&;(,68:LXR1+WHHWK&;]M'S$KO$0J^8AGD Z956T
MAO$*#5F&K,,VR(='5<NV.O76L5'5P0S*SA%1M;N-97S"E_()GR.G;U<9H=4'
MU1*>YXQ%P-[7V'ONCOSA]_T5R.Q!P^T./>M(56#EZ=TR^_ XZ-T\+?$XZ-T\
M7W$C>NV2C/P#(?DYMK AV9!L2#X@DDWI^1'?IF^1<6G*T$O#LCMA757U@R'9
MD&Q(-B2?'LD'?QJU;:MG;W(98 K3MPEAMRL;PC;84J?FX!NPV(-Q\ _97)R:
M>33T&GH-O8;>JM K+P][EMWN&W=^MU+4J6Y&BG'G36ZS<>&-"W^2)M'0>]ST
MIBY/[V3(;7:L=N-TR&VWK&ZW>PKD&J!8X\#O!R;VZ#/'O_# "4/.+FKL?>!$
MD? F?+J+:L#*IX@?J7*L"EFT:-W&,:+-VKU-FSE7BJQV=]-.Q,>;^6 H,Y09
MR@SX[,EE2ACPV2/8:X8R0YFAS%!VTF?.1MNR&T]$RZ@8K$2[NC' 4X4:.P:?
MT8#15HFJXU/WABQ#EB'+D+7UK835J6^29G \#J)MBK9,,N<!>(P&J+9*5!V?
M^C=D58FL71GKPR-J%S&JPZ-JXX+[JE#U\CBU1Y>>6&'/<W?IB;M/;:U\WN+[
M@(/P+]BW&KMZ$%YHX&Y-!O@1T4O+W-LT^_$XR&W:FZ9%'@>]G?:F^9*5I_?4
MMJ^AU]![$O2:<GES/_]2BUJ5(ZLIG3?T&GH-O89>0^\AT*M:YUB-[B;]^DSQ
M_!92U#*)LZ?ASI] PH1QX8T+?RHFT=![W/0^O\MS>.3:+:O9>JYV!8='+H%]
M;9("4WER#?J5<>"W2B]Y$_&!*^+/2Y>OOWMGNE'?:._^6_XO.__2>7:6Y*H7
M"Y#CC4!XWI[C)R]/2Z,-M+QJO'X6X=GH]5F^=&K-%O+AFQB[8AB%C'O>G+ML
MB.DB3IPNPOS9S ^BN0="!_.X"[B'MQ2@+T3 _'G LMDE[-KE7HU=\N&$?;V\
M8@\\9"""=PZ(&(M\%HBAP)]Q%L&JB2A^Z<#WYB&+)CQB#CSQ7_P,?L[93 0X
M-+^#F8S9!+[T S:!=\</@HBSD+L\6-38)_C.KMM-"T82\1ODT"D9"P9SR@^L
M#</&,(I  N!SI!#H"(D0^+^Q[[K^0_B6?0F RGM8"G;.4$PM^N2C#U.#-YRS
M7AL_"I,&VYF/$N@T^+13_Q%H&='CE)N$G[5_K+$;(=C9!W\Z@\\X[GCVT0F'
M\S#$O^(3%QYW%Z&##URZ8@K$A#CEKWP*"W3YEQC.:46NQF-G" S+#'7.;B;
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M51\NE3--,)1#=:5T5B68XM_UQM_%:J8K:THQ9U#Q# O?A%OC3S:JL2=EG2F
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MCAV%(>[P'^&P\=3D33%)#;9VSH<5R_&%#*?,X%1.,8Y3#G3>8-7DJ&0QDG,
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M;=\RYBI?7">8*C&@Y(I\,\OJ=]3-[)!$>LU\Y<H>.!.FO,% O6E9>*?T=H-
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MU6H&<>:HG<@^0)]N:;ICT&-*J=XH 3\/^+0HWC'@ZTCSC6I)\QF@7Z/KVDM
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M[J:GRPYPV=G;T.O3P.5F%UBKS>*=8+5#&32UNJY6,QKVO"B#YC2PNK/N,CO
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M%HF2WPP79 G X0X_M-DJ*9)/"&GOUX5'UP:;RIXI?X!V,Z:&ZVP-D RCZ/
M(0L(YYFL#9 OS'%!9W^K*%\<9PB*/@-&)V(XUK<</!8.*5XP?JPS;\AT].,?
M/]85YMSR,61QJW G\\BD%;ER+MG1C"7CR)S'L'X:L\J:U4JM4]_1#*Z&WBST
M2NURPEB6';GNA+'\3GDJ)XSEXTPG,V$L%1H0^F;+ 3Y5A(.0;">_P"N-!8*M
ME#.!"I3;O=$]W.+<[M ;Z3X]OF#<0X<J8?5V7=6:)]P <B.D+"[[V152ZH@4
MG-A4+>>AK)N[N'>D-! IS595K9URS]J-D+(X.7U72&EB_]IZ"YL)KT#*WJI5
MN((^6*E*.:IFRWS^=!;:;O/Y.ZVS#\T&-CV8E^"%R^;?#/!I_;ECP+<!\$U-
M;;=*P*< G\Z'WC'@,>T2+)9R4$T&Z/?;70QV1!9CK86#@HYN7,K!-&0Y*V7_
M-4-[:=*F534T[&HZ]FDKNWJNEU6_E]9D6E4_^]"N5]5VO<3#>GC82\LRK5H[
M^]!JMM7&JL9")1X$'O;2RDRK4G"FWFFJK6;]!!LDE),Z7H=Z]])D7ZMB%*NN
MJ]IV@<7B@GO7I<]:==W:YU.#]*[[EFG5ES4N*RZD=]V?3*NNVZ#LA'S,<F[$
MWNEX+TWRM6J'#Q/75*VS55/:$\3$7H80:AJ5]E:KX-QD-*D]&4QL%%%LI.,N
M.XXH:MK9AT955^M;WE\4 R4;I07L)_ZB8?Q%4SOU=0JE"W6_6<XJ>"%![B<0
MA45<G2JF06P5B"HNN/<3;](HWM32ZFJS4?Q9!1OIP.9^>^=K&C;/K^*@B/E
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M>34L]5;B'SB"5ME/Y@Y,CRH4C6SL+Y9?V_40.)*RTC^0G0%64Q(F3IS0)QP
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M',^=/XYCH#;[X1 )?OMA\ 08PWN?H;-_]1(#481*X)-.^! %J?5C=!W-,)G
M4B[>$7![<(DJB6>J)YXQ'A]=ZORI@(D:L PVRD[JH.,*P]*Q+0P=PWH)\S)*
MOS?A_6B/P%_1Q(2M((P\=#O)!>"V;VIX!#^DPVWJ]-@(54XU2N\K-J\"($=C
M0D8&O.+(Z&J14XB7R]RQ5^[P"T_I G[H^B>W#J$.)[O!3M"/V R6WRYIK60W
M3PH6T!T6EQI=<3E&*5V,KL"&RE+P\'MO,>]PZ9-B$N);[GT.F.L;0"J>&!(O
M)]!DS"Z1CW)C  69R41+9=^)<]A'?.K2F&*'XHIR"XYA@%Z;<'"7;@X(>^+
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MIO94!H00G%H)<ID/KXU*$9 64!N(69278Y.-P';#J2'<F'EB8C3/$[.<*=E
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M@D1$DC%,?\.'A(1,PXDGAPBD)EP&\0CBV0,GE<*M20&-1T44 51K0IKWN:C
M9S'N)*9?IS9&%T<$6>E!1R%:7G*Q)APPFL(!$743XGIAAH^$WA)7 5)*2 _<
ME0U+HBX381E #'SAM.VNYP63Z!5^>,^208 2/%YXDTWB!LC(F&%BD)>V9&4,
M8H*NMA%*)&E@9[V"(!@YR:"4$W3WF?7= $'.E6^#B#6IN;]1Z\<V_S[G/M,]
M4EJ<:R.EP!)AI'BKD$BVS.4\D:?*>]7,B7LAQKBZ(#=9T/T"5*VH:-ZN_\/A
M07YEAU&'V)5-V \N; 0B<SD$=A*W.#RU),*#RE7'9&K-HG2P0,@/2_AGO+O=
M4OD_QV#1135VJAJ81" _31[F]((ICX^,HGHA$3OTTEU:A<[&Y#"M=>%%SR6H
M+E3]P, @/FFWXC2+B)%WZJL;YUHG.\TPWK5/Y!O6D_F&2?;F)G-+L'<>'-A+
M'N.1)"3,M%%HI!Z]\[I<1"6C-]Y86()1VR$6T3P_.\9*ADBRJ<AFPH@5_[8=
M^USF?(BR-B]IE5'J%,Y^F +9;-MQ+PY,O#8ZF+S/BNH>^ZY76?;'OO^XWW'-
M'8YCWW(771ZZP-LH6I]K2?,P9LEF9J%R0EU%#6K!Z)V",:KPEFJ/J!O//MYT
M[SY11][OUU>776P/<$:A,5=D*&/>Z$!,!B!=N$E:4,QQ-%*[DZJ<Q%1%^3XE
MU8B^ 7FGY$0D?Z)N_GX*",.;GGE?L32$PFI[45(>Y<@J-/( I&9T!2..P>/=
M(BD5BW^ J1$\O$@9]RZ[HBVH3W<"WXJW[TUN*9RM$*81@9B8Q.J(8K5D,9WP
M*TYU\&6N35C3+]-T11X&>'[D%*L"ON#F3?%B]Z_ _L$O O#7$\/SPO"_2GFW
M$[$PMXO0EB$U\Y?3AU.@.6-BUC&X4T]LQI\,_39A>HE@#'J)0YH8Y'%K4!0W
M;(Q4]+0D8O&.-PG%6.P"[PA,>C%N/2J&PD;,^%(>_AFYYA,P:@"G #LL &89
M.YYO\E)8EP&\;;(QX=7LD9.'9P(7&SBA); ]$.889%RLC$XO:T4KLU8.OI5]
M9ZT<E2?!YW!\X[UF<ZW+N]Y\5,K,N.^)S/PP[!M+SL9!'S;/@)$->!-^+4;8
MHE(N#%AC*)8'GY)1?Y[ B9X[KP81-1AR52Y"Q?M$E"5>'DBY./P3^1,QD&I*
M$Z[ZXM(A%E&1 2\*0?)*,9%FFJR E0X]Z038Q)/C<YF?#BES/2\ZCL8NJ2.?
M2I4*&40L]1J1E3-&ZH?JHO5E)_I8$?+/F<ASVE4\Z$ ISFA0\],"@22)HYB!
MKC\P:/-$J?26E0PM82*!'];Z)8$AKSLE/5)F%FALO+R@XJB)XZ=-/DK<>C)=
M/Q[IY?$BM"4?QH'K#=%E_%=@,R6\5X5O]??5JC*M3-!8M'W,P_IDS"P\A8+
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M5EF.]]9(CO]51&4RK RCTS3!::!T)&D) E>4;;,Z&N'87R/AP&UJ>-FX+Z\
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MC]QU-#C![T6P=#WYPZMYVFZC *>K379>M.P!2/*E2C47O5Z]\KZ<3< ^WR8
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MDL_=KTL^OYT4R2W\<57-LN__'U!+ P04    "  GB)E8NY#&"BH#  #N"P
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M(NWA 9O;IXT =]&7$#4!6(-36"6Z$6SFZAU>0U1-<KGNR5V7&5M&8RF!Y,_
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MW"F4'6Q+>B?^7+"35OUP82WIW;#].#RH6B-'_[5= /<7#";[8-:[E!Z>H4!
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MH2E^WF /X=OWD%9]K4B\/A6K3 /*891W&,R=O[[I^//H $E./\9L'-C5,7C
MZ<J44!L9P'0>(;=14JOUX)'8DUX8@Y#&Q_YY@\T?.O)TBG:I1'^DRD)F2A=P
M;TW(+V$AB*4%$%\?P@AC/"B1)<;=V%.#PP_>S_7*<XG5R$L\#!#_2'6#D!C^
M<)-Y",B6#C\Y/ MFXO"9JH%ZC6J]+]HOIJ,"0AY^5K+>P'P4T+I4T8-9=G(2
MMX^L>LYK^^KQ=/*SQ-OBW?%)I.*-94*=;SN,J+GG^,-L@PHCY0,*Y^^O">V!
MD1EYMV0"F=8Q7ZO&)OTL"/524^#$,E)?E/EN3.V1"3A_7Z _.,7K4J-KQ*H9
M18*23.63;I .5;1\4,2XKE3*5=X8\^*3,TL7=7X)^29^)%"%]U\>?OWW7\T(
MV1+[TV%\X_68+>81T+YX(]9$C"3HED!'1(FJW?<0L7@$M6;HOO;)[],V%-6F
M2(!20O2I$='8Y__QVV"P5RDUN"D#?#D%!2+B](5YNRV;C0T:$*M5/[I.$:=&
MIL(B[<WK1E?E[Z#6*2 &,VO+=X*B6H?3P$ZLP4DG[M"M1_RB8A@;I?"F)I$M
M+Y%)1_^NB<AI51<6E=.'<"KVRS&#88V=<[B];DO\VI%1ERG:,2HWPG5/;#9P
MTP!%HE4@$^4P)>E<QIC3@W.CJ,7\:+3G1X<:Q->F 'N3>>FZ8<YJ%3RFWLPO
M\JVIVP?4"7_^5!MX,+N:0/(_+<!H<_N##3@7F>M>YI!#$/7HA^L>#8<.JTVJ
M;*0\4E&89_ 1 ^=5"C,K3^7JQ;@E7QS.EUZ</J''[&X,_RB8&LU8QV_$M/UT
MHXS(HNR0CHLL.7^R8*X(E766>ZL@U>!EH&)EM)9+!?_C="QO*@LH+]E-+U:"
MJ;)A1L%N)+_^4&H'?+V(_;.2H]4;?R]E=F3F $O%K0DIP?8K704'EIN70?.=
MH; WT]H?]EHYN.X;[E#NG/17]LE"?'1ARK[>Y1/I=ON_O;>%?;!W;EF>6KL*
M&^-+D6D.5/WVN\!E^WKO3K:5^O0QU\F!B4<L\0RG@:%UD7@@P',H4&$T',U:
MTAY"9</VE<I3AB3+N"$-^H>AUO;+^E?ZK5,8 FR]9IJ3T(W2'$A[4@G68;IK
M>0#GSN'\)OCM_4#HS&?[*DHZ]I0>(;B9?J ZENBK+\7Y0"JVJEBG8?M3-&3V
MN.*,JKX:@P=R#Y5['G6@^I9MFFW#AT?4C?FY4.,15LT9U>R7D*''IWE$GG6N
M17[R-2KI<EOPEI8NR&1MV'OVZ.)% #[9X2Y'0N!%QI;0=>W0EFN[]/,L&9X:
M5!I]TP;&(0NE+FKK4V/[[]"]Q<>$N(W2$3WU.]8>,I2&O RPL!W:/*KO(2Z:
M,A5O_N37&P2_!W[/]BTT!9P%X9A[0#WJA_W7=7S^7V!F![2S^Q> SZ]KVV.@
MF0;L=5.*0W@+OHW-H0&W4I^@>QC\E)!. 2.\#^Z1Y3ON:@O>'2A\KND]\%@G
M.R8O"'L0=!<, F"MUD2]L>P;'S^E7]W_Z67\U"'M]N^8#V\HND03NUX$,_F@
M@SBIU<WW](M'+D)J7@@=8.'.'_'/PZ*F-VT\F")DKD8#=#F'LC LE'RL&!P@
MGTAY_\5)VJAOS]LPZ-XBMNT9N,9!U_YW*J_I)MMCT&R#$V&-GZX81=^.UPO!
MMMU08F1]G G;"/= K)@D=VH OF&+D?@^*CLF@LW.Y,3*ES76\KCEV2[K+4D:
MX+]KY-D9I;Y9#6^NQ7:0B;.\OD95\F&975*B](H\[/G5VJ\@^'5W9EP?7K"J
M N?7B=HURH(8MR ;=U\>04CK=G]'V98XT\770)T2R@&E?=A2DKK5ONUK?J C
M^F!P_$%E?I[5[:S4HBJ]C*,=K/0?UICH:, @P@<@[JJ!C<$;0XE(PDG='NMG
M+=D71JVQ:\<5@'CJ'%,#9>#[>PFZ]4[3\VE/IL^WJCR4$_,*6WQ*D"!NC_N7
M)G?G'\I-B[VEX)C/#:]P:M+\\M^8>^^PIK:M?70A:"Q(1$4Z44%1$5"J2 FH
M-%$!%5!:!$1 1%1 >D)O A$04%1 49$:Z9W0FR*]"$*HTB&AA)#Z6W'OL[>Z
M/>?[SN\^][GWC_"8Z<R<<ZTUYQCO.]8HNB(I0FL+_PA]9QG#%G)3'WL[TLM,
M4-.KF#8^&L?WN$Z_.=3: $C@--\BW<#=DH[:B9IX23*A5QMBR8?LEW-!=LT'
M;A9%4#;Z9:%6S[=#=/YAHPRN;QI[/HH([W3*/=R!8963SG>'MHWVEI*7T0..
M=1TDDY&D4&OQ4,P->ENH6K75T0%5\E&GU2T^<'DFRJ#D$7EV0P-.Q]$&487O
MOI2]PQT62OS2-IY EBK7)"IWF&B3>-]>&-_I?5^Y%^?P[>1&2#75?O#]/\P%
M_B00AXC8-R01MQ<S@/:=2(N^F:E&U(:PN0SS'7LCW<=^A0.4JX=H3^$3?B1-
M>C$HZU,F,*WIOS8E0W];]NE7QHM5$UM9(G: D&34"61 <B#> /G?#DPRUN(+
M'SP\_G8JRVIH3T7CLVWT&T9M!:N0^;,@U$A 43;K@FJL7A7F9=2"*FB;WZ 5
M[&R,5%*P?WEF[U"Z\3GLW#@K[8$O];P*?E%AE@.9^4;8%?(60)[31YRC]R3E
M;>#WI8F&Y?.#DVZ=G$^:V=5P*N\9^@)'5,Y,/RP^_#U<40]23O^(A26-1A;*
MB-\>2=J!*_XHI]O_3LG=GQ939;%JT>Z_7G=%A" 255I^AU7L:-/^9::?ZH8@
MPA39A,N'43W==M09G?-[:"<?G9BTNEA'I']##<WDZT'Z_SUS134+_S\BKDKP
M.Y(@;^W[B[>*__^ M_[4]!O>RL5&$,$W"_@?F34(NE_-H]2]UN1E2%!"<I <
MQ\PL#7<037@ON"\=,,O!C'U*(21#/]X&4:A*(\T7-;%G7)*\9,\ DC\BKO6U
MHCYD1Q*3=KJ\5*^&W>EN>;<X)V K#<HE:71-Y9,_48HXK>*5-4$S8%)XPE[A
ML7RQ"WB#SW 18T&TX^QV?<T1F!Z8T/H\<'$F\F**HM4SU>/>12)6X*0AQWIC
MD,X5AI]7=WX;N/E4,KMW)[HSG1G86^J]RO<VHF(RW\_$/J37]HUY>"8+F[=:
MALMRZGP,1?4Z8IJ(W-*WJ%[YUH%2(35V>5,;#R7GYJKU=&4*\$"!G/U?YQL\
MM11BSNO@=,GDD37.U:')@"ZKK-GM D-GN4,+O&&FCJ&50@/VT;+U9=Z1"R6W
M6(],?7VH,KXLFR_Z,45A]LJW'B%-=1=NV$Z7?L1M-<$J^NKE]S 2 ;+Z'CMJ
M[A9,]V4 &WQP0G:D[;K"AG7_U)'L1W0N7 A\&@9BN10&,#:#&C4C_=4O)4&Y
M_J-$HX*Z,P*/45)C "H0.B@)&4 ]>*BW+]7!5D;__-W[;^A[D_%6+U^7PDE&
MR /@0T/1-=#?<^FXC\'($%"0@O]N .?EN/Y0H44,_$V@YQAL P];)X/ST+F6
M0E!352C<]-^=*KH+.E U900(E81B_IB4CB 958)#)[$P !0X )]"RE>%OR\"
M]==%I*%^O%CP(FKCS"(?A#%+HOS0GA$'V['F&;]EO#GOTF2_ A5HHJD+="RJ
M@%,K>KI+9 L'\0QH"P0:F&N+=E:D5%<*" EVUCGZ.QW B4E>& \4JMWXAMY)
M4FFL31<Z9)>M59VH*KW*^H'F?='9I>WTBP'QR 3G#1?/0(.RO$=Z17'#8[)Q
MPP8G2T\T60NS<4ZK&[_.D5>!D.KQV2NCP:$B/L+-*:8EGOSO)K@^>Q7"A\V#
MNV^LRE;U34^%E,N^<\L['W^Q)S,%F_L\+DRM/3* TV_KO!K;0]F5X' &<%.L
M:5$(M6/V?AN+""U&[Y"([HV17;@01!H&!8T,CXXPLOFZ(6!N=%G**1DC-(1^
M\1YS*89XFQ06O4M))1M>7E1(@K_PH3])PK>B=L.GS6 D09#1-(JU$U>Q+[VG
M8M9,-:D4E)/2Q[=<,SBP#R?V>Q]'L,]1^&@"70357@K'GP8E?J3^P@SJ-*5V
MMAB] 0I$]UB8\2J.="LI!&2>$N .6"MB  (I=%[,F"9M!_B@6+.PI$FAX?@5
M3+E*!M@IR7'1YIF^^7,04?41A.F!X";S[<51'Z!)M["AL%4)-)6#6<+EB:<'
MXG,EGIPM3/?&EB1:JWLX4J41=6@RMR8=8H(BM/P/J^*:P?Y\J4<80) ="0W*
MBB6Z+G, Y0K)*82;MQ$GN.-Q7]ND7E?(_[)JV"\C?+]7H_^Z52UAJY.T!/K!
M/!\OI8S/KK(+E9#) [+3*A!:U-V$T<,$\[<"]](@\Q[NQQ?F/ZON6/)QZO?7
M5S+@$2L1OG;C/I?@$[ZU]C&4#3KPBMM*?=1M5WW.5W;1Q_,4V8]W0I]9"I6/
M%"6/C$0A[O9>"GUE1Q?L6EBER76*B1WAOG.OKIBUFQ+M+K*L*_*M(&/J/M>0
M.^X5D4?I6$W7Y%!%3=B1["OE_WCCWT5L(NE*1BAQ0T-6I]E+$P-XWT9L,=:Q
M^CC>G<9?^;QLK'(WIL]0KT6-%^*WTTN!<@'YR55H5VDYP2C0@9TN]/C9W4P+
MMHH8@>@6@ $8X&B) 0Z\ $RN%QOHA<@DP:X],FA?^M:%&9\Y;I.>F-[R@%?W
MGAJD,Q?D?SET?N170^Y'@DD1J]\^)/G24E*/NJ'+&K2MR6EW$GVVD\_6#"NT
M*SG:$%^R7LOKL6PPF>_:<K-MO2\]R9(%TQ*6T$"?NUBB\USQF8/$GM@XWNVG
MR"?VAP&T!Z^Q"M0#E.M>6OC$IL%K9@^&[E.RC"5/T26V.I$*/#4#48[BIV]$
MD="U1H;!*;KO6G(Q?58+^U%5$8"WA;H[)H !V**"$T_V%ZJ(Y@4]9 !QW)\<
MDE1\M+:,KQZNV*>PS[:GPU^8/>C*8[5IM>1MMK\U *6,Z5*?(/8RXSK_M #U
M_;]M ?HU !7P4OLCWK22&6^:"2/S9.\KP_B"H*&<FP%8F*!H['J0F;4?'0'B
ML#S8B2P2CEX;CV/&ELKV,7% =,4XR) 0J)FS?<*J,#,&4 TGDU;H7^'$L<H*
MS&/L3_:@]I^M@S=(,0T>$/\%ZH+C]9Q.*^']0Y]SXLB;'C3V;[*?:@O%%?8^
M>J,FGNKO\-RX<G\Z;DA8_4YP]]':2N43*5_;(>X4':];A22CD8Q'GB:@[-XF
M]';/66L^6.()Y!6%U1V)RB:LR:>H\R)Q;5>,*X\2#+/&+SZ8,NI=LNZ6Y0_Z
MV'ITX<M5#BY-50#@ #+3 ;$%>#^B:ND=R>0:0;W&P>&204'A$ -0&A/UA%HN
MH#-122TX=J3 +&)ON;5%LMW[LQ<&IY)X3=S4^"<<;T!92_:#S-1A-(GCBYN.
M:M>JPVG)PPT-7'Z'EGQ.)UW6%5D720#Z_X##?G;16\VO<W2K'V]L9XGI]('+
MP6V7=L/V4F\3S-H?VB:7R>FO5%U3#1GOSXTA?2OOS9R-7[Y=^G9R'CMW]Y9[
MTOVV3Y^ND5U58HU]%'$^]-T( 2]S?$/LP6WBK?W%+TU>1>ZW=E&I.PSGHREB
M N$6+P4=541O#_B'/U(6]W,>33P''D3<@>!+H% =<OYOJGS\]Z8DI(/7(=IK
MJ@[>4:.\2\9$_-BWX=GQ!8D^?,L\OV4VR_6]5ML585FN</P04@7$!;K!</R^
M<0: ;H<,/3&J0?W:W,D :EU(%+JOB@ #J#)!T^&J,)<.Q';4+ZV:5'D$&CN]
M9[2-NAFD,^.K+.MF7/BD7UNQOYG6^7\_[3:PV=5MG>XK)/AG,\+"2YYPJ"]<
MB764=I=X:KR\^TY*2:Q#-6>0-5L@6S2D.RD+</E7?C*NY;8%\(X=1 =BY\BZ
M-&[$%:./B*(B:ICY/O"(SZ!6S0"OZ\;#',P:#"#WP4S#5RU[+]J[*=(U%J!T
M;#*(\Q^IPC)_3G=FL"AQL"!P,E$]3(;73N1&.B1-]"UP+=TXZ*W#F_ZOYL.F
MFG8V=X.T;\7ZO3[R/0Q,[).7(T772QE_NBG:_OX<MWU5?N?]>W7KFZNWOG'=
M[$O$/$;*(3L]0.BUZ8X!/*=<*:O8#M]TK=7_<2>6/V06 %C[HQ* 5MHK%7'8
MHZ1=HMBBKPFR"<\=5.2:#I_0EN+\\JQDC=566>S3^]<^BM  E:TQ8Z)U$:QJ
MG'G5]Q]@'AB1;B 2SB;BCNSW'''%=!OHI0,\K#Z;O48I,"^>Y]4JL/AZXWPA
M0TQ&W;Z!PSRVXMKLTM.F/EKS7)[18C/'?I:I([B!CR/:>*%RKRLI)N.U T]2
M/X>=7!XP%3H_XJPY$5DU<4]N:NE8(P$6?$?)X!7.EORV=*C?O,$B04[PZCHD
M!_)8<[^/YD$?N.@,BW!4=?;X.'=-Q=E16(2$LTE%YT"A=6Y9P^8Z$?RP;["&
M8,CJ_L2#/BIKM"?(TZB:!OP257B@OI<!<,[<#]<^L)$](K!-^8O;SKGJ*5&8
M6M_$>H"7P7N2<%T"LNS-Y]YUXN50J[N->6(<LU<?:][3PG3B E&[99;"$G?D
M]N6OY'VB#;66*-B[^_"/PR_X0>^I+:D*OO5RI5AY.4M?E/21 7GVPP!!X['#
MLYIB@/"'D:)*R"U(/]8.&G'?2QCO;J+ 5:[Y/D/="L;6<#+H*5J]32C+UT\:
M_;GL42@S1XH[W_4WEDO" GDG%41BNF-Z??C5N5;EYY/PW/1]6PJ5]+--EO"+
M29*+%H^]BF(BSXRLJ<\.A59-W 58>Y@A9CX, !\Z$^7VT:RH(<\;1N8J]W]^
MC<=[&:II00H<3]OO+?\_U0KZ5U0>UY\T-^8OFHO8WC>$^!!/C5;^5Q $X"WX
MCS=*7),H0:3\#&H+]?3BYW@/6B>GE<6+N+N)5KY-JO<3IY(752&?<(6XB+$^
MY $[\N;RC..G#Y6L/$QD6QY]YGW* #VM+9@Q=;X@XW:\\;=4U_>X2WW<10_R
M5RX-F3U[=!)^^7868.OFI/Z\#GF@2^;I%AML:62/' -P[S]"NXC\8&*B:>.X
MEU.BZ;5J2,H'5@!I@#>:MQOA)FC6'\AJ$[HCP_-I_MH]FWN&A\CH9\&EVRG$
M'SR#AFGO*D50-4VDM/<ZCH=I8A=: Q.[8JTU%"=X1A;O/$:5Y3_$Y,#MVD(1
M^*S*?;.[!UN:TV=5^Z\OG+*^!7'V[[H]X3^7[XKY?!X0ZT'=0@5A\;F51^WP
MIN=N=J[.(\P)R[%GY#10PP[)D<5?-<\OI],VT:*0?$F;O*305TH#WJ5EQY;'
MW]N(VP6-3EIO%E]['-G-LLBT7G*9_\Y?,Q/4^/%87CH,6PL+Y6L(#*(<?^!>
M&(ZK9Z4V.7WUK59)MP_%@*C;(2D(-UC)F4-P>:-0T<G?7'I,P=Y&:<]\MMOJ
M[I/*8F/G@;6V+ZYC1E2QI+"X+=^N",6FC]4LW=_0&)/3\O3*"D^L*LI"1C*W
MQ6-Z*P/8C1J]Y27>M9@:_ZGGCF:_HXY GE;8R0-+*T<-1;L_"!YA[9G^!4X1
M$(,[Z%HJ((4PR\*N>AA-12"#F=$Q:BY8\@*(P5,ZL4JV *8''H1=OD059P W
M,A"TW04;UW\QV=G^E8CLC\_33US:HL #;8P2(;YQB87$R>LBR6FL\P"4O:^O
M%0T<;IHWD,Y/(H8(K;),OQG'G"<)$TM('8Z$'74?W% :I=Q\^Z+K\@DOWM8W
MCS[3/9-^"E)R7$-M2Q(ACUC<0S]@\M5V6"#(8<>9IW<2-(47C+9[9.S24A=^
MSS;URG(;U\HDP&6OU7FW8,&P[6).:&IY^;/]08=F/WW:"ZU+R$ 8T!O@6R9+
MNT'>JM23]4P\>6A?7#1T+7J7P20OG8N7M3M:4TP5=HTD7WO/3;$F02708>5L
MZH#F'7Z>H0+5XYII^V,6[1_\QF_H_Q-#X JQ#421XS\8 K=CDN&6L(WC72"D
M.(:B<1S;H%?@B.)1*:0OF]*J/'<$.MX/A']BY@YC+AI^K6-!2>V=F=U 8*E9
M_Y"&9<*V+0;=X;OL5^+'IZI-</Y(L1,2E(@M^&<RE$+!JT*65ET/)FRZ;T2^
M@7:F3ZH(>REW5HJZG5]1ZTD9VES5<B'9_;&6RGR(YPGXTR:E/2#LO2H2P1]\
MIJE%C3V5C;/=WTRT3A>XG<1>;N*9?)O@4.Q#7[2&W"0DE1P4FM6<>,"Q=;^3
M,\MZT7P)156RKH)+9N?=4<VP.U9C&J?D<UC0)VPRT&."=/RL*GD[]I"S(*A<
M:_EZ$C/>?BU(?&7'3/T[FZE2SMGO7\T+":,)D/@)";7CH@&=1+@$[GKA)N4S
M];KD(N$@/:<G=VX*W6\2W=\.2?VM;#WTDPGQ/\I61"*LD)L:'V%/+S9!33_!
MM']/78B=*+='_)&Y\"W@5O"K_="H;:V/*D%ZE4X5(4C;>\A6O&P=-*G(,9G^
M,CY0KWW*Z$K2$ZL7GGJ0V8O_>_"5]&LS2/1W]HTOD=E(X/9@N0LGT0#O/G4O
MT7\TPWX/(O\Q8.>O:%$5]E#_GQA2^S?S?E%W2YUO(SPW);6^LC<J'<J*>%-H
M),9N62.O?LQ(].&4U0LRIWG?W]$FCA0-5#,G 4US*Z('%&PD(=[!\FVH43 >
M$#,_0DWK()ZM D8SDO/5X(/BKH&OU>C28(>0#O]H CQ>_O2.RFC;.#3"?!O^
M^ -!1%W<R4O/6C.E0E/'B^)*+)+N02H 5Q<":N$YX;6@^9CDINF5T!L%3W32
M6GF;I- E6Y6):W?+%P2X#J91+6EY!=#=QFUO2!+;\CVUI=!IGU1+791V^>P6
M;LO6\7"07>&75MQGJ;,GNK59I)WEC+#V_G/L\W7 WIO1GBSJWA#* 2IW?,.P
M!+K^=+B(K8?,J['A4\4E NEH W,>RH* WSV6M:GJ)+:DX"1V*CRY2<[,9#"X
MQ'1J_;-.DS2.O0YZ0ZSD7]B-M6&8*Y?0&.AB!M'C+<#ZOK+<<CZF([BT<.OZ
MIJ+I9&@+E)>DJ8^7#),5A%Q]U%R1^Z2!'GXZ VIP3 W2WBN+#*!W8/.^PKCS
MHU"I/ OE5VX&WHC%[YN$J%Q)_#J1-J_=QA:%%RIZC2 Y&I1TR>IHWY',>M$H
M7MYB$!N,*;JGR?;@5/+V\_4\4G'L'&<EV3@19[R.T'*HFB--EEU4[3VDYSJJ
M7+>B+Q;=?S^^]")8J+6-8K RM)>%;#8B.;"C"L=I*-(EV^2PA(!-<T^HJ>CB
M?2Z!C[CXFM%;\"BZJNPDC8YC6#+M4DC1RV(W*85Y'Q(!19_H35N\?52"?."Z
MTY@PZE&*ZYSA<V$0G#K([AV7W[>[H&R\.^,NN[>OOGGK*'Q@?;0MM/!00\K]
M5Z9RD/@T50,G.GE13[EY+\M"M^'=B+&=DG4/'[F\O2WG\3)G1O;%W#'D;:VL
M8__1"^7O3]IMOL#*Y]L2OMF.A'KD![-.*^L6 &:OB^?087SB90OH!7E62D<=
M2!L;0^!O02ZRPQX\'4GV2Y11."F]4ONA\(!FR6"'J295/$N4[HW!+@4PS;X,
M(##G#0-H*UBB@<??3"!Z7JA3^?-PV!AJ],X,?&7!FP$PCS$7.-8.*ZT_!B3^
MT5'23FC*4?T^'%\HD[2Q7LX *O<P@$<I]'V?8QB 2A]NO09%N/I YX.GUKKB
M;;$0<*:"[S.M,V<R@.$+\Y,VB)5__"PL)=HLN.W[>+#OXQ$K_AZOX?MX6.9X
MSG^.Y_%]O!]7+DD5CP"O:PG^_;JF)^(M_IXWYPV*.2U%ERZ1;0=B%QG[ONU=
M%1E"2;87H)]V0\;L'GS\L#'^=7;Z?<HST7"E.X(\-Z5>^"F'I-W6^0,69O/7
M,P#N\D,C&B=F2\OM'D*H'E7LN5/MZ?Y%A/JK5D<5U4U#NR-D6^5ONLH8!6 7
MO$>FO_JFSMV%$++*K\%?)-.?8/']0CM!"?>PA $@]X.RM:=CS1C7<I_FN9,Z
MO6XL5H,:_>#%SP!4%USI5/#I-8)/)J@:[TAC+<!1"% &()0R6X"-#>[#XSZC
M'[XN%Z7S0ZJQJQQ]J*4Z.-4CGL[/^OTK?*D.1O5 I_?2]<AT_HV.Q7PC\'[4
MWB#)TWT'EFBD8%"X7F8VN#$;IF@D?[!!G[D4&*(6=5JY-PR?1+H#VP+""D4S
M!H %=0EA%C[Z08FYMB$G.E6-N39R%FK"8HTJOY(R]!ZS[1\K_7EMS,48_C'Z
MP+\9_><K)V<Y3OX].II8B;<_ ='MV[LGHI7M%.S)N[+O#JKX)/3SEDY9VXFR
M!F3SB9,7EP)OR%N5F/K.Z1_CNH$YDG"EOOW]AH7,E\$.=2[?WM^^.PNX.[+Z
M]K6/BB.IGB(XG2@3;:9;TUD_VGH]M^WN55JTI7?PR9C99#31J=4K='PI@"Y&
MLG>VZ%OU?'2JR$&G@']A@JPEM8WX6?.>V)I$AME O:>#"#>GII+44:-(=?9,
MJ)[:"#H+0&KI(UZK2--BZ()NU0E:J^_:LY_&3-E)'("MS_L])1]161M#'J<%
MR'HBI'0YW,(Z:0IBCN_/M<.[/!;9O9OT5Y.A<>\Q9PA&\^L$:/7@ +/^0Z?J
MB^>/N+A/CG<_;1Z #]>[SS5TE&BRA[_QRSRA)J@&(HRSHZB0Q"/X*_ZO[,E!
M<<E3+44O VRP1U^F$K:4S!YAG7;<1A],/-5Q_G".8RK)CV4]08O>=I(L9:$Y
M]JZBMAI1&.SKI9TK;FKN=GNFE/96J=]I6I %'JJG/#>2<(1U+5Z=L.7YF,[>
M\D[,0H&8/*5H7\SQ]]ZYVWB)6:>IB?C&<%GLYMN;*&=Z)/(SLEFB>R^7^<Q7
MW:OM]U/.F &/(ZIP]=&ARJ3QC[+.IQ +C]@:E"="7-:/HJUE6(A<7/&O[ =<
M0U;+'#3/5P3KY12;=7PU*;:V6!-L/ /=C[>__ -3^S7.#Y'>LW&%($D_+Q^&
MG1=S!0&NN8_" 'F)#F[1OL8DXB@#*.):/O1?5#^JO$4K![F'&XI>D\( U+69
M85.X(C0U!@-N=*;1-NT(Z]CV_]Y)#WD2U6SRMY.>?3:I%KP2IW_% C*=]#BF
M1H,;T+N]#M!!?!WPT,26 >1[8>$+NT*E\Y"?;%)Q=_H\0?CSBB!&1^;CJ)L0
M!,RVUS[*?71^'9#%46=P)#;LN"95+KX.L['1A<5O0S64'PL#UA$D!\E0Q,I*
M*FID-P.(D-(=5!PS.;!I1??, U;QZ G/\&CX:?S $=8^#,I>-\S(WY9P;# -
MX IJ&/(0F#HLI3EB'].K(NVV9-YB3BJ['LOOSS>L9.LT&Z8*C[V?K\?Z+G8J
M:B+V4_3)C]*[M54FNFRST37PG>7ZX\T!'EL"/=,W#5[X4.?U%KZ@=2^#%*4J
M,.G, *!(?C?_L8<50O')7V0_E?/>L@BY<85Z:6@O,C69C8 X1Y6E!=]]Y[:D
M=#_M.*?WTGRK;)$"T5VKAA(($4YA11BX:5:7ROLZ7\O/@N@&7\Q!O[D7>8T!
MN#^=R!.:B-;- AXD;:;OF(%M\5*Z<P<]4"#VF(^B9UU[J?84X%2@<6F+MW:S
M2-^;CC\M?H_&OEGCW^7/GB_]<NDL:]-!N6JN@FO#XA%O\-FY865#F5,&^MW1
M$;ZJL"?,[MXVE$V#B]U*=J<&"P[FGYV+LPNAJB F$99]#? /RC68$"4$RU#%
M@L-7#PLS$"ZV!WJ__-F/R:GR-$$!C_!WR?(R\<ZCR'7JI#AB/Z[(I2FZWAA7
M*8:?G\[XE>X!7@Q0S4/!3QJX"\5@M-<Q="$ -0T*SY9&9KQ+U)'O+IZC(Q!Z
M )R:B2*&(4AN$)H6:@.\+0M<RX)[0=!'56*EO_GC?^&C(["U PQ@T@K<8T9-
MSGJ0OB0\'DI^S "6<QC P!$&$.R#Z@9U1RR:WH$XT*$*>PMCJ92&123"NF41
M\ZAY"WM7HJ/8@CER*<KDX4,)%>))_S6,'N89Z@9N0]0<U'<?TL #>K*OZ^J/
M=FH&T&1.H9=I?\]AMY:1T$8-7,+.Y3,#&)\ ^F98'_IV4MO8K:3[[]WL->A=
M^47Q3=&Z^=7[OLCYAVO-ZK()^(;-8$>CZ6*H]O<HO(4=4WFP-KW'F(,:29N4
MQ0#.8.A7'5"D!5&J%*+>D<P%I;.+PTEK@#L7UQP6WXSBPDY?A9-.Y(/ZN!M5
M>XAJ"*Y$CP&,U(!'#JT'B=(W!^4*>SS!A!X(WES_';IT91VP(8;9@*"^!X4Q
M80!8YA/K0_VR"G !.M\7\(H!5 <R<U\F0P]BNMI\8<L:S!<W-S)0-,"H#O;S
M&GK6$37>'.NUJ)U*)]_,ZGG'Z^5UC?JYN8HMN.AM;8GF@-[32N:H^6]\.F_;
M[_CB/$CQ;-JZQZ0I-^5$T]=,GIO>ZF?5 4\,52X8% WD+A13-*"94@&^LO:G
M5' SV,NRB,4/('9CIZ8N@6SKT/=T(OF5AU!MGU\R !\=NNSH53U(*0@E[)@A
M8$DO%1D $$^]_79J(92@,J5BGF-O%X4>NE9WSQMYP[[>-AFJW0.WDPSUJ!R%
MATN.MU')\T74\@_%V;#K!)6<,4U<QNSZ0(I_F<M"[2>GN3C1A,^@K#QFHL@?
MH3$IOB ^65+L%!C&)3'O_>1F E$2H#>K*!/>1#6[6BK)IQ9N*^ZNUCZYL'5C
M98U9W:*!2^=Q.D_.J>WET1>]K2BGZ"U76IT<QM "U]T-I\_%><C4?G/JN?E,
M5UWP\;*N'@3RI7(/_1-]#\E 1#YM6V]!?P,J'Z.WA]^C[D4 4:E(OTS Z$/[
M;T-Y$[P>D,[:$/RKK\Q\WBUNB).V6[^C$'G!N]-CX0Y0.^WABWA>^AGM/DHS
MG+O4[3#02>Z\PM[>=**E:L2?[CXKME98:4G#J&S&A#DW*UF_'ESL/2[, '2#
M3K;6;8?WWG"Y*>@92P94540PAK1$I-Q'O&M]D$F4>&/PDH_.G.V&,.S!53;?
M$MUO.SB*A5MLDSDP8_%U#IICJ1&2:S3UI^ZMN<,X!1,W-;"C6K-RL]5PR7DQ
MS=I*6+?2]>SKMF2SLJ%9[MP0BU#%G$7=&Q"11( M<3/@@MVLL@?AA2"\K8QQ
M+-VI<EP']3 EY#7D!2K?X\C:5+(L67NT=5-M#5D\+NJ=2=:[))M=83R[[NU%
M27E$NXM$N\NV>/&3=%.I!_ .E1'VA9Y]=45]Z2=LGD;JYD:&*7)X1.LF__9>
M_L=T.\I_I]LQ28"AE2Z.>HKF=Y1K9MC)97\S#*HA7^-\ZK.#ZS*+)< [YP.Y
M#=!,7V/%4:/WW1@ /=B1$SS2 ^/?R00W-YH!3#\DP.@[L^&D4H!V'NR(!3M2
MZ,'HO_K]D1T;U-R"Y9K@N;='TR5\X)??8S[R5AYW&YYY>'%<<M?Y9Y]%>D0M
MDEYYM)834D-<V!]5N%XI:0(V^J)55!>:95C(26ES"0_#WJX)GNFM/[U8^LP*
M]DRXO2^)](@82W(8#7#,=WO7N6SQ0OW=8JE(Y)=P+E@HZS!6CO=1SBV1'(7C
M0]H@,LTEA5*<+MYGBZO<WC'0\5R8HGEU^^?*N5TB-L4B4;,%R\-EF-LJHCUW
M996-B0YGZ*-%VO?OU3]#K[)^$&"I&GO?H;K9M"/?$[=KMC#AUDO'0T-KW7X\
M%N'6ST*K8&,>'.\R28B:4FR$RWN9K#VZS_6Q3T<M FPBYQM?OU_4!EQEUY/F
MURD*_=0#.?2N;G9C=%CVGMVF1SX];-$\69_HOCBDJ^;[PL<%RX;D&J0*XP43
MP\)S<244];4JV)PH",9ICP']>>GNA-73_T)48JTJ<"]MV(Y*WMF$S ?'/<)K
MY^/V)UY8W,J&*GWUG,X:!I!6B+FD!"5O@IPG_W5JJ^C9G39;H"U=K)1O,$-^
MIZ\'$]?&\A7S(\T>*>:(Y E$ZUZV_>Z<C:@-)H%(Z'Q'HIRW,F)!OE[CY-T
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M-.O,HFB#!-\> 5"G=FG6T N6$%#P-'F?F=5:5++(U+2&LO7/))4_06M$!?7
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MAH]*V<]E2Q '4#]&SO^]1<KSB#XD14@#=+/VK5<'^XZOZZ::R@/:D5:BN86
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M?%S\*+=W'CUGO(^*JO999EJ4P<@)Z21ZM3F&D-KPN>]L?>F?;SS-"4X,$10
MF!;)Q8:!2/56I+B;=JU5"VYI^['YMU7;?367AJ]CMZ >5@AR6UK^EP_SKWN_
M1[?$-%)N3N13IRIC,^WE3[PV+O1WS$X=;C3>M8-WWMIW\\QZ,88_^D47*QP6
M)*]^Y%CQR0[BRSD+_53;SZ[[W6@"C$>):\J&F0%JNK2XRB=HO9A''W_'F OW
M5PH^WWF%#?A(XFK*!/'?2Z5K(*Q^QAE^ZQ/ C1IQ)-!T0#?=4?QNG"6"K1O$
M+H2S :TLYYA>A+^02YDX>.E&N[\B\%W_)L@7>8+IH>CEWUET[/BZG$R/<NS<
MX:ML8%:1Y=N6EK\?Q:/^ME244@ZF*;;IV$]6LDQ>!8\W;H9?.QBVGECI8(BE
MB5RKY61<H<6$L8%;N"0R<ZL1VLQS_7\G'O5_HU6AI!_U#5D%=;</SNI/J%_<
M83(J(23QF3O']/HV#M\-T$2EQF=3EI_!RP7AN!ARBD7( E>PJ(90^D#_SG'"
M%GD)!:]U+%7ZOE=2C^4475W5,C</A&/N"HQ/S1$&9ZL:MS!D.P+2!^FC+R,&
MCG$RFCXFCMFE:PL%^JINL9M&^*,+^_T]704/FT_A UP#AFT:V$"*KM>ITZ'%
M"Y[N:ZY ^\>?I41>#K7<(7>@[NOW9H&?0-3E<,HL,:60M#UPP9&:,&^DJ.IE
M'7S8A&FC3T.=;,LJ^'WG_>Z&H&FIZ:9ZJ9:<,UK0/??4@+481TP3;AN\>C:(
M=_)P=;1. 3K?3'N9HV:#^&^JAP[N;=N4N) (/Y0<O #W+EN+#4+S%6R2JATU
M%QN:G WC.!CQ$4Z$8%Y(0!=,!UD1K%TD1*!\L>99*9=N.]M-Q'T\&1]51T#O
M_\=[:D 4W;[;-?^6)406-/K\0L:JY3*4N@?B@ZQ(*5]RIR44AP?U<151_0>\
M;"N7E#9XW6C.5%05$TS!<&UE;84L6VJ=ZUBP:]P\M;W$*@E25);_*'&E3WHZ
M!\;:K\?YS#ATX30%34W$<9?MZ-*YJ>1EJUL=,Y3O^7[K164X_9VR>J?YFRB"
M3!FOYYEV)#?UY2:[$\POE^[<-CE>M:?JZ%SZKO63FY74@^I0X"OF8DFZ>0R]
M#%#8M7G60X:#XC1H6V3-D"E&^?##<N4AW3].PSOH&EQX/*RB]V#L'1[0/49N
M>-DR[/!PQ+$%,7A\22VA?&  ^IB9R9+1(LV7G[Y"<1JV[$BYLML8)7\@02R"
MYJB/+ZZC/R6@,IUKRN3;RX2IP5/G.F8^]#(;+B4$!R,GD\%,TJ<<<:]>K&,7
MP+?4_\5V((Y$>&N4T2C4D.4TT+NI<M/(L\X=R%JNRLZI89P?8=,-\![F#9L&
MN&+?]]F/@"!0ZOPIQ:*V!:'48*9B3DY1RP+=3E77I*^C3SY@1YR_ULDUSR@
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MTFRB7DM6@?KA;L/<($U;^QW!$C6ZQE#@4I3;4I; ?AOEQJ';\O[[71;OGEH
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M=?O #[VV3LW[3HUDG40BO!GW?=@V6AVP&:,@VM?&K@K;.@R%]+\%[,SY^&"
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ML[[$_]*)RJ3*-7*'.O)^G(>0Y;-H/!^(+;^_ [O4_X# +"9035:$SY-,M=A
MA0N*<0+ &*]NFNEAN&J^%!0\X31HDAXI:I6R+QC?Q:@)Z-AS[]@6R,6MD,?
MH2\24(-_VP'J++.H#%QEEZBW#4DVJ:^*V^I*2HW5@OC*M%"S2HW,?&3AHL*%
M:U9<30J9*:[/QMUO)#EIG%9H3W4JAB;V:"J!-ZVGP3]@.HE;=4F12$$W@\/:
MAESC=9-')+/N:OBJ;+FUF+C9@N*Q4I>YD3 8\"C=<$NX<3'B.F$8IURN:DC/
M+/222UW"&_X7NKV2HP[==E\K83<5D.U3]1U<;LUEGW4OS'\,G2VL$VU2%:!=
MSN@[6_G,XIC];2[G[G=I8L'&7&&IYWTW:W+<DH<L[]7Z)U-LF)"+J\)3CR$1
MJ,#LT?YGX\=%3O2:=^99(^FZ-A2(E]VX>W6+Y][D*Z:;D(]2S*ZVYGVY*BT=
M)2X9X:CO$QFQ>9/]'RHD*V2.YN*_6@#;+::<:KF^^+MB(:' E]8>)+WV_3$1
MGLW:9WPWPT7R"#^;4JOZ Z]>H2:?WY3><JSE.OCB9$T2CU+;_N<^WL N8-=:
MX.Q/B7=T5^N &WDI$#6XMT6X=VC3?M'1VAW+V5D!>N=NV]2+MMT0C#I("L64
MFLIA!*EZ#^-(92%5CV/MD2)Z*)( P,C"XPG6V##M*\.DS44W8S4^I#;NGDR)
MAB![8BCO*$;H8ZL>[I67)%B U&B8'7;SU0.&O+ PW>L734Q@PK[;A?V:@H&)
M?] UH-?5=EV2@W1AV\&>"I$'4?O.R!U0UX0)^XW;\:[RHQJ(F)@?"AHML0S)
ME3V&?\U-\<(7\E.6,AVJQR2O7)^V'MQ=%"(B8^ & ,K*0]ZR/ZTC_XEHEG^&
MVR&-CNS0CI2DB1+_>LAQHDGDNY'-?C<Y!L#D<<^JXE>TP^IT:']-W$ O5*N$
M;O($/('7QXWWLNQ%0TGNH>50/XV=!?\&#M]A S6&_@(.-7!88ZH59.W090O)
M:8)":;FC5]O"A1X/;YW1L>!2Z0RJK-6;YL+[W_:^-G S*O?-@&M 2=A7<C$L
M9]$0-J[RF=CENHO7H$WF\-WY&UFB,90P/ZD-M>I@] S[4=EJJHLP:$[5^=O4
M5$A)'3>_Y>.PI^R1M7VZQNRH_.%<*7TS;\XMB5P#$-P%#8$_]W+R+0_2+V#K
MW3H(4_Y%K'OZ3/B+3<<JD(@.F;ZIDTT%W?0XJ OQ<&3=",0G2G,O=*7U6-N/
M_B2<:L+B^9M?U (P)D;H'S-7]$_\9S/Z.8Z4Y2GZMW'QAO]GY_O?'O>CKP&7
MN/8*'VRRZ$"'@-$C;=LB16?UE'UQ%<G=++\S^N;3*S3,$\>3-2WFYJG'W^GN
MT3NY60Y2FY.XZ<_B5K7^U3PFP<)!2GJ14T\:+SU4\C+"WNUIB(K2@O (]^(+
MAY]%F]7DO6O_ZIL@YK1FN;PVFY;*2LHO#+\;T'<@J%AY  !&QH*!-S]#P:&8
M%MQ::VK1P&ALS1XAL5;CM+QH@%_'Q!NG7<L__FEDC?-RKY2<IFCU?GFGW?O?
ME?NF"F[1'-EBM]A5W( #J!=G[MR0\51.[>DY7CT2:['C4>^]^LM[G/34HJY
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MNDA;3]-4R9<[FATN3#("I9S<0C?\HXOR1]F3YZH1%5TL'#]ZLS)PI=\)6?)
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ML"*_L+30$B)H#21-#[O8^E*/#7RPCZ^+51-PAE&/#S[L'I"M?##[4.?XF$C
M>0?47O7^]_F0]9C8J[KN5N& 3Y+H?]BW(DKO"Q7;9H -&"9"3&%'"%ZEZ&B,
M;ZY+WO'Z)VIJRWQI.,.1:C#=Y=M5J\S0\RB.X<.+VQ 6L=WO<$#PK/]8! B:
MW)/;>HH(2&6_6]O(2&Q5YCW!LGF5AK%UV$T/[(K[]^<QA36I("7U^S"9/Z8#
M5*>J/'C"GA,NLH3]<$+JISD\+X[ T*G]W@CKG<*=#5HA^[2B.IN^>V>;\[L=
MBP>]V@=T*H]SGY@;F44_^_6)C/NAS+'#/'UO]\6^@RL_)7ZT%/@-H5Q/J?[?
MM1/_3W3=^_BIU>R*/,%/8/&A38T6W_F['A9>M[*3IO&CA(B/)L*9,EC1[X]N
MF6Q+7L!FC0+&2ZJ&#>@C*[I+-J0?H-1%OI.@9^,0H/NL;NLE,*&KIC#P<6]>
M3RC9A>[MEL12BKGK6KAC%R\KCE3AW&(/R(MZ-20\CMF/ [AR!YY'/P]?N^!&
MBLJ[C+SVY46B@\ !&P,Y'"-)?3F\F;  I;,W P!1N302\]28MWASTO6H YB)
MM9.@SX$A,;58LZ+6,AJSK8?_)Y=-EH<-%NIW94]/UM6JMVPST;)IND^0EU\L
M$3LL;SK^M%50* ]3 A\_MO1ID#V6=?JY)_=&="UMSLM1G&!NML/5_M"@BW*X
ME[?1B='B]9;$KL' )8FL.BSH:8Y)ZFIE<P(B\39+FKPG+2ULW.V$Q$?=/N73
M\CKX9.]2Y %=];8J*?6)GOEYO(:SO^WGV//J1)Q**6K9D$:N[D837'KSPPS*
M]Y![%(:S%G-I6L.,T39JC?A+I=-.UPP<?)R;M/1#LUS4X)RTK:?)0>6?50T!
M;8+";2/%[B+6IH4D=B,8Q25:9[(<T\=<OGUTPJ7PN_WX66W\%?31%O"^U)3_
M/OC9=S[#G ]<6/PTG3^P>I1\&5%LV]P^ZUGML9F#K9_6)C@EE-4SUE0($5Z@
MB ;&VFR4Y<@4>M+J[IN^I!?L>-Y-K\:A :6;36OT3OIQZ?N:-WGY@-:;TS38
MTSQX.EJ/\6N?E"D_:U29S38C"F>5$)VOK1MJ'VNAY[O"5SL?&RW< L-]LFIL
MN =Q!Q23?X#E4%"/HX6+5[A_NF70!Y'UH Q[88]E^F$S_B?:99$J MH$3=VY
M.FS80O7^[NW(P$5,1\0,T59FZ!DNR@B,$M2+"[J^<KA#LRTLU5[NN?7;A -E
M"8CHJU5?&!OP=RQ,Q_7/L;K_%R>S_E5*RU=YAZXL+_U8(^$1P"4'-7#[!G)>
MT>\9JPKFG"[HZAIZ0QTX>W6' '^.D-P\YS(CWL1,WFD,$A+)7!&D4QA(?JO*
MEVU1OE*'51NEB'-G<WSLM$1P\56EOO=+2&"L=\69Z)G]WROXIT#;Y$CS4/0\
M_?0S'+#X:WA=R?]'X54,#]3KU %K8#\I,RACISG*:L$Z+$> T@^[?PA^S@.E
M7M2IY'S%V]OXEW(5GDWOL.NGO0.Q[SQ#">L>P:8><6Z;4XO74YJZ2>=1Z!66
MZXK'B+&,?QD+C&76&2*B;>6O:"NJ'_][M#4&[1IJ_J>1^3]$ZST[>M5Y.9>9
M>[Q1!39>;\N[37E''N/S_USN(_LI\=.C1WZ/.?Q(TJI#RP&*1S*__7S/8%;J
M?;2?$%6V91*PY<(J 6;6CC^='>0O@AZ7QF@F^[D#V>'.4:V3\4YBN&R*79&Y
M!"IUX]#,)O. <_?YC=P)81IQ.8-(+-2+TOI_5NU C>:4QA1_^TZV%[U6A'JH
MBTYM,DO178[K+L=(BO?MY0]9#&K+OHOW!ZL+#9!5L*VO\8NF<8?3!BBY$$4?
MZ@E;KAXGH3\1%FZ3!#8_-U+1TJXC>G3/C90KV9/:!#E+S>F&@=1^$@8K##HR
MJ'[\H(_8 RJTC0"8T$5M78)G*>V+F*KP&1,_!/7;PO-Y4Z\'_/NCGW_<F%=*
M9& O2(S/)EJ^EH%M__Q.AGU!!I?/7!NQ-\;Y\60N'>' (P$XL+O><DI46EAG
M'$)SC)(.:]:' Q)Z.X7RV)!#Y^+WCZO=30J_]=$O(95/LNH/[[6 7:WL^+ZL
M.KES[/IAB?77'1&H!AKJ@DD%Y$1[##W=75>*JBO&=+^-/5BQ#?>% Z]A-*FN
M>J[AY*Z9^I!'LE,G#.,W8\5VCRK "MXZG8Z/6E&N[FR\CO T_ITB'R]C+JK@
M0';Z#:O;6:>/[ T$-*I\EU#/D=XE31JU7!F*T ,BW"'Y=[6)WMN_*UPT@KHC
M;QG:VT,92PF*_RS]QV^49J@_>3W>,U)%0!)&/1&3L4M"G)@^0[XYX/2+S\@+
M.>\>W"%P\Z"W3,TDJW!!LZ[VE_7?B)(XN8LV<X;MWX9+_3Y\\1][A.8^NYU=
MR^K*!FG+XKN6GWXLJCJ)U,]&EI;+B(:R;?3/4(@D&JVMH-7]/X_76V9>H=P.
M;8M3:1+U@^QV+\2.-K]]N=LT%4N#1+Y>"0GO<_8TR^L4C)6A^81Q-8QA+"WU
M#D$)6ZP0E.. * 2C4(8#!0Z\@,47?=/;JG\N?WX=YR2<@6[-1GAZK>FD4"$\
M4#<RH@$'P"YPX J&L&_+ (S'CE0P6 T[)EJBE_:SHCWWV+0>8V;T'\4H]#Y:
MF9H?KH:=C'..L5[8KH[-_+$+"^>0#>N24FK23XJ"NO+"/8^"0ZC,5P&3LQVF
M^_(;DPX/#>]3K_"?"5D]/<%(O^E;Y[R-^< 0W>*18O( @+$ [MS:7XJK7R_?
MW.^S(XH=NI&X'57AM/QYDD9ZVW R2U%4<6C],YXOK@LJ.L$!-G7"T?\Y1[-_
MUE/-V<V(XE;+>!;A9N>M+M?XA+63\^,'^3%QWL,9H4]7E3UD_.>EYXU#/4D?
MRX\>)&JT-%9%/GN[T*<F(TOEL[R9,-O!0=9K/X\&N+TG\]72L5^;@&K]X%[<
MFFP;^:&*IAJ@'9B XWU6DK3I0^%SG7X.7G/@3O*9^EKI*7E_Y,H*2\5SME%4
MC'PK_Y_43(H*)9T=<^<ZS)S/]?,B$IZ=8QS/4E)2@]?)IT+*2E@4;/6>3%;X
M?._L4(M<FU]^&3IXD]NF'(<?I+YMU*%#GA=VZLL+4WBVF:20W\HEXV!'W\7%
MQ?=6#8,J K#:JH]/*,K+^?GUZ8U/',WC%]GO)-204+U,RS19Z=1J)MX&3:0G
MT9J*G[RV2J:[2P F(/^S@2.6U#Q-*I+0FJJ>*?RST==V+YJ_KYF\])^L6T37
MF=NN5^AR\K?P?/7EYSM,E/3^F@^>ZS]M4R<WW'++KB@*?0I/W&X[ON)E(C+8
MXJ%*ST<H\.N\>Y)!*;YH.2SJ^Z[6B=U\%1]9SV'25[4J^H62;X5IQULQ.Z=:
M)+?T-*=0A-7AP%D^'/@0"$MM03 $&-B3^J=AY(&#<EV#U&M0NP0<4%J\A -P
M0*_Z&XB+T,?,*;@GUYJ_=M_ 1AJ$><V8F5W^1[WP3[64V2G\([H#:S@@)W:N
MM]4.(B(U%0O^R13*6&9U<A_OSWGV\0@]OLVY$Z];<6$/C=YI.G3 >'\ 09NB
MCLKXJ(C7BMV6+4F[YI.JM+3/U\LN+!#84>9RY*[.]FX&=! #X^GH8^M1!H<X
M:X6&3KK6^5M$">GG>HV#GWY:U/ASY'AC>\U-WI67R#? =$*9\:OP4D0G,<G&
MR@8'?B7N;8_0WQ-WRV1]X8^I4RN>,&4VXP3-#0'Q7T56%?14HAY]A95>4^(B
M.P1</@[[1/JPHV+WCLEA;Y%@#@[T=!>A8GN_;(P:_O7[O9V<[AP+.SA 0^)V
ME"X=C6)P>>B9#GLA"(8.Y<]';2:!'9;NJ"GM:SR5BV-IMOW%\6J/["-P92"-
M[4+2'V"U76J(Y]$O$,E]QWN^=MZ^*I9@Z[4H-P:M6-/5_T;5:2:6:HA"Q9^!
MJWZCWYEH?+2=14\W^6;[*D9F^E;3]4?->74_*(B$_GWZ9'T](TH<0I;2RBKL
M!?G$6NN9)CW>>%*%P](@+7L+927-M?5CV)?2R%!@J&:$>P!TIL6[=!V'"GM3
M5E@8S@AX(87J,0+%8A2@WAK7,^4[3*WUUY>S,*F&LD+0UHNJK%O9ZTRF6YQC
MQ"9H6NW%/F=EATDDI)]UB4674969CL*!-3+$#C!0O\)>ZH$25&(TL*I*$6U0
MM?U^G(!"'RQ 'RDC91D>^R%2(R8PJCU=BA P^56T0O_F>*YP+SFVX0,G]Y>S
MUD'/'X*;G^@4Z:N+LN?[BG,UGWR43F"M!)DE4DCB4%*N)IW6X5M$9,5(_O&C
MD5(W,6P/>85/)HHD,M:9V.;A^MVZ2-LQD<\#Q4EN^1Q$FN("#K3LM-RC*Q7!
MJMK^QX5E@..^9XE>7LZV&_FK^[A?+1VL[_&>R])AWC/!67)?>J_I],] #G*M
MB!S8%\-X/+>R^7 =G/:-]D?%#@ENI %M 1U*\TB/B,AN8YG(^,,.Q:.G%6(?
MN2E27\[W1MBY)$AO^WPC+XMO%<(TZ:&T%,C '9/ROBB7GFCN.8^5&\SB#"][
M2[Q1IBVP=$^WA!OYL[Z<Y;TYA2?@XA8O3-V^EW0U5 V65$59&3B;DZR)VH8"
M/E-? @QC><W#EQX4M[Z6PWA$W;&=:.W5E%M(.4.62G*Y@$6GM185_U7</K52
MY\(M,:2+^6FJ'4\%.V4BGZC#OCU=-W8<# Z0HIKX1SIVB74D^0ZF93V.7/!F
MY9:LTE=TWGRC.#.7DEH4'FYN*8+.B)*=&6H>DR#P4-";3:S=CT9*:JWF]B(1
M#E#! 6QA!$U(.T;PK9;E7\S8$Q':1-81S@)JCWK2LMG8<GEPJ8):I6&D !KR
M!!TM'F;U.5P=L,.$8(1(K$0DL8LG"\:W[K>,Q_HP;T1(B(0#08#"_X8)GI%S
M%>J6T@-.<K,]V^($VEV)^:,V[ECDE4+RK8CHW%=6R,/^L/.S;[*\]<%^%""-
MI'JYFMYQ4I96YCJ@R&6].@+5AJ(E_ZB-,]\47KU=A324J\49Q&G.](6&NCFY
M,<U<6O5@UDU:Z@N];Y"[&KI\GP?)3NXDGL3_PDUA\='E>2_7( R![Y@V#]CV
MV=]PS<L?MQ11IRO+!S3<A26 J6[K*=^/R,@RO[?,]4!?L4U]NJ+_B5KN_H#%
ME[6[B=*$?X,VB_3U7XIKSE/ 7G#>X1WSR)=N+1[CAQW!I'/SVMNH6 E5C:Q?
M&^:DWWIU_%9A7=DM W^**!9KCO8)](]2SGFM_VTJ:#YA*[_Q;Y:5^<-.S"CE
M":%A?S7AGZSM]R0S\T]/B?H/>V=@V?X9?/[U.90RKS 1VN(TB%T/-46*'F3\
MV[I711Y"["G-0>A.4?P88A'7>!==KIH]GRYC9!$9=I-LTBK]&"=D"_2U:"(Y
MJWLP[\7+[^P8_E'J4&V?OZW;P&D^+4<LZ'^Q+S02_G=LI?_M>_4_.\$D343+
MFG[]=1[L [/Q'Y*(0E;Y9WR$G%Y]YWO6UBUZ>%["" <>BF9K7I)MQ*E*>?=$
M$^WI&=\&LHKMAH(>&PD9->2^[%&LNCL-O'C6VI-Q7HKS?D2(P_O[W3]>CV>(
MXW^PTG6^V_/$4\0Z$_RPF9]K3-)5- 3,O$Y;\11UDS5C41->JFO='E+*S3;4
M&]]QUD%A2,<Q<M[@O5<3&1%.G94#&&=69!P19=>;&GOR6>,$<V)ZR%J'W<UG
M-3O#>$"O6D)4P2?0"^C<R/=ZJ+D%/5?,=,!]0*\4HW.9Q<?HL[['-^[DV=-0
MO$K6+RE])W;2#DI**)1>;QHF?]4DD,:3EH6U<VT4\^<,K=K;]X4*6"T2!$J%
M\Z0#Q%<Q4(D>F57C"0]C*"RW5+&0J!KM#!3,20I$K#U@$=6%Y+U&^?6?,\!Z
M9X'+0D*U!"H-XTF+T,0I:I^8V3KSCZ@:FJBK#)A<[P1XFO[I 8>=TMR\]4DK
MVYNJA6S/PW+MJ+F'F$2=<IY9._7Q-V41[,4ON3Y6R_@B2R\VJ-=Q9<><N)ZA
M-R'Y63SV>W0H<6!DF<_B!@'O>;$'<\OX+?98TT^%4.1:#=\6/H"J\$:5\:\-
M8Q@N->2SG;K;*LPV7)K5)CQV=MF!/IWLUHP#M(<GSTP]1,_UYQ_=Y4Y"1KT]
MLVL\6'^J<46$XV),'974_W/HNSU9#HXBF-Z&KG4K3DR^HPU)\\6"WNYR6%\O
M?A2U4U)_;0Y:7Q!K[%B$ V57*FAWVEU:"=]]T_KTKO=2,)?7+'=A9(7WLG8@
MNU@\ X%V;Y6DBH7?@^Y\8$3#VWI2"8G4L_Q$<J1LGF^NDUK$B;CG><<40P:^
M^]-2]>XLJH]/==?_[<S!YL\G$/_%TP9W:3@0'0Z2O(U0*ZKGN_U@=DVS9L/D
MPV*UC0A-)PK84!:$ATW^JA]JD_PID+;72);=:WB:&5J2;SRS/;GA^V)_811I
M4FX-/_]6KLO$C=BJC'^JF<]'>$02ZU;!VOG15H)$Z?/+#+H3GFXQ* EZ(90D
MP(=HA=5+_!UFF.F=T[>?HADJ&$VJ1JC"$D>SG7GDEL&G#O=GQ>83CCIZ6U1T
MTF]#)"YECB@Z&=S#WS,L2(<<S&Y;]49 VQ" /3().$^U[13D#:+Y6F(S2>[E
M.CC1+I5^LQ5Z9/P)#I WXM"#%5B-;U[(NA_HR^KV\'>3^N7EE=A:+58Z^.UE
MG[@RGK&:F@WPK,\ Z<;ST#MG/6J&0^U@'W[NL^%3*M[>Y>,C_7SG"Z]J+A"!
M_G(9E.19O+>34!H['+BGH#$AMJ9SZ);G$9(]AAPJ6HL*6AT'V?MHOS<[;(XN
M],*(0V F&>PS>>:)<S7OOC1052B$X8O>+@V)Z A96(?7T[L.*ZY(Y3M820LT
M*B(D_5)&6+1YP01A\HD%!)8\NL.X6:DO7"]3&K3I+F1?EPF' ]:W;X7AP.M+
M3]^:*)B0PCD<B B!O3:BHI[M@0.491:9Y>LGS!!/NL&JW9:H1;.HO6M0L'"I
M8UVP%X*R:_DL0G#@P$!+4 B"5TQ5_RVO#+#.;$DL,!X:O!^V#+_4\3[JHI:!
MHL_YEK7OIEU2@E;!!QIJC(?&Y>^'[7K.:X+&%G\MT@5D#AMVZ+FE%R6)6AR@
MN36?:E(5I\:Z"[R1:*$Y3/ P$@,Q@HX%LF#X+1"LYHL(8:X660PX0*?=-((8
M!@<P6WI.IGJHJ8QSZN' L0C-X:=;'_MFD6'M[;<MMU%&%U* !\,M;3J->OS1
MPO_7WEM'Q=5DZ\.'0" )%C0X! @0W%U#\.#N(3B-NZ:10();<+>@#4$;=W?O
MX X!@KM__<[,._+.W-_,_;Y[?W]]:_4Y:U&G.7VJ:M=^GJ=J[SJ^6V.02?!>
M$\NYR!Z*W0/ 01NXW[*72'[S5O.W'T5M. _X?.G-XG %KQ^]>,G'4?L'8+!N
MQ>,^!@'NKP*]%G 1ED-71R*CP66'^'ZT=TZUR@\ %#GU(X6W6<"]L##AG,B=
M8SW*%5^91[:OX(M[?&CG)7AM;85I#3YX7L]=O\RY?Z$8D0-7K(=NA@^ KR#D
M :@"+19D8B+!/?[)*@%X[6)%*H3B[(I:9/BEW . _H+$\.AB6017?/<&WF^"
M?WK,)V#+%HPNN%0R(#H2%*ZKB;RNS>^Z4;Z$ ]JTEKL_R\6>\7T,T06<8TK1
M7O>.M2SJC:*$2MR\\Q8&-W$7DM],?[[&4;^5N!&]%9JLTMY;GF+6T&3P/7>,
M",.\ ,ULCCO/M, LSQW!3<\RMO5ZPAM9,L'M(HX/P ]/@T/-S1MJCYN.V=*X
MJZF&:)7YB*W/M%W@QRVWW0YG-5_A*K9I90GO9SJU98+$)%6]NZBY4DF>V$'0
MH]1[O,.3NSM461%=W@>@O63;DSDAMRH\;[O&59X&,<4=7^C'=BH&:"ZD$.PY
M+=C39\-LH5EN"3Y&@_.@TM>W@>Y[7OAPS*884+Q>S>C5I!&Q2",0FK&"BV/6
M_=]GFOG*\"UA"2>ZD, J.3X-K8/./9+X_%+[XA,6Q U:I$/WS1)Y\P)H</BR
M_UA)5[%N^,1W5^J@/OW$;DG^TZU9J$4F!CLYQE)[-T@+PA1/^#YFL<M6?^4Q
M3Y! R&U>7.N*P_&SGX(BIEQQN4N@X_LQH<X$C/(8=3GN-_ZBM(B(O(00?KI'
MQ'-:+!#3FL9@&FB<:Z,M.X$GT8F05$<SV9BWL@M-WDI0BGS,D^FI/>O!L9Q'
M;D'J2$&T!-3.VXM-S-?(]97Q2+7),VGVKS[Y;N^S/QE9T<.H"LTS@*2X)W0E
MN 4*=CQ.51[L36HUZ]3#P-0!8)=V)C4Z'W/.];GU!123C_*J@RQNZ[CQE.0P
M<C;1PT[",&5WBU':8L6$8\9UK1)F8Y*T.!9]*SH[@&XU^C6R3^;)BYF/ZHAV
MBZ,S,;[]+;%"6?NO^WE8 *4O.E_4FT3M:O2\NY%8Z+KE#@5JV:H[Y[#BCH4W
M1Z4&^=K-QQN*5IGSZAN.U,^Z/Z\,L7L5X^./&RX,;?0.*K&A?J)%T$++T &F
M#U]"]9^TV9F>TT+3M<P_]9O>_32N/1"L4>03/-%'-[UT7%Q=DI_S, >9"\@>
M"[J.$^+&?Y"SI<"6H4Z>_$M8VK\Z!J:Y=M%?.3@QF^YA._8<[EU.DR>5N7^^
MT[H?^&ZW*K)+ !99%ZY"*"NYC.B0ZY>A37$8%7_!E &6[3EV.7A^8K\T$X]^
MBWKQP^OB]N@4DD;<,4VD041WVW<S1,MTZ?D1KUR4,%GXLW%NP0TCU6 W6ME
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M&+;Q?ETDX4023N*N@;329?, _$/MG#H5;'^!T!&_WO?"P3#=\!).VXE$*EC
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MEJL!YLDK/-\E1ER%'HLX[G>O9+R#D:^Y!++LE7Y27ECLP6'4X)CE[!.A6"%
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MG$[)X[3_W50:(E77J/[\I:%Z@/S">1]3KE9-*G:7(G#.%9OOOM0^NLT:N2<
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M_HLP@PN9"9W5'VU$*-C9QQSIJ(@Z8Y^L9,==.8IYGBS2;U6"K># =/( 6#X
MX(1;B_LIN*/>NI^X?P!8+F&#X,/B6^,'0%3S 6@Y A^I@=O+CB+O$ SAE[O@
M'TW-*4OP2->=]S"X1.U>?(>@#&(F0T:<:"+=K1_=]DSH:")/31XL[:59)R\[
ME"FI;HY=^$Q1]&-3\=#'YY>JNJ.<9=@2Q5K5C0D.E.UH7^9ZM1%N<A\ =Y>S
MTJ"U#EB4Q;GFX_W-22>SBBL& HN<+[&!*/YB9NM;7#TJ]-@.H743"@K*#1K\
M=6=#S(N+A%N33,8A[]]9CP,D&+E>&&<V^Y"U*AY%03EKG$&.%PB/SH8]C1?K
M:H<6OGWG0OG>TA0"HH8B?;G]L4#:-\\.+-5YD'@WKH6$5WG]\'Z1/\OX2#?4
MTJC62]TH2/TK7QA.#Z+?CV77 L9M:Y8]+H)W-3Q8>I+$EA8_6%%&;XY%^"OU
M2HM@FB<Z@]>V!8QXIMH4$<JXX2]G-NIFUS9NUF+;VGK$M?=R0#AOPMV8=O6S
M?]#\+$U"N/*MI0(A7+B9G)UF8NR$G.P.>!7[O.GO=J_F6^ZZBJ!CUN*3/_(P
M25N.XGEO<A3]0SV<11&6H%5CH^+EW[>>P<ZJ3?B6GEK%NS6'I3$U2] ?\]UO
MV7I/S7-WHBR_,T86,L9:=MEJF[.S)O(; ] L[STJJF8'^>0EO;BJH7@.W2KY
MI\RQ NC93HW/3=OO?ST2PY"V:>D0)6V9S5PB\BC0D301Q7 <2(TL:+LMLEJ!
M<$)DQQ89GMA2Q.Y!'0G)5,:^NWSMG(^-CM<[FDXA2RF4LU5Y4BU@H3=3,L U
MQLX1[!<7%Q C_&[=GV,N#W!S04];:%J7U)592V<=#,QYW\K*2Q6Q/(W7R!\7
M$5 D;A73U#] /_/4T.-9SSIU;%IFZK'GLXY(B2GG3.L8_)1WEA3)8F8;A'%*
MW;L#B!GQ-+R"MXN-OFY9D[V]A'(%2*4>P!;*J4@<?VWH OWNGD[N.;[;V)!#
M7A=I U?;*Q-%#KH>CX[WWS"%KG;E)XVG#M!O\@)7.QP<T<367^8H/PK;TWY1
M'#!5*Q@M2FJ=')?K1K.P^>C]-J$>>>-R''D$NEXI$3JM2KJ<>6/0FU_3\AP)
MA/V=[>)1GOX@J3;D<^>&Y'MMDM:EF:.8*^PG<@QR9V:T(OLAP-S$F;Z(LKDN
MZIQ7O"CJDUPT-;)/JR558Z&??&NQZQ/4]M6>/X7C^N<M/?F(0!_3E0;+#>U2
M+J3JB$G=@,J^L/J$FUQ\*L+NE;3:-5JFD)Y.1+DG&5;:@7G'")M[?):CG<CZ
MWQ>UWN>6]T  U]'Y#LZ3#N*@F$?X$CT+U(]$WM"'7@9(A[TUG;3)QO;OV^S%
ML>_3"UL+"P@8/2]90OLQA+BK2-HT5>*&S: ;FL33@D6_=<!&$M#&%9T-Z=2H
M]QZS=%ILOV;D#N)\[4<90TCL0' J$@ZXU1&,V%8;".QJ4U7'"'Q)8FZ99'W_
MMN6U70)L ^GNL8-&,G>UI5O>G+P#7] LJO2XEGJBJ<@TXDT70.(H6R.V%AV2
M<$.L(3FY7*7XVMJHED@O,(AP\\J/+(5/++W;5R D:&>36-I[[O-3LK-WT;?O
MVM0^4OM=PM#9K3P5(JZ_RCN?B#D12UDRKV/;DFDK)DO1O@IPN1GH,=!4&JO&
M8N0^SKO;E9R69/ 3ID*@5GWM,L\N@W2,X5B[W8IB?1&_3?W$5'^B08*,#ZW_
M*4-Z$H+N,=>'6I N\O?JRLKG\N@=(#M*0I+O)B?4L8XQBF0&3A.Q(USS_[ O
M.Q+-#B#-\?;) V"M?%X,OCIX<7?.,&S7R%<LYV._;29;%=9Z8" FHA-PCQ5N
M?.^=<G]C>%0Z%?0-UNU8?W*O.O%QRNX!^&TEO[F+?>=^?!RVQZ/)VF47U6Q<
MBQICC_RQ>K/E, Q$?K*^=#'[ (0[A^<99J!:ND9GA>PP]*X;=U@KOWY5OWPT
M9*H3]KK[*&X@7T/5U:&\@:8ACU)TKV#V<9K<6^]1<5][Z;/-W 2MB>QF?!5#
MW5<S+]_2B!+39O84_F)(2I&N'3\K?LJDD,?(@+:I;3--.4(=R_B)U<CWZ<($
M;H(KSU#^CJ?HQ*:'[8&!2<-C[^_A%/;K6WQB?F'FZP1KR5L\_$WB2I43V=HL
M^T9029LB$_N&R,PS+D'V'L'7C!@5;W<(23'$$4<#YC5HRDD[B>XS"GHLN=:Q
MQ#@QHFV8B/G"@H#HZ./G#B-4-2#F_3FUVBD=M9KF$,W:FIB9SE8))"KSY(BL
M[XK8Y@%I P$] &D<7ML#\'X'&QCGSFJ6\YJ.?1$AXK59%CU6VQ[?S7OVK34Y
M?+C:/HME:)[']5,_;2<;;1S.NSPWX^B&\CZCB%3 ;5(S8_O:K-9Y>WI'=\R]
M#_L=;@4RF$N.ORZNP?8F2Q)3S/=QRIV "C3"N3KBW"3H+'T:AX.]-XAS)</=
ME'A@.4;T=%N4M+(BFZ/AL3HA=2KP.EA0Y=T1=<@X93%[P"C)\CVO2)P][-JV
M#%RP8V'S+6+6"U0K>P6I_A&]09*$J?1T1=-6NK"YJ^"+8K3=QWA=)L2YJQ]1
M157I%JH- ?TX(U215L#>#D/Q%QNFW-KZN)?^7(S' D9J&.LP@GK)/,?RDB6[
MB!FC)C:I\V^:;T;(8PB"^G@Q)&5Z%*:*BW6L^(/B<G6>C/8.D238L/:'![@^
M04FM5?:;XT08HV+(='X9%R2&0A$BO2Z#FSBC]4@MCF^=!.L2*V35N1A==EJ.
MV$9A^MP+Q#O42#-M$QH7N^%*W$;14^644=_1PO!-RV";$O%QW"XC?]Y@):5<
MPU#P[1HA<0J2]]'64OHDPMR4G+[L^+X8:6/;0EPJ@"DZ)W/;S1 : 3-@MYB#
ME*IH?1PTC>K79=C\>,IS\"B,Q3 N> 3ZE#L#;&3\:EL33O8LS=$; =EY0E<R
M3_8P<F-1TJF-27S7 P<W>O%'CL-[O@(NN16--<U0G!E%O$[J*#)N-';^L)#-
M_1(7U!$D#Q-I%^($N2 -/K;X)+TRH2B'R'.KA&!.&\DEQ60A5KT%?7T/&*9C
MF%+P>7;FLU)?>U[C5)N?<DHHEB1C_<>YMH39-A$HAZF( 9?/P42^.QH!\C?@
M5.$^J%LB A\I+ZG,B-4F"Y,+=WWT/F53\E!9W"*#1XT [8RR)&O'!G9 U).M
M9.KJ]('6>A,WY48;&P<0]<^AVJ*2GX,R![[L'[\B3(@7_9#W/(]::+V0EK:(
M:S.E*I70*^6>4&BVK)Y3N0YOF<U+RXQ">IYEC6<O-9(:D=13K=X,A=EQ.G'6
MN#WU\*".X93A(*\T>M2=R1C"-]? UTH+A] X]*Y!C4TLCE\G>I))*(^_\)(M
M"-P)P&CJ78LF4.O0EV;C5T<L<*(:V A2-H:7#K8BYM4-*<^9".;TI!PVA7,L
MSSUL":XJL-@Y\(D33=_$2+?R"CX##OZCA/-_$]SW3^JG"$H46%V5KC=NXVU.
M+'/_==S.B#N^I%I"Z1Y6\0"D+UVN@0/)9\\-3^8> !*[P_P!YLX;:3>6,;7N
M'.OIDR'B!&FUAA4%>P2A^S@YF2/2^$+2T+FGH@TA,KC\OL;'_4$:6_ZHSU*T
M<B>FB#DU/$&>JG/$GR9+DA=TC:(4\L2->8<=4M'NZ%V;?"WWO$A"F;Z']9.Q
M$[#[I0:,CK(/X0WEA[ZW<'2^.:LSQACX0+6XR^S**G"^O&<+B0Z!"M=_B.'%
M>=><?-JUU6=#_M6 N@\H9X'&8 #4J>2RP(]95&0*6T1@+5I.#4>CR@?G1MU$
MQ/CXW<:7MF?("E+&>S)Y.]/UX7F-8^7!^1H,:+7:".*?D<R+TC&S,M&?T:?J
MY'V"8;7A[54.T3_%YHJ3XX^.:C6/CG!2"O>2IHO@DB.-N,%K'DTT:^4E.;OZ
MO$F'*!OR;3;/?\DGN,PF<,N0HK_AVGQ_2X@O?\9PUO#MN-9\FQ-16EY6%"_*
M!*4OXY@6OV*(-9><'&JH:2K36I55:28[WIL'@'6$4#D:5G"6O=19/I#;4R"3
MOR2.MBI2R7!E?8&L6(_+D$J6X45PBP'P%)3<,:C)73$;@3S@[=&+W2:\T$]@
MJJ 6);85Y44N&Z  ,VI69=?5ZS*J3F,Q_5$NG5-[!468QP:HD@%8KKH:@1*N
M2RM!R3F,,Z]*-Z=0&]7LU=MO+C^D=SA252<T)PSXTKA0):5E2TIH5)Z7MZ*/
M$ K1/3K#$ZM.8[...:I&9;/8JS;C8.X6]JL,.P331Y\)/-E?J_::,ZV+6J%D
M+W!=$T1;/Q+%_PD@^ )D4^G7B_'1,E0[&B 2Q8T&PLG'=ONQZ9@HD5;^:YTZ
M)JKSNI!)=KT.:^;&O#@$$XHHL0\H$B/4P!/: %&B4W7#/6(6*+%(]=S==_1N
M3%8[1,+A^<U04MG^V]KR1F@=VQHXEKYY_G08DS 3E;&H PV!<(2J-J]DSL=L
MVL=Q2U:,HA8J^JOKH\9/:90ZA F1@Y 0.^R?HXEN5JZ?Y'FB\LQ4$)=3<=)Y
MR0O.,M$=$2BBV/F5U</O,I6Z=X \_6,3@G82OFN,^[@TKU4&.J;E]-FWC2%F
MT>)M%.^?21Z32548'V6B%]'GE>;8.-B19%MT'Q=7U?:Z H$B>^\CZ .7OD#V
M7*0JXV=W/P@JR]AGO;,X3J40X=Z7011P& )LE+6'2GY4J315#[Z@>8W-A_\Z
MZBMCFZ2C*,GYCH-?;!<KR%41(O5-C%-5C[UWF"J*+=1LD<"<(FT);J.ROPW@
MU^G.X),QD8,LJ33RVU/%FY]*B#^_>8P] "-OX>0E4'WRC([S1DS0;V-^%]>A
M$Y$SH@=!L^9C+L+DLM+C6?KPTCR2:+,=GHJO# +B]KT$]&M,Q^6/):4H+G)3
MM"<H4OHSE"LC],R-!S/7;/>33BGN^#)13]75)JW3L>CUYZHDJ5@=*"BZ^9N=
M+J3*9 OJST)\"A;FQ4$D+\C-ESA#LN8^M"!E2-[1(6I$T2%% 8R.TJ0@>L/G
ME@->0JEN6'UN* G-6)3%P"]<\D2_>:]CMAA1'F+E"JU/X6ZV5*;F&"8 GF&C
M4WI 2QZ@DUWDT\SG?.*6'PG-/T0U%V]))<%N<[\0*B9;ZI(3:BH)SK-"V$^$
M-+[MJ-?/C*>Z2"3H<<3\9H&8D_U]_8@$:R?<_!5DMFB !%T89T";6DE=<:@A
MU2_5F!9B^S<U+]U?FJ>'K,(J1H@<_Q>72L%*X2NV'/ 7^:XDRMN+0A+YGRY%
M_S>G!TO2Y&2]&G+HHM7>HV'I3*JJ.+B][7]F-;C5\MT$[HIW'P#OL;L VML+
MPYO->B+ZNY*P^S+%\FCDKT=:BVV;KSFZE4B<ER-WM1S=N26C.]U )#B69>;T
M15LX[)2$FCL%["(S9-\:^.F);1:2N^GI>S<2.B[<B')?7 Q9Q$@QHGWXA)WR
M05N42J@OX? 9_U2Q'>:5I]IWSG&/=3VD.8:2]]+['708$[YW/79Y=F/2YJ]=
M5GB[@VU (+S&V-RH/K8Z,Y>4@7ML!07^96<\?DO/N+SEQHD$Q0@9)I5I7:=:
M23_"?O;G'-WG2._-(R09<K-]^;8;!;<Z-)(%W224M=%.'B.D(B_^(/&K:R )
MPU%C;GSM;E/ZH6I2VK7.<B59B2<S^IDLQB@*GQF)SR_S/%=<)10VRY6RBETF
M=D8[RRW&HP#!$"/*EP0("+/NI(K&80YJ9YBHA@,KH:1DTYNX(0+(55]-H[7[
M"["]&Z,[O/.!_;YAALIL7\%K><KK$_W)O<T(%VB#UR>-'^HV4RLS6\@_.Y?1
MZWJ'[?E*<SJN]>(?K6Q%<*4KA0PF8,O5TO'>W/&GHVR"S$* M=.#I_*F+ED#
MI(/O=709>:1Q5S6UWEGM_K3O)%=Z,9[R[?+#_LC;RNH((>[%G:Z5^-=&:!KF
M$O3=8KX>2,<<85M0H3A<A.C<[0NV14-#*Z:G=?5JD29\/[ZD?&?WH&7NX245
M[<%+(/,KC,0L#8'AFXTO<D8LZI?HM[-_Q6AB"T3XKN"QK:^/BS"D\_,%BK:\
M[!'D=D+@W9'D4_5!RI?^4K1AL7XPTF+ZBXX7&LFDN=SMA'E!L^VC!6_4PS2?
M#7:ZZ9G<NRPHBY)X+Q(TQAAY'K^!*0I6]#V2IU9>&7N! -OLQ0J82!MJ+:;J
M>(4O\:F#*(E1&^B;K?F56ZI(^U*:\&RSWI,.,2;TS53FIQX[%S3N55.7:AE#
M"_F2)]IL=6*,^1;;4&!Y$GP8:D 3?ZX\8OMVEM\R8LM^MK<4$6%8;-'I]$ _
M'!=AL-3/Y7RE7DNX&UKF78IP(L?^_8?7>UO!:X!M,?_P_M.UJM;&&N620DB?
M/YJMB2!THFQ+]U0)A3(=MPY;W-'EM?Q8O'F:^P\-)?'':V[D-.Q@7_4OIS[2
M6ML6W9WR^7+$DCCVVGC&%L/NRRM]B*G&A4/.D[_]-^D4MOCZHN[;ER'[ I:/
M\-]/\-H/8I(SLT4XP69S%%$-!)T(S;_(,$U"D3PB:1!GKP!;6YD1$=E?!9D8
M*B-ODUGP6K=H^E$M-L$)SV OWXGY'=PTKKNV3_O_?-[<XE:HC\!\@O,V,.5)
M+UM,W:R"!PHA'E0"< A>\9'5C)>;Z\V-"ZQ/F.]Q2^"-2G76\_/-\=NQVHS.
MU)_9B8\9>%6I.XL:&%:4P=992LST RO"<ZN,E"$?[NVMRTO*!>W22O,4,'@Y
M=^@0$Q^ 3U0R#T!^Y,W5 S"=<_\\G/8^7>1@ZP'0^:US_G"]D.:PT_4<2RJW
M;V->S!'JD!1LRHB 1.)*+[WVS6F8(0<^*GTTI:<.CGA2C$@[9D?,=C_3A]*T
M$Y"52(Y8;]7PV1_.$>HO9'V Q</X&(8IPU^0ZQ52[>ISX2)T+[CK/ "_G"0L
M':R(W,MLYGN)GU4.FJBP3?HZ1,(BS!L/SS/'%J1L7(AZ' 1D*&U-^A.5408;
M#S5Y"88]89H2@"/X,'R1_DN\!9H\7I0KWSS1HF@/(HD_PJV50-E3.<[D"&:E
MM_L5VOF#S1JFVKE(_AB$D\X_&;YG^W)4,2 :@2@;+4EB>DWM*P7KC/W21OJV
MM7F('G>X.\+>8?V8]S"JF-@G)J8%99'X<_SRZ7*&F\\K\D_KD4JZ)_:QACU<
MC<&"OAMQ5%KKZ/L=#F2?0G8M_L/=$_]/Q[^)+_\C6#2NZ5\N'%Z\F68^;5+M
M?,2P*X.F*ED3VXO5HURG%!9I;!"II;F(<3B<Y?9JZ@'X[ PJ3E+8IDGNIG43
MS@M9'T5!?P#0GQ[VW >)/P"^+T1N;2,O+12#1$[9R6^!.K@:<)D!MZ.L8%[C
M<6+>OH!_IQ/.$9Z0?Q+YJ38J<JB/^0#@B!(T$UY"EP_P%=TL5]*,[.PR:[PR
M7D$V0NF;[/5%A:1DFW+=^VC\UINXC[_UHCEJUZCG1K&Q.=J3NJZ?A#U78-#I
M:4]&3F7&2,BQK/>.[1QMC(\O[]Q05(Y#O V)/Q&OJ1_?8TS*E:BF&^UMD'NM
M#'>!9$]1J$B2@3R>,,X"R&IB8R AD68K8;!Z2+FM%RM56#H&AX[.QV*\6QB\
M+3[5N 9O.+?CJX@!%SUE"A^K9>W0VZAK3E"3QMUSCL/\>2,3&Z#O_0,EGXHX
M8WRK.KVA^V6<1,GXME)PJ'9KTY7ZGF04&3]A];7M8K]7,",%M.G+R.-RIZW$
MFGB-4VJ_F-JU= 7ZP8^T-?'3B^X0EHP]K*HQ24KBV5?/WB6.(&X:.J4_IB9[
M41,D]SY!$VQ2;>[EI=)O_*6"G82TX3OB=Z <4;@]+Z%C-)$Q9G%G?V:/::A(
M#H=Y,RSPL8):Y(IJ% +!&BX"M3#%]W01]A=N82.XS]K<S:+Q)B.M^2><6Y[K
M6&FR=>"Z824IKP?G15KU8_G7+&51E?*OFZ@]70'QEE*ZT]0%/5D/4;8.:]9V
MGZ2/C6[8+PHS)_$\D3]<^JR06'.\L"#GX(#F*$6$C>: \GX(NH&2RJ*W1D"
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ME_&1^A'I:^<1'#(F@15FV&^F_<6R_W>&!?VG+/O=L+_;-0O@H8-0BX=.!$"
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M-2U8G(LDPQ;C2*#2?)0S[;3ZY.&[^P;CYZQ+Q<^*/:%*D^=06^OS*7.I-<6
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M @F8ZONIE[Z6*E.M^P^-!.>B$A*4-?)@C(J:$8A[6>$<_&WA;!EH_Z/"P6,
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M_6[E_*&,Z0D!#^.[%R2=C#K?)+^-55K=^[_:>\NHN+9M771"(0G!@WN0X"%
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M*JK%A<6'[4F)3X TE[RI>@DW7'3Q#O#(S6S2H=!/-(/<YN)<[E+?GC#]"MC
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MWIX/$V>9?MT-XEX"ZVXXJ EP<;6%.-L\U_W@1DHU^X#S5,A)C !.K2_CGC'
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M[9?#S?#"W=/HDJ[TKSPE+XYV5SBK1_7$L>^ V7@M(Z4?P.!+YF7^!0K-EQ*
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M])0DI+1D! 14;%2T#(S,+,S$E.Q<[$Q<]$S,3/\L H>"@H*&BH:+AH;+1$)
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M)Z 4!N28Y^UU)YO1AV4?"G_7A %K0WJR,?P+I=XI"M^&T&5_!.S)#M.[4^9
M)L\((]U]Q<27];TU1!<,!UV#'L<;T>])5FN!@ &))R\Y&)"[5=Y!&.*6*G%_
M,15X:39Y[=S\9V&_,= >?[ \<#S=LB."7\NV0?Z'%,/*4LR:[C<8\(?PO,P?
M'4JR-7S.UH#]2V?-].&7L(TGQ7(=?I%H14 -#-@5Y!^]-9>P2WUNG(<!>V+T
M2@1S@TDDH=NMJI/[RT*S5$U5'XYIX168&$VWHG4+T'Q]2/ZD]I$TS]F[ODKP
MKRN5PSZ'8N#02&C;K;N?W#Y.!AX2V\. ?/BZBL!-['7C^[,$&" M)?=.8(Z
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MVN8O@I!Z:?>$9Q?4[/R% ?:R'NXUCO7E.\0?MK%XAW]3&!\_GYCVVH_D[XM
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MWJ^+?T.V&F2<=5B8$C#R_;1&U$YOLZ_!DZ*<_'/8JVH-L1Z;=PRZ8406JVD
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MZQG6#<^JEO&*5GS\5D:L\0 /]\A2MHQTVC-?UIS63!ZQ,O0J>(O[O%_;=J/
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M&5:%:&$V@)0>E,] \^0-\]13)QQ)G((W9\F6G@UWR8AN2WUB=L=E&1Q?+!Y
M]XTAME+#:\3SU-M**$D (YE4+-S&7,K5HRK$-[C3JT\9NY<CK-G>L.4NL-5>
MYUDVTT_G0O:T3WOD(&8,;^B ].;6FZG%7\UWH!!BJ^'H'?OJ>SH$60;/ A [
M^',F!P$N)) ,O8)NPR:Z-5*.L@@"'<TE,)'UZ&3)PP'AFQ$SE@.?BV4:Y3(Y
M>+N/&$$\WWYRT*-O"8@@HKTB_GU3:78>^V$"2>40/@E*AQDJ$?ZX-QBLC0H?
MN0.8Q7"!@JW.(J\9AT4F[+ <"%,(:(I*M"C4([U3(YN@M&F1<'H99##@<]IM
MJ$*,:L83592N<BIN]6#P%HHW@LTGU&]L;_<B-V<+S2)5,,Z/]#BQ&2K9ZBGG
MW_22G\6R8:_1JX/0%##\NDT3SAGKS!2<U@52EH^7W']6'I4[986LOX]['X\?
M_OV[RSG"5X RV?74!7(]K!JI(IHA[>F^WI\L%=UIER"N^[@=ID),G/;I.T\D
M/ER ]6]A1,_2>9!/K3C6+$.MHHFA(ACW)(.!D"V5!N<[!L\'N,Z-!N+U-@F\
MQBS9#"]9Y:G >L<ZT:MVGOH?L5TW0%AGBEE6B)!_NRYMA3+_F$YE!!O?5'.C
MR-%FI2.!CH75G<);8BL (Z3"N!#TAG7N3(8)H?N*E1-[9>^:1\'2W\6%S'HG
M?JDAGK9-<Y'(6LBF46*9HBZ_5&Y=E#3BYTZFKB+[4LIFSZMS,]T@9!!&Y: W
M5&C@R*@-8C%.5U4M7W+VJYL5(U22PKA<;\6NF?(SIXX=[M"UW.?R-U;TRW]#
MD@%/1QZOG>6:[)HS_(P(#-(KG?81!!K%:\\D:</Z0I-Y04 YI=45D%BJ-$>#
M7W5&R>=@0O@VQ3!-88Q>(UNJ/_\AM2)^SBG.JNN3KI+XSLJB%_&!P0QDF7G*
MG36FEJ/*UF&G=H"44*5\"W?KV/2"X12%C&*1Y.I_</>647&NS9IP$Q)<@KL$
M"!(DN&L([NX2'!K7QB$$@FN0X 1W=W=W"^X>H)&&QH?L5\[>^\S,F37?.O/C
M^W'_Z+7ZOIZKJJZJYZ[N?JI'%%\![,G03!K]3S'/40T'W=\-[NEW'#I6]) Y
MD!O:+L.7H7'C[&,GY?ZC)0T0PX;9;L=JKQ7:(%>HZ/2ETO]P/Z&94YR:L<F
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MIV[U"05L/)+L+]8%V''4E;;MY$9OKH\065%D"DOH9CQW5[PG%C_\4)3^=I*
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M%-],O2G#*RIA.];CO'LIFA9C8E+-9Q[0<O<^@VS1U3U=_:S=UB'5I;]5:Q3
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M,WJNG#!Q1+V?,Y_]AG&#S8#QS2X-DLIPQR41*-^W"SF[M.>B_ZI@-_[Z5&J
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M=;2TZ,T>M%X]/TP0Q_*1>OZD%ACAU(,;NVP]PIGXB4*O",^_9BM/H9$C[ID
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MD6YG='W_CW!E_$L=E^6WA/Q:_U8'%=C7C]T T4#!)2>LG-/D?#R-Q1Z+!TD
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M(HC3BT*&C,07W%>)K5<_D=JGF;=T=.%PWP K9A=XX/J;U1VX#7B,9:5BFB*
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M#!/!I/G0%,ZO>3$XB-(.<$IXA.CBU/%.>83M;%I]B#FGI$<D&K>6Z[1H%]R
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M#C9HH4'L^&H7^!$:V2V($8G>.A2^D#2+-+ZGR,W@TD?^_N/@?$^4(9Q8^(!
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M]>.9?])?+T:ETT^';M=X!@HLC'6=# <&_MDP6 SCFB7,P7Y3S,,_'!R+0LZ
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M'>[5>L[@5P<XG"PIN@;K@_>XO[S=B14'>'G)V/:6YT0W,Y&90UN(A0(<? 1
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MZZ?5(.+KJ&0K.R]7\D135UY5^LCB-V2/\P-;@@ZZ"5[E[F'$SHM:[I]..5X
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MJZ, $6*XFP]M:PJST<?)?FVD1]J00YL>G/ST!W.*D&H:5+5ZG$9B<D5+748
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ML]MA#N7T7H?L;;\0/T6.KC[IWW;N@-ZC23D6P(.X30=CDI&NJ?L=T,UYU?K
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M]/K*A$&#!&OW.7P]2QU3;[>S*QU -TRXXU6"=!$W+S&=E#7WO6CZ6Y"=U2\
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M.O)+Q66-<KI*Y>.2"L YQ%4^4DS,H#Q?B?:6&(YCCW,\J=QW>3)R 5BJGK\
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M].P",*3O@;;'QLRQ7P"\0.>L3WZ"EE!.H*V>"T!V\4=X<P/S?K+%$2]LHC;
MX=,"_/A\1^7<O1%_/D:9 7==AU^"#LN+S"]? &+FB6$3 MOGE\;PW.S6)@^>
ML3I?T9M?CL:S*0X@.@:7P/5F K:4Y..,:[3'V=4!K[[ D)T'"ET 2B%3V]BX
M"P E; )_BO=.V)3M_Z/%$326$<+C (NP.'TL#22#=:G57P#*'X*&Z\^^S.]R
M8#K._7Z]NO5<E<?[%1?OBQ>R8; \WZ/0IB4Y-/STH.;7.2Z)U1Y<;-TVQ-[!
M#OYZ^=3YUOD"8$,,.KTRCC<UQAD?MAQ\OV+65M@NYQ0^:BUDN\;?0)A-*+[;
M$]@IO:/<?*%/&5H;J[WW\ + #EMRW3DZPP]1I">!8Y,^P(\9<6&%.&G\S/.+
MVT<JN!#^AOQ?O^? 5B-2883[=I/@WP*(<TCZ O)HO@ <;+S$%J%A70UJN+U?
M5^EC\;R.\G=>AX#U-8#.^BX .7V//OOEX$4X+?P8?=*YB,1+]9LX1CQC/P*>
MTB"*V^"8@^_49X33>/\5:LU@.#58\ 7@=P97A+''OO1YBVNNQHO7JZ7/3C\-
M?GT9@\$K/PT5DX6R$PZ\M"H71QV420WB=<4SS/:YG_EO8<1=N0#$;H%_9VLK
M++_8FMP?;*TR9'=?\D[=^ 6  B;&@;<V5G@"]V4'=L.$)1\+78<=BO'@>I[B
M?C7PC_R[!F.-[W8U94<I?DU]# $2L,ZUQ:;L7RLV+&B?"'+@%2)"X )0.4[=
MOGW"7B^!6_^W-KR<1O#]:J/%7=F'I;S!&VP"W,&[HJY2<NX H (0%JTSTAI_
MZQ$SV#-3?9L0(NCJL2IR']NGLY-1*/\I6\G7FW"Z?U@UYDKC0K!9$O/V< WU
MNWN7R IRIQI?[R*$5]J.:'R 9A,D)<HN\M#DQYP=SF%YO)=/@U)',1^1\L&9
M;Z>?H42J=A0HO]"PG,3Q,UC+4'[+1DL+\]TKDZ7RF^!9A-.:KDMO+B=Y'EZ>
MFB.&;QK0,H9M"=YCVP<GR6F39DW4&WKD.FOFJ3E4FLUMXKHGM7CDV"W.ZN0Q
MH-FU/D*9.X!5$B9V-U'=+TW=VA*.\400W7;H][Q,4DL_:C_SC%%QR,YQ[@!"
MS9X N6M3<W;7B)M3Y;K_5Z\%S.NNEB)=]\D:O02-Z:S)8;L4KN=1R823S,WK
MSHQ?I$M.,QO.] N14%]L%K-E7U3$##H2.UMX,Z^M>\8T2=$OHAFC50;),<H=
M/XR")!),UNA'TI)J!V )3"+< \]T781Y&+)S3Z/["&O.@'1RRU5"66=,H9O4
MKC1Y7_-=W9MMV%5F-Z*=BVK>M1''$=M/Y55G=H&MMC7;\@OU\B3%\D8S(EIV
M$&7R%8X>0GU-WS+XEEYWS]9$Y;/%M@>\W[YF,>N8>-O;=;R5=[0JP^LG_'[-
MNK9V=[0AE.Q3D@37S+3.W6:FO';^Z!BAWJGGM!8/RV<J2>/$I*Z\%#5<DV,6
M,JIBRAQZD,N9F+/$!/CL5M"?R89>[FS&;E"U3JMP0*<&;D0^G.ZR$ZB*4R,^
MM=V7VS QJGZUU=OF(:!0TH,<"[SQJ5UT7CS6/M^14RIN?)5N<L[N&^,6[65V
M23:;52=TQ8C63(SA*=7G3\,5;WM"O:X_LO7HTJ%F)@+8R%+EB.N7^,L7OI8!
M,+VB"1>\#Z BU9+@ ^H:(,1*[YK3QYT^?&K-I,@9U5G+Q</,A=G4GU =$IH6
M\O,J;#%(@+SK]D6?M^RW&0<\'Z<U.$YQEWDIEZ,!\10,E\=<90LFXF^VM"2H
M*SPLVK;/S4Z2>*,>IM-Y;VN*E=A2^&[-*4PTY<;(<YM&9*PXLVBC'H5E1]66
MI9%*3QK1=H83>3JUZK-WR#V5?J,WQ>\> #)4W %<^>R\FA;N>H9C335Q&F;7
M'0=+CI2LPU+H*J;<(HAL;4;*QA-9*5E,R)3<A;KTW=P_3+_+W9&.GYCTT_7.
M=T0QW&5]>^AYY><SX< :-$02  D:I'I?X>AG6ZW))O&(<ZZ6C_?L>*K^=/<2
M1R9TN/%#J$0=1JYUMT,U=;/QF]O6C%)%/ZE)-)44ME]T*A.)'!1:#O[ZW>"&
M&1%V@2KH,Z1+]C3UDV?>6N7LHQ'SKMIDOIA>_2LK@3[, Q\]]#.']S4<=:,F
MW5<5R!(@KQYT=M2@46+;'W_6=+E/[0I^FW3$U#U$&5(IU82'ZP8FHY?)6UH.
MBDJMLCM^=)&,ANFBVJUE.F<[FULZ5[A>CR.,UQ)C>Z1A#CV"<8K5]Q]9!D\!
M7.EL N6*BAVE396X8W1]O-B*!0O<J*Y$/UB@RFA_<S ;SRS0\/1L0Y-FEF5Y
MZ8=U)#5<YOTG>M>TI9!S)Q]!L3@7%AX!Y'RGCM>FU$PS!=2=>CBS<?A%N!$'
MM++.*HILF^Z9NSI**W]Y9</ I:I/YEX99<_5$IPR-U.72R]9F=;)PF.PYC=A
MC02G;DV;;(GDW=F[+C_/4JIC R6\F$\@\3,<5163JQ#UH0XWI2Z'0?4 .P/*
MV#V:R/CI!KYAL13ZWJ0M-/3.+7T"2=9 IO8[;@&-^Q5KQ@]==TKWR!-M;T1&
MF!F97 ]4%M$NR'\I81>MUC[3^^ZI(]C%F^U3S\VF-&.S]:L,,SZ=NO#DTP-Z
M0,50G 'GKMDP7%B']0;.GEB"S?WIM0[U"HX$R\,CG2X8]Q"S=R]SK-LW6=HB
M&?AP\07 UE&W%_;=^N3=SUC_K_+VO2=DT2(:1)$O-M5 (EPWD=\F2H7$='KI
MU5P!2ZF=:'8U<T5,<8>QM;_,&&B1'7,S>8P@IH<AR7GY E!BBB:3$TW]B;W]
M?9-<IW)$*'M"["Q*X:F.KX9[%)?\G$^_QWC<*$>HD1*=WI^OX<K(SXM?]"GJ
M[S2&<Z38>/JL^?3V@,E5GSR7?9<Y\5GW/C##8B?,)PD7O&ES 0#@F<YWY_6!
M;R&M1X^.O<58HO+:<I=/E6D&KBE/3J4M1'YO>)485*VL8KQSKJ@R^DBB[KEP
M./C:Y<"K%;T^0)!VW?9P0W^\PSY]GG1T1H<6([V@C(O 7$>$O\4PDG6 U2?
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MJG=9Q6IJ<'F$J0+"S=U?,X%'_1.D53G@X03!Y6_:,S2IUP'O0&&63.UA^35
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M8S'X-3[M$>G&6[%26"!D?]-^BRG?5MR9^\P@<MH;,^6:*NDR6<*;)%6.!,;
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MH*=];#P_N!1SU&]$\17PUJICWF:):!:J3QS9&F"./8/%1:]^WW;3H^(Q-X?
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M()^+C8.[PN>:LPW/*,A>ROQ1WS8GW,4$JVH2&;J+O '>G99-"*R3WR 5$9;
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M$AS?[O,Y?E [4IWK\ZD:0M<2H=H6W4]3F3:U![35:0!*?6%3/"5-[$(D6[F
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M+>0?6#)_HL&V!"^RI2/VEHG=]A5=5+49.4LX&[8@*"::RIQ5THTZT?<8O<.
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M"[P;JT%"?(?&D5*F:9QG:%@N< W/,E_A\DT'J+.@+^_QN@- ([WT4@_U\NA
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MXB $R'E$PX,/0V!%"+Y8JQ7D6R66EINNV1\CSE M:)9V]1LU,Z?.#,P^_0I
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MJK1&Y4FBFO..Y:IAO.Q08?M)!A=C;>2B>Q5N[\-'$V?%5+5X\^.[,H-BZ!-
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M6YC%Y#3&=$SRIT23]&:TYEZ0VU\57;)'B-+-T 1-:$-X0;@KYAD[,F; NYI
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M&M34MJ4/%Y0Q0A 0! D:YD$9)3(8'  1$ PHD8BH(! B B*S$! 1&<(H(*B
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MU([STE&U\S!\J(<D2<MR&MZB=K/93/9XCO"IZZ8/WKPQ(/N/-8<J,(ZS /P
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MCP4<58@A?'GGR'#P[[?FYF0!_)RG6<#CG6V.WZ</,/<GT)&[$[9XLI39\-+
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MZZPR@P54,#0?64)I(D=YIW::@2MLINK+KCA\&BZLZC*"&@3QK:KM-*89""W
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MVWTJD376'YT1, .[8VR!@AQE[V_LR4S>90)]Q _)5CH*';FQB[$R0*!:^;*
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M-#(U+GAS9%!+ 0(4 Q0    ( ">(F5CK?H#K@P,  %\0   5
M  "  99N 0!S9W)Y+3(P,C0P-#(U7V1E9BYX;6Q02P$"% ,4    "  GB)E8
M#A_+F6N^   #&P$ %               @ %,<@$ <V=R>2TR,#(T,#0R-5]G
M,2YJ<&=02P$"% ,4    "  GB)E87?]8A6M]  !PG   %
M@ 'I, ( <V=R>2TR,#(T,#0R-5]G,BYJ<&=02P$"% ,4    "  GB)E8[YDV
MC@%S  !HE@  %               @ &&K@( <V=R>2TR,#(T,#0R-5]G,RYJ
M<&=02P$"% ,4    "  GB)E8"8,&KK@D 0"5/P$ %               @ &Y
M(0, <V=R>2TR,#(T,#0R-5]G-"YJ<&=02P$"% ,4    "  GB)E8JWX.!(W4
M  !M_@  %               @ &C1@0 <V=R>2TR,#(T,#0R-5]G-2YJ<&=0
M2P$"% ,4    "  GB)E8_ +B<%@#  !U$@  %0              @ %B&P4
M<V=R>2TR,#(T,#0R-5]L86(N>&UL4$L! A0#%     @ )XB96.FA55>Z @
M:0L  !4              ( ![1X% '-G<GDM,C R-# T,C5?<')E+GAM;%!+
4!08     "@ * )$"  #:(04    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>sgry-20240425_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sgry="http://www.surgerypartners.com/20240425"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgry-20240425.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:DeVeydtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sgry:EvansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfEquityAwardsToBeIssuedInLieuOfCashIncentivePaymentsEarnedInTheCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">sgry:FairValueOfPriorYearsAwardsForfeitedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-2">0001638833</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-3">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c-1" id="f-4">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">Surgery Partners, Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-5">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.211%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Value of Initial Fixed $100 Investment Based On:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Summary Comp. Table Total for CEO (Evans)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Comp. Actually Paid to CEO (Evans)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Summary Comp. Table Total for CEO (DeVeydt)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Comp. Actually Paid to CEO (DeVeydt)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Average Summary Comp. Table Total for Non-CEO NEOs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Average Comp. Actually Paid to Non-CEO NEOs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;TSR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Peer Group TSR&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Income (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Adjusted EBITDA (in millions)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$6,457,600&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$7,260,168&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2,473,172&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2,646,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$204.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$142.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$135.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$438.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,092,825&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,342,023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,670,372&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,192,139)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;380.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,307,123&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,217,126&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,541,025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,060,779&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;339.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,541,863&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,996,689&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;559,528&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,280,517&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,284,162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,249,898&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;185.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-6" unitRef="usd">6457600</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-7" unitRef="usd">7260168</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-8" unitRef="usd">2473172</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-9" unitRef="usd">2646951</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="1" id="f-10" unitRef="usd">204.3</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-1" decimals="1" id="f-11" unitRef="usd">142.1</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-12" unitRef="usd">135300000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-1" decimals="-5" id="f-13" unitRef="usd">438100000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-14" unitRef="usd">6092825</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-15" unitRef="usd">-3342023</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-4" decimals="0" id="f-16" unitRef="usd">1670372</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-4" decimals="0" id="f-17" unitRef="usd">-1192139</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-4" decimals="1" id="f-18" unitRef="usd">178.0</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-4" decimals="1" id="f-19" unitRef="usd">147.8</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-20" unitRef="usd">87000000.0</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-4" decimals="-5" id="f-21" unitRef="usd">380200000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-5" decimals="0" id="f-22" unitRef="usd">4307123</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-5" decimals="0" id="f-23" unitRef="usd">14217126</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-6" decimals="0" id="f-24" unitRef="usd">1541025</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-6" decimals="0" id="f-25" unitRef="usd">6060779</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-6" decimals="1" id="f-26" unitRef="usd">341.2</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-6" decimals="1" id="f-27" unitRef="usd">146.1</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-28" unitRef="usd">70700000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-6" decimals="-5" id="f-29" unitRef="usd">339600000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-7" decimals="0" id="f-30" unitRef="usd">3541863</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-7" decimals="0" id="f-31" unitRef="usd">16996689</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-8" decimals="0" id="f-32" unitRef="usd">559528</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-8" decimals="0" id="f-33" unitRef="usd">13280517</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-9" decimals="0" id="f-34" unitRef="usd">1284162</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-9" decimals="0" id="f-35" unitRef="usd">6249898</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-9" decimals="1" id="f-36" unitRef="usd">185.3</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-9" decimals="1" id="f-37" unitRef="usd">111.9</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-9" decimals="-5" id="f-38" unitRef="usd">1300000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-9" decimals="-5" id="f-39" unitRef="usd">256600000</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-40">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt"&gt;Reflects compensation amounts reported in the Summary Compensation Table for our CEO for the respective years shown. Until his appointment as Executive Chairman on January 13, 2020, Mr. DeVeydt served as Chief Executive Officer of the Company. Mr. Evans, who previously served as Executive Vice President and Chief Operating Officer, was appointed to replace Mr. DeVeydt as the Chief Executive Officer of the Company effective January 13, 2020.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt"&gt;Reflects average compensation amounts reported in the Summary Compensation Table for our non-CEO NEOs for the respective years shown. The following non-CEO NEOs are included in the average figures shown: &lt;/span&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023: David T. Doherty, Jennifer B. Baldock, Marissa A. Brittenham, Bradley R. Owens&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022: David T. Doherty, Thomas F. Cowhey, Jennifer B. Baldock, Harrison R. Bane, Bradley R. Owens&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021: Thomas F. Cowhey, Jennifer B. Baldock, Anthony W. Taparo, Bradley R. Owens&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2020: Thomas F. Cowhey, Jennifer B. Baldock, George M. Goodwin, Anthony W. Taparo&lt;/span&gt;&lt;/div&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-8" id="f-41">Mr. DeVeydt</ecd:PeoName>
    <ecd:PeoName contextRef="c-7" id="f-42">Mr. Evans</ecd:PeoName>
    <ecd:PeoName contextRef="c-5" id="f-43">Mr. Evans</ecd:PeoName>
    <ecd:PeoName contextRef="c-2" id="f-44">Mr. Evans</ecd:PeoName>
    <ecd:PeoName contextRef="c-3" id="f-45">Mr. Evans</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-46">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt"&gt;&#x201c;Compensation Actually Paid to CEO&#x201d; in each of 2023, 2022, 2021 and 2020 reflects the respective Summary Compensation Table total  adjusted as set forth in the table below, as determined in accordance with SEC rules.&lt;/span&gt;&lt;div style="margin-bottom:9pt;margin-top:3pt;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.331%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.813%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.813%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.813%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.813%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.817%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-right:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Evans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;DeVeydt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Evans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Evans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Evans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,541,863&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$559,528&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$4,307,123&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$6,092,825&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$6,457,600&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Equity Award Amounts Reported in Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,250,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(125,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,500,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,645,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,400,000)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Add: Fair Value of Current Year Equity Awards Outstanding/Unvested at Year End&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,512,317&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,175,972&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,062,532&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,283,461&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Add: Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;645,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in Value of Prior Years&#x2019; Awards Outstanding/Unvested at Year End&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,977,917&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,794,029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,437,390&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,285,321)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;336,661&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,839,592&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,926,960&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,620,973&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,212,059)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;582,446&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Fair Value of Prior Years' Awards Forfeited in the Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Fair Value of Prior Years' Awards Failing to Meet Vesting Conditions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,824,332)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$16,996,689&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$13,280,517&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$14,217,126&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$(3,342,023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$7,260,168&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Fair value or change in fair value, as applicable, of equity awards was determined as follows: (1) for restricted stock awards and earned PSU awards, the closing price on applicable year-end date or, in the case of vesting, the closing price as of each vest date, (2) for unearned PSU awards, closing price on applicable year-end date multiplied by the probability of achievement as of each such date, and (3) for option and SSAR awards, a Black-Scholes value as of the applicable year-end or vesting date(s), determined based on the same methodology as used to determine grant date fair value for the applicable grant.&lt;/span&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-7" decimals="0" id="f-47" unitRef="usd">3541863</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-8" decimals="0" id="f-48" unitRef="usd">559528</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-5" decimals="0" id="f-49" unitRef="usd">4307123</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-50" unitRef="usd">6092825</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-51" unitRef="usd">6457600</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-10" decimals="0" id="f-52" unitRef="usd">-2250000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-11" decimals="0" id="f-53" unitRef="usd">-125000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-12" decimals="0" id="f-54" unitRef="usd">-2500000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-13" decimals="0" id="f-55" unitRef="usd">-4645000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-14" decimals="0" id="f-56" unitRef="usd">-4400000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-15" decimals="0" id="f-57" unitRef="usd">8512317</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-16" decimals="0" id="f-58" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-17" decimals="0" id="f-59" unitRef="usd">3175972</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-18" decimals="0" id="f-60" unitRef="usd">2062532</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-19" decimals="0" id="f-61" unitRef="usd">4283461</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-20" decimals="0" id="f-62" unitRef="usd">375000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-21" decimals="0" id="f-63" unitRef="usd">125000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-22" decimals="0" id="f-64" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-23" decimals="0" id="f-65" unitRef="usd">645000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-24" decimals="0" id="f-66" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-25" decimals="0" id="f-67" unitRef="usd">4977917</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-26" decimals="0" id="f-68" unitRef="usd">10794029</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-27" decimals="0" id="f-69" unitRef="usd">8437390</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-28" decimals="0" id="f-70" unitRef="usd">-3285321</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-29" decimals="0" id="f-71" unitRef="usd">336661</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-30" decimals="0" id="f-72" unitRef="usd">1839592</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-31" decimals="0" id="f-73" unitRef="usd">1926960</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-32" decimals="0" id="f-74" unitRef="usd">4620973</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-33" decimals="0" id="f-75" unitRef="usd">-4212059</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-34" decimals="0" id="f-76" unitRef="usd">582446</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-35" decimals="0" id="f-77" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-36" decimals="0" id="f-78" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-37" decimals="0" id="f-79" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-38" decimals="0" id="f-80" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-39" decimals="0" id="f-81" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-40" decimals="0" id="f-82" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-41" decimals="0" id="f-83" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-42" decimals="0" id="f-84" unitRef="usd">-3824332</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-43" decimals="0" id="f-85" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-44" decimals="0" id="f-86" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-7" decimals="0" id="f-87" unitRef="usd">16996689</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-8" decimals="0" id="f-88" unitRef="usd">13280517</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-5" decimals="0" id="f-89" unitRef="usd">14217126</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-90" unitRef="usd">-3342023</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-91" unitRef="usd">7260168</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-92">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt"&gt;&#x201c;Average Compensation Actually Paid to non-CEO NEOs&#x201d; in each of 2023, 2022, 2021 and 2020 reflects the respective average Summary Compensation Table total adjusted as set forth in the table below, as determined in accordance with SEC rules.&lt;/span&gt;&lt;div style="margin-bottom:9pt;margin-top:3pt;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.526%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.526%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.526%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.528%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-right:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,284,162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,541,025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,670,372&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$2,473,172&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Equity Award Amounts Reported in Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(654,625)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(661,875)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,020,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,537,500)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Add: Fair Value of Current Year Equity Awards Outstanding/Unvested at Year End&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,326,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;840,847&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;768,546&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,496,764&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Add: Fair Value of Equity Awards to be Issued in Lieu of Cash Incentive Payments Earned in the Current Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142,125&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in Value of Prior Years&#x2019; Awards Outstanding/Unvested at Year End&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,251,193&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,008,559&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(502,425)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81,948&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;900,376&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,714,650&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(401,924)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;132,567&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Fair Value of Prior Years' Awards Forfeited in the Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,706,708)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Fair Value of Prior Years' Awards Failing to Meet Vesting Conditions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(382,427)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$6,249,898&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$6,060,779&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$(1,192,139)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$2,646,951&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Fair value or change in fair value, as applicable, of equity awards was determined as follows: (1) for restricted stock awards and earned PSU awards, the closing price on applicable year-end date or, in the case of vesting, the closing price as of each vest date, (2) for unearned PSU awards, closing price on applicable year-end date multiplied by the probability of achievement as of each such date, and (3) for option and SSAR awards, a Black-Scholes value as of the applicable year-end or vesting date(s), determined based on the same methodology as used to determine grant date fair value for the applicable grant.</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-9" decimals="0" id="f-93" unitRef="usd">1284162</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-6" decimals="0" id="f-94" unitRef="usd">1541025</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-4" decimals="0" id="f-95" unitRef="usd">1670372</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-96" unitRef="usd">2473172</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-45" decimals="0" id="f-97" unitRef="usd">-654625</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-46" decimals="0" id="f-98" unitRef="usd">-661875</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-47" decimals="0" id="f-99" unitRef="usd">-1020000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-48" decimals="0" id="f-100" unitRef="usd">-1537500</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-49" decimals="0" id="f-101" unitRef="usd">2326667</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-50" decimals="0" id="f-102" unitRef="usd">840847</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-51" decimals="0" id="f-103" unitRef="usd">768546</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-52" decimals="0" id="f-104" unitRef="usd">1496764</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-53" decimals="0" id="f-105" unitRef="usd">142125</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-54" decimals="0" id="f-106" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-55" decimals="0" id="f-107" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-56" decimals="0" id="f-108" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-57" decimals="0" id="f-109" unitRef="usd">2251193</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-58" decimals="0" id="f-110" unitRef="usd">3008559</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-59" decimals="0" id="f-111" unitRef="usd">-502425</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-60" decimals="0" id="f-112" unitRef="usd">81948</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-61" decimals="0" id="f-113" unitRef="usd">900376</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-62" decimals="0" id="f-114" unitRef="usd">1714650</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-63" decimals="0" id="f-115" unitRef="usd">-401924</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-64" decimals="0" id="f-116" unitRef="usd">132567</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-65" decimals="0" id="f-117" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-66" decimals="0" id="f-118" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-67" decimals="0" id="f-119" unitRef="usd">-1706708</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-68" decimals="0" id="f-120" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-69" decimals="0" id="f-121" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-70" decimals="0" id="f-122" unitRef="usd">-382427</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-71" decimals="0" id="f-123" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-72" decimals="0" id="f-124" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-9" decimals="0" id="f-125" unitRef="usd">6249898</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-6" decimals="0" id="f-126" unitRef="usd">6060779</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-4" decimals="0" id="f-127" unitRef="usd">-1192139</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-128" unitRef="usd">2646951</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="c-1" id="f-129">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt"&gt;Reflects the cumulative total shareholder return for the Dow Jones U.S. Health Care Providers Index.&lt;/span&gt;</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:Additional402vDisclosureTextBlock contextRef="c-1" id="f-130">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt"&gt;For compensation purposes, "Adjusted EBITDA" is calculated as income before income taxes, adjusted for net income attributable to noncontrolling interests; depreciation and amortization; interest expense, net; equity-based compensation expense; transaction, integration and acquisition costs; net loss (gain) on disposals, consolidations and deconsolidations; litigation settlements and other litigation costs and other adjustments that are not related to the assessment of normal operating performance. We use Adjusted EBITDA as a measure of financial performance. Adjusted EBITDA is a key measure used by our management to assess operating performance, make business decisions and allocate resources. Adjusted EBITDA is the core long-term metric we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled "Compensation Discussion and Analysis - Elements of Named Executive Officer Compensation."&lt;/span&gt;</ecd:Additional402vDisclosureTextBlock>
    <ecd:CoSelectedMeasureName contextRef="c-1" id="f-131">Adjusted EBITDA</ecd:CoSelectedMeasureName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-132">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As described in more detail in the sections entitled "Compensation Discussion and Analysis" and "Executive Compensation," the Company&#x2019;s executive compensation program reflects a variable pay-for-performance philosophy, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;with a significant emphasis on long-term performance and stockholder value creation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. While the Company utilizes several performance measures to align executive compensation with Company performance, all of those Company measures are not presented in the Pay versus Performance table. Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not specifically align the Company&#x2019;s performance measures with "Compensation Actually Paid" for a particular year. We believe the "Compensation Actually Paid" in each of the years reported above and over the three-year cumulative period are reflective of the Compensation Committee&#x2019;s emphasis on "pay-for-performance" as the "Compensation Actually Paid" fluctuated year-over-year, primarily due to the result of our stock performance and our varying levels of achievement against pre-established performance goals. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;img alt="9.2 Pay v Performance - 1TSR graph.jpg" src="sgry-20240425_g2.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-134">&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;img alt="9.3 Pay v Performance - 2Fin Perf graph.jpg" src="sgry-20240425_g3.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="c-1" id="f-133">&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;img alt="9.3 Pay v Performance - 2Fin Perf graph.jpg" src="sgry-20240425_g3.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TabularListTableTextBlock contextRef="c-1" id="f-136">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:32.5pt"&gt;Adjusted EBITDA&lt;/span&gt;</ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="c-73" id="f-135">Adjusted EBITDA</ecd:MeasureName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
